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Abstract 
The development of therapeutic proteins is a driving force in the current manufacture 
of biopharmaceuticals.  Freeze drying is widely used in the fabrication of final dosage 
forms of therapeutic proteins.  Using a series of A33 Fab mutants, this thesis aimed to 
correlate their physicochemical properties to the outcomes of freeze-drying.   
Preliminary studies employed a homogeneous freeze-drying process on 96-well 
plates.  It was found that K65M and K133M surface mutations, the use of acetate buffer, 
low pH, increased ionic strength, and the use of NaCl, caused the most monomer loss; 
whereas S75K, C226S, and L50K mutations, high pH, and the use of Na2SO4 caused the 
least monomer loss. 
Several in-silico modelling tools were used to design mutants for studying the impact 
of protein conformational stability.  Rosetta software, RMSF and B-factor analyses were 
used to evaluate the mutant candidates and restrict the mutations mainly located in the 
flexible regions.  Unstable mutants were prepared as controls to validate the prediction 
accuracy. 
In freeze-drying, most of the stabilising mutants had 20% less monomer loss than 
C226S, while the destabilising ones had 14-46% more monomer loss.  Tm and ΔΔG 
estimated the monomer loss in freeze-drying with low degree of accuracy.  Compared to 
freeze-drying, a more distinct difference was observed in the aqueous phase as all the 
destabilising mutants aggregated more than 5 times faster than C226S and the stabilising 
mutants did.  Tm correlated well with the aggregation in aqueous phase, indicating 
conformational stability was more important in aqueous phase than that in freeze-drying.   
In addition, excipients barely exerted influence on the stable mutants but provided 
sufficient protection for the unstable ones, which was reflected by their correlations to Tm 
values.  The rank-order of excipient effects for individual mutants, relative to that of wild 
type, became less similar as the mutant ΔTm magnitude increased. 
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1 Introduction 
1.1 The significance of freeze-drying for proteins 
After downstream processing, purified proteins need to be formulated into their final 
dosage forms to preserve activity and efficacy.  A therapeutic protein is deemed to be 
the active pharmaceutical ingredient (API) while the auxiliary inert ingredients are called 
excipients.  The selection of proper dosage forms depends largely on protein 
characteristics, patient requirements, and the mode by which it is administered into 
patients.   
Aqueous, ready to use formulations of protein therapeutics are desired as they avoid 
the need for reconstitution at the point of use.  However, a significant number of protein 
pharmaceuticals (biopharmaceuticals) formulated as aqueous solutions, are prone to 
degrade, denature or aggregate (Edwards & Hrkach 2000).  One solution is to formulate 
such proteins into solid forms with long-term retention of integrity at lower moisture levels 
(Abdelwahed et al. 2006).   
There are various ways to fabricate and to formulate dry powders, including freeze-
drying (lyophilisation), spray-drying and spray freeze-drying.  Among them, freeze-drying 
is one of the most common ways to obtain dry powers from protein solutions.  During a 
freeze-drying process, the protein solution is frozen, followed by sublimation of water at 
reduced pressure and low temperature.  Upon removal of the frozen water, a dry cake 
can be obtained in different solid forms (mostly as amorphous).  The solid proteins, 
together with the inert ingredients, will mostly be reconstituted into a liquid dosage form 
immediately before injecting into patients (i.e. parenteral administration).   
Freeze-drying can be easily carried out under sterile conditions.  Sub-zero 
environments and low moisture conditions can preserve the biological activity of a 
product.  Well-structured cake morphologies, presented as a porous plug, have won 
great popularity among end-users as these improve the final activity recovery and time 
required to reconstitute into the final solid dosage of product by rehydration.  In addition, 
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compared to the manufacturing cost of purified active proteins, the cost of freeze-drying 
accounts for a relatively small proportion (Sharma et al. 2005).   
1.2 The freeze-drying application to overcome the 
limitation in aqueous formulation 
The instability of proteins in aqueous phase has been reviewed extensively (Wang 
1999). The benefit of freeze-drying mainly derived from its reduction in the deleterious 
chemical reactions as the diffusion of protein molecules is greatly inhibited in the vitrified 
solid state (Tonnis et al. 2015). This section will focus on the limitation and instabilities of 
liquid formulation that could potentially be minimised or improved by freeze-drying. 
1.2.1 Protein aggregation 
Protein aggregation is one of the major challenges in formulation studies.  Unfolded 
or partially denatured proteins would associate and form oligomers under processing 
conditions like expression and purification (Wang et al. 2010).  Excipients were found to 
mitigate the aggregation.  For example, sucrose increased the conformation stability and 
reduced insoluble aggregates of an IgG1 monoclonal antibody (Manikwar & Majumdar 
2013).  The excipients stabilise protein in aqueous phase through direct binding or 
indirect interactions (e.g. preferential interaction); while in freeze-drying, excipients play 
roles as cryoprotectants or lyoprotectants and provide high Tg in the dried state (Ohtake 
et al. 2011).  When excipients could not provide sufficient stabilising effect in aqueous 
phase, alternative to freeze-drying was considered.  It was found that a lyophilized form 
of recombinant human epidermal growth factor (rhEGF) decreased degradation rate of 70 
times at 50°C compared to aqueous formulation (Santana et al. 2014).  Therefore, it 
would be worthwhile to alter protein degradation pathway and use appropriate excipients 
in the solid formulation. 
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1.2.2 Improved storage condition 
Protein pharmaceuticals are desired to be stored under dried condition and cold 
temperature to extend their shelf life.  The dried state provided reduced hydrolysis and 
deamidation reactions induced by inappropriate pH or temperature (Ohtake et al. 2011).  
The low temperature could reduce the protein motion rate, minimise the interaction and 
aggregation of protein molecules in aqueous phase.  However, the refrigeration and 
transportation cost remains as a concern.  Upon fabricating the liquid form into solid 
state, the motion of proteins along with excipients are highly restricted, therefore 
providing opportunities for ambient or higher temperature storage conditions. 
It was reported that the denaturation temperature (Td) of lysozyme substantially 
increased from 70°C to more than 120°C as the water content was decreased from more 
than 25% (w/w) to less than 5% (Martínez et al. 2016).  Another study showed that 
lyophilized IgG1 mAb samples with 6.8% moisture resulted more 2-5 μm particles than 
samples with 0.6% moisture after accelerated shipping-like stress (Telikepalli et al. 2015). 
Therefore, it is obvious that a high moisture content is detrimental to preserve the 
lyophilized protein samples though a minimal moisture content (less than 1%) is 
necessary (Colandene 2007).  In addition, it was often suggested that the storage 
temperature should be below the Tg so as to maintain the physical stability of dried 
product (Breen et al. 2001). 
1.2.3 High concentration dosage form upon 
administration 
Subcutaneous and intramuscular routes are the common delivery methods to 
administer the mAb drugs (Neergaard et al. 2014). Due to the limited volume restricted 
for a single administration dosage, the liquid solution needs to formulated in an 
adequately high concentration (>100 mg/ml) (Yearley et al. 2014).  As a result, problems 
include aggregation, solubility and high viscosity rise in such highly concentrated solution 
(Singh et al. 2014).  
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Converting the aqueous protein into solid form could mitigate the association of 
protein molecules in the liquid.  A desired high concentration solution could also be 
achieved upon reconstitution of dried powders without ultra-filtration to concentrate the 
protein in a liquid state (Harris et al. 2004).  Sucrose was used to stabilise the high 
protein formulation, which caused prolonged reconstitution time (Beech et al. 2015).  A 
systematic study was done to tackle the long reconstitution time issue and it was found 
that incorporating wetting agents, a high temperature annealing step and reconstitution 
under vacuum conditions could reduce the time for reconstitution (Cao et al. 2013). 
1.3 Basic introduction of freeze-drying 
Freeze-drying is a widely used technique to obtain dry solids and has been applied 
in the pharmaceutical and biopharmaceutical industry since 1930s (Constantino & Pikal 
2004).  The operation of freeze-drying is straightforward.  However, the physical 
chemical theories involved in this technique are fairly complex and some remain to be 
understood.  The product properties and processing parameters are always 
interdependent, and one needs to have a deep understanding so as to design an 
appropriate freeze-drying process.   
The basic operation procedures are normally similar and there are some 
terminologies that need to be introduced before elaborating the theories in detail.  
Therefore, this section aims to introduce the basic theories while the detailed kinetics and 
thermodynamics would be discussed in the next section. 
1.3.1 Freeze dryer equipment 
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Figure 1.1 A typical freeze dryer 
 
Before conducting a freeze-drying process, APIs together with proper additives are 
mixed in aqueous buffer solution.  The solution is then filled into containers such as 
vials, which are then put onto the shelf of a freeze-dryer to be freeze-dried.   
A typical freeze dryer is illustrated in Figure 1.1.  Freeze-drying is conducted within 
a confined space.  The shelf temperature can be controlled with cooling fluid inside the 
shelf.  The heat conduction between the shelf surface and the bottom of the containers 
ensures that the desired temperature of product is achieved.  In order to achieve a good 
heat transfer, one needs to make sure that the whole bottom of the container contacts 
well with the metal surface of shelf.  This is simple to achieve for some glass vials with 
flat bottoms.  However, for a standard 96-well plate, there is a gap between the bottom 
of the wells and the shelf surface.  One can either trim off the bottom lips (Grant et al. 
2009) or place an aluminium plate in between the gap to achieve full contact. 
The condenser, which is usually underneath the shelf, is designed to collect water 
vapour in the chamber.  The condenser is the coldest part of a freeze-dryer unit.  Water 
vapour accumulates on the condenser surface and deposits as ice.  The condenser 
ensures that a saturated water vapour is avoided at a certain pressure and temperature, 
so that water can be continuously sublimed from product. 
The vacuum pump reduces the pressure within the chamber and ensures that the ice 
sublimes into the gaseous state directly, bypassing the liquid state.  It also facilitates the 
movement of water vapour from areas of higher pressure, to areas of lower pressure, 
thus accelerating the drying. 
When sterile conditions are required, stoppers are partially inserted into vials before 
loading onto the shelves.  At the end of the freeze-drying, the stoppers are fully inserted 
to seal the vials by either raising the chamber pressure (e.g. pumping in nitrogen) 
(Geigert 2004) or by pushing them down with the shelf above them.  After taking the 
samples out, the condenser is heated to melt the ice, and the liquid water is collected in 
the tray underneath it. 
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A modern freeze-dryer can be monitored using a computer with real-time 
measurement of the temperatures of the product, shelf and condenser, as well as the 
pressure of the chamber.  Step-by-step procedures of freeze-drying can be programmed 
in advance and adjustments can be made during the process. 
1.3.2 Three steps in freeze-drying 
Freeze-drying consists of three consecutive operation procedures, which are: 
• Freezing, in which the protein solution is cooled down and frozen;  
• Primary drying, in which most of the ice water is sublimed; and 
• Secondary drying, in which the residual water is further removed until the final 
solid form is constructed. 
Although these three steps are relatively distinctive, they are inherently 
interdependent.  A previous operation may exert dramatic influence on a subsequent 
one.  For example, one needs to carefully manipulate the temperature and rate of 
change of temperature, as these parameters will influence the number and size of ice 
crystals formed, and thus exert impact on the drying rate (Section 1.4). 
1.3.2.1 Freezing 
There are three states to describe the morphology of the frozen solids, which are 
crystalline, polycrystalline and amorphous states as shown in Figure 1.2.  In the 
crystalline state, the substances are arranged in an ordered and repeating pattern, with 
the molecules regularly connected by specific interactions.  By contrast, in an 
amorphous state, the molecules are stochastically arranged.  When a solution consists 
of multiple crystalline solutes, they could form into a polycrystalline state if those solute 
molecules could not form a unified crystalline structure. 
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Figure 1.2 The description of crystalline and amorphous states.   
(Redrawn from http://en.wikipedia.org/wiki/Crystal) 
 
There are two types of classifications for crystalline states.  One is a variety of 
polymorphs; another is different solvates (e.g. hydrates).  For the polymorphs, 
molecules may arrange into different morphologies at certain temperatures and 
pressures.  For example, needle, feather, and spherulite forms of ice can be generated 
at various environmental conditions, while the familiar hexagonal stellar dendrites of 
snowflakes are the most stable form (Libbrecht 2001).  In terms of solvates, the solutes 
can interact with solvent and form complexes.  Hydrates are a common form of solvate if 
water is used as solvent, while some salts or other compounds will form crystals together 
with water molecules.  The importance of different crystalline morphologies lies in that it 
renders the composition of the freeze-drying solution more complex, as phase transitions 
between them may occur, which each increasing the uncertainty and unpredictability of 
the process. 
Theoretically, the crystalline state is more thermally stable, whereas the amorphous 
states are prone to experience a series of relaxation stages, and can also rearrange into 
crystalline states at specific temperatures and pressures (Craig et al. 1999).  However, 
the kinetics of relaxation processes are often beyond the experimental time-scale, and 
may even last for years and centuries.  For this reason, amorphous states can exist for a 
long time.  Most of the water (typically >99%) is usually frozen into ice crystals formed 
via non-covalent hydrogen bonds.  The solutes, and the rest of the water, can either 
become crystalline or amorphous, depending on the properties of the solutes, and also 
the cooling rate. 
Amorphous forms are typically favoured over crystalline solids for protein 
biopharmaceuticals, as they provide a higher dissolution rate and solubility, improved 
mechanical properties, and also better preservation of the tertiary structure of proteins 
(Yu 2001; Zhou et al. 2002).  A comprehensive understanding of the properties of the 
two solid forms, and a robust and well-understood manufacturing procedure is 
indispensable to ensure products with an acceptable period of validity and a consistent 
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efficacy.  For example, the glass transition temperature T’g and the eutectic point Te are 
characteristic temperatures for amorphous and crystalline states, respectively.  At the 
end of freezing, the temperature of the drug phase should be well below the T’g or Te 
(Tang & Pikal 2004). 
In a typical formulation for freeze-drying, the solutes are not saturated.  As the 
temperature is decreased, the water typically crystallises first, while the solutes remain in 
solution.  In fact, the solute concentration increases, in a process called freeze-
concentration.   
The formation of ice is initialised by the generation of nuclei, followed by the growth 
of the water crystal.  As water molecules diffuse in the liquid solution, there are certain 
domains in which the local density becomes higher.  If the size and lifetime of these 
random high-density domains can be reached to a critical nucleation point, the nuclei will 
generate and surrounding water molecules would accumulate to form a cluster and start 
the growth of a crystal.  This theory is the basis of the quantitative "homogeneous 
nucleation model", in which the water is assumed to be without any impurities (Oxtoby 
1992; Anisimov 2003).  In practice, however, nucleation can also be induced by a 
substance in the protein solution, or by other external factors.  For example, a 
temperature probe immersed in solution can unavoidably provide the nuclei source.   
Once the nuclei of ice have been formed, the growth of ice crystals will immediately 
take place.  There are many forms of ice and most the stable one is hexagonal stellar 
dendrites, which is obtained when water is slowly cooled to sub-zero Celsius (Kenneth 
2005; Franks & Auffret 2007).  The occupied volume of water is enlarged due to the 
density drop and the molar heat capacity is halved after freezing. 
Freeze-concentration occurs when water is extracted from solution due to ice 
formation.  With the formation of ice, the solutes become more concentrated at the 
interface between the ice front and the bulk liquid solution, and would diffuse into the bulk 
solution.  If the diffusion cannot keep up with the ice formation, adverse impacts can be 
induced such as instability of the solutes and protein denaturation at the interfaces of 
protein-air and protein-ice (Bhatnagar et al. 2008).  If the solute continues to be 
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concentrated beyond its saturation concentration, the solution would become either 
super-saturated, or the solute would crystallise together with the ice formation.   
Crystallisation of solutes requires an initial nucleation and takes time to reach an 
equilibrium crystallisation stage at a certain temperature.  It is influenced by the cooling 
rate, the solute type and concentration, and the crystal morphology.  Although crystals 
are the most stable solid state, the actual states formed depend largely on the 
interactions among proteins, excipients and water, together with the processing 
conditions.  In practice, polymorphic forms (including hydrates) are more common for a 
multi-component solution, in which the metastable forms can experience solid-solid 
transitions to more stable states during the subsequent process and even during storage 
(Franks & Auffret 2007). 
A super-saturated solution will form if nuclei do not appear in time or, if the 
crystallisation equilibrium is not fully achieved before the product is cooled further and 
equilibrated.  A super-saturated solution induced by cooling is also known as an 
“undercooled” solution.  The temperature at which ice, the crystalline solute and a super-
saturated solution begin to coexist is known as the eutectic point (Te).   
Theoretically, there is no liquid solution below the Te if equilibrium has been reached.  
In practice, an undercooled liquid solution still exists when the cooling rate is too fast.  
This partially frozen stage can remain until the temperature is further lowered to a point 
where the super-saturated solution is converted into a solid-like glassy state. 
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Figure 1.3 A phase diagram for sucrose-water system  
The solution is in fluid phase and unsaturated at Point A. As the temperature drops, the solution 
often experiences a super-saturated state before being frozen into a solid state. As increasing amount 
of water is frozen, the solute (i.e. sucrose) concentration increases in the rest of fluid water along the 
equilibrium freezing curve. When the Te is reached, the solution either crystallises or keeps increasing 
the concentration until reaching the T’g, depending on the complexity of solution. This diagram 
illustrates that one needs to operate the freezing under the T’g (Heljo 2013; Franks & Auffret 2007). 
 
The term “chilled” is often used to describe a supersaturated protein solution induced 
by cooling, but which is still not frozen.  It is stated that even though an undercooled 
solution could cause a protein to denature by unfolding that leads to inactivation, this cold 
denaturation can be completely reversible (Singh & Nema 2010).   
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Figure 1.4 Undercooling was found to preserve LDH activity 
Hexagrams, squares, triangles and circles represent storage conditions at undercooled at -12 and -
20°C, 4°C, room temperature and frozen at -12 and -20°C, respectively. No activity loss was found for 
the undercooled conditions over 60 weeks while other conditions all reduced the LDH activities in 6 
weeks (Franks & Auffret 2007).  
 
It was found previously that undercooled conditions (i.e. -12 & -20°C) could almost 
fully preserve the activity of LDH for more than one year (Figure 1.4).  By contrast, the 
activity was lost within two weeks when LDH was kept frozen at -12 & -20°C.  The 
reason can be that in the frozen solution, the solute concentration is dramatically 
increased, which may accelerate competitive degradation reactions such as aggregation 
at elevated protein concentration.  In the undercooled solution, the solute concentration 
is not changed significantly, and any degradation reaction rates are decreased by the low 
temperature.   
As the product temperature is further reduced from Te to a certain point, super-
saturated solutions, in which the solutes do not crystallise, are maximally concentrated 
and converted into amorphous solids.  This solid state is regarded as a “glass” and the 
temperature at which it forms is known as the glass transition temperature (T’g).  This 
phase transition is known as “vitrification”, “glassification” or “solidification” (Liu 2006). 
T’g is an important parameter used to develop a freeze-drying process.  If the 
amorphous state is the desired form of the product, a necessary condition is that the shelf 
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temperature should be lower than the T’g so that all of the substance can be converted to 
a glass, and the product not damaged by exposure to a phase shift (Tang & Pikal 2004). 
Annealing is often used during a freeze-drying process, where the temperature is 
briefly increased above the final freezing temperature, followed by cooling at a slow rate.  
This can transfer the material into a more stable structure by allowing the crystallisation 
of bulking agents such as mannitol or glycine.  Inadequate crystallisation of bulking 
agents may lead to a decreased T’g, and also vial breakage during primary drying (Milton 
et al. 2007).  Annealing can also increase the ice particle size, which helps to reduce the 
primary drying time, but both increasing and decreasing reconstitution rate have been 
reported (Franks & Auffret 2007; Searles et al. 2001).   
Some of the features of annealing are listed in Table 1.1 (Tang & Pikal 2004; Franks 
& Auffret 2007; Liu 2006).  Differential Scanning Calorimetry (DSC) is often used to 
design a proper annealing process, as discussed in Section 1.5.4.1 (Liu 2006). 
Table 1.1 Essential points of annealing  
Time point At the end of freezing 
Duration 2 h or longer (fill depth 1 cm or more) 
Temperature Te     >     T   (10-20°C)>    T'g 
Crystallisation rate 
Higher mass ratio of bulking agent > 
lower mass ratio bulking agent 
Lower temperature results in higher 
crystallinity but lower crystallisation 
rate 
Crystallinity monitoring 
 Frozen solution X-ray diffraction   
 DSC 
Features 
 Full crystallisation of bulking agent 
 Increased ice particle size 
 Reduced specific surface area 
Advantages 
 Prevents decreasing T'g & also 
vial breakage during drying 
 Shortens primary drying 
 Improves cake appearance 
Disadvantages 
 Increased residual moisture & 
prolonged secondary drying 
 Decreased reconstitution rate 
 Phase separation, pH shifts, etc. 
 
Often the protein solution to be freeze-dried is made up of several components and 
the phase changes are very complex.  Both crystalline and amorphous states can 
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coexist under certain conditions.  As water accounts for the majority of protein solution, 
the formation of ice is generally the first thing that is induced by freezing.  The 
crystallisation of other substances, including hydrates, and the formation of amorphous 
states, can both take place if stable nucleation exists and Te and T’g have been reached, 
respectively.   
Partial crystallisation can also commonly occur during the freeze-drying process.  
This situation can happen when the crystallisation of solutes has not been fully completed 
due to a quick temperature drop to the T’g point.   
1.3.2.2 Primary drying 
After the solution has been frozen, the temperature of the condenser is set to a very 
low point (e.g. -60°C) to initialise the primary drying phase.  A vacuum is established 
and more than 90% of the water during the initial freezing process will sublime. 
Ice sublimation is an endothermic process.  During primary drying, the shelf 
provides the majority of the heat for the ice to sublime.  Increasing the temperature 
difference between the shelf and product makes heat transfer more efficient.  In fact, the 
shelf temperature can be raised to a certain point to accelerate the heat transfer while 
maintaining the product structure integrity.  However, it is advisable to retain the shelf 
temperature below the T’g to avoid the ice melting back into the supersaturated solution. 
The collapse temperature (Tc) indicates the temperature above which an amorphous 
product loses its macroscopic structure (Tang & Pikal 2004) due to a decreased viscosity 
(Liu 2006).  It is typically at approximately 2°C above T’g (Colandene 2007).  A 
collapsed cake results in high residue moisture, which may cause sample degradation, 
and loss of an acceptable product appearance (Liu 2006). 
Tc is equivalent to Te when the product is in the crystalline state (Tang & Pikal 2004).  
For a mixture of amorphous and crystalline states, the Tc of microscopic collapse occurs 
between T’g and Te, while the Tc of macroscopic collapse is equivalent to Te.  Operating 
between T’g and Te is sometimes used to shorten the primary drying time in cases where 
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no significant degradation takes place.  Cake collapse phenomena are listed in Table 
1.2 (Tang & Pikal 2004; Liu 2006). 
Table 1.2 Collapse phenomena at different temperature 
State status 
Collapse phenomena 
(“T” is the product temperature) 
Amorphous state (T'g < 
Tc ) 
Tc < T 
Amorphous phase collapse & macroscopic collapse 
with decreasing viscosity 
A mixture of amorphous 
and excess crystalline 
phases 
T'g < (Tc of microcollapse) 
< T < Te 
Te (Tc of macrocollapse) < 
T 
Amorphous phase 
collapses onto the surface 
of crystalline phase 
(microcollapse without 
macroscopic collapse) 
Macroscopic collapse 
(melt down) 
Crystalline state (Tc = Te) 
Tc < T 
Macroscopic collapse (melt down) 
 
During primary drying, sublimation occurs and the water vapour is condensed as ice 
on the condenser.  The concept of water vapour pressure and how it is influenced by 
temperature is important to understand as the drying force during sublimation.   
The “saturation vapour pressure (SVP) of water/ice” is the pressure at which water 
vapour is saturated at a given temperature.  It occurs as a dynamic equilibrium where 
the rate of evaporation equals that of condensation into water droplets.  The SVP 
increases exponentially with temperature as shown in Figure 1.5. 
During the sublimation process, the temperature of the condenser is always 
maintained below that of the shelf.  As water vapour sublimes from the ice front, the 
vapour pressure of water is unsaturated due to the relatively higher temperature with 
respect to the equilibrium temperature.  The water vapour will be generated continuously 
from the ice as long as the vapour pressure does not reach the SVP of water.  As water 
vapour accumulates above the ice, its vapour pressure increases and would migrate to 
zones of lower water-vapour pressure.  As it approaches an area of lower temperature, 
such as at the condenser, the SVP of water decreases.  If the vapour pressure of water 
is higher than its SVP at that temperature, the water vapour would form ice droplets.  In 
fact, the temperature difference between the ice front area and the condenser ensures 
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that ice continues to sublime to water vapour, travels to the condenser and then deposits 
into ice.  Therefore, it is preferable to set the lowest achievable temperature of the 
condenser so as to ensure a sufficient mass transfer rate into water vapour.  The 
condenser also plays a role in minimising the movement of water vapour into the vacuum 
pump. 
The drying process must be undertaken in a vacuum with pressure below the solid-
gas phase-boundary for sublimation to occur as shown in Figure 1.5.  The reason is that 
ice will only sublime at a low pressure when maintained at a low temperature.  Only 
when the pressure is sufficiently low, the solid water (i.e. ice) can undergo a phase 
transition directly to the vapour state. 
 
Figure 1.5 The phase diagram for water 
Figure was extracted from http://astronomy.swin.edu.au/cosmos/s/sublimation. The pressure-
temperature relations for water is shown in the figure. The boundary lines of Solid/Gas and Liquid/Gas 
represent the “Saturation vapour pressure (SVP)”. As pressure is reduced, the ice will be converted to 
vapour if the pressure is lower than the SVP. The water vapour will also be converted to ice if the 
temperature is reduced for the pressure to be lower than the SVP. 
 
1.3.2.3 Secondary drying 
Secondary drying aims to remove residual, often more tightly bound water that is 
trapped within the solid product mass.  The residual water can be either in the form of 
hydrates or simply free from the substance. 
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During secondary drying, the shelf temperature is further increased so that residual 
water within the product can diffuse to the surface and evaporate.  However, one needs 
to be sure that the product temperature is not so high as to induce the glass transition 
and the subsequent collapse of amorphous solid.  The temperature that the amorphous 
state starts to experience glass transition during second drying process is the Tg, and this 
phase transition is known as devitrification.  In most cases, a higher Tg is achieved 
where there is less residual water. 
The diffusion of residual water plays a major role during secondary drying.  At this 
point, little water is in the form of ice and so cannot be removed simply by sublimation.  
Instead, it needs to migrate from within the solid matrix to the outer surface and then 
evaporate. 
Conventionally, the content of residual water is expressed as a mass ratio relative to 
the product.  This is easy to determine by established techniques including Karl Fischer 
titration (Section 1.5.3.1).  However, as the molecular weights of different products vary, 
it cannot actually represent an absolute measure of the dryness of final solid product.  It 
is obvious that for two products with the same mass ratio of residual water, the lower 
molecular-weight product would be surrounded by fewer water molecules.  In fact, it is 
usually the molar ratio of product and water that truly affect the subsequent 
stability/activity of product (Franks & Auffret 2007). 
As the drying process approaches the end, one needs to consider the proper 
dryness of product so that maximum quality can be obtained.  Even though the freeze-
drying process will remove most of the water and provide a low moisture storage 
condition for the product, this does not mean simply that lowering the water content leads 
necessarily to a better product.  For example, a study (Chang et al. 2005) showed that 
the chemical degradation rate of a IgG1 antibody was minimal at 2-3% residual moisture 
within the examined 1-5% residual moisture conditions; another study (Breen et al. 2001) 
showed that a humanized monoclonal antibody formulated at 2-3% moisture resulted in 
less aggregates than formulation at 1% moisture when samples were stored below their 
Tg values. 
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Containers are left open during the freeze-drying process and can be sealed when 
taking them out from the chamber after the process cycle.  If sterile conditions are 
necessary, stoppers can be partially inserted into the containers when loading and then 
fully inserted after the cycle by bringing down the shelf above them.  This also avoids re-
absorption of moisture from the atmosphere. 
1.4 Interplay of freeze-drying parameters 
In this section, the formulation and various freeze-drying process parameters will be 
discussed and correlated.  A major aim is to develop a deeper understanding of 
operation parameters in order to optimise the freeze-drying process. 
1.4.1 Formulation and freezing 
1.4.1.1 Product property 
The formulation and freezing steps are used to build the structure of products, which 
influence both heat transfer and mass transfer.  Several aspects of the product attributes 
are of particular importance and they are described below. 
Thermal conductivity refers to the efficiency of heat transfer to, and through, the 
product.  As ice accounts for the majority of the solid, the ice crystal size distribution 
strongly affects the thermal conductivity. 
Table 1.3 Impact of cooling rate on ice crystal dimensions and ice sublimation time 
Cooling 
rate 
Nucleation 
rate 
Number of 
ice crystals 
Size of 
ice 
crystals 
Ice 
sublimation 
time 
Low Low Small Large Shorter 
High High Large Small Longer 
(Extracted from (Franks & Auffret 2007)) 
The size distribution can be influenced by the cooling rate during freezing (Franks & 
Auffret 2007; Tang & Pikal 2004).  As shown in Table 1.3, a high cooling rate results in 
small ice crystals and decreases the sublimation rate due to less ice connectivity.  By 
contrast, a low cooling rate results in large ice crystals with better ice connectivity that, 
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therefore, reduces the time for ice sublimation.  The formation of an amorphous product 
can reduce the connectivity compared to crystal states.  Also, if a glassy product forms 
around crystals, it would act as an insulating skin that inhibits the heat/mass transfer.  In 
addition to the cooling rate, these aspects can also be influenced by formulation (e.g. 
solid content). 
The specific surface area of the ice front is another significant property that greatly 
impacts the subsequent drying efficiency.  Clearly, larger specific surface areas lead to 
more efficient sublimation of the ice into gaseous state.  Excipient choice, solid porosity, 
solid content, fill volume and cooling rate have all been found to strongly influence the 
specific surface area. 
 Excipient modification 
Excipients can be designed to increase the ice front surface area.  It was found that 
increased ratio of mannitol/sucrose resulted in larger specific surface area and less 
extent of collapsed cake for a IgG1 formulation (Schersch et al. 2010); another study 
showed that increased sucrose concentration resulted in an increased ice surface area 
(Bhatnagar et al. 2008). 
 Porosity/solid content 
A porous product would present a larger ice surface area, and the product would 
become more porous as drying proceeds.  Usually, a low solid content leads to a more 
porous product.  However, too little of the solid would result in poor mechanical strength 
and break up of the solid plug. 
 Fill volume 
Deeper filling of a vial by the frozen product, leads to a lower specific surface area.  
However, in practice, increasing the surface area by using vials with larger diameters, 
can lead to the suboptimal utilisation of the freeze-dryer shelf space. 
The fill volume can also affect the choice of containers.  Usually between one third 
and one half of the vial volume is filled with solution, in order to achieve good heat 
diffusion.  A fill depth of more than 2 cm should be avoided, while the final freezing 
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temperature should be held for 1-2 hours before primary drying, to ensure sufficient time 
for complete freezing (Tang & Pikal 2004).   
The fill volume (or more precisely, fill depth) contributes differently to the specific 
surface area throughout the primary and secondary drying processes.  In the beginning 
of primary drying, there is little void space within the frozen product, and so the available 
surface area is only made up of the top surface of the frozen solid.  As drying proceeds, 
the solid should become more porous with more available void space, and thus increases 
the specific surface area.   
 Cooling rate 
Three different cooling methods have been discussed previously (Tang & Pikal 
2004) and these are summarised in Table 1.4 with their influence on supercooling.  It is 
also found that supercooling heterogeneity between vials is caused when samples are 
placed onto a precooled shelf.  A recommended cooling rate of 1°C/min is suggested 
which provides uniform ice structure and minimises phase separation between proteins 
and stabilisers. 
Table 1.4 Three freezing methods 
Freezing methods Supercooling effect 
Liquid nitrogen freezing High 
Loading vials onto precooled shelves Low 
Ramped cooling Medium 
 
As illustrated before, a high cooling rate would create more ice crystals and thus 
larger specific surface area.  Even though thermal conductivity outweighs specific 
surface area in ice sublimation during primary drying, the specific surface area will play a 
more important role in the diffusive process in secondary drying.  In addition, as proteins 
are likely to denature at the ice-water interface, it has been found that the adverse impact 
of fast cooling is greater or equal to slow cooling of 11 cycles (Hang & Endrick 1996). 
1.4.1.2 Excipients 
Excipients are defined in the Handbook of Pharmaceutical Excipients (Raymond C 
Rowe 2009) as "inert or inactive ingredients" which "aid the formulation and manufacture 
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of the subsequent dosage form for administration to patients".  They can be used to 
protect active drug-substance proteins from denaturing under the processing stresses 
and storage conditions, and thus preserve and prolong their stability and activity.  To be 
more specific, they can act as buffer salts to maintain the solution within a proper 
physiological pH; they can physico-chemically alter the T’g and Tg of product-excipient 
complexes, so that the active ingredients can resist more extreme conditions; they can 
also play a role in providing a robust cake structure or elegant morphology that meet the 
market demand.  Actually, it is the excipients, instead of active ingredients, that usually 
account for the majority of the composition of the final solid dosage.  Therefore, the 
selection of suitable excipients and their composition within the initial protein solutions 
are of equal importance as the adjustment of operating parameters (e.g. temperature, 
pressure) during freeze-drying. 
In practice, certain excipients have gained particular popularities, and their specific 
functions have been investigated.  For example, mannitol is a crystalline excipient that is 
added to support the formation of the physical structure of the product, whereas trehalose 
and sucrose work as amorphous excipients to stabilise proteins with higher T’g and 
reduced motion (Ohtake et al. 2011).  PEG, sorbitol and many other excipients are also 
useful additives that are widely applied in the biopharmaceutical industry to reduce 
temperature and dehydration stress or/and inhibit protein adsorption (Kamerzell et al. 
2011).  However, a rational selection or design strategy, of suitable excipients and their 
composition, is still not well developed, and it is found that some excipients can serve in 
multi-functional roles to stabilise proteins.   
A straightforward way of choosing excipients is by undertaking so-called “Design of 
Experiment (DoE)”.  In DoE, a range of potential excipients are formulated with active 
proteins, in a specific set of compositions.  The impacts of different excipients in 
stabilising proteins are then compared from their corresponding protein activities after 
freeze-drying.  As a result, the combination of excipients that can achieve optimal 
activity is determined and an equation indicating how individual excipients can contribute 
to the stabilisation is proposed by statistical calculation and regression.  This approach 
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was used previously (Grant et al. 2009; Grant, Matejtschuk, et al. 2012) to determine the 
most suitable excipients to preserve model proteins of lactose dehydrogenase (LDH) and 
granulocyte colony-stimulating factor (G-CSF).  In their research, 96-well plates were 
used to reduce the sample material requirements, and to rapidly screen the possible 
excipient alternatives and to analyse their interactions in the protection of active proteins.   
The DoE method has presented a generic way to choose the suitable excipients.  
Its application, however, provides only very limited, if any, understanding of the 
mechanism of excipients.  Meanwhile, as one can only apply one operation condition at 
a time in a single freeze dryer, the screen of suitable processing parameters (e.g. 
temperature, pressure) is not as straightforward as that of suitable excipients.  To 
achieve this, the recognition of molecular structure of both products and additives, and 
the understanding of thermodynamics and kinetics are crucially important. 
Theoretically, all inert compounds can be used as excipients.  Generally, excipients 
can be categorised as buffer salts, bulking agents and lyoprotectants (Wang 2000; 
Kamerzell et al. 2011).  Their functions are explained as follows. 
• Buffer salts: maintain the required pH and salinity (ionic strength) during freezing 
and upon reconstitution. 
• Bulking agents: support the appearance and physical strength of the product, e.g. 
crystalline and amorphous structures. 
• Cryoprotectants and lyoprotectants: alter the physicochemical properties (e.g. T’g, 
Te, Tg) of product by interacting with products or forming product-excipient 
complexes. 
It is emphasised that in many cases, one excipient can provide many attributes to 
the product. 
 Excipients as buffer salts 
Buffer salts are used to maintain the pH and salinity (ionic strength) of the protein 
solution, not only during freeze-drying, but also for the reconstitution of dried solid at the 
point of use.  There are two issues that need to be considered when choosing suitable 
buffer salts:  
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(1) Whether the buffer salts are likely to precipitate; and  
(2) What is the form of precipitation? 
The first issue involves the potential to induce a pH shift if one of the pair of the 
buffer salts precipitates prior to the other.  For example, in a sodium phosphate buffer 
system, the mole ratio of NaH2PO4/Na2HPO4 to obtain a pH 7 buffer is 0.72.  The 
individual eutectic points for NaH2PO4 and Na2HPO4 are -9.7°C and -0.5°C; while at a 
ternary eutectic point, in which NaH2PO4, Na2HPO4 and water co-crystallise, the mole 
ratio is 57.  This means that if the initial pH of the buffer is 7 with a mole ratio of 0.72 for 
NaH2PO4/Na2HPO4, which is far from 57, Na2HPO4 would crystallise prior to the co-
crystallisation of NaH2PO4 and Na2HPO4.  As the basic buffer salt being subtracted from 
the buffer system, an acidic pH-shift would be induced (Murase & Franks 1989).  It was 
found that a decreased initial buffer concentration at 8 mM and slightly lower initial pH at 
5.7 could mitigate the pH shift of sodium phosphate buffer compared to 100 mM buffer at 
pH 7.4 on freezing (Gó Mez et al. 2001), while potassium phosphate had stronger 
resistance towards pH shift compared to sodium phosphate buffer system (Pikal-Cleland 
et al. 2000).  Other studies show that citrate buffer is better than phosphate buffer for pH 
6.5, and glycocholate buffer is better than succinate for pH 3 to 5 (Wang 2000). 
The second issue that needs to be considered when selecting a proper buffer is the 
form of precipitation.  Instead of an anhydrous crystal, the buffer salts may form 
hydrates.  Some of the hydrates are of a metastable state and would decompose into 
water molecules and the anhydrous form.  Take NaCl for example (Figure 1.6), it would 
spontaneously precipitate with two water molecules and form the hydrate of NaCl.2H2O 
as the temperature is dropped below 0°C.  At its eutectic point of -21°C, almost all the 
Na+ and Cl- ions become crystallised.  This dihydrate, which is not stable, decomposes 
into NaCl and water when temperature is raised to nearly 1°C at its peritectic point 
(Franks & Auffret 2007).  The undesired water cannot be dried during the sublimation of 
ice and would prolong the secondary drying.  If the water exists in the final solid dosage 
of the product, it will promote the destabilisation and inactivation of the protein. 
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Figure 1.6 Solid/liquid phase diagram for the binary water-NaCl system  
The dihydrate NaCl.2H2O is crystallised from the solution at the eutectic point. As temperature 
increases, it decomposes into anhydrous crystalline NaCl and water at the peritectic point (Franks & 
Auffret 2007). 
 
 Excipients as bulk agents 
Bulk agents can be utilised to confer a robust physical structure for the final solid 
dosage.  In other words, they provide the desired mechanical strength for solid states.  
Crystal and glass are the two typical solid states that formulation scientists would aim for.  
The choice between amorphous and crystalline formulation depends on the market 
demands and the property of proteins.  Crystalline solids give rise to an attractive 
appearance but offer little chemical protection for the unstable active ingredients.  
Amorphous states provide good reconstitution performance and their storage conditions 
can be adjusted by suitable excipients.  For example, insulin exhibited better stability in 
an amorphous state than a crystalline one (Pikal & Rigsbee 1997).   
In order to achieve the crystal form of the product, excipients that can spontaneously 
crystallise are favoured.  Mannitol is one of the common crystalline agents and it can 
help form a rigid homogeneous cake for the lyophilised plug (Raymond C Rowe 2009; 
Kaialy et al. 2016). 
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Unlike the spontaneous crystallization of compounds like mannitol, some organic 
compounds, especially poly hydroxide compounds (PHCs), do not form crystals at their 
Te even at low cooling rates.  As the temperature further decreases, these compounds 
vitrify into glass directly.  Excipients with high T’g are suggested as they can increase the 
T’g of the complex, and thus provide a higher operation temperature for freezing and 
primary drying.  For instance, sucrose is a commonly used amorphous agent and it 
could hinder the crystallisation of mannitol formulation (Park et al. 2013). Due to these 
favourable features of PHCs, they can be mixed with products if an amorphous state is 
the desired form for end-users.  As amorphous excipients reduce the ice formed, they 
can shorten the primary drying time while prolonging that for secondary drying. 
In cases where an amorphous state is to be achieved, excipients that can raise the 
Tg give rise to a higher operation temperature for secondary drying, and the condition to 
preserve the solid form during storage.  Sucrose, dextran and many other excipients 
(e.g. polymers) had been found to stabilise the amorphous solid state of proteins (Ohtake 
et al. 2011).  However, excipients that offer amorphous structures may devitrify into 
crystalline state.  Therefore, storage temperature should be well below their Tg (Bianco 
et al. 2013).  For example, lactose crystallises at 360 K to form monohydrates from an 
amorphous solid, leaving the rest of the glass with less water content.  This transition 
renders the protein further dried and out of the protection of lactose.  Interestingly, 
however, by removing water from the amorphous state, the Tg of the remaining product 
will increase therefore leading to improved storage stability.  This is deemed as “self-
stabilisation” (Franks & Auffret 2007). 
 Excipients as stabilisers 
Stabilisers are the excipients that can help active protein resist the undesired 
chilling/freezing/drying conditions during freeze-drying.  Theoretically, bulk agents that 
can assist to provide a stable morphology (e.g. glass) can be also regarded as 
stabilisers.  The stabilisers can be further classified into cryoprotectant for freezing 
protection, and lyoprotectant for drying protection (Wang 2000). 
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Various excipients corresponding to different denaturation processes during freeze-
drying have been summarised in the literature (Wang 2000) and are listed here in Table 
1.5. 
Table 1.5 Choices of excipients to protect APIs from various denaturation process during 
lyophilisation 
Processing stresses Type of excipients 
Freezing 
stress 
Concentration effect 
with accelerated 
chemical reactions 
 Polymers to 
increase 
viscosity  Polyhydric 
alcohols (PEG, 
DMSO, DMF) 
 Salts (potassium 
phosphate) 
 Amines 
 Sugars/polyols 
(sucrose, 
trehalose) 
 Polymers (serum 
albumin, dextran) 
 Amino acids 
 Metal ions 
 Amphiphilic 
excipients 
Ice-water interface 
with high surface 
tension 
 Surfactants 
(tween 80) 
pH changes 
 Amino acids 
(glycine) 
 Polymers 
(BSA) 
Drying stress (Dehydration) 
 Excipients to form glass (e.g. Sucrose) 
 Excipients of high Tg (trehalose) 
 (Extracted from (Wang 2000).  Note: dehydration is the removal of hydration shell 
around proteins, which would induce aggregation/inactivation of proteins.) 
1.4.2 Primary drying 
The step of primary drying accounts for the majority of sublimation of ice water.  
This process is a combination of heat transfer and mass transfer.  Specifically, the heat 
provided by the freeze dryer (e.g. shelf) gives rise to the driving force for the sublimation 
of ice from product.  The relation between heat transfer and mass transfer can be 
mathematically described (Franks & Auffret 2007) as 
𝐾𝑉(𝑇𝑆 − 𝑇𝑃) = ∆𝐻𝑆(𝑑𝑚/𝑑𝑡) Equation 1.1 
In Equation 1.1, the definitions of each parameter are listed in Table 1.6. 
Table 1.6 The parameter definitions of Equation 1.1 for heat and mass transfer 
Parameters Definitions 
Kv Heat transfer coefficient 
Ts Shelf temperature 
Tp Ice front temperature 
ΔHs Latent heat of ice sublimation required at Tp 
dm/dt Rate of mass transfer of water vapour from ice front to the condenser 
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Figure 1.7 Diagram of coupled heat transfer and mass transfer  
The shelf supplies the energy (Qin) for the water to sublime with energy (Qout) at a mass transfer 
rate dm/dt. At product temperature Tp, Hs indicates the sublimation latent heat (Franks & Auffret 
2007). 
 
Figure 1.7 describes how the heat input is transferred to the removal of ice.  It 
should be noted that Equation 1.1 represents an instantaneous situation, and so some 
values would change according to different parameters.  For example, the latent heat of 
ice sublimation varies with ice temperature.  Moreover, the heat transfer coefficient 
depends largely on the structure of the product.  In the following section, a variety of 
factors that influence heat and mass transfers will be discussed, and their contributions 
weighted. 
1.4.2.1 Heat transfer 
Heat transfer is made up of three mechanisms, i.e. radiation, conduction and 
convection. 
(1) Radiation 
In most cases, the exterior of the freeze dryer is warmer than the interior and 
heat can radiate from the door and walls of the freeze dryer. 
(2) Conduction 
Conduction of heat is caused by direct contact between two materials of 
different temperatures.  For example, conduction takes place between shelf and 
vial, vial and product, and between products of various temperatures.   
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(3) Convection 
Heat convection is mainly a result of gas collision and flow.  As gas 
molecules randomly travel through the space (Brownian diffusion), they interact 
with each other and exchange heat from higher temperature to lower 
temperature. 
Compared to conduction and convection of heat, radiation accounts for only a minor 
part of the entire heat transfer.   
The thermal conduction is mainly affected by two factors, i.e. temperature difference 
and conductivity.  They can be illustrated as follows. 
Table 1.7 Conduction of heat 
Conduction of heat 
Temperature difference Thermal conductivity 
Shelf/vial 
Vial/product 
Temperature gradient within product 
Contact area with shelf 
Thermal conductivity of container 
Thermal conductivity of product 
 
As the container is heated by the shelf, there would be a temperature gradient within 
the product from the highest at the bottom to the lowest at the ice front, which ensures 
continuous heat conduction.  The thermal conductivity of the product thus critically 
affects the heat transfer efficiency.  In general, ice crystals have better thermal 
conductivity compared to amorphous solids.  In addition, some aspects described in 
Table 1.7 undergo continuous changes as well.  For instance, the thermal conductivity of 
the product will decrease as the product becomes more porous.   
As convection of heat is caused by the motion and collision of gas molecules, the 
pressure, which indicates the density of gas molecules, is used to reflect the extent of 
convection.  The gas not only transfers heat from the shelf to the ice front, but also 
transfers heat generated by condensation of water vapour.  Figure 1.8 shows that the 
sublimation rate is proportional to the chamber pressure but will reach a plateau when the 
pressure goes above a certain point.  It should be noted that the pressure within the 
chamber does not exceed the SVP of ice at the operating temperature (Franks & Auffret 
2007). 
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Figure 1.8 Effect of chamber pressure on sublimation rate  
The water sublimation rate increases with the chamber pressure but will reach a plateau when the 
pressure goes above a certain point (Franks & Auffret 2007) 
 
 
Figure 1.9 Contributions of radiation (left, diagonals), conduction (centre, cross-hatched) and 
convection (right, blank) to the total heat transfer for three vial types and two pressures 
(Franks & Auffret 2007). 
 
The weights of the three heat transfer mechanisms have been compared in Figure 
1.9 (Franks & Auffret 2007).  It is shown that convection is a major influence among the 
three mechanisms, especially at higher pressure.  The contributions between radiation 
and conduction vary from the containers, i.e. conduction account for more if a container 
of better contact with shelf is used. 
1.4.2.2 Mass transfer 
Mass transfer refers to the water migrating away from the product.  Clearly, 
sublimation of ice is a crucial part and the surface area of the ice front where sublimation 
takes place is a key factor.  In addition, water can also migrate inside the product before 
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sublimation, and therefore the morphology of the product affects the rate of mass transfer 
to a certain extent as well.  It is summarised that fill depth, total solid content, and cake 
porosity would influence the product morphology, and therefore exerts an impact on the 
specific surface area.  In the meantime, after ice becomes water vapour, it would 
migrate to the condenser and condense onto its surface.  The rate for ice migration 
depends on the pressure difference between the area near the ice front and the 
condenser.   
In addition to the pressure difference providing the driving force for the migration of 
water vapour to the condenser, the pressure within the chamber itself also plays a role in 
accelerating the mass transfer.  Obviously, a higher pressure would lead to more 
possibilities for gas molecules to move around more intensively and reach the condenser. 
1.4.2.3 Monitoring the end-point of primary drying 
It is of critical importance to determine the end-point of primary drying so as to 
minimise the drying period and lessen product denaturation.   
 Temperature 
As the drying process approaches the end, the temperature of the product 
approaches the shelf temperature.  However, it might not be accurate to measure the 
temperature of a dry product without any interference with the product (Corbellini et al. 
2010).  In addition, the vials with thermocouples dry faster than vials without 
thermocouples (Patel et al. 2010), so it is suggested that one needs to extend the primary 
drying time to at least 10 - 20% more after the end-point determined by temperature 
meters (Tang & Pikal 2004).  A series of product temperature measurements are listed 
in Section 1.4.4.1. 
 Gas/pressure 
Dew point sensors can detect the relative humidity of gas to indicate the change in 
gas composition.  It is said that there is a significant dew point decrease when it comes 
to the end of primary drying as gas composition changes from ~100% water vapour to 
mostly air or nitrogen (Tang & Pikal 2004). 
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A "pressure rise" test is a common indicator of the sublimation endpoint.  In the test, 
the chamber is isolated from any gas flow and its pressure is measured.  The 
completion of ice removal is determined by an absence of a pressure rise within one 
second (Chouvenc et al. 2004).  However, the limitation of this test lies in that the 
isolation of gas flow is not always practically feasible.  For example, there is sometimes 
no particular valve between chamber and condenser to cut off the gas flow. 
According to Table 1.11, the completion of sublimation can also be indicated when 
the thermal conductivity of the gas (i.e. Pirani gauge) decreases and levels off to total 
pressure measurement (i.e. capacitance pressure probe) (Franks & Auffret 2007; 
Colandene 2007).  Anemometers can measure the gas flow but they cannot differentiate 
different gas types (Franks & Auffret 2007).  When mass spectrometers are incorporated 
into the detection of gas, more sensitive monitoring is provided not only for the gas 
elements but also for the product profiles, which offers great insight into protein 
denaturation (Barresi et al. 2009).   
1.4.2.4 Practical recommendations for operation parameters 
 Target product temperature 
The product temperature in primary drying is 5 to 40°C below the shelf temperature 
(Tang & Pikal 2004), due to the heat removal by sublimation.  It would be ideal to hold 
the product at an optimum target product temperature throughout the primary drying.  
Theoretically, the product temperature should be lower than Tc so as to avoid collapse.  
Practically, however, a slight increase in product temperature would decrease the primary 
time (e.g. 13% time is reduced by 1°C elevated temperature) (Tang & Pikal 2004).  The 
operational safety margin temperature between product temperature and Tc is suggested, 
as below, in terms of primary drying duration (Tang & Pikal 2004).  Basically, the longer 
the primary drying, the smaller the safety margin used, so as to minimise the cycle 
period. 
Table 1.8 The operation margin temperature between product temperature and Tc 
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Safety margin 
temperature (lower than 
Tc) 
Primary drying 
duration 
2°C t > 2 days 
3°C 10 h < t < 2 days 
5°C t < 10 h 
 
Interestingly, it is also found that the product temperature can be operated above T’g 
with negligible denaturation.  This is because the viscosity of the formulation is high 
enough at low temperature (e.g. -15°C) to inhibit protein unfolding (Tang & Pikal 2004).  
Addition of crystalline bulking agents with high eutectic melting temperatures can also aid 
avoiding collapse when operating above T’g (Colandene 2007). 
 Chamber pressure 
In primary drying, the partial pressure of water is the same as the chamber pressure 
except at the endpoint of primary drying.  Low partial pressure of water facilitates high 
sublimation rate.  But very low chamber pressures would produce larger heterogeneity 
in heat transfer (Tang & Pikal 2004).  It is recommended that 50-200 mTorr (typically 
100-150 mTorr) provides optimal homogeneity (Tang & Pikal 2004). 
1.4.2.5 Conclusion 
In the primary drying process, a perfect situation lies in that the heat provided equals 
the heat needed for mass transfer.  If heat is over-provided, the product temperature will 
increase and may exceed T’g.  If heat provided is insufficient, the drying process will be 
prolonged and may induce protein denaturation.   
Basically, raising of the shelf temperature is a common way to accelerate the primary 
drying process, but the temperature of the ice front should not be higher than the glass 
transition temperature T'g.  If the product temperature is likely to surpass its T’g, 
increasing the pressure can be used to enhance the mass transfer, and thus cool down 
the product temperature. 
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1.4.3 Secondary drying 
1.4.3.1 Two existence forms of water 
After the primary drying, some residual water still remains in the product.  This 
water can be classified into two existence forms, as listed in Table 1.9.  The majority of it 
is trapped within the glass as free mobile water while the rest of it is within the crystalline 
system, either as a thin adsorbed layer on the crystal surface, or as an integral part of 
crystalline hydrates with stoichiometric ratios to the crystalline solutes (Yu et al. 1999; 
Wahl et al. 2015).   
Table 1.9 The forms of residual water after primary drying 
In amorphous 
system (majority) 
In crystalline system 
Trapped in 
amorphous solid & 
free to diffusive 
Thin adsorbed 
layer 
Crystalline hydrates  
 
1.4.3.2 Diffusion as the rate-limiting step in secondary drying 
Water removal during secondary drying involves two steps, i.e. diffusion and 
desorption.  The diffusion refers to the diffusive process of water from the bulk product 
to the surface.  It is then followed by desorption, in which water evaporates rapidly and 
migrates to the condenser.   
Though it is not clear if water diffusion is the rate-limiting step compared to water 
evaporation, many models assumed diffusion of water as the rate-limiting step for water 
desorption during secondary drying (Kodama et al. 2014).  Diffusion is significantly 
influenced by temperature and specific surface area while pressure and water content 
does not significantly influence the secondary drying rate (Pikal et al. 1990). 
 Specific surface area 
The specific surface area is a key aspect that affects the drying rate in secondary 
drying.  As illustrated in Section 1.4.1, it can be affected by formulation, porosity, fill 
depth of the product and the cooling rate during freezing.  Basically, high porosity, low fill 
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depth and high cooling rate would induce a large specific surface area.  However, these 
aspects contribute differently for the drying rate in secondary drying.  It has been found 
that cake thickness has little effect on the drying kinetics (Franks & Auffret 2007).  This 
may be due to that in the secondary drying there is already a high degree of void space 
within the cake, so the fill depth will not affect the specific surface area significantly.  On 
the other hand, a high cooling rate during freezing generates a large specific surface area 
and accelerates secondary drying, but the primary-drying rate would be compromised 
(Franks & Auffret 2007). 
 Temperature 
Adjusting the shelf temperature is one of the most common ways for process control 
in secondary drying.  The aim is to accelerate the drying rate by raising the product 
temperature but maintaining it below Tg so as to minimise cake shrinkage (Rambhatla et 
al. 2005).   
As water is gradually removed from the product, the drying rate will decrease to a 
plateau if a constant shelf temperature is set.  In the meantime, the Tg of the product is 
supposed to increase with less water content.  Therefore, an ideal operation would 
gradually increase the shelf temperature in order to efficiently reduce water content to a 
desired composition (Pisano et al. 2012).  Specifically, it is recommended to increase 
the temperature at the rate of 0.1 or 0.15°C/min for amorphous formulations, and 0.3 or 
0.4°C/min for crystalline products (Tang & Pikal 2004). 
Softening point (Ts) is the temperature at which the glass softens into a liquid.  In 
some cases where the residual water can only be removed by raising the product 
temperature above Tg, it is suggested that the temperature should remain between Tg 
and Ts (Figure 1.10) (Franks & Auffret 2007). 
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Figure 1.10 An ideal operation of adjusting temperature between Ts and Tg  
Line AB and CD are glass transition and softening temperature profiles derived from DSC.  Wg is 
the sucrose concentration of maximally freeze-concentrated solution.  Line bcd is the ideal secondary 
drying pathway. (Franks & Auffret 2007) 
 
A more practical way of adjusting the product temperature is shown in Figure 1.11, 
as it is not straightforward to control the temperature exactly as shown in Figure 1.10. 
 
Figure 1.11 A more practical way of adjusting the product temperature between Tg and Ts  
The step line in between line AB and CD is a more practical secondary drying pathway. 
 
1.4.3.3 Monitoring the end-point of secondary drying 
When the desired moisture of products is achieved, the secondary drying should be 
terminated otherwise products would experience unnecessary denaturing processes at 
high temperatures.  It is a delightful fact (Tang & Pikal 2004) that the freeze-dried 
samples can be extracted by the use of a “sample thief” without interrupting the freeze-
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drying cycle, and the moisture can be determined by TGA, near IR, Karl Fisher titration, 
or a modified MTM method. 
1.4.3.4 Conclusion 
In conclusion, during secondary drying, the diffusion of water relies largely on the 
specific area whereas water content has little effect to the diffusive process.  
Temperature control is a more efficient way to control the product quality compared to 
pressure, and the product temperature is advised to be kept below Tg so as to avoid 
collapse from the amorphous state to a crystalline or solution state.  A gradual increase 
of shelf temperature is proposed so as to reduce the drying period while retaining the 
product integrity. 
1.4.4 Real-time monitoring for product 
properties 
1.4.4.1 Temperature monitoring 
There are different ways to monitor the temperature of products.  Each of them 
involves strengths and weakness.  The following table is a summary for the various 
methods discussed in the literature (Franks & Auffret 2007; Tang & Pikal 2004). 
Table 1.10 Temperature monitoring methods 
General aspects 
Limitation Close contact with product 
Probe liberate heat 
Increase the ice nucleation 
probability 
“Thin wire thermocouples” is preferred to “resistance thermometers (RTD sensors)” 
  
Various measurements 
  Application Mechanism Limitation 
Thermocouple 
The temperature at the 
bottom of vials 
The junction of 
two different 
metals is 
heated/cooled 
and a voltage 
Cause less 
supercooling & 
larger ice crystal 
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is produced to 
correlate 
temperature 
RTD sensors 
The temperature at the 
bottom of vials 
a resistor (e.g. 
platinum) that 
changes 
resistance 
value as its 
temperature 
changes 
 
Barometric 
temperature 
measurement 
(Manometric 
temperature 
measurement, 
MTM) 
 The temperature of ice 
sublimation interface 
(0.5 to 2°C lower than 
vial bottom) 
 The completion of ice 
sublimation 
A pressure rise 
test (PRT) with 
a water 
vapour–
temperature 
diagram 
An interruption of 
the cycle & lacks 
the continuous 
output  
Conductimetry 
 Conductance                  
 Eutectic temperature 
 Warning of abnormal 
conditions 
Conductimeter 
Eutectic 
temperatures are 
unrelated to the 
physical state of 
the drug substance 
 
1.4.4.2 Chamber pressure monitoring 
Various chamber pressure measurements are summarised as below (Franks & 
Auffret 2007; Tang & Pikal 2004). 
Table 1.11 Chamber pressure monitoring methods 
 Feature Mechanism 
Heat 
conductivity 
vacuum gauge 
(Pirani pressure 
gauge) 
Calibrated against air 
 correction for pure water 
vapour 
 
𝑤𝑎𝑡𝑒𝑟 𝑣𝑎𝑝𝑜𝑢𝑟
𝑎𝑖𝑟 𝑜𝑟 𝑛𝑖𝑡𝑟𝑜𝑔𝑒𝑛
= 1.5  
Measure the 
electrical energy 
needed to 
maintain a 
constant 
temperature 
Membrane 
differential 
gauge (capacity 
gauge or MKS 
Baratron gauge) 
Independent of the gas type 
Capacitance 
changes caused 
by a deflection of 
the membrane 
sealed against a 
fixed low pressure 
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1.5 Analytical methods to characterise protein properties 
1.5.1 Size/Conformation/Structure 
1.5.1.1 SEC-HPLC 
SEC-HPLC is one the most widely used analytical method to characterise protein 
monomer/aggregate profiles in aqueous phase.  Based on the differences in molecular 
weight, pure protein monomers would exhibit a single peak in the chromatogram while 
aggregates (e.g. dimers, trimmers, etc.) would present peaks before the monomer peak.  
A typical SEC-HPLC process can be completed within 15 min.  The disadvantage of 
SEC-HPLC is that it cannot distinguish aggregates of different molecular weight, and 
becomes less sensitive for large aggregates.  SDS-PAGE is needed if the exact 
molecular weights are required. 
1.5.1.2 DLS 
Dynamic Light Scattering (DLS) can be a complementary method to SEC-HPLC that 
can also indicate the molecular weight of proteins, especially for large molecules and 
particles.  However, it provides more of a qualitative indication of the molecular size 
profiles.  Plots of intensity versus particle size obtained by DLS, often only show 1-3 
peaks, and these are heavily biased towards the larger particle sizes present, because 
intensity is proportional to the sixth-power of the particle radius.  The PSD of individual 
species therefore cannot be directly compared with the profiles obtained from other 
analyses (e.g. SEC-HPLC) that are more quantitative for the number of particles.   
1.5.1.3 RP-HPLC 
RP-HPLC is used to differentiate the hydrophobicity of different protein species.  
During a freeze-drying process, intact protein monomers can degrade into fragments or 
interact with each other to form aggregates.  Proteins of different states would present 
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different hydrophobic patches and interact differently with the carbon chains immobilised 
on the resin.   
Under good control of ACN (Acetonitrile) composition and its gradient, RP-HPLC can 
be used to differentiate between aggregates formed by covalent and non-covalent 
bonding (Wang 2005), which is a great strength compared to other aggregation 
characterisation techniques based on size (e.g. SEC-HPLC, DLS, SDS-PAGE).  
Theoretically, covalently bonded aggregates are more hydrophobic compared to 
monomers, especially when they are unfolded, which makes them reside longer on the 
resin.  As for non-covalently bonded aggregates, they would dissociate when interacting 
with ACN and display more than one peak.  Other types of denatured status can also be 
characterised, which is summarised in Table 1.12.  In order to obtain more detailed 
molecular profiles (e.g. intrinsic heterogeneity such as glycosylation) of protein, RP-HPLC 
can be coupled with mass spectroscopy (Dillon et al. 2006; Carr 2002). 
Table 1.12 The characterisation of denatured status by RP-HPLC 
Denatured status 
Differences from intact 
monomers 
Reference 
Aggregation 
Covalent binding Longer residence time 
(Wang 2005) Non-covalent 
binding 
More than one peak 
Deamidation 
Neutral pH, shorter 
residence time (Carr 2002) 
Oxidation Shorter residence time 
Structure 
heterogeneity 
(LC/MS) 
Differences in disulfide 
bond  
Multiple peaks for whole 
antibody but merely two 
peaks (heavy & light 
chains) after reduction (Dillon et al. 
2006)  Fragments by hydrolysis 
cleavage 
Shorter residence time 
Partial unfolding Broad peaks 
 
It is known that the mobile phase used in RP-HPLC (typically acetonitrile, ACN) 
would also unfold proteins to a certain extent upon binding or elution (Lau et al. 1984).  
The hydrophobic peptides inside the protein would then become exposed to the outside 
and proteins would become more hydrophobic, leading to a longer residence time on an 
RP-HPLC column.  The unfolded proteins can potentially further re-fold or form 
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aggregates with other proteins.  Due to this uncertainty, one needs to first ensure that 
the composition of ACN that can elute proteins does not render the proteins to re-fold and 
form aggregates.   
1.5.1.4 FTIR 
Fourier transform infrared spectroscopy (FTIR or IR) is a commonly used in-line or 
off-line method to characterise protein secondary structure.  The principle is that the 
amide I, II, III and A vibrational modes of proteins absorb IR distinctly and exhibit unique 
band shapes (Hayashi & Mukamel 2007).  Both liquid and solid states of proteins can be 
analysed (Colandene 2007).  Various denaturation processes, together with 
corresponding changes in IR spectra, have been discussed in the literature (Wang 2000) 
and these are summarised in Table 1.13. 
Table 1.13  Infrared spectroscopy characterisation for protein denaturation during lyophilisation 
Common denaturation Reflection in IR spectra 
Disruption of hydrogen bonds 
An increase in frequency and a 
decrease in intensity of hydroxyl 
stretching bands 
Unfolding of proteins 
Broadening and shifting (to higher wave 
numbers) of amide I component peaks 
Aggregation and/or increased 
intermolecular interaction 
Conversion of α-helix to β-sheet 
 
1.5.1.5 CD 
Circular Dichroism (CD) is a valuable analytical method to evaluate the protein 
structure preservation.  During a measurement, left and right circularly polarised lights 
(LCP light and RCP light) are passed through a protein sample, and the difference in 
absorption detected over a range of wavelengths.  For instance, secondary structures 
such as α-helix, β-sheet and random coil present distinct circular dichroism in the far-UV 
range (Figure 1.12) while near-UV CD can be an indicator of tertiary structure, which 
includes dipole orientation and interactions of side chain aromatic amino acids (Kelly et 
al. 2005).  As environmental factors exert significant impact for the protein structure, CD 
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can be used to evaluate the formulation efficacy for the stabilising of proteins in terms of 
pH, salinity, temperature and excipient types. 
 
Figure 1.12 The CD features of pure secondary structure elements at far-UV region  
(Extracted from http://www.proteinchemist.com/cd/cdspec.html) 
 
1.5.2 Surface area 
Surface area is an important feature of the freeze-dried product.  The BET 
(Brunauer, Emmett, and Teller) surface area testing method measures the specific 
surface of finely divided and porous solids.  It is essentially based on the BET theory of 
multilayer adsorption assumptions, and measurement is carried out by obtaining 
equilibrium pressure and the amount of gas adsorbed onto a sample surface (Brunauer 
et al. 1938).  Multipoint BET testing is a useful method to determine the surface area 
and porosity of samples (Colandene 2007).  Attention should be paid to cakes with 
collapsed features, as the BET data in these samples do not fully reflect the previous ice 
trace (Liu 2006). 
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1.5.3 Water content and sorption 
1.5.3.1 Residual moisture 
Because water is often involved in protein degradation (Section 1.2), its presence in 
the final product can be deleterious in preserving the potency and stability of product as 
well as its appearance (Krasucka et al. 2012).  For example, water serves as a 
plasticizer to decrease the Tg of amorphous solid (Towns 1995).  Therefore, it is 
important to characterize the final product for its water content.  
A variety of analyses can be used for the determination of water content, such as 
loss on drying, thermogravimetry, near-infrared spectroscopy, gas chromatography and 
Karl Fischer Titration, which have been discussed in literature (Krasucka et al. 2012; 
Towns 1995; Mary 1967; Zhou et al. 1998) and summarised in Table 1.14.  Among 
these, the most widely used is Karl Fischer Titration.  Karl Fischer Titration (KF Titration) 
is a standard and versatile method to measure the moisture of samples and is commonly 
used in the biopharmaceutical industry (Crescent 2004).  Other moisture measurement 
alternatives can be used if the analytes are not compatible with the KF titrant.  A major 
downside of most moisture analyses, is that they measure only the total amount of water, 
and do not provide information on the distribution of the water within the sample (Franks 
& Auffret 2007).  As water interacts differently with amorphous and crystalline solids, 
more advanced moisture analysis is required if the degradation mechanism by moisture 
needs to be investigated.  Near-infrared (NIR) imaging provides an efficient analysis for 
the water content across the shelf so the water distribution could be visualised (Trnka, 
Palou, et al. 2014). 
Table 1.14 The analysis of moisture content for freeze-dried solids 
Measurement 
classification 
Name Mechanism 
Type of 
moisture 
Feature 
Destructive 
technique 
Thermal 
method 
Gravimetric 
method (loss on 
drying, LOD) 
Measurements before 
and after the removal 
of water by heating 
(20 - 30°C) under 
vacuum 
Surface 
moisture & 
loosely 
bound 
water of 
hydration 
Under estimation of total 
moisture 
General criteria: not over 
1.0% 
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Thermogravimetric 
analysis (TGA) 
Record loss of mass 
by heating with 
linearly increasing 
temperature to over 
1200°C 
Generally 
total water 
content 
Sensitive to 2 mg 
Need to differentiate between 
moisture & volatile 
Volatiles verified by MS 
Non-
thermal 
method 
Gas 
chromatography 
using a thermal 
conductivity 
detector 
Calculate based on 
water density and 
calibration (e.g. Peak 
height/area) of 
internal standard 
solution (e.g. N-
propanol) 
Overestimation of moisture 
Micro scale 
High throughput 
Karl Fischer 
titration (KF 
titration) 
Titrants 
stoichiometrically 
react with water 
10 mg sample 
Complex sample handling to 
prevent ambient water 
Non-destructive 
technique 
Near-infrared 
spectroscopy 
Fiber-optic diffuse-
reflectance probe 
measures reflectance 
through intact glass 
vials 
Rapid (20 s/per analysis) 
In-situ measurement 
Little sample preparation 
Prevent atmospheric 
moisture 
Need reference moisture 
(e.g. KF titration) 
 
1.5.3.2 Water desorption 
Dynamic Vapour Sorption (DVS) is used to measure the sorption/desorption 
isotherm of product samples.  Samples are exposed and equilibrated at individual levels 
of gas moisture, in which isotherms are plotted by recording sample mass against the 
corresponding temperature. 
DVS aims to evaluate how formulation, processing, and storage conditions would be 
affected by water interaction.  Sorption degree and kinetic data can be obtained for a 
range of humidities (e.g. 5-80%) and correlated to the product stability, and water-related 
reactions such as crystallisation, hydrate formation.  A Symmetrical Gravimetric 
Analyzer (SGA) is a similar water sorption instrument, which can be operated at high 
vacuum conditions (Liu 2006). 
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1.5.4 Thermal analysis 
Thermal analysis plays an important role in determining the stability of the drug in the 
final dosage form.  An explicit classification and discussions for a variety of thermal 
analyses have been carried out previously (Kett et al. 2004; Liu 2006). 
1.5.4.1 Calorimetric analyses 
 DSC 
Differential scanning calorimetry (DSC) is a thermo analytical method that measures 
the heat absorbed by a sample as the temperature is steadily changed.  A reference 
sample or empty metal crucible (“pan”) with a well-defined heat capacity, and a sample 
(in an identical pan) are placed within the device.  The temperatures of both reference 
and sample are raised at a controlled rate, and the instrument then measures the 
difference in heat-input (current) required to retain an identical temperature change 
between reference and sample, as measured by thermocouples. 
DSC is typically used to determine the temperature (or temperature range) of a 
phase transition by detecting its heat capacity change.  Compared to the sample 
maintained at a fixed phase, sample adsorbs or liberates heat during an endothermic or 
exothermic phase transition process, respectively.  Therefore, the corresponding 
temperature that would induce a phase transition can be characterised by a peak or 
trough in the heat input to the sample (Coleman & Craig 1996).  Modulated temperature 
DSC (MTDSC) differs in that a sinusoidal wave modulation is applied to the linear 
temperature programme used in conventional DSC.  This technique was developed to 
resolve reversible and irreversible processes (Coleman & Craig 1996).  The 
characterisation of glass transition temperatures in frozen state (i.e. T’g) and lyophilised 
state (i.e. Tg) is crucial for the understanding and design of a particular formulation and 
freeze-drying cycle.  The interpretation of a DSC thermogram for typical phase 
transitions in freeze-drying is briefly summarised in Table 1.15 from the literature (Liu 
2006; Craig & Reading 2007).   
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Table 1.15 Interpretation of (Modulated) DSC sensorgram for typical phase transitions in freeze-
drying 
  
  
Features in thermogram Examples of events 
Thermal events 
Endothermic 
Peaks Glass transition, melting 
(fusion), dehydration 
Exothermic Reverse peaks (Re)crystallisation 
Enthalpy 
change 
Step change Glass transition  
Thermodynamic 
reversibility of 
processes  
Reversible 
processes 
Equilibrium with its 
surroundings 
at each stage during that 
process 
Glass transition 
Irreversible 
processes 
Kinetically controlled 
processes which are 
dependent on absolute 
temperature 
Crystallisation, enthalpy 
recovery 
Applications  T'g, Te, crystallisation, melting, Tg, annealing, heat capacity change 
  
 DTA 
Differential Thermal Analysis (DTA) has similar features to that of DSC.  It was 
invented earlier than DSC but is not as popular.  The major difference is, in DTA, the 
temperature of the reference sample and the unknown sample is recorded while applying 
the same controlled heat flow to both reference and sample.  The phase transition is 
indicated by the difference in temperature change observed between the reference 
sample and the unknown sample. 
 IMC 
Isothermal microcalorimetry (IMC) detects heat flow under isothermal and humidity 
controlled conditions, which can reflect the real-time molecular mobility and reactions 
within samples.  Enthalpy relaxation and recovery processes have been quantified by 
IMC (Kawakami & Ida 2003) and the relaxation times enables the prediction of stability of 
freeze dried solid at particular storage condition (Liu 2006).  Further development can be 
made on the characterisation of phase transitions in the frozen state as IMC offers higher 
sensitivity as well as analysis at conditions more similar to those of freeze-drying, 
compared to DSC (Liu 2006). 
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1.5.4.2 Dielectric and electrical analysis 
 TEA 
Thermoelectric analysis (TEA) (or Electrical Resistance Analysis, ERA, ER, 
Electrical Thermal Analysis, ETA, Freezing Resistance Analysis, FRA) measures the 
electric resistance while the temperature is ramped.  The principle is that the sample 
exhibits high electric resistance (low electric conductance) at low temperature (e.g. frozen 
state) compared to that at high temperature (e.g. liquid state).  Although works have 
shown that TEA can measure T’g, Te and ice melting temperature, this analysis is not 
widely employed due to inconsistency of outputs from different instruments due to their 
non-standard feature of the frequency applied (Liu 2006). 
 DEA 
Dielectric Analysis (DEA) measures the dielectric properties of samples.  The 
permittivity of sample is plotted against temperature, which can be used to reflect certain 
thermal properties (e.g. Tc) of formulations for freeze-drying.  Applications of DEA have 
been found in the characterisation of collapse temperature, the difference between 
frequency-independent first-order transitions and frequency-dependent higher-order 
transitions for frozen solutions, and in correlating product degradation with dielectric 
relaxation kinetics and activation energy (Liu 2006). 
 TSC 
Thermally Stimulated Current (TSC) Spectrometry is another dielectric thermal 
analysis, which correlates molecular mobility with temperature.  TSC has been 
recommended as a sensitive tool (even better than DSC) to detect the properties of 
freeze-dried solid, such as Tg, relaxation in glass state, fragility, crystallisation and 
melting temperature while its application in the frozen state has been rarely reported (Liu 
2006). 
1.5.4.3 Mechanical analysis 
Thermal Mechanical Analysis (TMA) measures the macro dimensional change under 
a constant stress with regard to temperature for both frozen and freeze-dried solid states, 
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which is specifically employed to prevent vial breakage during freezing (Liu 2006).  
Dynamic Mechanical Thermal Analysis (DMTA, DMA), in which periodic stress under 
alterable frequency is applied, can provide more sensitive detection of state transitions 
(e.g. Tg) than DSC (Kararli et al. 1990). 
1.5.5 (Thermo) Imaging analysis 
Naked-eye observation would provide a direct insight into the appearance of freeze-
drying formulation.  In the meantime, observation with instrumentation offers greater 
insight for the microstructure or other physical properties (e.g. mobility) of frozen and 
freeze-dried samples.  Moreover, a cooling system and vacuum pump can be attached 
to mimic the conditions applied in freeze-drying.   
1.5.5.1 Naked-eye observation 
Determination of the frozen state, freeze-drying extent and cake morphology based 
on naked-eye observation is a simple way to analyse the freeze-drying state.  Although 
naked-eye observation largely depends on individual subjectivity, it is straightforward to 
operate without the limitations of advanced instruments.  It can be at least used to 
screen the formulation for aesthetic appearance during process development, and is 
regarded as one of the criteria for product market-acceptance.  Freezing and 
sublimation rates, as well as the observation of cake-collapse events, can be qualitatively 
indicated before more advanced instruments are employed for quantitative 
characterisation. 
1.5.5.2 FDM  
Freeze-Drying Microscopy (FDM) is a valuable tool to simulate freeze-drying 
conditions while visualising the sample with a microscopic view.  Equipped with an 
adjustable cooling and a vacuum system, freezing and freeze-drying processes can be 
mimicked and observed on the microscope.  In addition, the crystallinity of the sample 
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can be detected if a polarised light is used such that crystalline-state solids would be 
brightly or colourfully reflected.   
FDM has been successfully applied to determine the collapse temperature (Meister 
& Gieseler 2008).  Other applications, such as the ice morphology, and water diffusion 
coefficient, have also been undertaken but their transferability to a real vial needs to be 
evaluated (Liu 2006).   
1.5.5.3 SEM & CESEM 
Scanning Electronic Microscopy (SEM) utilises a focused electron beam, which 
enables higher resolution for the microstructure morphology (10-20 nm).  Therefore, this 
resolution allows the characterisation of macromolecules (Millqvist-Fureby et al. 1999) 
and traces left by the sublimation of ice (Doillon et al. 1986).   
Similarly to FDM, a cooling system can also be affiliated to SEM to achieve Cryo-
environmental Scanning Electronic Microscopy (CESEM).  Changes in microstructures 
can be monitored as a function of temperature change, although it mainly provides an 
observation of sample surface texture (Liu 2006). 
1.5.5.4 XRPD & FDXRPD 
X-ray Powder Diffractometry (XRPD, XRD) is a standard method to qualitatively 
indicate the crystallinity of samples.  When the X-ray chamber is temperature and 
humidity controlled, the impact of storage conditions on the physical structure can be 
studied (Liu 2006).  A recent study has shown that XRPD can differentiate bulk 
amorphous phase separation with only one Tg detected by DSC (Newman et al. 2008).   
Similar to FDM and CESEM, freeze-drying accessories (i.e. a vacuum pump and 
cooling system) have been mounted to the XRPD instrument to enable the in situ 
monitoring for the crystallisation during a freeze-drying cycle (Cavatur & Suryanarayanan 
1998), which is called FDXRPD.  However, it is not practical to investigate the 
amorphous phase transitions and needs to be utilised together with DSC (Liu 2006). 
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1.5.5.5 NMR 
Solid-state Nuclear Magnetic Resonance (NMR) can measure the molecular mobility 
of drug and excipient molecules.  By correlating the molecular mobility with physical 
structure, many bio-physical/chemical properties (e.g. aggregation, activity, stability) can 
be studied to assess the formulation and storage conditions (Liu 2006). NMR 
characterise fast molecular dynamics of solid-state formulation with timescales much 
shorter than structural relaxation (Yoshioka et al. 2011). It has been found that this fast 
dynamics correlates with formulation instability better than structural relaxation does 
(Cicerone & Soles 2004).  
1.5.6 Storage conditions  
Essentially, the stability of active protein ingredients only has a practical meaning 
when particular storage conditions (e.g. pH, temperature) and period are also defined.  
The storage period, under certain storage conditions, that can preserve half of the active 
drug molecules, is called the half shelf-life.  A variety of structure changes would take 
place during storage, which gradually leads to a certain degree of irreversible 
destabilisation and deactivation.  For instance, crystallisation of amorphous solids during 
storage is a common phenomenon.  Its advantages and disadvantages have been 
discussed in the literature (Liu 2006) and summarised in Table 1.16.   
Table 1.16 The impact of crystallisation of amorphous solids during storage 
  
Crystallization of 
amorphous drug 
molecules 
Crystallization of stabilizers 
Relative 
possibility 
Less likely More common 
Consequenc
e 
Increase the storage 
stability, reduced 
solubility 
Crystallise to an 
anhydrate 
Crystallise to a 
hydrate 
Lose its function as 
a stabilizer, confer 
water to the drug-
containing 
amorphous phase 
Remove 
plasticising 
water from 
amorphous 
phase 
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Therefore, a robust freeze-drying formulation and cycle does not only depend on the 
sample preparation and freeze-drying operation but also largely relies on subsequent 
preservation during storage, which inevitably should target the end-use point of the drug. 
Due to the scope of this project of freeze-drying process development, the impact of 
storage conditions to the product quality would be less of a focus. The reconstitution of 
lyophilised products was conducted on the same day upon completion of freeze-drying, 
which minimised the instability occurred in the solid state.    
1.5.7 Reconstitution 
Freeze-dried products need to be dissolved into a liquid solution at the point of use.  
This is known as reconstitution.  It is important to ensure that a solid cake can be fully 
dissolved within a certain period, and that end-users do not encounter problems caused 
by un-dissolved powders.   
Protein stability and efficacy may be impacted by several factors during 
reconstitution.  This is summarised in Table 1.17 from the literature (Wang 2000; Liu 
2006).  In order to prevent any undesirable situations, surfactants, stabilisers, buffers 
are recommended to be used instead of pure water for reconstitution (Wang 2000).  This 
is a feasible strategy but it renders the drug administration more complex and requires 
patients to be fully educated.   
Table 1.17 Undesirable consequences for proteins during reconstitution process 
Factors Mechanisms Consequences 
High residual moisture of 
product 
N/A 
Prolonged 
reconstitution time 
Too rapid rehydration Not refold to native form 
Denaturation, 
aggregation, 
reduced activity 
Loss of formulation elements 
during lyophilisation 
pH shift 
Undesirable reconstitution temperature for APIs with 
temperature sensitivity 
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1.5.8 Robustness verification studies for 
process development 
A robust process should be able to withstand various environmental changes.  In 
the following, a range of factors are discussed that can be used to define the desired 
criteria of an optimised freeze-drying cycle. 
1.5.8.1 Reproducibility, feasibility & transferability 
A good process should firstly be reproducible with only slight and acceptable 
deviations in the product quality occurring with the expected degree of process parameter 
variability.  Secondly, it should be feasible to operate, which means it should not be 
labour-intensive and time-consuming.  More specifically, operational procedures and 
expense should be minimised.  The experience of practitioners and resources required 
(e.g. computer source) should be sufficient to operate the required tasks throughout the 
freeze-drying process and sample analysis.  Thirdly, transferability is also important.  
For example, an optimised process should also be well operated in another instrument or 
plant.   
1.5.8.2 Tolerance for operating failures 
A good process cycle should withstand slight deviations in the operating parameters 
and maintain the majority of product stability/activity.  Even though it is crucial to 
undertake experiments under Standard Operation Protocols (SOP), and to regularly 
maintain the devices (e.g. calibration of the meters), the aging of instrumentation is 
somewhat unpredictable and would lead to a small deviation of parameters.  Therefore, 
testing the cycle performance below and above the desired parameters is a good way to 
assess the tolerance of withstanding operating failures.  For example, a more 
conservative condition (lower temperature for drying) and a more aggressive condition 
(higher temperature for drying) has been utilised to test the cycle robustness of freeze-
drying for an antibody (Colandene 2007).   
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1.5.8.3 Scale-up study 
An optimised cycle would lose its market value if it cannot be applied to the 
manufacture at an industrial scale.  For instance, 96-well plates with 200 μl fill volume 
can be used in the initial screening step for the selection of formulation alternatives, 
followed by a verification test in 22 mm external diameter vials with 1 ml fill volume (Grant 
et al. 2009).  However, scale-up to larger volumes of bottles and freeze dryers may also 
be required in some cases. 
Scale-up studies also involve the use of mathematical equations to describe 
mass/heat transfer (e.g. Equation 1.1) and thus define the factors that change the 
process upon scale-up.  The essence is to ensure that at least one of the parameters 
(e.g. sublimation rate) remains constant when scaling up.   
1.6 Summary of protein freeze-drying research 
Based on the previous discussion, it is concluded that freeze-drying is a complex 
bioprocess operation to fabricate therapeutic proteins as stable solids for reconstitution.  
It involves not only the selection of excipients type and concentration but also the 
optimisation of processing parameters.  Thus far, many theories have been described to 
understand processes leading to undesirable reactions.  Advanced analytical methods 
have also been developed to maximise the characterisation of product properties (Ohtake 
et al. 2011; Kamerzell et al. 2011). 
Significant considerations for process control of freeze-drying at each step has been 
briefly summarised in Table 1.18.  It is noted that the influence of some controlling 
methods are not limited in certain steps.  Instead, they may impact some properties at a 
subsequent step.  For example, the cooling is conducted during the freezing step but the 
cooling rate will impact the morphology of the ice and thus affect the sublimation rate and 
the morphology of the final dried product. 
Table 1.18 A brief summary for the process control and analytical methods during freeze-drying 
Process steps Essential properties/events 
Process control & analytical 
methods 
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Formulation General product properties 
Excipients, container, solid content, fill 
volume, etc. 
Characterisation 
of liquid/frozen 
product 
T'g, Te, Tc, annealing, etc. 
DSC, DTA, FDM, TEA, DEA, TMA & 
DMTA 
Freezing 
Thermal  
conductivity, specific surface area  
of ice front, porosity 
Cooling rate 
Primary drying 
(ice sublimation) 
Heat  
transfer 
Radiation (not significant) 
Conduction Temperature difference 
Convection Shelf temperature, pressure 
Mass transfer Condenser temperature, pressure 
Secondary drying 
(water diffusion) 
Drying 
rate 
Diffusion (rate-limiting) Temperature 
Desorption (rapid) (Not significant) 
Characterisation 
of freeze dried 
product 
Size/Conformation/Structure HPLC, DLS, FTIR, CD, etc. 
Surface area BET 
Water content 
and sorption 
Residual moisture 
LOD, TGA, gas chromatography, KF 
titration, near-infrared spectroscopy 
Water desorption DVS, SGA 
Thermal 
property (Tg, 
crystallisation 
propensity, 
etc.) 
Calorimetric analysis DSC, DTA, IMC 
Dielectric and electrical 
analysis 
TEA, DEA, TSC 
Mechanical analysis TMA & DMTA 
(Thermo) Imaging analysis (collapse, 
mobility, surface texture, crystallinity) 
Naked-eye, SEM, XRPD, NMR 
Storage, reconstitution, process 
robustness 
N/A 
1.7 Guidelines for systematic development of freeze-drying 
processes for proteins 
Thus far, there is not a generic way of conducting a freeze-drying process for a new 
product.  Most process development is based on empirical knowledge and a range of 
key factors are selected to optimise the process in a limited range.  As can be seen from 
Table 1.18, there are a number of parameters to be considered and many of them 
interact with each other.  Moreover, numerous physical and chemical reactions (e.g. 
aggregation, unfolding) take place at different stages of freeze-drying, which make the 
deactivation and destabilisation of API unpredictable and difficult to interpret, and it may 
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take decades to fully understand their correlations.  To date, a general methodology of 
undertaking the development of freeze-drying has not been systematically reported 
though extensive work has been done for specific aspects (Hang & Endrick 1996; Pyne 
et al. 2003; Taylor et al. 2010b) or particular protein products (Chang & Fischer 1995; 
Abdelwahed et al. 2006). 
A loop approach is usually undertaken to formulate, freeze-dry and ensure 
preservation of freeze-dried product is achieved.  This will be accomplished in parallel 
with the characterisation of liquid/frozen/freeze-dried state and cycle design as proposed 
(Liu 2006).  This approach is a typical approach for the development of a freeze-drying 
process, and it features the data input from analytical methods to directly optimise the 
formulation (excipients, concentration, etc.) and process cycle (temperature, time, 
pressure, etc.).  Obviously, this loop approach largely relies on experience and the 
protocol developed for a particular product may not be applicable to another active 
ingredient. 
 
Figure 1.13 A typical loop approach to optimise the freeze-drying process  
(Adjust and redraw from (Liu 2006)) 
 
A more rational and systematic approach has been proposed in Figure 1.14.  In this 
approach, the initial development focuses on the formulation and characterization of the 
thermal properties.  The cycle development is then conducted after the optimised 
formulation has been determined, which is accompanied by a cycle robustness test and 
process analytical technology (PAT) tools.  In the end, the scale-up study and PAT 
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implementation will be carried out before the optimised freeze-drying process can be 
licensed. 
 
Figure 1.14 An example of a rational way to systematically undertake freeze-drying process 
development  
(Redrawn from http://freeze-drying.eu/html/research.html) 
 
Based on the above schematic diagram and knowledge about freeze-drying, the 
features of the methodology of a rational freeze-drying process development can be 
summarised as follows. 
 From formulation development to cycle development 
Due to the feature of the freeze-drying unit operation, a range of formulations 
can be tested in 96-well plates, vials, ampoules within a single batch while the 
process parameters (e.g. shelf temperature, time, etc.) can only be tested 
sequentially.  Thus, it would be wise to screen the formulation alternatives in the 
initial stage with a set of “generically good” process cycle parameters. 
 From high-throughput scale-down test to low-throughput scale-up validation 
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This thumb of rule is also generally applied to other development for the 
optimisation of individual unit operations.  Obviously, it is an effective way to test 
the potential operating conditions as many as possible and minimise the cost and 
risk of failures in large scale manufacture. 
 From single, more general objective to more specific, multi-objective optimisation 
The formulation of pharmaceuticals involves the transition from thinking in an 
engineer’s perspective to a pharmacist’s one.  From an engineer’s point of view, 
the target to optimise a process focuses more on the protein itself, which includes 
aggregation, yield of product, etc.  From a pharmacist’s view, the market value 
of the product is more concerned, which includes type of formulation, shelf-life, 
route of administration, etc.  Certainly, these two points of views are correlated 
and they both cover the stability and activity of the drug molecules.  
Nevertheless, it is important to notice that it is impractical to satisfy all the criteria 
in the very beginning.  Thus, a few more generic targets (e.g. aggregation) 
should always come first. 
To sum up, a rational and systematic methodology for the development of freeze-
drying of proteins is required.  It should be straightforward to carry out with detailed 
guidelines and should be applicable for most proteins. 
1.8 The influence of Gibbs free energy on protein stability 
in freeze-drying and liquid formulation 
Formulating protein in a desired form to prevent environmental stress is a long 
standing topic.  Numerous studies have been undertaken to examine the influence of 
various conditions that would affect protein stability.  It has been found (Wang et al. 
2007) that antibodies would denature or aggregate under physical stresses (temperature 
change, shear, etc.) and chemical stresses (disulfide formation, isomerization, oxidation, 
etc.).  Liquid (Wang 1999) and lyophilised formulations (Wang 2000) are common 
methods to preserve the proteins and adequate considerations should be made on the 
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choice of concentration, pH, excipients and process equipment/containers.  However, 
due to the diversity of proteins and research groups, the formulation recipes are not 
standardised and are mostly species-dependent for various proteins, which greatly 
undermines the cross-comparison and usually one formulation technique could not 
directly be applied to another one.  As a result, it takes great effort to screen potential 
formulation conditions for different proteins. 
Therefore, a more fundamental understanding is required of protein instability so as 
to assist more quantitative, standardised and efficient optimisation of formulation 
conditions.  Several theories and mathematical terms have been developed to describe 
the protein-protein interaction and stability.  For example, the osmotic second virial 
coefficient, B22, describes how strong the proteins interact with each other in solution 
(Gabrielsen et al. 2010).  The interaction depends not only on the proteins themselves 
but also on their surrounding environment including pH, temperature and ionic strength 
(Guo et al. 1999; Neal et al. 1999; Haas et al. 1999).   
Gibbs free energy could be used as a term to describe the stability of proteins.  If a 
process is advantageous, the change in Gibbs free energy is negative and the product is 
more stable (ΔG < 0); if a process is disadvantageous, the change in Gibbs free energy 
is positive and the product is less stable (ΔG > 0).  This theory has been applied to 
describe protein folding and unfolding processes.  The spontaneous folding or unfolding 
is regarded as the change of Gibbs free energy towards a more stable state.  Due to the 
lack of consensus, ΔG has been used to indicate either folding or unfolding free energy in 
different research groups (Kaufmann et al. 2010)(Kumar et al. 2006).  If ΔG indicates the 
folding energy, the protein with lower ΔG at certain condition is more stable.  In the 
subsequent discussion, ΔG will be used to indicate the folding energy. 
In order to lower the protein ΔG so as to preserve the protein in a native folded state, 
one can either change the solution condition (e.g. pH, ionic strength, temperature) or 
modify the protein structure like mutation or chemical modification (e.g. PEGylation).  
Using mutation to stabilise the protein has been widely used in pharmaceutical industry.  
If a mutation is more stable than the wild type, the change in ΔG (i.e. ΔΔG) is negative.  
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It has been found that mutations on residues would alter the charge and hydrophobicity 
so as to impact the non-covalent interactions including electrostatic interaction, 
hydrophobic interaction and salt bridge (Lehermayr & Mahler 2011; Chiti, Taddei, et al. 
2002; Bosshard et al. 2004).  It may also alter the secondary structure as more β-sheet 
and less α-helix structure would raise the aggregation propensity (Chiti & Dobson 2006; 
Pawar et al. 2005).  As a result, the change in protein conformation would influence its 
stability and result in unfolding, misfolding and irreversible aggregation (Fu et al. 2010; 
Bloom et al. 2006; Chiti & Dobson 2006).  In order to generalise and quantify the 
conformation change impact on the protein stability, ΔΔG has been used to predict the 
structural alteration influence under certain forcefield by calculating the various 
contributions from different interactions (Benedix et al. 2009; Schymkowitz et al. 2005; 
Das & Baker 2008).  In the later chapters, the mutation impact on protein aggregation 
and stability will be reviewed (Chapter 3); the use of various in silico prediction methods 
for ΔΔG will be discussed and their performance will be evaluated (Chapter 4); the in vitro 
measurement technique for ΔG and Tm will be assessed (Chapter 5). 
1.9 Aims and objectives 
1.9.1 The gap in current freeze-drying research 
Based on the discussion above, we can see that it is not straightforward to select the 
best composition of formulation, optimised process development and rapid and reliable 
measurement.  Many literatures focus on formulation or operating parameters to 
develop freeze-drying process (Wang 2000; Kasper et al. 2013).  Thermal properties 
(e.g. T’g, Tc), moisture content and morphology (e.g. surface area) have been adequately 
characterised and great efforts have been made to ensure the quality of product using 
excipients and adjusted processing parameters (Chang et al. 2005; Meister & Gieseler 
2008).   
However, limited reports are found on development of the lyophilized products by 
modifying the active pharmaceutical ingredient (API) and improve overall Gibbs free 
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energy.  On the other hand, reports have been found that it is practical and useful to 
mutate one or a few residues for proteins in order to raise the stability (Shoichet & Baase 
1995), the production efficiency in fermentation (Kabir & Shimizu 2003) and stability in 
aqueous solution (Teilum et al. 2011).  Therefore, it would be a promising strategy if the 
lyophilised protein products can be stabilised by mutagenesis so as to ease the 
subsequent effort in formulation and process parameters.  As protein stability directly 
relates to the efficacy of the drug of interest, the activity and aggregation of proteins 
should always be considered in the first instance to filter out suboptimal candidates. 
With respect to the regulatory chain for clinical trials, the application of mutagenesis 
needs to be performed in the beginning of clinical and process development. Once the 
mutational work has been conducted, the intrinsic amino acid sequence will need to be 
maintained unchanged throughout the clinical trials. 
1.9.2 Aims and objectives of the project 
This research project aims to investigate how to apply protein engineering principles 
to enhance the quality of freeze-dried biological macromolecules such as antibodies.  
A33 Fab and a range of mutants derived from it will be used as model proteins to study 
freeze-drying. 
Figure 1.15 illustrates the step-by-step strategies used to develop the freeze-drying 
of engineered proteins. 
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Figure 1.15 Schematic diagram for the strategy to conduct the study of freeze-drying of proteins 
 
As can be seen from Figure 1.15, the first study (Chapter 3) aimed to characterise 
the edge effect of the freeze-drying, and propose a method to minimise that.  This 
method was then used to run freeze-drying on 96-well plates in the subsequent studies.  
Afterwards, the impact of surface-charge on Fab was studied for freeze-drying across a 
range of pH, ionic strength and salt types.  Monomer loss and cake morphology were 
used to indicate the Fab stability and cake macro appearance. 
The next step is “Hybrid mutagenesis design” (Chapter 4).  It aimed to develop 
stabilising and destabilising mutants for both freeze-drying and liquid aggregation kinetics 
work in the subsequent two chapters.  Both B-factor and RMSF would be used to 
identify the flexible sites, and with Rosetta to propose potential mutations that could 
rigidify those flexible sites.  In addition, several destabilising mutants would also be 
developed as a reference to validate the mutagenesis strategy. 
In the section of “Freeze-drying of mutants with conformational stability” (Chapter 5), 
the aim was to assess the impact of protein conformational stability changes (ΔTm) due to 
mutations designed from the previous chapter, upon the aggregation tolerance of 
proteins to freeze-drying. The results implied that both Tm and ΔΔG could not elucidate 
adequately the monomer loss after freeze-drying. 
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Due to the more complex range of factors involved in freeze-drying than that in liquid 
phase, it was decided to conduct a series of liquid aggregation kinetics studies (Chapter 
6) upon the designed mutants from Chapter 4.  It aimed to validate the usefulness of Tm 
and ΔΔG more generally for protein formulation, and provide a simpler denaturing 
pathway whereby the aggregation rate might be expected to correlate better.  The 
stabilising effect offered by excipients would also be evaluated, such that propose a more 
efficient formulation screening strategy with good Tm correlations.  
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2 Materials and Methods 
2.1 Materials 
2.1.1 Buffer 
Various solvents and buffers were used for this project.  Most chemicals were 
purchased from Sigma, which included ammonium hydroxide, isopropanol, sodium 
acetate, monohydrate citric acid, sodium citrate tribasic dihydrate, sodium monobasic 
phosphate, sodium dibasic phosphate, potassium monobasic phosphate, phosphoric 
acid, sodium chloride, potassium chloride, and ethanol were purchased from Sigma 
Chemical Co.  Ltd.  (Dorset, UK).  Chemicals used to prepare HPLC solution were 
HPLC analysis grade.  All of the other chemicals were reagent grade (or above).  After 
preparation, buffers were filtered through a Stericup Filter Unit with pore size 0.22 um 
(Millipore, Watford, UK). 
A series of compositions for the buffer used is listed in Table 2.1.   
Table 2.1 A list of buffer compositions 
Buffer Composition 
Final 
pH 
Phosphate 
Buffer Saline 
(PBS) 
KH2PO4 0.2 g/L, Na2HPO4 1.15 
g/L, NaCl 8 g/L, KCl 0.2 g/L 
7.4 
Extraction 
buffer 
12.11 g/L Tris base, 2.92 g/L 
EDTA 
7.4 
Protein G 
equilibration 
buffer  
Na2HPO4 2.655 g/L, NaH2PO4 
0.757 g/L 
7.4 
Protein G 
intermediate 
buffer 
Na2HPO4 2.655 g/L, NaH2PO4 
0.757 g/L, 99.8% isopropanol 
50 ml/L 
7.4 
Protein G 
elution buffer 
Monohydrate citric acid 9.638 
g/L, sodium citrate tribasic 
dihydrate 4.155 g/L 
3.4 
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2.1.2 Growth media for E. coli 
The growth media were prepared according to the formulations indicated in Table 
2.2.  Deionised H2O was used to dissolve the media ingredients, which was then 
autoclaved at 121°C for 20 minutes. 
Agar plates were prepared under aseptic conditions by pouring 15 ml of warm liquid 
agar solution into a petri dish and cooled at ambient temperature.  Afterwards, these 
plates were placed up-side-down, dried at 37°C and incubated at 4°C. 
Table 2.2 The composition of growth media 
Growth Media Composition Final pH 
Luria Bertani (LB) 
agar 
10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl 
+ agar 
7 
Luria Bertani (LB) 
media 
10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl 7 
2XPY media 16 g/L phytone, 10 g/L yeast, 5 g/L NaCl 7 
2XPY agar 
16 g/L phytone, 10 g/L yeast, 5 g/L NaCl, 20 g/L 
select agar 
7 
SM6GC media 
5.2 g/L NaH2PO4, 3.3 g/L Na2HPO4, 4.4 g/L 
KCl, 1.04 g/L MgSO4, 4.16 g/L citric acid, 0.25 
g/L CaCl2, 112 g/L glycerol, 10 ml/L SM6 
elements 
6.8, adjust 
with w/50% 
NH4OH 
(The pH adjustment for SM6GC media should be achieved by a slow addition of NH4OH 
as an excess of pH 7.15 in the local pH would induce the precipitation of phosphates and 
calcium within the solution.) 
2.1.3 Model proteins 
A33 Fab and a range of mutants derived from it were used as model proteins to 
study freeze-drying.  The A33 Fab targets a cell surface marker in cancer cells (King et 
al. 1995; Welt et al. 2003) but its exact antigen has not been recognised yet.  The wild 
type (WT) A33 Fab was provided by UCB Celltech, UK and the various mutants were 
engineered at UCL by Shahina Ahmad during her PhD project (Ahmad 2011).  The WT 
A33 Fab molecule, which exhibits a free cysteine in position 226, tends to dimerise with 
another Fab molecules through disulfide bridge formation.  To avoid this dimerization, 
the free cysteine was mutated into a serine in the C226S mutant (pseudo-wild type).  
Additional point mutants (e.g. K65M, K133M, S75K, L50K) were designed by varying the 
surface charge of the molecule and thus impacting on the aggregation propensity and 
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stability of Fab.  For example, S75K was less prone to form aggregates than the WT 
Fab (Ahmad 2011).   
The production, purification and assays involved to characterise the Fab properties 
are illustrated throughout Section 2.2 and will be used in the subsequent chapters. 
2.2 Methods 
2.2.1 Plasmid Mutagenesis 
The mutagenesis aimed to change the genes in wild type plasmid so that different 
Fab could be expressed during cell culture.  It is mainly made up of “site directed 
mutagenesis” and “TOP 10 transformation”. 
2.2.1.1 Site directed mutagenesis 
In this step, reagents and protocol was used by referring to “QuikChange II XL Site-
Directed Mutagenesis Kit”.  Specifically, a mixture of 5 μl 10x reaction buffer, 2 μl 
dsDNA template (100 ng/μl), 2 μl forward primer, 2 μl reverse primer, 1 μl dNTP mix, 3 μl 
Quik Solution were prepared, which was then topped up to 50 μl by adding ddH2O.  
After that, 1 μl Pfu Turbo DNA polymerase was added to the 50 μl mixture and the whole 
mixture was used for PCR.  The entire PCR consisted of 25 cycles and lasted for around 
7.3 hours with cycling parameters as shown in Table 2.3.  After PCR completed, the 
PCR reaction solution was digested with 1μl Dpn I, which was followed by gentle mixing, 
spinning down for 1 min and incubated for 1 hour at 37 C.  A DNA agarose gel (Section 
2.2.6) was conducted to confirm the reaction products were present and detectable. The 
details of designed primers were listed in the subsequent chapters. 
Table 2.3 PCR operating parameters 
 
Temp  
(°C) 
Time  
(min) 
Heated lid 105  
Initial denature 95 2 
25 cycles 
95 1 
60 1 
68 15 
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Final extension 72 10 
Final hold 4  
2.2.1.2 TOP 10 transformation 
In this step, reagents and protocol were used by referring to “One Shot TOP10 
Chemically Competent E. coli”.  Specifically, competent cells were thawed on ice after 
being taken out from -80°C freezer.  Then 5 μl of PCR synthesis solution was added into 
the competent cell vial with gentle mixing.  The vial was then incubated on ice for 30 
min.  After that, heat-shock was executed by putting the cells into 42°C water bath for 30 
seconds without shaking, which was followed by incubation on ice for 2 min.  
Afterwards, 250 μl S.O.C.  solution was added to the competent cell vial and the vial 
was shaken at 225 rpm in 37°C incubator for 1 hour.  Then the cells were spread onto 
Tet+ LB agar and incubated at 37°C overnight.  If colonies could be observed the next 
day, single colonies would be picked and grown overnight for plasmid extraction and 
sequencing (Section 2.2.2.3, 2.2.2.4) to verify the success of transformation. 
The plasmid purified from TOP10 cells was further transformed into W3110 E. coli 
(Section 2.2.2.5) to prepare glycerol stock (Section 2.2.2.6) for subsequent fermentation 
use. 
2.2.2 Production of cell and plasmid stocks 
The production practise of cell and plasmid stocks was undertaken under aseptic 
conditions with the use of laminar flow cabinet and necessary disinfectants (e.g. 75% 
ethanol).  After being taken out from storage, cells and plasmid stocks were preserved in 
ice. 
2.2.2.1 Streak Cultures 
Streak plates were made to obtain the strict condition to select plasmid before 
culturing.  Cells kept in glycerol stock were scraped and spread onto LB agar following a 
quadrant streak technique, which offers the growth condition for isolated bacterial 
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colonies.  The streak plates were wrapped and sealed with parafilm followed by 
incubation at 37°C for 12-14 hours. 
2.2.2.2 Overnight Cultures 
5 ml LB Media was placed in a 50 ml Falcon tube.  An inoculation loop was used to 
pick cells from a single cell colony in the streak plate and inoculate the Falcon tube with 
LB Media.  The Falcon tube was then incubated attached onto a thermo shaker at 37°C, 
250 rpm for 12-14 hours.   
2.2.2.3 Plasmid extraction 
Protocols adjusted from a QIAprep Spin Miniprep Kit were applied for the purification 
of plasmid DNA from the 5 ml overnight culture in a Falcon tube.  The following 
procedures were conducted with slight adjustment from the kit instructions. 
1. The overnight culture was centrifuged at 5400 g, 4°C for 10 minutes. 
2. After removing the supernatant, the pelleted cells were resuspended in 
resuspension buffer containing RNase A and LyseBlue.  The resuspension of 
cell/buffer mixture was then transferred to a microcentrifuge tube. 
3. Lysis buffer was added with an equal amount of resuspension buffer.  The 
previously added LyseBlue is a colour indicator to visually indicate the extent of 
mixing during the alkaline lysis stage.  A homogeneous coloured suspension 
was eventually obtained after gentle mixing. 
4. A neutralization buffer with the 1.4 fold volume of lysis buffer was added.  The 
solution was drastically mixed until became colourless, which indicated an 
effective SDS precipitation. 
5. The solution complex was then centrifuged at 17900 g for 10 minutes to achieve 
a tight white pellet. 
6. The supernatant was transferred to a 1 ml QIAprep spin column and the DNA 
would bind to the silica-gel membrane within a brief period.  The QIAprep spin 
column was centrifuged for 30-60 seconds and the flow through was disposed. 
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7. To remove the remaining nucleases and carbohydrates bound on the column, 
0.5 ml binding buffer was added and flow through was discarded again after 
centrifugation for 30-60 seconds. 
8. To wash the column, 0.75 ml wash buffer was added.  The column was 
centrifuged for 30-60 seconds and flow through was discarded.  A further 
centrifuge of 60 seconds was used to remove residual wash buffer within the 
column. 
9. The plasmid was eluted by adding elution buffer or water of 50 μl to the column.  
The column was stood for 1 minute, centrifuged for another minute, and flow 
through was collected for the recovery of plasmid. 
Plasmids were stored in water at -20°C for short term storage and elution buffer for 
long term storage.   
2.2.2.4 Plasmid Sequencing  
A Thermo Scientific Nanodrop (Wilmington, USA) was used to verify the plasmid 
solution purity before sequencing.  The sensor was initially washed and cleaned with 
ddH2O.  A baseline was set by the use of water or elution buffer according to the 
plasmid storage condition, followed by the scanning of a 2 μl plasmid solution sample.  
A260/280 of 1.8 is desired to indicate the low contaminant of protein and A260/230 of less than 
2.0-2.2 shows minimal contaminant of lysis/wash buffer or carbohydrate. 
After dilution with ddH2O to 100 ng/μl, the plasmid solution was send to Wolfson 
Institute for Biomedical Research for sequencing together with custom primers at 5 
pmols/μl requested from Operon Biotechnologies.  A BioEdit sequence alignment editor 
(http://www.mbio.ncsu.edu/bioedit/bioedit.html) was used to compare the sequence 
analysis results with the master sequence to recognise any errors within the plasmid 
sequence. 
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2.2.2.5 Bacterial Transformation 
The transformation of E. coli with the plasmids was conducted by using a Bio-Rad 
Micropulser electroporation unit (Hertfordshire, UK).  After allowing the cells to thaw on 
ice, 1 μl plasmid solution (~100 ng plasmid) was transferred to a tube with 50 μl cells 
followed by gentle tapping to mix.  The tube was incubated for 2 minutes and the 
mixture was then transferred to a pre-chilled electroporation cuvette (1 mm gap width).  
The cuvette was inserted into the pre-chilled electroporation chamber without any 
condensation in the unit, and a 1.8 kV electrical pulse was instantly applied to the 
sample.  250 μl SOC media was added to the mixture and the contents of the cuvette 
were transferred to a 15 ml falcon tube and incubated at 37°C, 250 rpm for 1 hour.  After 
incubation, different volumes of pre-culture were dispersed onto 2XPY agar by a lawn 
spreader.  Finally, the plates were sealed with parafilm and incubated at 37°C for 14-16 
hours. 
2.2.2.6 Glycerol stocks 
Glycerol stocks were used for long term storage of E. coli with or without the 
presence of plasmids.  On the condition that the growth is within the log phase, 50 μl of 
40% v/v glycerol/dH2O was filtered with a sterilised 0.2 um PVDF filter and added to an 
equal volume of overnight cell culture.  The stocks were stored at -80°C and would be 
thawed only for immediate use. 
2.2.3 Pilot scale Fab production 
2.2.3.1 Inoculum preparation  
A pre-culture was undertaken to provide a vigorous cell growth condition with a log 
phase production.  The cell suspension of 250 μl was taken from an overnight culture 
and added to 200 ml 2XPY media in a 2 L baffled shake flask.  OD600 was monitored 
periodically by a Cecil Aquarius Spectrophotometer.  After incubating for 4 hours at 
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37°C, 250 rpm and OD600 reaching 1-2, 30 ml pre-culture aliquots were transferred into 
four 2 L baffled flasks each containing 30 ml SM6GC media.  These seed cultures were 
incubated for 12-16 hours until a final OD600 of 4-5 was achieved.  All of the seed culture 
was the inoculum for the subsequent fermentation. 
2.2.3.2 Fermentation (30 L Sartorius)  
The pilot scale fermentation was performed in a 30 L Sartorius Stedim Biostat C Plus 
bioreactor for the production of Fab proteins.  The sterilisation was carried out in situ by 
decanting 18 L SM6GC media into the bioreactor before inoculation.  The feed bottles, 
tubing, inoculum flasks and all other ancillary components were sealed and externally 
autoclaved before using.  After sterilisation, the bioreactor vessel was cooled and 
maintained at 30°C throughout the fermentation process.  After that, the inoculation was 
achieved by a gravity feed of 2 L log phase seed culture into the fermenter vessel via the 
sterilised inoculum flask, yielding an entire working volume of 20 L. 
The fermentation was monitored and controlled on-line.  The overall homogeneity of 
the internal environment was conserved by agitation using a 3-tiered impeller.  A pH of 
6.95 was maintained by the addition of diluted acid (i.e. 15-20% v/v H3PO4) and base (i.e. 
15% v/v NH4OH) solutions through a Biostat control unit.  Adequate oxygen level was 
controlled by sparging sterilised air at 20 L/min.  The mixing of the feed gas with pure 
oxygen (6:4 volume ratio of oxygen:nitrogen) was conducted if the dissolved oxygen 
tension (DOT) was lower than ~40% (assuming standard air as 100%).  An anti-foaming 
agent, namely PPG 2000, was added by Biostat control system to mitigate the cell lysis 
rate. 
The vent gas composition was monitored online during the fermentation.  Culture 
aliquots were taken every 2 hours for OD600 measurement to follow the cell growth.  In 
order to enhance the structural integrity of cell walls so as to reduce the leakage of 
desired intracellular protein, 150 ml of magnesium “shot” (1 M MgSO4.7H2O) was added 
to the fermenter and the temperature was lowered to 25°C to slow down growth rate 
once the OD600 reached 40. 
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A DOT spike and a decrease of carbon dioxide level indicated the advent of a 
stationary phase in which carbon source within the media had been used up and cell 
growth was limited.  At this stage, the bioreactor was switched to fed-batch operation 
with a constant feed flow of 0.7 ml/min 80% w/w glycerol/dH2O, which held the cell 
culture in a stationary phase.  The protein expression was induced by adding 50 ml of 
IPTG (64 mM).  Based on previous fermentation runs, an optimal intracellular target 
protein amount was achieved by commencing the harvest of the cell culture after 22 
hours of the induction. 
2.2.3.3 200 ml fermentation 
DASbox Mini Bioreactor was used to perform fermentation for multiple mutants in the 
same time.  A maximum of four bioreactors were used with working volume around 170 
to 180 ml.  Most of the operating parameters were determined by scaling down from the 
30 L Sartorius fermenter protocol (Section 2.2.3.2).  Due to the miniature property of the 
reactors, several parameters were optimised after conducting a few cycles. 
In the pre-culture stage, 1 ml glycerol stock was taken from -80°C freezer and 
inoculated into 20 ml 2XPY define in a 250 ml shake flask.  The cell culture was 
conducted at 37°C, 250 rpm for 3-4 hours until the OD 600 reached 1-2.  Afterwards, 2 
ml of the cell culture was transferred into 20 ml define media, which was cultured at 
30°C, 250 rpm for around 16 hours until the OD 600 reached 3-4. 
The entire cell culture in define media was then innoculated into the DASbox 
bioreactor, which had already been filled with 150 ml define media.  A minimum DOT of 
30% was controlled by a combination of agitation, gas flowrate and oxygen proportion in 
the gas.  The screw at the end of the gas sparger was removed to prevent blockage due 
to high cell density.  The pH value was maintained at 6.95 by 15-20% v/v H3PO4 and 
15% v/v NH4OH.  Temperature was kept at 30°C in the beginning. 
About 20 hours after inoculation, magnesium shot was conducted when OD reached 
40 and temperature was decreased to 25°C.  Then after around 10 hours, a DOT spike 
was observed when the nutrition had been used up and growth entered a stationary 
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phase.  The OD usually reached 150 to 200.  A fed-batch was conducted immediately 
after DOT spike by adding 0.5 ml 64 mM IPTG and continues 80% w/w glycerol feeding 
at 0.7 ml/h.  It is noted that different mutants would exert various growth profiles so one 
may customise some parameters including agitation rate, Mg shot/IPTG amount and 
glycerol feeding rate.  The fermentation broth was harvested 16-24 hours after induction. 
2.2.3.4 Tubular bowl centrifugation  
Cell harvest was achieved by using a Carr Powerfuge P6 Centrifuge (Sittingbourne, 
UK) with a feedstock flow rate of 500 ml/min.  The slurry temperature was cooled at 
10°C.  The sedimentary solid in the centrifuge were discharged periodically when the 
capacity of centrifuge bowl was reached.  The dewatered cell paste was then split into 
aliquots, packed in sample bags and kept at -80°C. 
2.2.3.5 200 ml centrifugation  
Cell harvest with low volume (100 – 300 ml) was clarified by BECKMAN COULTER 
J2-MC centrifuge (High Wycombe, UK) at 10,000 rpm and 4°C for 90 min.  The 
supernatant was removed afterwards and the sediment cell paste was grabbed out, 
stored into sample bags and kept at -80°C freezer. 
2.2.3.6 Protein extraction  
In order to obtain the target protein whilst minimising the contamination by the host 
cell proteins (HCP), EDTA, which is a chelating agent, was used to disrupt the cell wall by 
removing stabilising agents such as magnesium and release the target proteins in the 
periplasm of E. coli.   
The cell paste was resuspended in extraction buffer to form a 15% w/v slurry.  400 
ml aliquots of the slurry were individually transferred into 2 L baffled shake flasks and 
incubated for 14-16 hours at 50°C, 250 rpm.  The extraction solution was cooled to 
ambient temperature, centrifuged at 10,000 rpm, 4°C for 1.5 hours in a Sorvall Super T21 
centrifuge (Basingstoke, UK) and the supernatant collected and stored at 4°C. 
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2.2.3.7 Protein filtration 
Near solid-free solution from the last protein extraction step was filtered to remove 
any large particles and unwanted proteins of larger size than the target proteins.  This 
was done by using a vacuum filtration system with filtration membrane filters of 
decreasing membrane pore size down to 0.2 um. 
2.2.3.8 Protein G chromatography 
Protein G chromatography was conducted on an AKTA Purifier FPLC system 
installed with a XK50 column.  The column was packed with Sepharose Fast Flow 
Protein G resin.  The purification was initialised by equilibrating the column with 3 
column volumes (CVs) of 25 mM sodium phosphate, pH 7.4.  Afterwards, the protein 
filtrate was loaded through a sample tube by a sample pump without reaching the 
maximum dynamic binding capacity of the Protein G resin.  A first washing step was 
carried out with three CVs of equilibration buffer to remove any unbound substance, 
followed by two CVs of equilibrating buffer plus 5% v/v isopropanol to remove any 
hydrophobically bound impurities.  Finally, the target proteins were eluted by 3 CVs of 
60 mM sodium citrate, pH 3.5, and neutralised by 1 M Tris base, pH 8.5.  The 
neutralised samples were aliquoted and stored at -80°C. 
2.2.3.9 Size-exclusion chromatography 
The product solution at this point contained some protein fragments and aggregates 
of target proteins.  A preparative size-exclusion chromatography (gel filtration) was 
applied to further purify the product.  It was done using an AKTA Prime FPLC system 
with a Superdex 200 chromatography column.  The protein solution was injected into a 5 
ml sample loop and connected to the FPLC system.  Phosphate buffer saline (PBS) 
solution was used during the gel filtration step.  It was conducted by equilibrating the 
column with 2 CV, injecting the sample from the sample loop and recovery for the 
fractions of protein monomers.   
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2.2.3.10 0.02 μm fitlering 
When multiple Fab mutants were needed, it took excessively long period to prepare 
individual mutants through size-exclusion chromatography.  Therefore, Fab samples 
were filtered through Anotop 25 0.02 μm syringe filters (GE Healthcare, 
Buckinghamshire, UK) to remove any aggregates. 
2.2.3.11 Buffer exchange 
Buffer exchange was conducted by using Slide-A-Lyzer Dialysis cassettes with a 10 
kDa cut-off (Fisher Scientific, Leicestershire).  A syringe was used to inject protein 
sample into the dialysis membrane chamber.  A small amount of air was left in the 
syringe before filling the syringe with the sample in order to minimise any sample loss in 
the syringe’s dead volume during injection.  After that, the dialysis cassette was kept 
within a bucket filled with the dialysis buffer, which was more than 200 times the volume 
of the sample.  The bucket was incubated at 4°C with a stirrer rotating at the bottom to 
facilitate the dialysis.  The dialysis buffer was replaced after 2 h before dialysis 
overnight.  The dialysis cassette was taken out from the dialysis buffer the next morning 
and the sample inside the cassette was transferred to a falcon tube and store at 4°C. 
2.2.4 Protein quantification 
The protein concentration was calculated using the Beer-Lambert law: 
𝑐 =
𝐴
ε𝑙
 
Equation 2.1 
 
where A is the absorbance value, ε is the extinction coefficient, l is the path length of 
cuvette and c is the unknown protein concentration.  The extinction coefficient of Fab is 
1.4 (mg/ml)-1cm-1 (Ng & Osawa 1997). 
98 
 
2.2.5 SDS-PAGE 
SDS-PAGE was operated to qualitatively determine the Fab amount from 
fermentation and purification sampling.  For each sample, 15 μl sample, 7.5 μl 0.2 M 
DTT and 7.5 μl 4x Laemmli sample buffer (BIO-RAD) were mixed.  Then the mixture 
was incubated at 95°C for 10 min to denature the protein.  After heat block, a Mini-
PROTEAN TGX Gel (BIO-RAD) was installed on a gel tank.  Protein samples together 
with marker and standard sample were loaded onto the gel wells, which was then run at 
200 V for around 40 min. 
After running the gel, the gel was stained by InstantBlue (Expedeon) for 30 min.  
The staining buffer was then replaced with RO water to de-stain.  The washing water 
was repeated for 2-3 times until clear protein bands could be visualised.  Images were 
taken to record the sample characterisation by SDS-PAGE under white light. 
2.2.6 DNA gel electrophoresis 
DNA gel was conducted to verify if the plasmid of interest existed in the sample.  A 
gel was prepared by adding 0.5 g agarose into 50 ml TBE.  The solution was then 
heated by microwave and shaken to fully dissolve the agarose.  Then 2.5 μl ethidium 
bromide was added and sufficiently mixed.  After that, the entire agarose melted solution 
was poured into a plastic tray and a comb was inserted on its top.  After 10-15 min, the 
agarose cooled down and solidified.  Wells were created by vertically remove the comb. 
The plastic tray containing solidified agarose gel was then put into a gel tank.  The 
electrophoresis was operated at 100 V for around 30 min.  When finish, the gel was 
visualised under UV lamp. 
2.2.7 Freeze-drying 
Freeze-drying was conducted on the freeze dryer Virtis Genesis 25EL.  Micro-titre 
plates filled with solutions were loaded onto the freeze-drying shelves.  Freeze-drying 
cycle was conducted after programming the method on PC.  If not specified, the method 
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parameters were shown in Table 2.4, but it would be adjusted according to practical 
requirement.   
Table 2.4 An example for the process cycle parameters of freeze-drying 
Freezing 
  
Temp 
(°C) 
Time (min) Ramp/Hold  
Step # 1 20 30 H  
Step # 2 -40 120 R  
Step # 3 -40 60 H  
      
Endpoint of 
freezing 
Freeze -40 (°C)    
Extra Freeze 0 (Minutes)    
Condenser -40 (°C)    
Vacuum 500 (Milli Torr)    
      
Primary & 
secondary 
drying 
  
Temp      
(°C) 
Time (min) Ramp/Hold 
Vacuum 
(mTorr) 
Step # 1 -40 60 H 100 
Step # 2 -20 30 R 100 
Step # 3 -20 600 H 100 
Step # 4 25 300 R 20 
Post Heat 25 60 H 20 
Secondary 
drying 
setpoint 
27 N/A N/A N/A 
 
After a freeze-drying cycle had finished, samples were taken out from the chamber.  
Precautionary measures (e.g. stoppers) were used to prevent water vapour from coming 
into the containers.  An eye observation by practitioner was applied to indicate the 
morphology of freeze dried samples in individual containers.  Cake with plumpy 
appearance would be determined as good morphology while those of collapse structures 
would be regarded as bad ones.  The freeze dried solids were then reconstituted with 
reconstitution buffer and shaken onto a thermomixer to achieve reasonable solid 
dissolution at 300-500 rpm for 5 min.  OD600 was carried out again to check the turbidity 
and compare to the previous values of liquid formulation.  The spinning down of sample 
was taken if the reconstitution solution was of high turbidity and solution was transferred 
to another container if necessary.  In the end, the reconstitution solution was analysed 
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by assays as required.  Each type of the assays for a same batch was completed within 
24 h. 
2.2.8 Size-exclusion chromatography HPLC 
(SEC-HPLC) 
Fab fragments, monomer and soluble aggregates within the sample, were analysed 
by size-exclusion chromatography HPLC (SEC-HPLC) on an Agilent Zorbax Bio Series 
GF-250 column (Agilent, Berkshire, UK) with an Agilent 1200 HPLC system, and a mobile 
phase of 200 mM sodium phosphate, pH 7, at a flowrate of 1 ml/min, for 4.5 min in each 
cycle.  Calibration curves were established prior to each batch of analyses.  Protein 
samples at 1 mg/ml were loaded in 10 μl onto the column, and the Fab monomers eluted 
at 2.6 min.  A typical SEC-HPLC profile is shown in Figure 2.1. Analysis was performed 
on liquid formulations prior to freeze-drying to determine the initial monomer 
concentration in each sample, and then again for fully reconstituted freeze-dried products 
to determine the final monomer concentrations.  Relative monomer loss was calculated 
as shown in Equation 2.2. 
𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑚𝑜𝑛𝑜𝑚𝑒𝑟 𝑙𝑜𝑠𝑠 =
𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑚𝑜𝑛𝑜𝑚𝑒𝑟 − 𝑓𝑖𝑛𝑎𝑙 𝑚𝑜𝑛𝑜𝑚𝑒𝑟
𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑚𝑜𝑛𝑜𝑚𝑒𝑟
 
Equation 
2.2 
 
Figure 2.1 A typical SEC-HPLC chromatogram.  
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10 μg of Fab was injected to the Agilent Zorbax Bio Series GF-250 column (Agilent, Berkshire, UK) 
with an Agilent 1200 HPLC system, and a mobile phase of 200 mM sodium phosphate, pH 7, at a 
flowrate of 1 ml/min. Fab monomers were observed at 2.6-2.8 min. 
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3 Impact of surface-charge mutations 
on the freeze-drying of Fab 
3.1 Introduction 
Formulating proteins in a desired form, while preventing degradation during 
manufacturing and storage, is a long-standing challenge.  Considerable research has 
increased our understanding of the conditions that influence protein stability to 
denaturation, chemical modification, or aggregation, such as physical (e.g. temperature, 
shear) and chemical stresses (e.g. pH, redox potential, ionic strength) (Wang et al. 2007).  
Both liquid and lyophilised formulations are commonly used to preserve proteins, and 
typically require the optimisation of protein concentration, pH, buffer type, excipient 
composition, vial/syringe enclosure materials, and process equipment/containers (Wang 
2000; Daugherty & Mrsny 2006; Uchiyama 2014).  Freeze-dried dosage forms offer 
longer shelf-life and ease of storage and transportation (Manning et al. 2010).  The 
influence of process development and formulation upon freeze-drying performance has 
been well characterised (Kasper et al. 2013), and a range of properties including thermal 
transitions (T’g, Teu, Tc) (Kett et al. 2004; Meister & Gieseler 2008), porosity (Fonte et al. 
2012), residual moisture (Schersch et al. 2010), reconstitution rate (Telikepalli et al. 
2015) have been found to be impacted by the freeze-drying process. 
Freeze-drying of proteins is usually conducted with the addition of excipients (e.g. 
disaccharide) to inhibit aggregate (Shukla et al. 2011) and reform the hydrogen bond as 
water is depleted during drying (Mensink et al. 2015).  Lyophilised protein formulations 
with higher concentration has often been suggested as it reduces the fraction of proteins 
accumulated to the ice-liquid interface during freezing (Kueltzo & Wang 2008).  It was 
found that freeze-drying of high protein concentration (115 mg/mL) in buffer-free 
formulations resulted in comparable stabilization to buffer-based formulations (Garidel et 
al. 2015). 
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  Empirical testing of various formulation compositions is typically required in pre-
formulation stage, and usually carried out in vials.  The lower sample volume, and shelf-
space requirements of microscale freeze-drying, now offers the potential to screen many 
more formulations for stability to the freeze-drying process, and simultaneously an 
acceptable final cake morphology.  We previously developed a freeze-drying framework 
using 96-well plates with trimmed bottom lips, in which the microscale activity data was 
found to scale up well into stoppered vials (Grant et al. 2009; Grant, Matejtschuk, et al. 
2012; Grant, Dalby, et al. 2012).  Recently, the freeze-drying of lysozyme formulations 
was explored on a microscale heating stage, with samples under a glass cover slip, or 
inside a hollow circular polypropylene holder (Peters et al. 2014).  This freeze-drying 
platform was similar to that used in freeze-drying microscopy, and the sample holders 
further enabled the pore size and microcollapse to be analysed by scanning electron 
microscopy and micro-X-ray computed tomography, without additional transfer or 
manipulation of samples.  Others have found the freeze-dried solids formed within 
custom fabricated brass well plates, commercial 96-well plates, and conventional vials to 
be comparable in terms of polymorphic form, residue moisture, cake collapse and 
reconstitution time (Trnka, Rantanen, et al. 2014). 
Beyond freeze-drying process and formulation optimisation, proteins can also 
potentially be mutated, or chemically modified (e.g. PEGylation) to improve their stability.  
Mutations have been explored widely for stabilising proteins in the aqueous phase, and in 
vivo (Chiti, Calamai, et al. 2002; Calloni et al. 2005; Teilum et al. 2011).  However, few 
studies have examined the impact of mutations upon freeze-drying performance, and 
these have been limited to only a few specific mutations.  For example, the S80R 
mutation of RNase A was found to increase the population of domain-swapped oligomers 
after freeze-drying in 40% acetic acid solutions (Vottariello et al. 2011).   
In the following sections, the mutation impact on protein aggregation and stability will 
be reviewed.  The impact will be classified into substitution of alanine/glycine and 
proline, charge, hydrophobicity, and secondary structure.   
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3.1.1 Mutation impact by A/G substitution 
The mutation between alanine and glycine has been studied by many researchers.  
Due to the additional methyl in the alanine side chain, the replacement of A/G is an ideal 
mutational example to investigate the impact of β-carbon on protein stability.  The 
mechanism lies in the α-helix stabilisation by alanine (Rezácová et al. 2008), which would 
impact on conformation entropy (Rezácová et al. 2008; Scott et al. 2007).   
In the secondary structure, glycine is not good to form α-helix structure while alanine 
contributes to its formation and occurs more frequently in α-helix structure (Pace & 
Scholtz 1998).  As glycine has no β-carbon, this amino acid can exert more backbone 
conformation flexibility than alanine (López-Llano et al. 2006).  Therefore, it requires 
more free energy to fold the regions with glycine due to the greater loss of entropy 
required.  It was found that mutations of glycines to alanines in amyloid beta-peptides 
would increase the helix content and reduce the beta-sheet formation, which could inhibit 
the amyloid fibril formation (Xu et al. 2005).  Scott (Scott et al. 2007) measured that the 
Ala to Gly mutation typically causes a 0.4 kcal/mol increase in conformational entropy in 
the unfolded state.  After studying 22 A/G mutations in α-helices, Rezacova (Rezácová 
et al. 2008) found that alanine persistently stabilised the conformation compared to 
glycine as more non-polar regions could be buried on folding so as to reduce the 
backbone entropy.  This technique was also used to reengineer G-CSF to increase its α-
helical propensity in the anti-parallel 4-helix bundle (Bishop et al. 2001). 
Alternative findings suggest that glycine acts in a more conserved way in evolution 
and inhibits aggregation (Parrini et al. 2005).  The reason is that glycine exhibits low 
propensity to adopt β-sheet structure, which is a factor that promotes the forming of 
amyloid fibrils.  It is also observed that in elastomeric proteins, a high glycine proportion 
prohibits the formation of aggregate into a stable β-sheet structure (Monsellier & Chiti 
2007).  Therefore, there is a trade-off between using alanine to stabilise the α-helix 
structure and glycine to prevent aggregation. 
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3.1.2 Mutation impact by proline 
The substitution of proline is another strategy to improve protein stability.  It 
performs in the way that its unique side chain pyrrolidine confers to proline a strong 
conformational rigidity, which greatly reduce its entropic instability (Eijsink et al. 2004).  It 
is found that the pyrrolidine makes proline difficult to constitute a β-sheet structure, which 
renders it more conserved in fibronectin type III domains and less prone to aggregate 
(Steward et al. 2002).  The introduction of proline substitution in amyloidogenic 
polypeptide can substantially increase their solubility so as to lessen amyloid formation 
(Williams et al. 2004).   
Proline may also play a destabilising role.  Morimoto (Morimoto et al. 2002) 
conducted several mutations into prolines on amyloid β peptides.  Though most of the 
substitution showed less aggregation propensity, one proline mutant showed much 
higher aggregation propensity, which was thought to form a β-turn structure.  Moreover, 
due to pyrrolidine ring hindrance, proline would disrupt the secondary structure like α-
helix and β-sheet (Savage & Gosline 2008).  Thus, the position of proline in the protein 
secondary structure needs to be considered so as to assist favourable folding free 
energy.  Wedemeyer (Wedemeyer et al. 2002) investigated the protein folding 
mechanism by incorporating non-native proline isomers.  They found that prolines in 
loosely ordered loop positions are not essential; prolines that are completely buried or in 
tight turns should be in their native cis-trans forms so as to properly fold into functional 
structures. 
3.1.3 Mutation impact on protein charge and 
hydrophobicity 
Naturally, the polypeptides of proteins fold in vivo to enable the burial of non-polar, 
hydrophobic residues and exposure of polar, chargeable ones (Dill & MacCallum 2012).  
The compact protein tertiary structure is stabilised by hydrophobic interaction, Van der 
Waals force, hydrogen bond, disulphide bond and salt bridge within the protein, hydrogen 
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bond interaction with solute molecules as well as long-range electrostatic interaction 
between proteins considered as colloidal stability (King et al. 2002; Dobson 2004; Baneyx 
& Mujacic 2004; Stefani & Dobson 2003; Uversky 2003).  The aggregation of proteins 
upon solution condition change (pH, ionic stress) is mostly initiated by unfolding or 
misfolding of proteins, which expose their hydrophobic core to the outer surface and 
enhance the intermolecular interactions including hydrophobic interaction, electrostatic 
attraction and hydrogen bonding (Stefani & Dobson 2003; Uversky 2003).  In order to 
strengthen the intrinsic protein stability, mutagenesis strategies could be applied to better 
pack the hydrophobic core, increase surface net charge and alter secondary structure to 
favour lower aggregation propensity (Lehmann et al. 2000; Eijsink et al. 2004) 
Improving the net surface charge so as to enhance the electrostatic repulsion has 
been utilised by many researchers (Chiti, Calamai, et al. 2002; Lehermayr & Mahler 
2011; Sheinerman et al. 2000).  Chiti (Chiti, Calamai, et al. 2002) studied the mutation 
impact on muscle acylphosphatase (AcP) and found that the aggregation was favoured 
when the charge of mutants was close to neutrality.  Strickler (Strickler et al. 2006) 
engineered more surface charge on five different proteins and observed a notable 
increase in stability over the wild type.   
The extent of charge mutation on protein stability, however, should not be over-
emphasised and should be carefully selected.  As hydrogen bonds and van der Waals 
mainly contribute to the folding stability, charge mutations only give rise to small effect on 
structural stability (Dill et al. 2008).  The free energy change is more accurately 
predicted if the charge mutation locates at the surface (Seeliger & de Groot 2010).  It is 
suggested that the charge-charge interactions stabilise the protein in both folded and 
unfolded states, which may cause the net contribution to be destabilising (Pace et al. 
2000).  An introduction of charge mutation within the hydrophobic core was found to 
destabilise the folded protein structure (Wang & Moult 2001). 
Increasing the hydrophobicity on the protein surface would likely promote 
aggregation.  Munch (Munch & Bertolotti 2010) used a sensitive fluorescent-based 
assay to quantify the hydrophobicity of mutants from copper-zinc superoxide dismutase-1 
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(SOD1).  It was found that the aggregation was initiated by exposing hydrophobic 
surfaces of the mutations.  Wu (Wu et al. 2010) conducted mutagenesis on an anti-IL-13 
monoclonal antibody and found that mutants with lower hydrophobic surface area 
demonstrated improved solubility without affecting the antigen binding affinity.   
As hydrophobic interaction is the essential element that stabilises proteins (Nick 
Pace et al. 2014), mutations that alter the hydrophobic core will destabilise the proteins.  
It has been found that mutations of isoleucine to valine in the buried regions of Borrelia 
burgdorferi protein all decreased the stability compared to the wild type with average of 
1.6 kcal/mol (Pace et al. 2011).  Wang and Moult (Wang & Moult 2001) found that 
several single nucleotide polymorphisms (SNPs) related mutants reduce hydrophobic 
interaction with a loss of non-polar burial area of more than 50 Å on folding. 
However, the substitution of an amino acid would often affect both the charge and 
hydrophobicity simultaneously and so it is not always straightforward to separate their 
individual contribution to protein stability.  An (DuBay et al. 2004) equation has been 
developed to illustrate the aggregation rate by incorporating the intrinsic factors 
(hydrophobicity, hydrophobic patterns, charge) and extrinsic factors (pH, ionic strength, 
protein concentration).   
3.1.4 Mutation impact on secondary structure 
The modification on secondary structure could change the aggregation propensity 
(Chiti & Dobson 2006; Chiti, Taddei, et al. 2002; Fernandez-Escamilla et al. 2004).  Chiti 
(Chiti, Taddei, et al. 2002) found that mutants of human muscle acylphosphatase were of 
higher aggregation sensitivity for regions with higher β-sheet propensity.  They also 
found that (Chiti & Dobson 2006) more α-helical and less β-sheet structure would inhibit 
the aggregation.  Studies on prion protein (Lee et al. 2010; Tahiri-Alaoui et al. 2004) 
revealed that the normal cellular prion protein (PrPc) is predominantly α-helix while 
pathogenic form (PrPSc) is rich in β-sheet.  The conversion from PrPc to PrPSc is 
influenced by the common methionine/valine polymorphism at 129th residue in PrP, in 
which harmful mutants form the intermolecular β-sheet conformation.  A study on human 
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Islet Amyloid Polypeptide (hIAPP) (Dupuis et al. 2011) showed that the early oligomers of 
hIAPP fibrils are formed by self-interaction of β-hairpin monomers. 
3.1.5 Aims of the chapter 
Increasing the net surface charge of a protein has been used increasingly to stabilise 
proteins against aggregation in the liquid state (Chiti, Calamai, et al. 2002; Lehermayr & 
Mahler 2011; Sheinerman et al. 2000; Strickler et al. 2006), and is most likely due to an 
enhanced colloidal stability through electrostatic repulsion, as surface charge mutations 
typically only give rise to small effects on structural stability (Dill et al. 2008), compared to 
the structurally destabilising effects of introducing buried charges (Wang & Moult 2001).  
The impact of surface charge mutations upon stability to freeze-drying has not been 
explored previously to our knowledge.  
Here aimed firstly to more accurately define the freeze-drying process that would 
minimise variability in drying between microwells, and established a process in which Tc 
is not the primary driver for destabilization of the therapeutic Fab fragment under study. 
We then varied the pH, salt type and ionic strength, to study for the first time, the impact 
of protein surface-charge mutations on the robustness of a protein to freeze-drying, and 
also on the cake morphology achieved.  While excipients can be added to stabilise 
against potential charge effects in either liquid or freeze-drying formulations, we aimed to 
examine whether charge effects on the protein actually exerted any influence in freeze-
drying. 
3.2 Materials and Methods 
3.2.1 Homogeneity of drying across the freeze-
dryer shelf  
A test of shelf homogeneity was carried out using polystyrene, flat-bottom 96-well 
microplates (Greiner Bio-one Ltd, Gloucestershire, UK).  The layout (Figure 3.1) of 
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plates on the freeze-dryer shelf enabled a comparison between the presence and 
absence of aluminium plates placed underneath microplates.  It also enabled an 
assessment of the impact of the presence or absence of neighbouring water-filled 
microplates upon the water removal from wells of central four microplates.  Four 
microplates were aligned in the centre of the shelf, alternated with and without aluminium 
plates.  Five microplates placed along the left side of the central four plates had their 
bottom lip trimmed so that each well rested directly on the shelf.  All of the 96 wells in 
the nine microplates were filled with 300 L water.  No microplates were placed on the 
right of the central four plates. 
In the freeze-drying cycle, the temperature was initially kept at 0°C for 60 min, then 
ramped to -30°C over 60 min and held at -30°C for 600 min.  Drying was initialised by 
reducing the pressure to 100 mTorr and held at -30°C for 60 min, then ramped to -25°C 
over 30 min, held at -25°C for 60 min, and then the process stopped, which achieved 
approximately one third of the frozen solution removed by sublimation.  Microplates 
were warmed to room temperature with all the ice thawed, then removed from the 
chamber and immediately covered with an impermeable sticky coversheet (Sealplate 146 
x 79 mm 50 Åm, VWR International, UK) to prevent water evaporation.  Before 
measuring the water remaining in the wells, any droplets adhered to the inner coversheet 
surface were added to the corresponding wells by pipette.  The water from each well of 
the central four microplates, was transferred by pipette to a balance to determine the 
masses remaining in each well.  All measurements were conducted on the same day of 
the freeze-drying. 
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Figure 3.1 The layout of the homogeneity test with 96-well plates  
The four sample plates (light blue and dark blue), filled with 300 μL water, were placed in the 
centre of the shelf. The 1st and 3rd sample plates (light blue) sat directly onto the shelf without 
aluminium plates underneath; the 2nd and 4th sample plates (dark blue) were in contact with aluminium 
plates underneath. Trimmed plates filling with water (brown) were place on the left of the sample 
plates to minimise the edge effect during sublimation. 
 
3.2.2 Differential scanning calorimetry (DSC) 
Aqueous protein samples of 1-2 mg/ml were loaded to 80 L into pre-weighed steel 
pans, with lids and O-rings, and the pan and lid then crimped together.  Sealed pans 
were weighed again to calculate the net sample weight.  Differential scanning 
calorimetry (DSC) was performed on a Q2000 DSC (TA instrument, Crawley, Surrey, UK) 
using a sample pan together with a reference pan.  Samples were held isothermally for 
2 minutes, and then cooling ramped at 10°C/min to -90°C.  Modulation was then applied 
at +/- 1.5°C every 60 seconds with a sampling interval of 1 second.  Heating was then 
ramped at 3°C/min to 25°C.  The glass transition values were determined from the 
transition midpoints using Universal Analysis 2000 software (TA Instruments, New 
Castle, US). 
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3.2.3 Freeze drying microscopy (FDM) 
Freeze drying microscopy was performed on a Lyostat4 (Biopharma Technology 
Limited, Winchester, UK).  Samples were dispensed as 2 L onto the centre of the 
FDCS SP 70 m spacer, and a W13G 13 mm diameter glass slide placed on top using a 
vacuum pen.  The spacer did not contact the sample, and sample edge was moved over 
the microscope aperture via stage manipulators.  Samples were analysed throughout a 
freeze-drying cycle in which the stage was cooled to -40°C at 20°C/min, held at -40°C for 
30 minutes, and then heated to 20°C at 1°C/min.  Images were recorded every 5 
seconds to follow the morphology change, which was used to indicate Tc or Teu.   
3.2.4 X-ray diffraction (XRD) 
X-ray diffraction (XRD) was performed on Rigaku MiniFlex 600 (Ettlingen, Germany).  
Freeze-dried cake samples from a single well or combined from multiple wells, were 
loaded onto the centre of the circular sample holders, and the sample surface flattened 
using a glass slide.  Incident X-rays were fired onto the material and diffraction recorded 
for angles at 3 – 90°, at 5°/min with a step size of 0.02°.  The recorded XRD data was 
firstly converted to .xrdml format by PowDLL (Kourkoumelis 2013) and then analysed by 
PANalytical X’Pert Data Viewer (Almelo, The Netherlands). 
3.2.5 Fab sample preparation 
Fab was expressed and purified as described previously (Chakroun et al. 2016).  
Aliquots were stored at -80°C until required.  Fab samples were thawed at room 
temperature and dialysed overnight at 4°C against MilliQ water using 20 kDa cut-off 
dialysis cassettes (Slide-A-Lyzer Dialysis Cassette, Thermo Scientific, UK).  Samples 
were then filtered through Anotop 25 0.02 μm syringe filters (GE Healthcare, 
Buckinghamshire, UK) to remove any aggregates, and then concentrated to 2 mg/ml with 
30 kDa cut-off Vivaspins (Generon Ltd, Bershire, UK), and stored at 4°C to be used 
within 1 day. 
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3.2.6 Liquid formulations 
Each final sample for freeze-drying contained 1 mg/ml Fab, 20 mM buffer, pH 4-9, 
and either NaCl or Na2SO4 to bring the total ionic strength to 50, 100 or 200 mM.  To 
achieve this, 100 μl 2 mg/ml Fab in water was added to 100 μl double-concentrated stock 
buffer in each well of a microplate.  The buffers used were sodium citrate for pH 4, 
sodium acetate for pH 5, HCl-histidine for pH 6, sodium phosphate for pH 7, HCl-Tris for 
pH 8 and TAPS for pH 9.  For each freeze-drying batch, one mutant was formulated in 
36 different conditions (6 pH x 2 salts x 3 ionic strength), in triplicate, for a total of 108 
samples.  Samples were randomly assigned to the 60 central wells of a 96-well 
microplate, to minimise variations arising from edge effects and plate locations.  Water 
was placed in the outer wells.  Two freeze-drying batch repeats were obtained for each 
mutant (except K133M due to limited sample) to independently examine the process 
reproducibility. 
3.2.7 Size-exclusion chromatography HPLC 
(SEC-HPLC) 
SEC-HPLC was performed based on Section 2.2.8. 
3.2.8 Freeze-drying 
Freeze drying was conducted on a Virtis Genesis 25EL freeze dryer (SP Scientific, 
US).  Microplates filled with 200 μl samples were loaded onto the freeze-drying shelves.  
The shelf was initially held at 20°C for 30 min, then ramped to -40°C over 120 minutes 
and held at -40°C for 60 minutes.  Primary drying was initiated by reducing the pressure 
to 500 mTorr, then holding at -40°C for 60 min with pressure further decreased to 100 
mTorr once holding was initialised.  The temperature was then ramped to -20°C over 30 
minutes and held at -20°C for 600 minutes.  For secondary drying, the temperature was 
ramped to 25°C over 300 minutes with pressure further decreased to 20 mTorr as 
secondary drying started, and held at 25°C for 60 min before stopping.  Samples were 
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stoppered in the freeze-dryer, and then removed from the chamber for immediate cake 
morphology scoring. 
3.2.9 Cake morphology scoring and 
reconstitution 
An eye observation was used to score the morphology of freeze-dried samples in 
individual wells.  Cake morphology was scored against a reference image (Figure 3.2), 
where a plump cake occupying the well was scored 0.9-1; a cake with edge defects or 
non-homogeneous covering of the well was scored 0.5-0.8; and a cake that occupied 
less than half of the well was scored below 0.4, with a score of 0 representing no visible 
cake.  Scores were obtained by two independent practitioners, and averaged to provide 
a semi-quantitative judgement of relative cake morphology.  Freeze-dried solids were 
then reconstituted with 190 μl water, and mixed gently by pipette aspiration 10 to 20 
times to fully dissolve the protein.  OD340 and OD600 nm measurements in a platereader 
were used to verify the turbidity, and mixing repeated if high turbidity was found in any 
wells.  Reconstituted samples were held at 4°C and analysed as above by SEC-HPLC 
within 24 h. 
 
Figure 3.2 The evaluation criteria for cake morphology 
 
3.2.10 Net charge calculation 
The net charge of each mutant (in the absence of salts), was calculated by loading 
PDB files into Propka (Dolinsky et al. 2004). 
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3.2.11 Sweet plot 
The sweet plot was generated by Design-Expert 8.0.6 from the monomer loss and 
cake score response surfaces.  The software automatically searched for the best fitting 
models that resulted in lowest p-value, and suggested models were then used to predict 
the sweet zones that met the inputted user requirement. 
3.3 Results and discussion 
3.3.1 Homogeneity of drying across the freeze-
dryer shelf 
A homogeneous removal of water from samples is a pre-requisite for the quantitative 
comparison of formulation stabilities in a freeze-drying process cycle.  The freeze dryer 
is specified to provide homogeneous cooling to within 1°C difference across the shelf.  
However, due to the structure of a freeze dryer, certain areas of the shelf can experience 
more or less efficient drying rates due to the impact of the condenser, vacuum pump and 
the chamber shell.  Edge effects, in which samples sitting on the edge experience a 
higher drying rate than those in the centre, is fairly common for freeze drying, and needs 
to be minimised.  The water vapour pressure above those samples at the edge is lower 
than that in the centre, leading to a higher mass-transfer rate for samples at the edge.  
Moreover, the drying rate also varies for different container geometries and materials 
within.  As a result, any factor that can induce heterogeneity should be minimised. 
The aim of the homogeneity test was to map water removal during freeze-drying in 
different areas of the shelf, to determine the extent of edge effects when using 96-well 
microplates, and to trial the use of aluminium plates for establishing thermal contact 
between wells and the shelf.  A previous pioneering study facilitated the use of 96-well 
microplates for freeze-drying, with hundreds of samples assessable in one process cycle 
(Grant et al. 2009).  That work also revealed a decreased drying rate from the central 
wells within a single 96-well microplate, compared to those on the outer edges.  To 
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achieve relatively homogeneous water drying, only the central 60 wells were used for 
samples, while the outer-edge wells were filled with water.  As an alternative approach 
we tested the placement of water-filled microplates around the sample-containing plates, 
to provide necessary water vapour pressure.  In the previous study, the bottom lips of 
microplates were trimmed off so that the well bottoms were in direct contact with the 
freeze-drier shelf.  To avoid trimming every microplate, a simpler approach would be to 
place an aluminium plate in the air gap between the well bottoms and the shelf.   
Figure 3.1 shows the layout of the homogeneity test using 96-well microplates.  The 
centre region of the shelf was chosen to load plates because it could offer relatively 
homogeneous drying compared to the shelf edge.  Trimmed plates filled with water were 
placed on the left of the four sample plates to investigate whether this setting could 
minimise edge effects during freeze drying of 96-well microplates.  Figure 3.3 shows the 
mass of water remaining in each well of the four microplates, after partial drying in the 
homogeneity test.  As can be seen, edge effects within each microplate were observed 
with higher drying rates in the outer wells of all four microplates, compared to those in the 
centre.  The edge wells on the left side, adjacent to the water-filled trimmed plates, had 
a slightly lower drying rate than those on the right. 
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Figure 3.3 The mapping of water remaining in the four 96-well plates for the homogeneity test of 
shelf  
The layout details were shown in the Figure 3.1 legend. A gradient of light blue to dark blue was 
used to indicate the remaining water from more than 0.25 g to 0.16 g of each well after the 
homogeneity test. 
 
Very little significant difference in drying rates was observed between the drying of 
microplates with and without aluminium plates underneath.  This suggests that the 
aluminium plate does not improve the heat-flow considerably between the shelf and well 
bottoms as expected, and may even have introduced some slight heterogeneity as 
shown in the second and fourth plates.   
The final setting in Figure 3.4 was selected to achieve homogeneous drying for 
samples in the central 60 wells highlighted, with water in the outer wells, for each of the 
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four central 96-well microplates.  The surrounding trimmed plates are also filled with 
water.  Aluminium plates were not used beneath the plates.  Using SEC-HPLC for the 
characterisation of freeze-dried solutions with a 5 minute cycle time, a total of 240 
samples required 20 hours to process. 
 
Figure 3.4 A proposed layout for freeze-drying in 96-well microplates 
 
3.3.2 DSC and FDM to validate the freeze-drying 
cycle parameters 
3.3.2.1 DSC to measure the glass transition temperature 
The glass transition temperature (T’g) is a key characteristic for a freeze-drying 
formulation.  The freezing temperature should ideally be lower than the T’g, to ensure 
that the frozen sample is vitrified into an amorphous state.  Modulated-temperature 
differential scanning calorimetry (DSC) enables the deconvolution of reversing and non-
reversing signal (Gill et al. 2010), to allow a more accurate determination of T’g from the 
reverse heat-flow component (Kett 2001).  Figure 3.5 shows the DSC profile of Fab in 
pure water for the reverse heat-flow (green line).  A T’g could not be detected ascribed to 
the low concentration and low protein molecular weight of Fab, with no other thermal 
events observed such as endothermic relaxation.  The inflection point (-4.58°C) was the 
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initial melting of ice.  The profile for Fab at pH 4, with NaCl added to an ionic strength of 
200 mM, was dominated by the eutectic crystallisation of NaCl at above -24°C, still the 
Tg’ of Fab could not be clearly identified (Figure 3.5, blue line).  Therefore, FDM was 
used to characterise the Tc as the DSC could not detect the T’g due to the low 
concentration of Fab. 
 
Figure 3.5 The DSC profile for Fab.   
Green line: Fab at 2 mg/ml in water; blue line: 1 mg/ml Fab at pH 4 with NaCl to make the total 
ionic strength at 200 mM 
 
3.3.2.2 FDM to measure the collapse temperature 
FDM was used to determine the critical collapse temperature, Tc, which directly 
represents the collapse phenomenon under vacuum conditions (Meister & Gieseler 
2008).  It has been observed that collapse during freeze-drying had no effect on 
aggregation or the integrity of freeze-dried proteins in a saccharide system (Sarciaux et 
al. 1999; Taylor et al. 2010c), which might be different from the salt system applied in this 
study.  Therefore, we selected our highest salt condition at pH 7 for Tc measurement by 
FDM, as a worst-case formulation. 
119 
 
 
Figure 3.6 Freeze-drying microscopy for 1 mg/ml Fab at pH 7, and NaCl to 200 mM ionic strength 
 
As shown in Figure 3.6, the vacuum was applied at -40°C and the drying frontline, 
observed as a black thin line, migrated to the centre of the sample as the temperature 
was increased progressively, and as the ice sublimed.  No structural change was 
observed within the drying frontline until around -30°C, where some pink regions 
appeared behind the sublimation front in the dried region.  These indicated degeneration 
in the dried structure, and led afterwards to complete structure loss near the drying front.  
Therefore, the Tc was close to -30°C, and so carrying out the primary drying at -40°C was 
sufficiently low to prevent the cake structure from collapsing in most formulations.   
Having established a microscale freeze-drying process in which the well-to-well 
variability was not significant, where the freezing and primary drying temperatures were 
well below the Tc, we then investigated the influence of pH, ionic strength, salt type, and 
protein surface charge mutations, on the retention of the protein monomer, and the cake 
morphology. 
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3.3.3 Formulation and mutant effects on 
monomer loss 
The scope of this research focused on the effect of buffer conditions and mutations 
upon freeze-drying.  Therefore, the conventional preservation by disaccharide was not 
applied.  The monomer loss for each mutant during freeze-drying is shown in Figure 3.7, 
where it can be seen that the freeze-drying process led to 10-30% monomer loss in most 
cases.  The data varied greatly for different pH, mutant types, salt types and ionic 
strengths.  Despite the clear general trends arising from formulation factors, we 
observed batch-to-batch variations, and hence we averaged the batch data together to 
determine the underlying trends in the following discussion. 
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Figure 3.7 The monomer loss of Fab mutants determined by SEC-HPLC 
Data were averaged from two freeze-drying batches, except K133M with one batch.  Triplicates 
was used within each batch.  Error bars are Standard Error of the Mean (SEM).  The Y-axis scales are 
matched for ease of cross comparison.  One data point of K133M at pH 8, Na2SO4, 100 mM was 
ignored where the cake floated out from the well. 
 
3.3.3.1 Influence of pH on monomer loss 
The influence of pH on monomer loss is shown in Figure 3.8, averaged from the 9 
freeze-drying batches carried out (two repeats for each of the five mutants, except 
K133M).  The monomer loss of all the mutants in general decreased as the pH was 
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increased from 4 to 9.  The trend was mostly monotonic, except for a spike at pH 5, 
which gave an unexpectedly higher monomer loss, and a dip at pH 6, such that 
interestingly, pH 6, 8 and 9 were more favourable than the physiological pH 7.   
The t-test (Figure 3.8B) showed that monomer loss at pH 4 was significantly higher 
than any other higher pH except pH 7, and significantly lower than at pH 5; monomer loss 
at pH 5 was significantly higher than any other pH conditions; monomer loss at pH 7 was 
significantly higher than Ph 8 and 9.  Formulation at pH 6 achieved comparable 
monomer loss with respect to pH 7, 8 and 9; while monomer loss was also comparable 
between pH 8 and 9. 
 
(A) 
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(B) 
Figure 3.8 Average monomer loss for formulations with different pH  
(A) Each data point was averaged from all the 3 ionic strengths, 2 salt types and repeats of in total 
9 batches (n=162) for the 5 mutants. The error bars were standard error of the mean (SEM).  
(B) The p-values of two-sample t-test assuming unequal variances for the monomer loss in (A). The 
p-values less than 0.05 were highlighted in green. 
 
All mutants and also C226S tended to aggregate the most upon freeze-drying at low 
pH.  While the increased net positive charge at low pH can exert greater electrostatic 
repulsion between protein molecules, the increased ionic strength can conversely lessen 
intermolecular long-range electrostatic repulsions, allowing hydrophobic interactions to 
dominate.  The same conditions also lead to decreased conformational stability of A33 
Fab (Chakroun et al. 2016), due to increased short-range intramolecular electrostatic 
repulsion, and also the weakening of salt bridges.  The combined effect would be a 
greater population of both partially and globally unfolded protein states, and faster 
aggregation from those states during freeze-drying. 
It is interesting that pH 7 was not the optimal pH condition for the freeze-drying of 
Fab, and that the pH-dependence was not simply monotonic.  It is well known that the 
pH in the solution phase during freeze-drying can undergo dramatic changes due to the 
freeze-concentration effect as liquid water freezes, in a manner that depends on the 
buffer species and also the ionic strength.  In addition, some buffer species can become 
frozen prior to the others.  For example, Na2HPO4 can crystallise prior to the co-
crystallisation of NaH2PO4 and Na2HPO4 if the initial pH is 7, which induces a shift to 
lower pH (Franks & Auffret 2007).  Therefore, the lower performance at pH 7 for Fab 
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freeze-drying may also indicate that the phosphate buffer did not maintain pH 7 during 
freezing, whereas Tris and TAPS buffers are not greatly affected by freezing.   
The stabilising effect at pH 8 and 9 was potentially also caused by attractive 
electrostatic interactions at close to the pI of 9, which can promote precipitation in the 
native folded state.  The protein was freeze-concentrated during freezing, and its 
solubility dropped at subzero temperature, which caused it to precipitate when its 
concentration was over-saturated.  Such precipitation may be reversible and hence 
serve to protect Fab from aggregation or unfolding during the freezing and drying 
processes.  Owing to the precipitation, the protein is less likely to interact with Cl- or 
SO42- at higher pH, and this would also potentially result in less conformational change. 
3.3.3.2 Influence of pH and mutants on monomer loss 
Figure 3.9 shows the pH impact on individual mutants for the freeze-drying monomer 
loss.  The rank order of the mutants was broadly similar from pH 6-9, and also at pH 4, 
but changed considerably at pH 5, at which condition, the salting in and destabilising 
effect of acetate was likely to have had an adverse impact.  We separately compared 
citrate and acetate buffers at pH 4 and found that acetate led to considerably more 
monomer loss than citrate (Section 3.3.3.3).  Pseudo wild-type C226S and the two 
positively modified mutants, S75K and L50K, each witnessed a spike at pH 5, while two 
negatively modified mutants, K65M and K133M, showed a decrease in monomer loss at 
pH 5 compared to pH 4.  In general, except for K65M, pH 6 to 9 provided similar 
degradation stress in freeze-drying, where the monomer loss varied within 3% for each 
mutant.  The K65M mutant was most sensitive to pH change, and dipped 5% at pH 6, 
rose 4% at pH 7, and decreased again by 7% and 3% at pH 8 and 9 respectively, and 
influenced most of the overall trend in Figure 3.8, as it also resulted in the highest 
monomer loss. 
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Figure 3.9 The impact of pH for each mutant upon monomer loss  
Each data point was averaged from all the three ionic strengths, two salt types and repeats of two 
batches (n=36). The error bars were standard error of the mean (SEM). 
 
The sensitivity of the mutants to pH, during freeze-drying was greatest at pH 5 
overall.  The average monomer loss (across all pH) followed K65M > K133M > C226S > 
L50K/S75K.  This sensitivity difference was caused probably by mutants’ surface 
charge.  S75K and L50K increased the net charge by one, which made them generally 
more colloidally stable, and less sensitive to positive hydrogen ions at low pH compared 
to C226S.  K65M and K133M decreased the net charge by one so they were less 
colloidally stable and caused more monomer loss almost across all the conditions.  The 
charge decreases on K65M and K133M also results in increased hydrophobicity, which 
made them less sensitive to pH change.  The significant drop for K133M at pH 5 is very 
interesting, as it was the opposite to all other mutants.  This may have resulted from an 
increased rate of protective precipitation with this mutant of higher surface 
hydrophobicity, when the salting-in destabilising effect by acetate buffer was reduced.   
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3.3.3.3 Influence of acetate and citrate pH buffer on monomer loss 
 
Figure 3.10 Average monomer loss for S75K formulations with/without acetate at pH 4 and 5  
Error bar: standard error of the mean. 
 
A stable pH and proper ionic strength are the key elements that affects the protein 
aggregation in freeze-drying.  A good selection of buffer type and salt concentration 
plays an important role to stabilise protein in a native state.  Figure 3.10 shows that the 
use of acetate buffer at pH 5 resulted in more monomer loss than those with citrate buffer 
at pH 4.  This suggests that even though pH 4 is more extreme for protein, probably the 
salting-in effect of acetate destabilised proteins.  This may also be attributed to sodium 
acetate’s low T’g (-80°C) that would cause collapse (Chang & Randall 1992).  In order to 
make sure acetate buffer is detrimental to Fab stability, the most stable mutant S75K was 
formulated at pH 4 with acetate buffer and went through freeze drying.  As shown in 
Figure 3.10, it turned out that when S75K was used, pH 4 acetate condition resulted in 
three times the monomer loss compared to pH 4 citrate and pH 5 acetate.  Therefore, it 
is very obvious that the acetate buffer is not a good option for freeze-drying. 
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3.3.3.4 Influence of salt types and ionic strength to monomer loss 
The influence of salt types and ionic strength (IS) on monomer loss is shown in 
Figure 3.11, averaged from the 9 freeze-drying batches.  The monomer loss was 
comparable between formulation with NaCl and Na2SO4 at 50 and 100 mM IS.  At 200 
mM IS, samples containing NaCl had significantly 5% more monomer loss than samples 
containing Na2SO4. 
 
Figure 3.11 Average monomer loss for formulations at different salt types and levels of ionic 
strength  
Each data point was averaged from all the 6 pH and 3 repeats in 9 batches for the 5 mutants 
(n=162). Error bars were standard error of the mean. Two-sample t-test assuming unequal variances 
were performed between formulation with Na2SO4 and NaCl at 50, 100 and 200 mM ionic strength, 
respectively (*** p<0.001, ** p<0.01, * p<0.05). 
 
The Hofmeister series ranks the ability of anions and cations to salt-in and salt-out 
protein (Baldwin 1996).  For anions, Cl- is of higher ion chaotropicity than SO42-, and 
exerts more salting-in effect, in which anions preferably interact to polar protein residues, 
increase the protein solubility and change its conformation (Roberts et al. 2015).  Anions 
with lower chaotropicity (higher kosmotropicity) salt-out more strongly, where preferable 
*** 
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hydration of anions induces the dehydration of protein, increased protein-protein 
attraction, and ultimately precipitation.  
The effect of the Hofmeister series, and particularly NaCl and Na2SO4, on freeze 
drying has been studied previously.  It was noted that kosmotropic salts could preserve 
enzyme activity through preferential hydration (Ru et al. 2000), while freeze-drying with 
NaCl resulted in remarkable aggregation, oxidation and deamidation (Pikal et al. 1991; 
Sarciaux et al. 1999).  It was also found (Izutsu & Kojima 2000) that NaCl lowered T’g of 
protein-nonionic polymers mixture 5 to 20 °C more than Na2SO4 when salt molarity 
ranged from 50 to 200 mM.  It was suggested that the salting-in NaCl largely removed 
protein from the polymers’ protection and formed polymer-rich and protein-rich phase 
separately; the salting-out Na2SO4, however, was separated from the protein-polymer 
mixture, remained the mixture in a single phase and did not alter its T’g. 
As shown in Figure 3.11, formulations with Na2SO4 performed better than their NaCl 
counterparts at 200 mM ionic strengths.  Increasing ionic strength resulted in greater 
monomer loss, with an average monomer loss of 10.63%, 13.20% and 16.27% for 50, 
100 and 200 mM NaCl respectively.  By contrast, Na2SO4 led to an initial increase in 
monomer loss from 10.57% to 11.92% for 50 and 100 mM, respectively, but then did not 
increase further at 200 mM Na2SO4.   
Protein-protein and protein-salt interactions in the aqueous phase have been studied 
extensively (Roberts et al. 2015; Bye & Falconer 2014; Roberts et al. 2014).  The 
difference between NaCl and Na2SO4 at 50 and 100 mM IS was comparable, as it is 
generally thought that favourable hydration of protein molecules occurs at low ionic 
strength, where the net charge of a protein dominates the overall repulsive protein-
protein interaction (Lehermayr & Mahler 2011).  Therefore, comparable monomer loss 
was detected at low IS.  By contrast, the monomer loss difference was significant at 200 
mM IS, as the hydration layer is removed from proteins as ions compete for water at 
higher ionic strengths (Bye & Falconer 2014), while the repulsive electrostatic interaction 
between proteins becomes more shielded.  During freezing, the solute concentration 
rapidly increases as liquid water forms ice.  For Na2SO4 samples, the SO42- ions would 
129 
 
exclude Fab from its hydration shell and promote protein precipitation.  This salting-out 
effect could effectively maintain the native state of Fab if precipitation occurs rapidly.  By 
contrast, Cl- ions would more likely bind the Fab surface, and neutralise the protein net 
positive charge, but also destabilize and partially unfold the protein by weakening salt-
bridges, that leads to unfolding and also aggregation as the Fab becomes concentrated 
in the unfrozen phase.  During reconstitution, most of the Fab precipitated in the Na2SO4 
sample would dissolve back to a native state, while those in NaCl may misfold or remain 
aggregated. 
3.3.3.5 Influence of salt types, ionic strength and mutants to 
monomer loss 
Figure 3.12 analyses the influence of salt for individual mutants.  Fab mutants all 
responded more to an increase in ionic strength with NaCl than with Na2SO4, except 
K133M which was insensitive to ionic strength with NaCl.  The response of monomer 
loss across 50-200 mM ionic strength with NaCl was similar for all mutants (except 
K133M).  With Na2SO4, the monomer loss for pseudo wild-type C226S increased initially 
with IS from 50 mM to 100 mM, and then plateaued to 200 mM.  K65M and K133M also 
potentially had minor increases with IS from 50 mM to 100 mM, and dropped to a 
comparable level at 200 mM compared to 50 mM.  By contrast, the two mutants with 
one additional positive charge, S75K and L50K, were each relatively insensitive to IS 
from 50-200 mM. 
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Figure 3.12 Average monomer loss for formulations at different salt types, levels of ionic strength 
and mutants 
Error bars are standard error of the mean. Each data point was averaged from all the 6 pH and 
repeats of 2 batches for each mutant (n=36, except K133M with one batch and n=18). 
 
Ionic strength clearly differentiated the monomer loss of mutants based on their 
charge at 50-100 mM, more than it did at 200 mM.  This is consistent with the net 
charge on the proteins having an influence on colloidal stability that becomes more 
effectively weakened at higher ionic strength, particularly as freeze concentration raises 
the local ionic strength.  At 50 mM in particular, pseudo wild-type C226S, the mutants 
S75K and L50K with one additional positive charge, were more colloidally stable than 
those with one less positive charge (K65M and K133M).  The insensitivity of K133M to 
ionic strength in NaCl appears to be derived from an increase in monomer loss at low 
ionic strength, given that K133M was more stable than K65M under all other conditions.  
This indicates that the K133M variant was more sensitive to unfolding at lower NaCl 
concentration, possibly due to removal of a potential salt bridge interaction that it forms 
with E216 in the heavy chain.  This further suggests that this salt bridge interaction is 
particularly critical to stability of the Fab. 
3.3.3.6 XRD to examine the crystallinity of the sample 
As formulation with Na2SO4 generally resulted in decreased monomer loss and a 
higher cake morphology score than with NaCl at the same ionic strength, from 50 mM to 
200 mM, X-ray diffraction (XRD) was used to measure the crystallinity of freeze-dried 
samples, so as to determine the influence of crystallinity in freeze-drying.  It has been 
found previously that the crystal pattern depends on material composition, drying 
process, storage condition, and relative humidity (Haque & Roos 2005).  To avoid 
significant interference by signal and noise from the sample holder, samples from a total 
of 12 replicate wells were combined onto the centre of the sample holder.  This was 
sufficient to obtain an XRD pattern of predominantly the freeze-dried material. 
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Figure 3.13 The X-ray diffraction patterns for NaCl and Na2SO4 conditions with and without Fab  
The signal from a blank sample holder is shown in dash, thin, black line for both Figure A and 
Figure B.  All the samples were combined from 12 wells of freeze-dried cake in identical conditions.  
Samples were in pH 5, 20 mM acetate buffer, and either NaCl or Na2SO4 to bring the total ionic 
strength to 200 mM, with or without 1 mg/ml C226S Fab.  In Figure A, NaCl condition with no Fab is 
coloured in orange; NaCl condition with Fab is coloured in blue.  In Figure B, Na2SO4 condition with no 
Fab is coloured in green; Na2SO4 condition with Fab is coloured in red. 
 
The samples freeze-dried at pH 5, 200 mM were analysed by XRD as Fab stability 
was most significantly different between the Na2SO4 and NaCl formulations in these 
conditions (Figure 3.7).  Figure 3.13 shows the XRD intensities for a blank sample 
holder, and also NaCl and Na2SO4 samples, both with and without Fab.  The two peaks 
that appeared at diffraction angles of 44.5° and 78.0° with a blank sample holder were 
ignored when analysing the freeze-dried samples.  The NaCl formulations gave higher 
crystallinity at diffraction angles larger than 50°, whereas Na2SO4 samples resulted in 
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higher crystallinity at diffraction angles smaller than 50°.  The addition of Fab in the NaCl 
formulation partially suppressed three of the peak intensities, with no peak 
enhancements, or new peaks formed.  By contrast, with Na2SO4, the presence of Fab 
resulted in new or enhanced peaks at 22°, 23°, 26°, 38°, 46° and 52°, and suppression of 
peaks at 19°, 28°, 29° and 48°.   
These results suggest that a slightly more amorphous phase, or proportion of the 
material, was achieved in the presence of Fab, for the NaCl formulation.  By contrast, 
the presence of Fab in the Na2SO4 formulation led to a slightly altered but still crystalline 
state.  In general, the differences caused by Fab were small and the XRD patterns 
indicated that the freeze-drying with Fab retained most of the crystallinity attributable to 
the salts.  Figure 3.7 shows that the C226S Fab with NaCl resulted in nearly 30% 
greater monomer loss than with Na2SO4 at pH 5 acetate, 200 mM ionic strength.  While 
previous studies found that proteins in an amorphous state correlated to stabilisation by 
excipients that could interact with them (Section 1.3.2.1) (Izutsu & Kojima 2002), the 
present study indicated the opposite effect.  Given the small differences in crystallinity, it 
is unlikely that relative effects of NaCl and Na2SO4 on monomer loss are due to their 
impact on crystallinity. 
3.3.3.7 Molecular analysis for the influence of mutations on 
monomer loss 
Mutational charge is linked strongly to aggregation and related amyloid diseases 
(Chiti, Calamai, et al. 2002; Calloni et al. 2005), with increased aggregation when the 
protein net charge approaches its isoelectric point (pI) (Chiti, Calamai, et al. 2002; Chi, 
Krishnan, Kendrick, et al. 2003). 
Table 3.1 The net charge of mutants at different pH as calculated by PropKa 
pH C226S S75K L50K K65M K133M 
4 26.68 27.83 27.77 25.62 25.79 
5 16.43 17.47 17.65 15.28 15.54 
6 11.1 12.1 12.2 10 10.12 
7 8.46 9.49 9.35 7.33 7.46 
8 6.84 7.85 7.81 5.81 5.85 
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9 4.44 5.43 5.41 3.48 3.48 
 
 
 
 
(A) 
 
 
(B) 
Figure 3.14 Average monomer loss for the different mutants  
(A) Each data point was averaged from all the three ionic strengths, two salt types, 6 pH and 
repeats of two batches (n=216). Error bars were standard error of the mean.  
(B) The p-values of two-sample t-test assuming unequal variances for the monomer loss in (A). The 
p-values less than 0.05 were highlighted in green. 
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The net charge of each mutant (in the absence of salts) are listed in Table 3.1.  The 
average monomer loss of the mutants during freeze-drying were ranked in the order 
S75K < C226S < L50K < K133M < K65M as shown in Figure 3.14A, although the 
differences between S75K, C226S, L50K were statistically insignificant (Figure 3.14B).  
The average monomer loss increased from 9-11% for S75K, C226S, and L50K, and then 
to 14% for K133M and 18.5% for K65M.  This shows that while adding one positive 
charge (L50K and S75K) did not significantly stabilise C226S colloidally, the removal of 
one positive charge (K133M and K65M) was colloidally destabilising.  This suggests that 
although C226S already possessed sufficient net charge to provide colloidal stability, this 
colloidal stability was easily lost.  As the pI of C226S Fab is calculated to be between 
8.41 (Chakroun et al. 2016) and 9.44 (Ahmad 2011), Fab was positively charged across 
essentially all of the pH conditions tested.  Removal of just one positive charge would 
significantly increase the number of conditions at which the net charge is close to zero.  
By contrast, the addition of one more positive charge has less potential for impact where 
the net charge is already more than 10 at pH 4-6 as calculated from PropKa. 
Mutational charge has been recognised as one of the reasons that contribute to 
aggregation and related amyloid diseases (Chiti, Calamai, et al. 2002; Calloni et al. 
2005).  Protein tends to associate with each other when they do not possess net charge 
as an electrostatic repulsion for long-range interaction.  It has been found that 
aggregation is favoured when the protein net charge approaches its isoelectric point (pI) 
(Chiti, Calamai, et al. 2002; Chi, Krishnan, Kendrick, et al. 2003).  Studies also found the 
removal of charged residues would result in destabilisation (Sheinerman et al. 2000).  In 
this work, one positive charge is removed on the surface of K65M and K133M.  
Therefore, compared to the wild type C226S, the instability results of K65M and K133M is 
in accordance with previous work as their net charge is one unit closer to neutrality when 
the working pH condition is below their pI. 
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Figure 3.15 The overlay of the predicted structure before and after the K65M mutation  
Mutation is shown in cartoon in Picture A and stick in Picture B.  C226S is coloured in cyan with 
residue 65 in red; K65M is coloured in green with residue 65 in yellow. 
 
 
Figure 3.16 The overlay of the predicted structure before and after the K133M mutation  
Mutation is shown in cartoon in Picture A and stick in Picture B.  C226S is coloured in cyan with 
residue 133 in red; K133M is coloured in green with residue 133 in yellow. 
 
The monomer loss in K65M is 4% more than that in K133M.  As both of the 
mutations are on the loop regions of heavy chain, the difference in monomer loss may 
due to their mutational positions that lead to different biophysical properties.  As 
calculated by POPS (Fraternali & Cavallo 2002; Cavallo et al. 2003), the K65M and 
K133M positions are of SASA fraction 68.81% and 54.16% before mutating, and SASA 
fraction 38.08% and 63.97% after mutating.  Shahina also found that K65M is of lower 
solvent accessible surface area (SAS) (21,208.3 Å2) than that of K133M (21,241 Å2) 
(Ahmad 2011).  This liquid kinetic work also showed that K65M was significantly less 
stable than any of other mutants.  Therefore, nearly half of the SASA is reduced by the 
K65M mutation while K133M mutation even yields more SASA.  As a result, the 
electrostatic repulsion is greatly weakened by K65M. 
136 
 
Compared to C226S, adding one more positive charge almost has no effect to the 
monomer loss in S75K and L50K.  This phenomenon suggests that even though the 
electrostatic repulsion could inhibit the association of Fab but its effect is limited.  
Moreover, long-range electrostatic interaction is a weaker force compared to hydrophobic 
interaction and hydrogen bonding.  As a result, its benefit for stabilising may be shielded 
and even acts in a destabilising role if short-range non-covalent interaction is 
compromised.  Studies (Pace et al. 2000) have found that charge-charge interactions 
actually stabilise the protein in a native state, but they also reduce the free energy in the 
unfolded states. 
 
Figure 3.17 The overlay of the predicted structure before and after the S75K mutation  
Mutation is shown in cartoon in Picture A and stick in Picture B.  C226S is coloured in cyan with 
residue 75 in red; S75K is coloured in green with residue 75 in yellow 
 
 
Figure 3.18 The overlay of the predicted structure before and after the L50K mutation  
Mutation is shown in cartoon in Picture A and stick in Picture B.  C226S is coloured in cyan with 
residue 50 in red; L50K is coloured in green with residue 50 in yellow 
 
In the present work, the mutational charge changes in S75K and L50K led to less 
than 1% less and less than 1% more monomer loss, respectively.  As shown in Figure 
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3.17 and Figure 3.18, even though both of the mutations are not predicted to change the 
secondary structure, the relative exposure of the two positions to the outer surface is 
different.  As calculated by POPS (Fraternali & Cavallo 2002; Cavallo et al. 2003), the 
S75K and L50K positions are of SASA fraction 52.59% and 25.51% before mutating, and 
SASA fraction 91.22% and 41.03% after mutating.  Therefore, the S75K position locates 
relatively outward compared to L50K.  The mutated lysine in S75K could play an 
important role in supressing protein-protein attraction by repulsive electrostatic 
interaction.  The mutation to lysine in L50K, on the other hand, may create more steric 
disturbance and less intra-chain hydrophobic stability. 
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3.3.4 Formulation and mutant effects on cake 
morphology 
 
Figure 3.19 The cake rating of freeze-dried Fab mutants averaged from two freeze-drying batches, 
except for K133M with one batch.   
Triplicates were used in each batch.  Error bars were standard error of the mean.  The scales of 
all the vertical axes were set at the same level for the ease of cross comparison.  One data point of 
K133M at pH 8, Na2SO4, 100 mM was ignored due to the cake floating out from the well. 
 
The cake morphology scores obtained by visual inspection of all freeze-dried Fab 
samples are shown in Figure 3.19.  Scores ranged from 0 to 1 with more acceptable 
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cakes formed at higher ionic strengths.  The cake scores showed a complex 
dependence on pH and mutants. 
3.3.4.1 Influence of pH and mutants on cake morphology 
 
Figure 3.20 The impact of pH for each mutant upon cake morphology 
Each data point of cake morphology was averaged from all the 3 ionic strengths, 2 salt types, and 
repeats of 2 batches for each mutant (n=36). 
 
Figure 3.20 shows the mutants’ cake morphology at different pH after freeze-drying.  
The mutants in general behave similarly at different pH.  The cake morphology dipped at 
pH 5 and increased at pH 6 (except K133M), then it fluctuated between score 0.3 to 0.45 
at pH 7-9.  C226S resulted in 0.1-0.2 higher than the average of the four other mutants, 
but this was due to the observers’ criteria change over the later freeze-drying batches. 
In fact, the cake scores largely depended on the mass of the cake.  Therefore, a 
green dash line was plotted against the five mutants line in Figure 3.20.  This is to 
determine if the variations among different pH were caused by cake mass or the pH 
conditions.  At pH 4-7, the cake of all mutants, except K133M, closely related to the 
trend of their mass change.  At pH 8-9, most mutants, except C226S, tended to remain 
plateau instead of rising to a highest score.  The C226S mutant was most sensitive to 
the change of pH; while K133M was least sensitive across all the pH. 
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The pattern of average mass change (black dash line in Figure 3.20) across the pH 
looked relatively the opposite of the trend of monomer loss as observed in Figure 3.8.  
Therefore, a correlation was plotted in Figure 3.21.  The plot showed that approximately 
30% of negative correlation could be seen between the monomer loss and cake mass.  
This is very interesting as an increasing cake mass would reduce the monomer loss on a 
pH level.  This may be explained as a higher cake mass was more likely to retain the 
cake within the well, instead of floating out during freeze-drying. 
 
Figure 3.21 The correlations between monomer loss and cake mass at different pH 
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3.3.4.2 Influence of salt types, ionic strength and mutants on cake 
morphology 
 
Figure 3.22 Overall cake morphology score for formulations adjusted with NaCl or Na2SO4  
Each data point was averaged from all the three ionic strengths, 6 pH and repeats of 9 batches for 
the 5 mutants (n=486). Error bars were standard error of the mean. Two-sample t-test assuming 
unequal variances were performed between formulation with NaCl and Na2SO4 (*** p<0.001, ** 
p<0.01, * p<0.05). 
 
 
Figure 3.23 Average cake morphology score for formulations at different ionic strength adjusted 
with NaCl or Na2SO4  
Each data point was averaged from all the 6 pH and repeats of 9 batches for the 5 mutants 
(n=162). Error bars were standard error of the mean. Two-sample t-test assuming unequal variances 
were performed between formulation with Na2SO4 and NaCl at 50, 100 and 200 mM ionic strength, 
respectively (*** p<0.001, ** p<0.01, * p<0.05). 
 
*** 
*** 
*** 
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The impact of ionic strength on the average cake morphology scores for NaCl and 
Na2SO4 formulations are shown in Figure 3.23.  Cake morphology was improved at 
higher ionic strength, and the scores converged at 200 mM Na2SO4 and NaCl.  The 
significantly higher cake morphology scores for Na2SO4 relative to NaCl at 50 and 100 
mM ionic strength were not due to the higher cake mass obtained for Na2SO4 (Figure 
3.24).  Alternatively, XRD analysis indicated that Na2SO4 formulations had the higher 
crystallinity, which may also explain the difference in cake morphology.  SO42- is also 
known to be able to raise the T’g of L-arginine while Cl- had minor effect or decreased the 
T’g (Izutsu et al. 2005), while the use of salts with higher eutectic melting temperatures 
(Na2SO4 -2°C, NaCl -23°C) can also avert cake collapse (Chang & Randall 1992).  This 
suggests that in the current work, higher T’g or crystallinity of Na2SO4 may reduce the 
chances of cake collapse and give rise to a more aesthetic cake form. 
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Figure 3.24 The theoretical mass formulated in each well by considering buffer salt, neutral salt 
(NaCl or Na2SO4) and protein 
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3.3.5 Monomer loss vs cake score 
Though the cake appearance is an important factor for the drug final dosage form, its 
relevance to protein stability, however, is not validated.  A poor looking cake is usually 
acompanied with collapse.  It has been found (Schersch et al. 2010) that compared to 
non-collapsed one, even though the collapsed cake had lower specific surface area and 
more residual moisture, the protein stability was preserved and with similar reconstitution 
times.  In this work, the cake morphology was not correlated with monomer loss (R2 = 
0.0131) as shown in Figure 3.25, which is consistent with previous work. 
 
Figure 3.25 The correlation between cake score and monomer loss 
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3.3.6 Sweet plot for “monomer loss” and “cake 
morphology” 
 
Figure 3.26 The sweet plot for freezing drying performance with cake score > 0.6 and monomer 
loss < 0.15 
 
The cake morphology and monomer loss were not correlated, and thus the 
conditions that are acceptable for both objectives can be investigated using a “sweet 
plot”, in which several threshold boundary lines are overlayed (Grant et al. 2009).  
Figure 3.26 shows the sweet zones (yellow areas) when setting a cake score > 0.6 and 
monomer loss < 0.15.  Clearly, the formulation with Na2SO4 yields a much larger 
acceptable area than with NaCl.  For NaCl, the sweet zone is at an ionic strength above 
170 mM and at pH > 7.  For Na2SO4, the larger sweet zone is at an ionic strength above 
110 mM, and across all pH tested.  Therefore, if monomer loss and cake appearance 
are the main factors to consider, it is preferable to select Na2SO4 as the additive with 
which to control ionic strength. 
3.4 Conclusion 
This experiment demonstrated a rapid way to screen key formulation and protein 
property factors that influence the freeze-drying performance.  This was applied to 
investigate for the first time, the impact of protein surface-charge mutations on the 
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tolerance to freeze-drying.  It is interesting that even only single amino acid substitutions 
that alter the surface charge of the Fab molecule, could greatly influence the aggregation 
during freeze-drying.   
With no additional excipients added, the solution composition was relative simple to 
enable a clearer interpretation of the impact of mutants, pH and ionic strength and neutral 
salt type.  Mutants with one net surface charge removed led to increased monomer loss, 
whereas addition of one net charge had relatively little impact.  This indicated that the 
pseudo-wild-type Fab was already just above a critical point in colloidal stability whereby 
other factors had more dominant influences on monomer loss.  High ionic strength, low 
pH and use of NaCl led to greater monomer loss.  The ionic strength or the mass of the 
cake contribute mostly in improving the cake appearance while the other factors showed 
less impact.  Compared to NaCl, the use of Na2SO4 is a better option to minimise the 
monomer loss while retaining the cake morphology. 
The monomer loss data suggests that the freeze-drying system is complicated even 
in a relative simple solution composition without any excipients.  As batch-to-batch noise 
and replicates deviations may contribute to the low variation, several measures are 
recommended to provide a more robust, reproducible dataset.  These measures include 
1) use mat stoppers to cover the 96-well plates to prevent cake floating out; 2) use single 
channel pipette if multi-channel pipette is not accurate enough; 3) prepare stock working 
buffer at a time and aliquot them in freezer; 4) consider more repeats if triplicates deviate 
considerably; 5) it is better to run more mutants in each cycle with fewer conditions if one 
aims to differentiate the mutants’ response on freeze drying stress. 
The monomer loss observed in this experiment is not large enough (less than 50%) 
to differentiate the mutational impact on protein stability.  A suboptimal freeze-drying 
process could be developed in order to cause more monomer loss and larger 
improvement space for protein stability.  Double or triple mutants that encompass 
advantageous substitutions could be considered to reduce the aggregation propensity.  
To better elucidate the stresses, freeze-thawing could be used to separate the stresses 
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caused by freezing and drying individually.  In addition, the activity would also need to 
be assessed. 
The present study proposed a strategy of altering the active pharmaceutical 
ingredients (API) to improve their stability in freeze-drying.  Though clinical formulation 
would not contain high salt, the salt conditions used here help us probe the impact of 
charge modification.  Further study could focus on excipient screening on the API and 
buffer condition with improved cryoprotection and lyoprotection (e.g. higher charge, low 
salt and pH closing to pI).  We hope this API-based modification could be a 
complementary method for the traditional excipient-based formulation development. 
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4 Hybrid mutagenesis design and 
pilot scale production 
4.1 Introduction 
4.1.1 Bioinformatics tools to indicate the 
disorder of residues 
4.1.1.1 RMSF 
The advance of computer technology has enabled researchers to model complex 
biomolecules, their dynamics and interactions, as well as to calculate their free-energy 
(Pronk et al. 2013).  Root mean square fluctuation, or RMSF, measures the deviation 
over time between a particle position and its reference position.  By modelling the 
solvent environment around a protein, as a virtual box of water molecules, and then 
simulating the effects of thermal energy on molecular dynamics over time, the 
disturbance of atomic coordinates can be determined as an RMSF and used to indicate 
the relative flexibility of protein residues.  This information would offer insights that can 
guide potential mutations with the aim of replacing the flexible residues with amino acids 
that lead to more stability through improved interactions or packing.   
Many software packages and forcefields are currently available to carry out 
molecular dynamics (MD) simulations for macromolecules, including CHARMM (Brooks & 
Brooks 2009), Gromacs (Pronk et al. 2013; Abraham et al. 2015) and AMBER (Case et 
al. 2005; Salomon-Ferrer et al. 2013).  MD simulations can be carried out on the 
molecular equivalent of the ps to ns time scale, which could cover local flexibility of 
methyl rotation, loop motion and side-chain rotamers (Henzler-Wildman & Kern 2007).  
Therefore, MD simulation is a valuable way to further analyse the structures generated by 
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X-ray crystallography or NMR, as deposited in the protein databank (PDB).  Ohmura 
(Ohmura et al. 2001) conducted a simulation for mutants of hen egg white lysozyme and 
successfully identified stabilising mutants.  RMSF values calculated from MD were found 
to be very similar to the B-factor values obtained by X-ray crystallography.  Together 
with dynamic Van der Waals energy, the stable mutants could fill the cavity in the core 
and strengthen the hydrophobic interaction without introducing unfavourable Van der 
Waals energy.  Another study (van der Kamp & Daggett 2010) on pathogenic mutations 
discovered that conformational flexibility was altered by mutations.  Two mutants 
exhibited notable Cα RMSF increases, which was most significant for residues around 
the points of mutation. 
4.1.1.2 B-factor 
B-factors (or temperature factors) are determined by X-ray crystallography, and are 
normally annotated within the standard PDB file format in the column after atom’s 
Cartesian coordinates and occupancy value.  It represents the extent of thermal motion 
of an atom such that a high B-factor value indicates a high fluctuation for that atom (Yuan 
et al. 2005).  Similar to RMSF, the B-factor is another index that can be used to 
determine if a specific residue is highly flexible.   
If the PDB file is not available, the B-factor can be predicted based on its sequence, 
and comparison to a large dataset of known PDBs (Yuan et al. 2005).  The B-factor is 
closely correlated with the protein secondary structure, as it reflects the disorder and 
flexibility of the folded conformation.  It has been found (Linding et al. 2003) that protein 
disorder is mostly found in loop or random coil regions of protein structures, as these 
exhibit the highest B-factors for Cα atoms.  To predict a more accurate loop structure for 
a sequence with unknown structure, available structures with homologous sequences 
can be cross-compared.  Those with lower B-factors in the target loop, and also similar 
sequence identities can be used to model the unknown loop structure (Choi & Deane 
2010). 
150 
 
Due to the different settings in X-ray crystallography and the heterogeneity of various 
proteins, the B-factor values are often determined at different scales.  Therefore, 
normalisation is required to compare multiple B-factor values on a similar scale and to 
remove outliers (Smith et al. 2003).  After normalising, B-factors have been used to 
guide iterative saturation mutagenesis and increase the thermostability of a lipase, by 
modifying only sequence regions with the highest B-factors (Reetz & Carballeira 2007).  
In that approach, a program was developed to calculate the amino acid B-factor by 
averaging all of its atom B-factor values except hydrogen.  It was found that two 
hyperthermophilic mutants displayed melting temperature 40°C more than the wild type 
after a 60 min heat treatment. 
4.1.2 Design of stable proteins based on 
consensus tools 
Functional proteins evolve so as to adjust to their neighbouring environment.  
Deleterious mutations become extinct and helpful ones remain.  As a result, the regions 
that keep their consistency usually play an essential role to maintain the stability or 
functionality of proteins (Miller & Kumar 2001).  For the structures of antibodies, most of 
the residues retain high sequence similarities in order to form a “Y” shaped conformation 
and target the various antigens through their CDR (Complementarity Determining 
Region).  The consensus theory can be used for two purposes, 1) it would be better to 
apply mutagenesis on non-consensus regions or, mutate the residues back to conserve 
ones originally exist in the ancestors so as to inherit its stability from ancestor species; 2) 
if the atomic structure is unknown for the protein of interest, one can use homology 
modelling to predict its structure by using a resolved, homologous structure.  However, 
the non-consensus regions may locate at the CDR.  Therefore, mutations upon the CDR 
would affect the binding and activity, which needs to be considered before mutagenesis. 
The influence of stability upon protein evolvability has been well studied (Bloom et al. 
2005; DePristo et al. 2005).  It is found that more than half of the single mutants 
151 
 
introduced into most proteins, would retain their native functions (Bloom et al. 2006).  
However, most of the mutations are neutral or deleterious to the level of that function.  
As missense mutations accumulate, the stability of a protein is exponentially decreased, 
which greatly affects the ability of a protein to adapt new functions (Tokuriki & Tawfik 
2009).  In order to improve the stability without compromising the functionality (or vice 
versa) of proteins, one can align the sequences of homologous species, identify the 
consensus sequence and design amino acid substitutions towards the consensus.  It 
has been found that (Steipe et al. 1994) the most frequently occurring amino acids exhibit 
a greater stabilising effect than less frequent ones.  To test the “consensus approach” 
the consensus sequence of a phytase was first calculated from a total of 19 homologous 
sequences (Lehmann et al. 2000).  Then, they constructed the Consensus phytases 
were then constructed, expressed, purified and their Tm-values measured.  The results 
showed that over 20°C improvements in the Tm could be obtained without compensating 
the catalytic activity.  In later research, many others also confirmed the “consensus 
approach” with improved protein stabilities (Lehmann & Wyss 2001; Jackel et al. 2010). 
4.1.3 Homology modelling 
Homology modelling (or comparative modelling) aims to predict the 3D structure of a 
protein based on its amino acid sequence and available structures with homologous 
sequences.  It is used when the experimental structures (e.g. x-ray, NMR) are not 
available in the database (Ginalski 2006).  Homology modelling can be classified into 
two categories, which are template-based modelling and ab initio methods.  The 
template-based method is used when the unknown structure has a high amino acid 
sequence similarity with one or more experimental structures.  The ab initio (or “de 
novo”) method is used when the sequence similarity to known structures is low.  So far, 
most templated-based methods have focused on cases when the sequence identity is 
greater than 35% (França 2015). 
The homology modelling building procedure is carried out step-by-step.  A general 
protocol involves template selection, sequential alignment, backbone/loop/sidechain 
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modelling, model optimization and validation (Venselaar et al. 2010).  In order to 
produce an accurate estimation for the native-like structure, the prediction work requires 
a comprehensive understanding for the evolutionary mechanism, sufficient sequence 
similarity searches from protein database and reasonable estimation for primary and 
secondary structures according to statistical distribution (Pavlopoulou & Michalopoulos 
2011). 
Various computational tools are available to achieve this purpose, which include 
Modeller (Webb & Sali 2014), SWISS-MODEL (Biasini et al. 2014; Arnold et al. 2006), 
and Phyre2 (Kelley et al. 2015).  A contest, Critical Assessment of Structure Prediction 
(CASP), for evaluating the performance of these predictions tools is held every two years 
(Moult et al. 2014).  Enormous progress has been achieved over the past 20 years for 
prediction accuracy.  The Z-score is used as a statistical measurement to describe how 
likely the energy of a predicted structure deviates from its misfolded ensemble 
conformations (Zhang & Skolnick 1998).  A good Z-score value should be within the 
characteristic range for proteins with a similar size in the same group (Wiederstein & 
Sippl 2007).  In the CASP10 competition, “BAKER-ROSETTASERVER” achieved the 
top position in the Z score analysis in the “Assessment of template-based protein 
structure predictions” (Huang et al. 2014).  Therefore, it is advantageous to use Rosetta 
to build the homology model based on an existing homologous structure. 
4.1.4 Computational prediction of protein G 
upon mutation 
A range of computational methods have been developed to predict the overall 
change in protein stability (ΔΔG) due to mutations.  Due to the complexity of 
macromolecules resolved in atomic scale, a computational method needs to compromise 
between the “search problem” and the “scoring problem” (Potapov et al. 2009).  With 
limited computational resources, the “search problem” aims to search potential 
conformations in greater number and detail; whereas the “scoring problem” aims to 
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describe as many structural interactions as possible.  Two types of forcefield are 
generally used.  One is the physical-based potentials (PBP), which considers the 
fundamental physical forces within atoms; and the other is the knowledge-based 
potentials (KBP), or statistical potentials, which depend more on a statistical summation 
derived from protein datasets (Potapov et al. 2009; Khan & Vihinen 2010).  Some 
methods are an integration of PBP and KBP (e.g. Rosetta), which can thus be classified 
as “empirical potentials” (Potapov et al. 2009; Khan & Vihinen 2010).  In addition, some 
prediction methods have been developed based on machine learning algorithms (e.g. 
neural network, support vector machine) (Capriotti et al. 2004; Cheng et al. 2006) and a 
combination of PBP, KBP and machine learning has also been developed (Khan & 
Vihinen 2010). 
Potapov (Potapov et al. 2009) has evaluated six computational tools to predict the 
protein ΔΔG.  It has been found that the correlation coefficients range from 0.26 to 0.59 
for Rosetta, Hunter, FoldX, I-Mutant2.0, CC/PBSA and EGAD, respectively.  However, 
those methods perform differently on different structure locations.  For example, 
CC/PBSA and Rosetta work better for exposed residues than buried ones while the other 
four methods work in the opposite way; FoldX and Rosetta predicted best for 
unstructured regions while the other four methods behave best for β-sheet mutations.   
Khan & Vihinen (Khan & Vihinen 2010) conducted a performance test for 11 online 
stability predictors.  It has been found that I-Mutant3.0 (structure version), Dmutant and 
FoldX achieved the best accuracies from 0.54 to 0.64.  They also compared the 
predictors performance on the mutation location properties (secondary structure, 
accessible surface area) and the overall protein structure categories (e.g. mainly α-
helical, mainly β-stranded, etc.).  They found that most programs behave with similar 
accuracy on secondary structural elements.  I-Mutant2.0, FoldX, MUpro, MultiMutate, 
and CUPSAT resulted in the best in sensitivity for structure categories.  Most programs 
except MultiMutate gave better prediction accuracies on exposed mutations than buried 
ones. 
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Niroula (Niroula & Vihinen 2016) has conducted a comprehensive review of the 
protein stability prediction by bioinformatics approaches from the human medical 
perspective.  Various aspects have been discussed, which include mutation databases, 
the principles implemented to identify variations-function correlations (machine learning, 
evolutionary conservation, energy functions) and a range of prediction tools.  Moreover, 
the extant problems are illustrated, which include improper transplanting of methods, 
overfitting and imbalance of training data. 
As discussed above, recent years have witnessed a tremendous progress in 
predicting protein stability.  Besides the problems mentioned above, there are still some 
other issues that impede the accuracy of the algorithm.  The most important one is the 
theoretical solution condition is usually not explicitly defined.  It is known that the ΔG not 
only relates to the protein itself but also depends on its surrounding environment.  
However, the aqueous solution conditions that are used to generate the experimental 
data differ across different labs.  As a result, the impacts of pH, temperature, ionic 
strength have not been sufficiently considered, or an “average” condition is reflected 
based on the sampling data.  Similarly, the processing parameters are also not fully 
addressed.  Though many studies are undertaken in aqueous solution, some stability 
tests are carried out in some other forms like freeze-thawing, freeze-drying and spray 
drying.  Some stresses involved in these treatments are not the same as those in 
aqueous phase or exhibit at different degrees.  In conclusion, the trained protein stability 
predictors are not adequately optimised if the contribution of solution interaction 
ingredients and processing parameters are not taken into account. 
4.1.5 Rosetta 
Rosetta is a flexible, multi-purpose protein modelling software.  It has been 
developed since 1998 and has achieved considerable progress in structure prediction 
(Chivian & Baker 2006), design (Kuhlman et al. 2003), stability improvement, and protein 
molecule docking (Leaver-fay et al. 2014). 
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In general, Rosetta uses both physical-based and knowledge-based potentials to 
capture hydrophobic effects, van der Waals interactions and hydrogen bonding (Das & 
Baker 2008).  To describe covalent bonding, Rosetta does not use physical-based 
potentials to describe bond torsion, but instead applies empirical torsion angle 
distributions (preferred rotamers) derived from the database of PDB structures.  To 
describe the protein folding or packing, the hydrophobic effect and electrostatic 
desolvation cost are computed by a Lennard-Jones potential with an implicit solvation 
model.  Hydrogen bonding is computed by an explicit hydrogen-bonding potential.  In 
order to score a protein structure so as to indicate its stability, the free energy is broken 
down into various elements (e.g. Van der Waals, solvation, electrostatics) and each 
element is assigned a weighted contribution.  As a result, the total free energy is 
computed as the weighted sum of the component energies (Leaver-fay et al. 2014). 
However, there are still some problems not optimally addressed.  The first one is 
that the long-range electrostatic interaction is ignored (Das & Baker 2008).  Therefore, 
some colloid stability caused by protein-protein electrostatic repulsion is not considered, 
which may lead to some bias when linking unfolding with aggregation.  The second one 
is that the entropy of a structure is not sufficiently considered.  It is approximated that 
the conformational entropies of various properly folded protein are similar (Das & Baker 
2008).  As a result, the stability scoring of a structure is based on a single PDB structure 
instead of ensembles of potential structures.  The third one is that due to the empirical 
nature of the scoring function, some energy terms are considered more than once.  For 
example, due to the complexity of quantum mechanical effects, the torsional potentials 
could not be decomposed into individual classical contributions, which may be over-
emphasised in non-bonded interaction energy terms.   
Potapov assessed the performance of Rosetta together with five other available tools 
for prediction of protein ΔΔG upon mutation (Potapov et al. 2009).  It was found that 
Rosetta performed less well than the others as scored by correlation coefficient.  
However, the operation parameters were not listed in the paper and we do not know the 
exact application executable file used.  As a response to the poor performance of 
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Rosetta, Kellogg conducted a thorough search to identify the optimal relaxation approach 
upon point mutation (Kellogg 2011).  It was found that the minimisation method involving 
limited backbone minimisation after repacking all sidechains achieved the highest 
experiment-prediction correlation coefficient of 0.69.  In spite of the improved prediction 
accuracy, it was noted that the structure samples used in Kellogg’s testing were all no 
greater than 350 residues.  Therefore, there remains a question as to whether the 
protocol is also applicable for larger protein molecules like antibodies including the 
antibody fragment Fab used in this project with 442 residues. 
4.1.6 Aims of the chapter 
The aim of this chapter was to develop stabilising and destabilising mutants for both 
freeze-drying and liquid aggregation kinetics work in the subsequent two chapters.  As 
flexibility is an important mechanism in defining overall protein stability (Fields 2001), 
both RMSF and B-factor would be used to determine the flexible sites, and then Rosetta 
used to identify potential mutations that could rigidify those flexible sites (Yu & Huang 
2014).  Several destabilising mutants would also be developed as a reference to 
validate the strategy.   
4.2 Materials and Methods 
4.2.1 In-silico mutagenesis 
The design of new mutants was conducted using the Rosetta software (Das & Baker 
2008).  Rosetta is a protein modelling software suite that uses algorithms for in-silico 
modelling and structure analysis.  The entire mutagenesis procedure encompasses the 
following three elements: 
 Structure cleaning 
 Homology modelling 
 Mutating and scoring 
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In the “Structure cleaning” step, the crystal structure of human germline antibody 5-
51/O12 (PDB ID 4KMT) was downloaded from the PDB website 
(http://www.rcsb.org/pdb/explore/explore.do?structureId=4KMT).  The raw PDB file was 
cleaned and only the “ATOM” section was retained.  The residue number was 
renumbered from 1 to 442, taking the original light chain numbering of 1 to 214, and 
heavy chain from 215 to 442.  Then hydrogen atoms were added to make a full-atom 
structure. 
In the “Homology modelling” step, Rosetta method “minirosetta” (Chivian & Baker 
2006; Raman & Vernon 2009) was applied to replace the residues in the 4KMT model 
with those from A33 C226S.  There are five disulfide bonds within the C226S variant, 
which are  
 Interchain disulfide bond: LC214 – HC220 
 Intrachain disulfide of light chain (LC): LC23 – LC88, LC134 – LC194 
 Intrachain disulfide of heavy chain (HC): HC144 – HC200, HC96 – HC22 
It was found that disulfide bonds randomly existed after residue replacement by 
“minirosetta”.  Therefore, in order to obtain a relatively promising model with all five 
disulfide bonds intact, 20,000 PDB were generated, clustered and ranked according to 
Rosetta Energy Unit (REU).  After residue replacement, 6811 structures contained all 
five intact disulfide bonds.  Among them, 1000 structures of the lowest score were 
selected.  A clustering step was then used to group multiple structures based on their 
similarities.  It aims to identify which category of structures is mostly likely to represent 
the real model.  During the clustering step, the largest category consisted of 573 
structures and the structure with the lowest score among that category was selected as 
the model of C226S to use in the subsequent “Mutating and scoring” step. 
In the “Mutating and scoring” step, a single point mutation procedure was conducted 
by Rosetta method “ddg_monomer” (Kellogg 2011).  Each of the 442 residues in the 
PDB structure was mutated into the other 19 amino acid residues.  As a result, a total of 
8398 structures with single mutations were created.  The files associated with the 
structure preparation were generated by using several python scripts, and the 
158 
 
corresponding jobs were submitted to UCL Legion High Performance Computing Facility 
(Legion@UCL) with Rosetta Version 2015.31.58019.  After mutating, the change in 
stability (ΔΔG) induced by each point mutation, was calculated with reference to the 
original C226S model. 
4.2.2 Analysis of residue flexibility 
After determining the ΔΔG for mutation candidates, several in-silico protein analysis 
methods were used to validate the potential mutants from different perspectives. 
4.2.2.1 RMSF simulation in Gromacs 
In the preparation step, the C226S and mutant PDB structures were obtained from 
Rosetta.  The protonation states of chargeable residues at pH 4 were determined by 
uploading PDB files to http://nbcr-222.ucsd.edu/pdb2pqr_1.9.0/.  In Gromacs, the Fab 
PDB file was initially converted to a topology file with its five inter/intra-disulfide bonds 
retained.  A OPLS-AA/L all-atom force field was selected and protonation status was 
manually adjusted.  The Fab was then centred into a cubic box with 1 nm away from the 
edge of the box.  After that, the box was filled with water molecules as solvent.  Then 
the entire solution box was neutralised and adjusted to an ionic strength of 200 mM by 
adding Na+ and Cl-.  In the end, the structure was subjected to an energy minimisation 
step, and equilibrated at 300 K and atmospheric pressure.  For equilibration, each 
mutant was simulated for more than 40 ns.  Jobs were submitted to UCL Legion High 
Performance Computing Facility (Legion@UCL) to facilitate parallel simulations.  At 
least three repeats were conducted to validate if data was reproducible.  The RMSF 
data was exported based on trajectories beginning from 20 ns to allow for relaxation at 
the beginning of the simulation. 
4.2.2.2 B-factor 
In this work, multiple homologous structures were aligned to C226S in order to infer 
the flexibility across all residues.  The raw PDB files of human Fab were downloaded 
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from http://www.rcsb.org/.  All the PDB files were modified so that only one set of light 
chain and heavy chain remained.  Due to the crystallisation uncertainties for excessive 
thermal motion of certain residues, it is noted that some residues were not displayed in 
their PDB files but shown in their sequence files.  As a result, only the residues that exist 
in PDB files could be used for sequence alignment with C226S and B-factor cross 
comparison.  Therefore, instead of using the FASTA sequence file, the actual sequence 
information was extracted from the PDB for heavy chain and light chain separately.  
After that, the sequence outputs of all the human Fab PDB were aligned with that of 
C226S using BioEdit (Hall 1999). 
In the PDB profiles, each atom has its own B-factor.  In order to have an overall 
inference for the whole residue, all the atomic B-factors of a same residue were averaged 
and assigned to their corresponding residues.  These residual B-factors were then 
tabulated into the sequence alignment file so that they were aligned according to the 
C226S residues.  In addition, the residual B-factors within each protein were normalised 
into a distribution with average 0 and standard deviation 1 (Reetz & Carballeira 2007).  
In the end, only the B-factors that accounted for existing C226S residues were retained.  
The average B-factors of C226S residues were calculated by averaging the B-factors 
from individual homologous structures.  In order to reduce the scattering, the B-factors 
were further processed by window-averaging across 5 residues.  The entire procedure 
to process the B-factor is shown in Figure 4.1. 
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Figure 4.1 The schematic diagram for processing the B-factor  
Raw PDB profiles were downloaded from the website, and only one set of light chain and heavy 
chain was retained for each profile.  Amino acid sequence files were extracted from these modified 
PDB, and were then aligned against the C226S sequence file.  In addition, the residual B-factors were 
obtained by averaging their atomic B-factors, and tabulated along the amino acid sequence alignment.  
Normalisation was conducted for the tabulated "B-factor/sequence alignment" and the averaged B-
factors accounting for C226S residues were retained, and were further processed by window-averaging 
across 5 residues. 
 
4.2.3 Design of stable and unstable mutant 
candidates 
After the in-silico mutagenesis by Rosetta, RMSF and B-factor analysis, mutant 
candidates were selected for generation in the wet lab.  Mutants were categorised into 
theoretical stable and unstable classes.   
4.2.3.1 Stable mutant candidates 
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Figure 4.2 The schematic diagram to design stable mutants  
21 mutants were designed based on a combined analysis of B-factor, RMSF and ΔΔG.  For hinge 
regions, HC-A227 and HC-A228 were selected for mutation.  For other regions, the top 5 residues with 
highest B-factor and RMSF were selected.  For a total of 7 selected residues, each was mutated into 
the three amino acids predicted by Rosetta to have the lowest ΔΔG values from across all 19 
candidates.  There were also 4 mutations that only based on lowest ΔΔG.  All the mutations had no 
influence on disulfide bond, salt bridge, CDR and cysteine addition. 
 
For stable mutants, Figure 4.2 shows the schematic procedure to select those for 
construction.  21 mutants were designed based on a combined analysis of B-factor, 
RMSF and ΔΔG.  The hinge regions in the heavy chains had no available B-factor 
values, but their RMSF values were very high.  It was suggested that the hinge regions 
accounted for the flexibility and instability of an IgG, and switching it to another subclass 
could potentially improve the formulation stability while maintaining its binding affinity 
(Neergaard et al. 2014).  Thus, the last two hinge residues, HC-A227 and HC-A228, 
were selected for mutation.  For the other regions (residues 1 to 436), both B-factor and 
RMSF were considered.  Because the scales of B-factor and RMSF were not equal, the 
B-factor and RMSF values were firstly normalised to between 0 and 1 according to 
Equation 4.1.  Individual residues were then ranked based on the product of normalised 
B-factor and RMSF, and the top 5 residues were selected.  For a total of 7 selected 
residues, each was mutated into the three amino acids predicted by Rosetta to have the 
lowest ΔΔG values from across all 19 candidates.  Three mutations were selected 
because Rosetta is expected to fit with 69% prediction accuracy (Kellogg 2011), so 
theoretically, three mutations should yield at least one stable mutant.  An additional 4 
mutations were selected based only on the lowest ΔΔG values predicted by Rosetta, 
regardless of the flexibility of the target site.   
Normalised value =
𝑅𝑎𝑤 𝑣𝑎𝑙𝑢𝑒 − 𝑀𝑖𝑛
𝑀𝑎𝑥 − 𝑀𝑖𝑛
 
Equation 4.1 
In order to design the mutants only based on B-factor, RMSF and ΔΔG values 
without losing or introducing new features, several additional filter criteria were applied.  
Mutations were avoided that would introduce a cysteine, remove a disulphide bond, or 
disrupt salt bridges.  In addition, mutations were avoided in the Complementarity 
Determining Regions (CDR) of the Fab as this would affect Fab function, and guide 
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mutations to regions that could be potentially useful in any Fab generated by industry.  
The CDR regions are listed in Table 4.1. 
Table 4.1 The Complementarity Determining Regions (CDR) of C226S 
Light chain Heavy chain 
CDR-L1: 24-KASQNVRTVVA 
CDR-L2: 50-LASNRHT 
CDR-L3: 89-LQHWSYPLT 
CDR-H1: 26-GFAFSTYDMS 
CDR-H2: 50-TISSGGSYTYYLDSVKG 
CDR-H3: 99-TTVVPFAY 
4.2.3.2 Unstable mutant candidates 
The unstable mutants were designed from only those candidates with the highest 
ΔΔG values as predicted by Rosetta.  These would increase the range of protein 
stabilities for further study.  Moreover, if all the stable mutants resulted in higher stability, 
the unstable mutants would provide a “negative control” role.  As above, the designed 
mutants avoided mutations from and to cysteine, salt bridge modifications, and CDR 
regions of Fab. 
4.2.4 Primer sequence design 
Primers were designed for site-directed mutagenesis of codons at the DNA level.  
Though one type of amino acid could be translated by different codons, certain species 
have their own preference towards specific codons.  It is a good strategy to mutate 
towards codons preferred by the host cell species.  In this research, the codons used 
mostly by E. coli were adopted from a previous codon usage work (Sharp et al. 1988). 
In addition to the codon optimisation, the primers for individual mutants were also 
designed to meet certain commonly used rules, which include: 
 Locate the mutation in the middle of the primer 
 A GC content of more than 40% 
 Include a GC clamp (G/C at the 3’ end) 
 Avoid more than 3 G/C bases in the final 5 at the 3’ end 
 Use a primer length of 25-45 bases 
 Ensure a melting temperature (Tm) of less than 75°C 
The calculation of the Tm is based on Eurofins’s equations as shown in Table 4.2. 
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Table 4.2 The equations for calculating the Tm of primers from Eurofins 
Sequences with 15 
or less bases 
𝑇𝑚[°𝐶] = 2(𝑛𝐴 + 𝑛𝑇) + 4(𝑛𝐺 + 𝑛𝐶) 
Sequences with 
more than 15 bases 
𝑇𝑚[°𝐶] = 69.3 + 41
(𝑛𝐺 + 𝑛𝐶)
𝐿
−
650
𝐿
 
(The L indicates the length of a primer.  nA, nT, nG, nC are the base number of adenine, 
thymine, guanine and cytosine, respectively.) 
 
The primers were ordered from Eurofins Genomics (Ebersberg, Germany) at HPSF 
purity and with a concentration at 50 pmol/μl.  Their sequences were listed in Table 4.4 
and Table 4.5. 
4.2.5 Laboratory production 
After obtaining the primers, Fab mutants were produced in the lab, which included:  
 Laboratory mutagenesis 
 200 ml fermentation 
 Purification 
 Buffer exchange to water 
For fermentation, one cycle usually lasts for one week.  It was hoped that each Fab 
could be produced to a reasonable quantity (e.g. 30 mg) to allow initial screening for 
stability.  Therefore, the DASbox® Mini Bioreactor (working volume 60-250 ml) 
(Eppendorf, Germany) was used as four different mutants could be run in parallel 
reactors. 
For purification, a 1 ml HiTrap Protein G column was tested initially due to the small 
amount of Fab produced in a 200 ml fermentation.  However, the binding capacity was 
not high enough and some Fab was lost.  As a result, a 90 ml Protein G column was 
used, which could bind all the Fab but resulted in more diluted protein upon elution.  In 
order to minimise aggregation during freezing and thawing, the eluted proteins were 
concentrated to 1-2 mg/ml first before storing in a -80°C freezer.  A detailed procedure 
for the above can be found in Sections 2.2.1, 2.2.2 and 2.2.3 with scaled-down operating 
parameters. 
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4.3 Results and Discussion 
4.3.1 Analysis of residue flexibility 
4.3.1.1 RMSF simulation in Gromacs 
The RMSF data from molecular dynamics simulation of the pseudo wild-type C226S 
Fab are shown in Figure 4.3.  It can be seen that the data deviate dramatically from 
different batches.  The deviation is especially significant when the RMSF is of high value 
(e.g. the last tail region).  Despite the large deviation, a general trend of fluctuation 
associated with secondary structures could be observed as shown in Figure 4.3 and it is 
relatively consistent at each repeat.  In particular, loop regions are always of high RMSF 
while strand and helix regions are of relatively low RMSF values. 
 
Figure 4.3 The overlay of C226S secondary structure and average RMSF at pH 4, 200 mM ionic 
strength 
The standard error of the mean is used as the error bar of RMSF from three repeats of simulation.  
The secondary structure is determined by PyMol.  The height of loop, helix, and strand regions are of 
height 0.3, 0.2 and 0.1, respectively. 
4.3.1.2 B-factor and its correlation with RMSF 
The PDB IDs of 26 accessed human PDB files were: 1A6T, 1B2W, 1C5D, 1DFB, 
1DN0, 1DQD, 1FGN, 1IT9, 1L7I, 1OPG, 1T3F, 2Z4Q, 2ZKH, 3D69, 3G6A, 3HC0, 3HI5, 
3VG0, 4GSD, 4HBC, 4HH9, 4HIE, 4LKX, 4OCY, 4OSU, 7FAB. 
The alignment results for C226S and those human Fab are shown in Table 10.1 and 
Table 10.2 (Appendix, Section 10.4) for heavy chain and light chain, respectively. 
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The normalised B-factors are plotted in Figure 4.4. 
 
Figure 4.4 normalised B-factors of light chain and heavy chain  
As shown in Figure 4.1, the residual B-factors were obtained by averaging their atomic B-factors, 
and tabulated along the amino acid sequence alignment.  Normalisation was conducted for the 
tabulated "B-factor/sequence alignment" and the averaged B-factors accounting for C226S residues 
were retained. 
 
The normalised B-factor after window averaging is shown in Figure 4.5. 
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Figure 4.5 The normalised B-factor after window averaging with 5 neighbouring residues  
Following the B-factor normalisation step shown in Figure 4.4, the B-factors were further window-
averaged across 5 residues.  The last 7 residues of heavy chain have no B-factor values as this part of 
sequence has no consensus with any of the other human Fab used for sequence alignment. 
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Figure 4.6 The correlation between RMSF and B-factor  
The RMSF is derived from Figure 4.3; the B-factor is derived from Figure 4.5.  The last 7 residues 
of heavy chain are not included as they have no B-factor values. 
 
 
Figure 4.7 A breakdown of secondary structures within the correlation between RMSF and B-
factor derived from Figure 4.6 
 
As shown in Figure 4.5, the B-factor values from the human Fab structures had a 
similar sequence dependence as the RMSF.  This implies that B-factors from the crystal 
168 
 
structures of Fab reflect a disorder in vitro that can be simulated by Gromacs in silico.  In 
order to verify that both independent measurements achieve similar flexibility results for 
the protein residues, it was useful to find out if they correlated with each other to some 
extent.  Figure 4.6 shows the correlation between RMSF and B-factor.  It is shown that 
a 55.66% variation could be explained by the linear regression model.  Therefore, the 
RMSF and B-factor values were statistically correlated.   
Figure 4.7 further breaks the correlations down by secondary structure type.  This 
indicates that the β-strand structures are the most rigid, whereas the significantly less 
common helical structure is relatively flexible.  The loop regions cover almost the entire 
magnitude for RMSF and B-factor, but also show the highest flexibility in some locations.  
As discussed in Section 3.1.4, proteins with more β-sheet regions were more prone to 
form aggregates.  However, strand structures are relatively less flexible than helical 
ones.  Therefore, in addition to flexibility, the formation of aggregates also depends on 
the structural conformation.  For the loop regions, it is interesting to see that only a small 
proportion of them exhibit significantly high flexibility, while the majority of them still retain 
low flexibility compared to strand and helix regions.  This result indicated that a 
mutagenesis strategy could be applied to convert those residues with high flexibility in the 
loop regions into ones with low flexibility, based on a combination of RMSF and B-factor 
analyses. 
4.3.2 In-silico mutagenesis 
4.3.2.1 Analysis for the overall distribution and the most stabilising 
mutants for individual residues 
After in-silico mutagenesis, 8398 mutations were generated.  Their ΔΔG values (in 
arbitrary Rosetta Energy Units) are plotted in Figure 4.8 and their frequency distribution is 
plotted in Figure 4.9.  It can be seen that most of the mutations had ΔΔG values of close 
to 0, which implies that most single mutations exert only a limited impact on the protein 
stability.  Moreover, negative ΔΔG values were all greater than -9.4, whereas positive 
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ΔΔG values extended much further with a maximum value of 235.  This result implies 
that the A33 C226S sequence already had a relatively stable form, which is not surprising 
given that it is already the result of significant selection and engineering as a potential 
therapeutic.  However, there remained some room to further stabilise the protein even 
though the extent was very limited.  As the ΔG is around -1100, a -10 ΔΔG improvement 
would only provide less than 1% stabilising impact on the free energy of the global 
structure.  On the contrary, the destabilising mutants may exhibit great detrimental effect 
with the maximal exerting more than 20% loss in ΔG, which include polar or chargeable 
mutations in the protein core, hydrophobic mutations on the outer surface, hindrance 
caused by large amino acid substitutions like aromatic ones and disruption of salt bridge 
and hydrogen bond.   
 
 
Figure 4.8 ΔΔG for 8398 (19 mutation/residue x 442 residue) candidates 
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Figure 4.9 Histogram for the mutant frequency distribution based on ΔΔG 
 
There were 2386 potentially stabilising mutants (i.e. ΔΔG values lower than 0) as 
shown in Figure 4.9.  To investigate whether they were biased towards particular 
secondary structure types, the ΔΔG values were plotted by colour on the Fab structure in 
Figure 4.10.  The blue regions in the figure represent stabilising effects, and the red 
ones indicate where no improvement could be made by any of the 19 mutations.  As 
shown in Figure 4.10, most of the blue regions are located within β-sheet structures (e.g. 
LC-N137, LC-S176), while some were in the turn or random coil regions (e.g. HC-L61, 
HC-T135).  As β-sheet is the most popular secondary structure pattern in this Fab, the 
stabilising locations do not show any statistical bias towards a particular secondary 
structure type.   
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Figure 4.10 A blue-white-red plot to represent the locations of stable mutants.   
For each residual position, there are 19 mutations.  The mutation with lowest ΔΔG is retained.  
If the lowest ΔΔG of that position is still greater than 0, value of 0 is used to indicate no improvement.  
Gradient colours from blue to white to red is used to demonstrate the ΔΔG from lowest negative value 
to 0. 
 
It was also interesting to investigate whether the stabilising mutants located more 
towards the outer surface regions, or within inner more buried regions.  During the 
folding of a protein, the inner core is heavily influenced by the hydrophobic interactions 
and Van der Waals forces to reach a conformational stability, while the outer surface 
regions are relatively flexible, and surface charges offer additional colloidal stability.  
Figure 4.11 represents the depth of each residue in the C226S, with blue regions for 
lower depth and red regions for greater depth (http://mspc.bii.a-
star.edu.sg/tankp/run_depth.html) (Tan et al. 2013).  It is very clear that most of the 
residues are close to the bulk solvent while the inner β-sheet regions are well protected 
by their surrounding outer structures.  Figure 4.12 correlates the lowest ΔΔG of 19 
mutants calculated by Rosetta with their depth for individual residues.  As no correlation 
is observed, it implied that there was no significant bias in the location of stabilising 
mutants relative to the surface, and the stabilising mutants were spread comparably 
across the Fab structure.  The poor correlation could come from the very rigid 
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conformation of Fab such that residues are already very stable in both the inner and 
outer regions.  This also implied that there were many elements (e.g. electrostatics, 
hydrogen bonding) accounting for the free energy and they did not exert an overall bias 
upon the locations for this Fab. 
 
Figure 4.11 A blue-white-red plot to represent the residue depth of C226S Fab.   
Gradient colours from blue to white to red is used to demonstrate the residue depth from low to 
high as calculated from http://mspc.bii.a-star.edu.sg/tankp/run_depth.html with default settings. 
 
 
Figure 4.12 The correlation between lowest ΔΔG of 19 mutants and the depth from bulk solvent 
for each residue.   
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The lowest ΔΔG and residue depth were extracted from Figure 4.10 and Figure 4.11, respectively. 
 
4.3.2.2 Analysis for all of the stabilising mutants (ΔΔG<0) 
Firstly, the distribution of the 20 amino acids in the C226S is shown from Figure 4.13 
to Figure 4.15.  Figure 4.13 summarises the occurrence of the 20 amino acids among 
the 442 residues.  Figure 4.14 and Figure 4.15 list the average RMSF and depth for the 
C226S amino acids, respectively.  Afterwards, all the stabilising mutants were populated 
in Figure 10.2, in which red to yellow gradient was used to indicate the strong to weak 
stabilising effect.  The CDR, RMSF and depth information were also listed alongside 
with the residue so as to show their influence upon the stabilising effect proposed by 
Rosetta. 
A clear opposite trend was observed between RMSF and depth.  Figure 4.16 shows 
that this trend could be approximately fitted by a power equation with R2 of 0.41.  This 
implies that the Fab residues on the outer regions generally have higher flexibility 
compared to the ones buried inside.  Most of the residues locate at depths between 3-5 
Å and with RMSF lower than 0.2.  The residues become less flexible as they locate 
closer to the protein inner core, but still retain at least 0.05 RMSF flexibility.  The 
residues on the tail of the heavy chain, which directly contact with bulk solvent, are the 
most flexible with RMSF values of more than 0.25.   
The opposite relation between RMSF and depth was also reflected on the 
distribution of amino acids in C226S.  As shown in Figure 4.14 and Figure 4.15, polar 
and chargeable amino acids, histidine and glycine have very high RMSF values, and they 
thus locate relatively close to the surface.  This implies that residues with increased 
polarity are more prone to be near the surface region so as to provide colloidal stability, 
while residues with decreased polarity are more prone to be inside the protein to provide 
conformational stability through Van der Waals’s force and hydrophobic interaction.  
Alanine also has a high RMSF but it distributes relatively deeper, which may due to its 
non-polar property. 
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RMSF values closely relate with the stabilising mutants proposed by Rosetta.  As 
shown in Figure 4.17, all of the stabilising ΔΔG were added up for individual residues with 
a window average of 9 neighbouring residues, and were superimposed with RMSF and 
CDR region.  It can be seen that for some locations, regions with increased RMSF have 
decreased total ΔΔG values (e.g. residues 39-44, 167-169, 198-206, 254-258, 287-289, 
306-307, 346-351), while regions with decreased RMSF have increased total ΔΔG values 
(e.g. residues 115-121, 293-296, 340-343, 359-361).  This implies that for some 
particularly flexible locations, it is a promising strategy to mutate towards residues with 
less flexibility.  However, not all highly flexible regions would benefit from further 
mutation.  For example, there were few stabilising mutational recommendations for 
regions of increased flexibility such as at residues 79-81, 92-94, 214-216, 276-277, 420-
422.  As checked in the PDB, those locations are all loop regions except for residues 79-
81 which are in a β-turn structure.  This implies that the Fab actually requires several 
flexible regions to properly connect rigid structures like β-sheets and to easily adapt to 
any environmental disturbance without altering the overall conformation.   
Similarly, it is also interesting to observe in Figure 4.17 that although all of the CDR 
regions (except CDR-L2) exhibit increased flexibility, only very few stabilising mutants 
were suggested for CDR-L2, L3, H1.  This implies that the flexibility of CDR regions 
does not impact the global conformational stability to a large extent.  This is beneficial as 
those regions could be more extensively engineered based on the target antigen, and the 
Fab could appropriately adjust their conformation upon binding without losing the overall 
structural rigidity of the protein. 
It is surprising to see that a few low flexibility regions with relatively high depth could 
potentially be stabilised further, such as at residues 70-72, 103 and 235-237.  The PDB 
structure shows that these are all β-sheet structures.  Phenylalanine and tyrosine are 
predicted to be most stabilising for residues 70, 72 and 103, which suggests that they 
might be better able to fill the cavity, or offer stronger hydrophobic interactions.  Residue 
236 is cysteine, and yet other non-polar substitutions, glycine, proline and methionine, 
were preferred.  Since cysteine was strongly suggested at neighbouring positions 235 
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and 237, it implies that these two positions may offer a more stable intra-chain disulfide 
bond. 
Figure 4.18 to Figure 4.22 subdivide the stabilising effect based on the type of amino 
acid mutations.  Figure 4.18 sums up all the stabilising ΔΔG from the 8398 mutants for 
each residue mutation.  For Figure 4.19 and Figure 4.20, weighted values of RMSF and 
depth are used to reflect the locations of different stabilising amino acid substitution.  
The weighted values were calculated as shown in Figure 4.21.  It aimed to capture the 
individual ΔΔG contribution at various RMSF or depth.  For example, if the particular 
amino acid always stabilises the Fab at a high RMSF location, its weighted RMSF would 
also be high.  Figure 4.22 summarises the extent of the residues in the C226S stabilised 
by point mutations based on their ΔΔG. 
Figure 4.18 shows that aromatic amino acids accounted for most of the stabilising 
substitutions, followed by methionine, aliphatic amino acids, cysteine, and polar amino 
acids, while glycine, proline and ionisable ones were the least stabilising.  Figure 4.22 
shows that aromatic and aliphatic amino acids stabilise wild-type serine and threonine 
residues to a large extent.  The large sidechains of aromatic residues greatly limit their 
mobility in solution (Gunasekaran & Nussinov 2007) and thus are preferable to stabilise 
the protein structure.  Though aliphatic ones are not as rigid as aromatic ones, aliphatic 
residues are still beneficial to replace flexible residues serine and threonine near the 
surface due to their non-polar property.   
The ionisable residues contribute relatively less compared to the others with aspartic 
acid the least favourable (Figure 4.18).  The reason might be due to the positive or 
negative charge on the amido or carboxyl side chain.  Those charges may exert some 
electrostatic repulsion within the structure, increase the residue distance and weaken the 
hydrophobic interaction.  Lysine and arginine, the two positively charged amino acids, 
are preferable near the surface while aspartic acid and glutamic acid, the two negatively 
charged ones, are more likely to locate deeper (Figure 4.20).  This suggests that 
positive surface charge could provide some colloid stability as the pI of the Fab is around 
9, while the negatively charged substitutions would neutralise the net charge if placed at 
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surface regions.  It shows that all of the four charged substitutions locate at highly 
flexible regions (Figure 4.19), and could reasonably stabilise serine and threonine (Figure 
4.22).  This implies that salt-bridges might be good for lowering the flexibility (Yu & 
Huang 2014; Amini-Bayat et al. 2012), in which buried negatively charged residues non-
covalently interact the positively charged ones near the surface. 
Glycine and proline are two of the three least preferred substitutions.  As β-sheet is 
the main secondary structure in the Fab, it is not surprising that glycine and proline, 
which disrupt β-sheets (discussed in Section 3.1.1 and 3.1.2), are less favoured.  As 
confirmed in the PDB, all of the glycine and proline mutations with ΔΔG less than -4, 
locate at loop or β-turn regions while the exceptions are cysteines at the β-sheet.  In 
addition, Figure 4.20 shows that glycine tends to locate at the inner core while proline 
tends to be near the surface.  This depth difference mainly comes from their structure 
difference.  Glycine is the only amino acid without a side chain, so it is more likely to 
adapt to the inner compact hydrophobic core of protein without causing structural 
disruption.  By contrast, proline is very rigid so it has to be near the surface so as to 
have minimal disruptive influence on its surrounding residues.   
 
Figure 4.13 The occurring times for the 20 amino acids among the 442 residues in the C226S.   
The 20 natural amino acids were categorised into 5 groups.  The occurring time of each type of 
amino acid within the 442 residues was shown in the figure. 
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Figure 4.14 The average RMSF of individual residues of C226S derived from Figure 4.3   
The 20 natural amino acids were categorised into 5 groups.  Their average RMSF were calculated 
from Figure 4.3. 
 
 
Figure 4.15 The average depth of individual residues of C226S derived from Figure 4.11   
The 20 natural amino acids were categorised into 5 groups.  Their average depth was calculated 
from Figure 4.11. 
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Figure 4.16 The correlation between RMSF (Figure 4.3) and depth (Figure 4.11) of C226S 
 
 
Figure 4.17 The relation between RMSF, CDR and sum of the stabilising ΔΔG of each residue.  
Data was derived from Figure 10.2.  A window average of 9 neighbouring residues was used for 
the sum of the stabilising ΔΔG of each residue.  The CDR regions were assigned with value 1 while 
non-CDR regions were of value 0. 
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Figure 4.18 The total ΔΔG for stabilising mutants grouped by the type of amino acids derived from 
Figure 10.2. 
 
 
Figure 4.19 The weighted RMSF of individual amino acid substitutions based on their ΔΔG 
stabilising effect  
Data was derived from Figure 10.2, calculated as shown in Figure 4.21. 
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Figure 4.20 The weighted depth of individual amino acid substitutions based on their ΔΔG 
stabilising effect  
Data was derived from Figure 10.2, calculated as shown in Figure 4.21. 
 
 
Figure 4.21 An illustration for the calculation for the weighted RMSF and weighted depth in Figure 
4.19 and Figure 4.20 derived from Figure 10.2.   
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Figure 4.22 A summation for the stabilising ΔΔG based on the type of residues  
Data was derived from Figure 10.2.  Each row represents the total ΔΔG when a particular amino 
acid in the C226S is mutated to the other 19 residues.  Each column represents the total stabilising 
ΔΔG of the 19 residues in the C226S that are mutated to another amino acid.  Gradient colours are 
used to indicate the magnitude of the ΔΔG. 
 
4.3.2.3 Analysis for the destabilising mutants (ΔΔG>0) 
There were 6012 potentially destabilising mutants as shown in Figure 4.9.  The 25 
mutants with the highest ΔΔG values are displayed in Table 4.3.  As shown in the table, 
all of them are mutated into proline and 19 of them are glycine to proline mutations.  As 
glycine has no β-carbon this residue would exert more backbone conformation flexibility.  
Proline, on the contrary, is rather rigid due to its unique side chain pyrrolidine.  The 
stability of X to P mutations depends largely on the secondary structures.  If proline is in 
the middle of an α-helix or β-sheet, it tends to break down the secondary structure and 
destabilise the protein.  As shown in Figure 4.23, most of the mutations were in the loop 
regions.  So the destabilising effect is not mainly due to proline’s structural disruption 
tendency.  As loop regions require relatively high flexibility to connect two ordered 
structures, the instability caused by glycine to proline might arise from proline’s rigidity 
that disables the flexibility for folding offered by glycine. 
Table 4.3 The top 25 destabilising mutants 
Mutant_ID ΔΔG 
LC-A153P 235.72 
LC-G66P 163.28 
HC-G26P 97.66 
LC-G101P 96.961 
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LC-G57P 90.729 
HC-G10P 87.695 
LC-G128P 86.686 
HC-G110P 86.35 
HC-G178P 86.001 
LC-G16P 85.343 
LC-A51P 83.233 
LC-N152P 79.539 
LC-G68P 68.295 
HC-G15P 66.995 
HC-G137P 65.807 
HC-G161P 63.958 
HC-G42P 60.577 
LC-G41P 58.336 
LC-G157P 56.228 
LC-G212P 55.195 
HC-G166P 54.732 
HC-G66P 53.383 
HC-D148P 53.251 
HC-N208P 52.194 
LC-L50P 41.124 
 
 
Figure 4.23 The positions of the top 25 destabilising mutations  
The highest ΔΔG values are achieved by mutating the yellow residues into prolines 
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4.3.3 Designed mutants and corresponding 
primer sequences 
4.3.3.1 Designed stable mutants 
The designed stable mutants and their primer sequences are shown in Table 4.4.  
The three oligonucleotides responsible for mutations are highlighted in red colour. 
Table 4.4 The designed stable mutants and corresponding primer sequences 
 
 
4.3.3.2 Designed unstable mutants 
The designed unstable mutants and their primer sequences are shown in Table 4.5.  
The three oligonucleotides responsible for mutations are highlighted in red colour.  It 
was found that the top 25 mutants with highest ΔΔG were all mutated into proline, and 14 
of them were glycine to proline mutants.  In order to cover other types of mutations, the 
mutants ranked after the first 25 were selected as well as shown in Table 4.5. 
Table 4.5 The designed unstable mutants and corresponding primer sequences 
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4.3.4 Laboratory production 
The primers were designed as shown in Table 4.4 and Table 4.5.  Some primers 
(e.g. HC-S219L, LC-N137L) were not able to provide successful site direct mutagenesis 
and so the corresponding mutants were not produced.  Some mutants (e.g. HC-A227T) 
were successfully mutated at the plasmid level, but could not grow sufficiently well in cell 
culture.  Due to the availability of bioreactors, some mutants were not expressed even 
though they could yield optical density more than 10 in shake flasks.  Table 4.6 shows 
the various Fab variants finally successfully expressed and purified for more than 5 mg, 
which were used for subsequent Fab stability studies. 
Table 4.6 A list of Fab mutants that had been successfully expressed and purified in reasonable 
amount 
  Mutant* Date* 
DOT 
spike* 
Abnormal 
event* 
Data at Harvest 
Fab 
mass 
(mg) 
OD600 at 
harvest* 
Wet cell 
weight 
(g)* 
Fab 
concentration 
(mg/ml)* 
Stable 
mutants 
HC-A227E 02.09.2015 - 04.09.2015 No 
pH not 
adjusted 
since 
inoculation 
for 1.5 h 
N/A 23.6  0.06  9.9  
HC-A227W 02.09.2015 - 04.09.2015 No 
pH not 
adjusted 
since 
inoculation 
for 1.5 h 
N/A 20.9  0.03  5.8  
HC-A228H 23.09.2015 - 25.09.2015 Yes N/A N/A 44.9  0.36  61.0  
HC-A228N 23.09.2015 - 25.09.2015 No N/A N/A 27.6  0.06  9.8  
HC-A228M 23.09.2015 - 25.09.2015 No 
Broth 
overflowed 
N/A 28.0  0.05  8.4  
HC-T135W 09.11.2015 - 11.11.2015 No 
Gas outlet 
blocked, 
unable to 
pump gas 
55 24.6  0.04  6.5  
HC-T135Y 09.11.2015 - 11.11.2015 Yes N/A 124 39.1  0.23  39.6  
HC-S134Y 09.11.2015 - 11.11.2015 Yes N/A 122 41.4  0.12  20.0  
HC-S134M 09.12.2015 - 11.12.2015 Yes 
10-20 
overflowed 
176 48.3  0.11  18.0  
HC-S134P 09.12.2015 - 11.12.2015 No 
foam to 
the 
headplate 
161 56.2  0.13  21.4  
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HC-S136G 09.12.2015 - 11.12.2015 No 
foam to 
the 
headplate 
181 40.2  0.14  23.3  
HC-S219Y 10.01.2016 - 12.01.2016 Yes N/A 281 38.1  0.25  42.8  
LC-L154A 10.01.2016 - 12.01.2016 Yes N/A 288 36.0  0.27  45.4  
LC-S176W 10.01.2016 - 12.01.2016 Yes 
very 
viscous 
broth 
313 43.8  0.22  37.8  
Unstable 
mutants 
LC-A153P 13.06.2016 - 15.06.2016 Yes N/A 219 38.0  0.08  14.3  
LC-G66P 13.06.2016 - 15.06.2016 Yes 
impeller 
failed to 
rotate on 
the last 
day 
256 31.6  0.13  21.4  
LC-G200W 13.06.2016 - 15.06.2016 Yes N/A 241.0  38.0  0.19  33.0  
HC-V215W 13.06.2016 - 15.06.2016 Yes 
viscous 
broth 
390.0  40.4  0.11  19.3  
* Mutant: The mutants listed here were used for this research project. There were other 
fermentations failed and the purification was not done. 
* Date: The dates ranged from inoculation to the DASbox bioreactor until the harvest. The pre-
culture date was one day prior to the inoculation date. 
* DOT spike: This was a good indication of normal cell growth, which usually resulted in high cell 
density and rich Fab expression. 
* Abnormal event: Due to the lack of operating experience and unforeseen reasons, the 
fermentation was not always operated in a standard manner.  The resulting cell density and Fab 
expression might be low, which should not be considered as the detrimental effect caused by the 
plasmid transformed.  
* Wet cell weight: The harvest broth was centrifuged at 10,000 rpm for 90 min. After decanting 
the supernatant, the weight of the sediment was recorded as the “wet cell weight”. The “wet” 
comment indicates the cell sediment was still partially fluidic. 
* OD600 at harvest:“N/A” indicates the OD600 was not measured for the harvested sample.  
* Fab concentration: The exact volume at the harvest point was not recorded. So an estimated 
volume of 170 ml was used. The concentration, which denoted the Fab in the harvest broth, was 
calculated based on the estimated 170 ml harvest broth and the final Fab mass (mg) obtained after 
purification. 
* Fab mass: This was measured after purification. 
 
It took 3-4 runs to optimise the fermentation with the small-scale DASbox 
bioreactors.  As a result, only a small amount of Fab protein was produced in the 
beginning (e.g. for HC-A227E, HC-A227W).  Therefore, it was not sensible to infer the 
Fab stability from their expression yields, as conditions were different. 
Admittedly, the engineering of proteins would potentially impact the host cell 
expression machinery, which would result in varied cell viability, density, expression level 
and folding state (Kabir & Shimizu 2003; Angov 2011).  The varied expression profile 
and altered host cell proteins (HCPs) would also impact the downstream stage and the 
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final purified product obtained (Tscheliessnig et al. 2013).  In addition, the integrity and 
efficacy of therapeutic proteins include the minimisation of chemical instability (e.g. 
deamidation, oxidation), physical instability (e.g. denaturation, aggregation) and 
preservation of biological functions (e.g. activity) (Manning et al. 2010).  However, due to 
the focus of this work, the impact on protein expression was not examined, and mainly 
monomer loss and melting temperature would be assessed for the stability in the next 
two chapters. 
4.4 Conclusions 
This chapter illustrated several in-silico methods to identify potential mutational sites 
and to design specific mutants with the aim of improving and diminishing Fab stability.  
Rosetta software was used to build a homology model and screen for the predicted 
impact of all the possible mutant candidates.  RMSF and B-factor analyses were used to 
restrict the mutants mainly towards flexible sites, as the increased entropy associated 
with flexibility is mainly thought to result from fewer interactions and hence less enthalpy 
available to offset the entropy change upon folding.  In the meantime, unstable mutants 
were also prepared as negative control to validate the Rosetta prediction accuracy. 
Due to some technical reasons, not all the designed mutants were finally expressed.  
For example, some regions with very low G/C content in the plasmid DNA are not 
appropriate to design suitable primers.  Other variants were not able to grow in the 
bioreactors, while there is also a limited availability for accessing the bioreactors.  In the 
end, 14 stable and 4 unstable mutants were prepared for Fab freeze-drying, liquid 
kinetics and biophysical stability characterisation. 
Table 4.7 The pipelines for commercial drug development of therapeutic recombinant antibodies 
Enabling
Technology,
Genomics,
Proteomics
Preclinical
Research
Preclinical Development
Toxicology, Formulation
Drug Delivery,
Pharmacokinetics
Clinical Development
Phases I-III
Regulatory, Quality,
Manufacturing
Postmarketing
Phase IV
Strategy, Management and Health Policy
 
The table illustrates the pipelines for commercial drug development of therapeutic recombinant 
antibodies (Harris et al. 2004).  The words highlighted in bold and underline, “Proteomics” and 
“Formulation”, are the stages that might be assisted by the protein engineering work proposed here. 
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The application of protein engineering should take place in the early stage of drug 
development pipeline.  The genomics and proteomics research takes place prior to the 
preclinical research, which was followed by studies on formulation, drug delivery, 
toxicology and pharmacokinetics (Table 4.7) (Harris et al. 2004; Li et al. 2010).  
Therefore, the protein engineering could 1) help the early proteomics work to screen out 
potential drug molecules with desired conformational and colloidal stability; 2) assist the 
formulation development when proper excipients or dosage form cannot meet the 
requirement on protein stability.  As changing the amino acid composition of a protein 
molecule constitutes a new molecule, the protein engineering requires the recommencing 
of all the corresponding regulatory implications.  Here we adopted a hybrid mutagenesis 
strategy to propose several mutants with in silico stability and would examine their in vitro 
stability in freeze-dried and aqueous forms in the next two chapters. 
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5 Freeze-drying tolerance and 
thermal stability measurement for 
mutant Fabs 
5.1 Introduction 
5.1.1 Experimental methods to measure the ΔG 
and melting temperature 
Up to now, ProTherm has been the most widely used database to store experimental 
data about thermal stability, including the Gibbs free energy change (ΔG), enthalpy 
change (ΔH) and transition temperature for both wild-type and mutant proteins (Kumar et 
al. 2006; Prabakaran et al. 2001; Bava 2004).  In the dataset, fluorescence, DSC, and 
CD have been the commonly used methods to measure the ΔG and melting transition 
temperature (Tm).   
One popular fluorescence method is the ThermoFluor assay (Ericsson et al. 2006), 
whereby the protein is mixed with SYPRO Orange dye, which fluoresces upon binding to 
hydrophobic residues of proteins.  As the temperature is increased, the native protein 
unfolds and exposes the hydrophobic core residues to the solvent, which bind more of 
the dye.  The resulting increase in fluorescence is monitored typically using a qPCR 
instrument.  The temperature that results in 50% of the total change in the fluorescence 
signal is used to indicate the protein stability.  Differential scanning fluorimetry (DSF) 
characterises the difference in Tm (ΔTm) from different samples and indicate the 
stabilising effect induced by mutation or ligand binding (Niesen et al. 2007; Rosa et al. 
2015).  In addition, a dye-free technique has also been developed based on the 
tryptophan’s intrinsic fluorescence property.  Tryptophan fluoresces maximally at λm≈331 
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nm in low polar, hydrophobic environment and at λm≈350 nm in high polar aqueous 
environment (Burstein et al. 1973).  As the protein unfolds, the fluorescence shifts from 
331 to 350 nm and the transition temperature would indicate the stability. 
Differential Scanning Calorimetry (DSC) can also be used to investigate the thermal 
stability of protein samples.  By heating the protein samples together with a reference 
sample, both endothermic and exothermic thermal events (e.g. crystallisation, melting) 
are recorded (Coleman & Craig 1996).  A change in thermal property (e.g. heat 
capacity) is reflected in the thermal event shift on the endotherm (D’Amico et al. 2003).   
Circular dichroism spectroscopy (CD) is another type of measurement used to study 
protein structure and stability.  The mechanism and operating guidelines have been well 
reviewed (Kelly & Price 2000; Kelly et al. 2005).  CD is often used to determine the 
types and relative proportions of secondary structure existing in the protein (Mehl et al. 
2009).  The α-helical structure exhibits strong CD ellipticity minimum at 208 nm and 222 
nm.  By plotting the ellipticity at 222 nm versus temperature, the Tm can be determined 
from the temperature at which 50% of the native protein unfolds when the sample is step-
wise heated.   
5.1.2 Freeze-drying formulation of antibodies 
Most approved monoclonal antibodies are formulated as liquids or in freeze-dried 
forms, to be administered through the intravenous (IV) route to maximise systemic 
distribution.  By contrast, oral, pulmonary and transdermal administrations are 
challenged by the instability and the low systemic distribution of antibodies (Harris et al. 
2004).  The freeze-drying formulation of antibodies has been well reviewed and studied 
(Daugherty & Mrsny 2006; Awotwe-Otoo et al. 2012; Harris et al. 2004).  Compared to 
liquid formulation, freeze-drying provides an alternative approach that reduces the 
physical and chemical degradation, aggregation and fragmentation of the protein during 
storage (Daugherty & Mrsny 2006; Chang & Hershenson 2002).  Freeze-drying is often 
used in those cases where stable liquid formulations are difficult to identify.  The 
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techniques utilised for protein freeze-drying development are generally applicable to 
antibodies as discussed in Chapter 1.   
Antibody formulations are featured by their high dosage forms, which can be 
achieved by reconstituting the freeze-dried cake with a lower volume of buffer (Shire et 
al. 2004).  However, aggregation is one of the major challenges that greatly impacts the 
drug efficacy and potentially causes unwanted and adverse immune responses.  Non-
reducing sugars, typically disaccharides like sucrose and trehalose, are excipients 
commonly used to minimise both aggregation and denaturation, arising from freezing and 
drying stresses.  It has also been found that freeze-dried samples with high residual 
moisture content (5-8% w/w) were more likely to undergo aspartate isomerization, 
including deamidation, than those with only 2% moisture; but that aggregation was 
reduced at higher residual moisture for storage temperatures under Tg (Breen et al. 
2001).  Reconstitution of the freeze-dried material with water can also lead to protein 
degradation, but slow reconstitution rates were previously suggested to allow a fully 
recovery of the native antibody conformation (Daugherty & Mrsny 2006).  To assess the 
stability under storage in the solid state, accelerated studies at high temperatures should 
be performed at below the Tg so as to be more relevant for its formulation stability (Duddu 
& Dal Monte 1997). 
5.1.3 Aims of the chapter 
This Chapter aims to assess the impact of protein conformational stability changes 
(ΔTm) due to mutations designed from the previous chapter, upon the monomer loss 
tolerance of proteins to freeze-drying.  Hence both aspects as well as ΔΔG needed to be 
assessed to evaluate to what extent the in silico and in vitro conformational stability could 
reflect the aggregation in freeze-drying.   
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5.2 Materials and Methods 
5.2.1 Freeze-drying of the new mutants 
The freeze-drying protocol used was mostly the same as described in Section 2.2.7.  
Each final sample for freeze-drying contained 1 mg/ml Fab, 20 mM sodium phosphate 
buffer at pH 7, and NaCl to bring the total ionic strength to 200 mM.  Five to six 
replicates were used to minimise the deviations within a running batch.  The bottom lips 
were trimmed off for the flat-bottom 96-well microplates (Greiner Bio-one Ltd, UK) before 
filling the sample solutions.  A pierceable TPE lyocapcluster-96 cover mat (Kinesis, UK) 
was put on top of each trimmed microplate to prevent cake floating out during the cycle, 
but allow water sublimation through the vent on the mat.  The Fab monomer was 
quantified by SEC-HPLC (Section 2.2.8) before freeze-drying and after reconstitution to 
determine the monomer loss caused by freeze-drying. 
5.2.2 Melting temperature (Tm) measurement 
The thermal transition temperatures of Fab mutants were characterised by their 
intrinsic fluorescence using the Optim1000 (Unchained Laboratories, Wetherby, UK).  
Samples were prepared in triplicates at 1 mg/ml in 10 mM sodium phosphate pH 7 buffer 
if not specified.  9 μl was pipetted onto the cuvette for each sample and loaded into the 
pre-warmed machine.  Samples were ramp-heated from 20-90°C at 1°C/min with 30 s 
incubation period for each temperature.  The barycentric mean (BCM) of the spectra 
ranging 280-460 nm was recorded against each temperature, and was then fitted to a 
sigmoid curve equation as shown in Equation 5.1.  It was observed that the fluorescence 
value decreased when sample was heated at more than 80-85°C during Tm 
measurement.  This was probably due to the aggregation of denatured proteins, which 
decreased the amount of light available for excitation of fluorophores.  This range of 
decreased reading was removed when fitting the sigmoid curve. 
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BCM =  𝑦0  + 
𝑎
1 +  𝑒−
𝑇−𝑇𝑚
𝑏
 Equation 5.1 
 
5.3 Results and discussion 
5.3.1 Freeze-drying for the designed mutants 
Due to the number and availability of mutants to examine, it was not practical to 
screen also a large range of formulation conditions for pH, salt type and ionic strength 
(IS).  Therefore, only the physiological condition at pH 7 was used as this would 
represent an ideal target formulation.  Based on the previous results, 200 mM NaCl 
resulted in the most monomer loss for C226S.  Therefore, the Fab samples were 
brought to an IS of 200 mM by NaCl in order to most readily differentiate the different 
stabilities of mutants to freeze-drying stress.  The pseudo wild-type C226S and initially 
only the 13 stabilising mutants were freeze-dried, and their monomer losses determined 
by SEC-HPLC as shown in Figure 5.1.  It was promising that 6 out of 13 stabilising 
mutants improved the monomer loss during freeze-drying by up to 3.97% (HC-A228M) 
compared to C226S.  Admittedly, as C226S Fab was known to be very stable, only 
small effects were expected from the designed stable mutants.  The average monomer 
loss of most mutants ranged between 9-11%, which was not significant enough to 
differentiate the stability of the mutants, although it was consistent with the relatively low 
range of ΔΔG improvements predicted for these mutants by Rosetta.   
 
** * 
* 
*** 
** * 
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Figure 5.1 The averaged monomer loss for the stabilising mutants during freeze-drying  
Error bar is SEM (standard error of the mean).  Pseudo wild type C226S was coloured in yellow 
while the others were in blue.  Two-sample t-test assuming unequal variances were performed 
between C226S and other mutants (*** p<0.001, ** p<0.01, * p<0.05). 
 
Despite the overall improved monomer loss for the stabilising mutants, it still 
remained uncertain if the enhanced stability was caused coincidently.  Due to the limited 
amount of purified Fab, this freeze-drying process could not be performed again to 
validate its reproducibility between experimental batches.  There might exist a possibility 
that the particular preparation of purified C226S was accidentally slightly unstable, which 
made the other mutants all appear to be improved.  Therefore, to validate the design 
strategy proposed by Rosetta with a wider range of ΔΔG, several unstable mutants were 
also developed, expressed and purified as described in Chapter 4.   
C226S and 4 destabilising mutants were freeze-dried with monomer loss determined 
by SEC-HPLC as shown in Figure 5.2.  It was shown that 3 out of 4 of the destabilising 
mutants designed exhibited significantly decreased monomer retention.  It was expected 
that the difference would be extended if a more unstable condition like lower pH was 
used.  This result was very promising and could exactly confirm the advantage of 
Rosetta in predicting the protein stability upon point mutations for the Fab. 
 
Figure 5.2 The averaged monomer loss for the destabilising mutants during freeze-drying  
Error bar is SEM (standard error of the mean).  Pseudo wild type C226S was coloured in yellow 
while the others were in blue.  Two-sample t-test assuming unequal variances were performed 
between C226S and other mutants (*** p<0.001, ** p<0.01, * p<0.05). 
 
** 
*** 
*** 
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It was found that C226S performed slightly differently between the two batches as 
shown in Figure 5.1 and Figure 5.2 with average monomer loss of 11.84% and 9.51%, 
respectively.  This implies that a minimum of 2% monomer loss should be considered as 
the batch-to-batch variation, assuming a systematic effect that applies equally to the 
whole batch of mutants.  In order to conduct an unbiased cross comparison to assess 
stability between stabilising and destabilising mutants, all the monomer loss of designed 
mutants was normalised against C226S in the corresponding batch with C226S set as 1, 
and plotted in Figure 5.3.  
 
Figure 5.3 The normalised monomer loss for the stabilising and destabilising mutants during 
freeze-drying  
Error bar is SEM (standard error of the mean).  Pseudo wild-type C226S, stabilising mutants and 
destabilising mutants were coloured in yellow, green and red, respectively.  Two-sample t-test 
assuming unequal variances were performed between C226S and other mutants (*** p<0.001, ** 
p<0.01, * p<0.05).  The SEM of C226S was averaged from the two batches. 
 
5.3.2 Thermal stability of designed mutants and 
their relations to freeze-drying 
After determining the freeze-drying monomer loss of the mutants designed, it was 
useful to see if this instability could be related to the intrinsic properties of the mutant 
proteins.  In that case, the performance of mutants could be predicted more efficiently 
and with less sample.  Melting temperature (Tm) is one of the most commonly used 
** * 
* 
*** 
** * 
** 
*** 
*** 
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descriptors to indicate the thermal stability of protein upon step-wised elevated thermal 
treatment.  Tm measurement was carried out for both stabilising and destabilising 
mutants, and is shown in Figure 5.4 and Figure 5.5, respectively.  All the stabilising 
mutants ranged in a narrow window with Tm-values from 77.5-80.4°C.  For the four 
tested destabilising mutants, all of them were significantly lower than the wild type, with 
LC-A153P revealing a highest Tm of 78.8°C and LC-G66P being the most unstable with a 
Tm of 72.9°C. 
Surprisingly, the pseudo wild-type C226S mutant achieved the highest Tm in both of 
the measurements.  The highest Tm of C226S may come from its large-scale 
manufacture process.  C226S was expressed in a 30 L fermenter with 2-3 g product 
yield, and therefore went through a shorter concentration process after purification.  For 
the other mutants, as they were expressed in 200 ml bench-top bioreactors, they resulted 
in only 10-20 mg product and were very dilute into Protein G column eluate.  As a result, 
they were concentrated multiple times before storing at -80°C.  This excess 
concentration process may cause the Fab degrade to some extent, although all of the 
initial Fab samples were prepared to 100% monomer as confirmed by SEC-HPLC. 
The C226S gave a slightly lower Tm when measured along with the stabilising 
mutants (80.7°C), than when repeated alongside the destabilising mutants (81.1°C), 
which demonstrated a good batch-to-batch reproducibility for the Tm measurement.  The 
difference may be caused by the total number of samples performed at the same time in 
the Optim.  When more samples are measured, it has been found that all the samples 
are incubated for longer at each step-wise increase in temperature.  At temperatures 
closest to Tm, the proteins are more likely to unfold and aggregate during the longer 
incubations associated with using more samples.  Therefore, the C226S would be found 
to have a slightly lower Tm as in Figure 5.4, compared to that in Figure 5.5. 
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Figure 5.4 The melting temperature (Tm) for the stabilising mutants measured by Optim1000 at 
pH 7  
Error bar is SEM (standard error of the mean).  Pseudo wild type C226S was coloured in yellow 
while the others were in blue.  HC-A227W and HC-T135W were not available for this measurement 
due to limited sample amount.  Two-sample t-test assuming unequal variances were performed 
between C226S and other mutants (*** p<0.001, ** p<0.01, * p<0.05).  
 
 
Figure 5.5 The melting temperature (Tm) for the destabilising mutants measured by Optim1000 at 
pH 7 
Error bar is SEM (standard error of the mean).  Pseudo wild-type C226S was coloured in yellow 
while the others were in blue.  Two-sample t-test assuming unequal variances were performed 
between C226S and other mutants (*** p<0.001, ** p<0.01, * p<0.05). 
 
To enable cross-comparison while minimising the batch influence, the Tm of the 
designed mutants were subtracted from the same-batch C226S value as ΔTm so as to 
represent the positive or negative impact of point mutations, while setting C226S as 0 as 
shown in Figure 5.6 (Cheng et al. 2012).  Figure 5.7 correlated the normalised monomer 
loss in freeze-drying (Figure 5.3) with the ΔTm.  As expected, a negative correlation (R2 
* 
*  **  
*  
**  
**  **  
**  
***  
***  
***  
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= 0.40) was found as a decrease in Tm resulted in more monomer loss due to freeze-
drying.  Therefore, Tm was a good intrinsic property, with approximately 40% accuracy, 
for predicting the stability improvement against freeze-drying, as caused by point 
mutations.  This promising result indicated that Tm can be used as an efficient pre-
screening tool, with 40% confidence to assess the developed mutations, and with a 
shorter analysis period (1 day vs 5 days) and less sample (9 μl vs 200 μl) than when 
running a freeze-drying screen.  However, due to the imbalance in the relative number 
of stabilising and destabilising mutants, with most of the dots scattered around the right-
bottom corner of Figure 5.7, the negative correlation was perhaps overly influenced by 
the four unstable mutants coloured in red.  Therefore, it would be beneficial to include 
more destabilising mutants to equally distribute the data points across the graph.   
 
 
Figure 5.6 The temperature difference of Tm (ΔTm) for the stabilising and destabilising mutants 
against pseudo wild-type C226S at pH 7 
Error bar is SEM (standard error of the mean).  Pseudo wild-type C226S was set at 0.  Stabilising 
mutants and destabilising mutants were coloured in green and red, respectively.  The SEM of C226S 
was averaged from the two batches.  LC-S176W was excluded due to its sigmoid Tm curve could not 
be obtained.  Two-sample t-test assuming unequal variances were performed between C226S and 
other mutants (*** p<0.001, ** p<0.01, * p<0.05). 
 
* * ** 
* ** 
** ** ** 
*** 
*** *** 
198 
 
 
Figure 5.7 The correlation between normalised monomer loss in freeze-drying and ΔTm against 
C226S 
 Data of freeze-drying and ΔTm was from Figure 5.3 and Figure 5.6, respectively.  Error bar is 
SEM (standard error of the mean).  Pseudo wild-type C226S, stabilising mutants and destabilising 
mutants were coloured in yellow, green and red, respectively.  Only mutants that appeared in both 
figures were plotted here. 
 
5.3.3 Rosetta’s ΔΔG prediction upon Tm and 
freeze-drying monomer loss 
The ΔΔG predicted by Rosetta for the stabilising and destabilising mutants are 
shown in Figure 5.8.  The stabilising mutants only extended a limited stabilising effect as 
indicated by its negative ΔΔG value; whereas the destabilising mutants showed greater 
predicted deviation as instability and two of them (LC-A153P, LC-G66P) had ΔΔG values 
greater than 150. 
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Figure 5.8 The ΔΔG calculated by Rosetta for stabilising (green) and destabilising (red) mutants.   
The C226S had ΔΔG of 0 as it served as the benchmark for point mutation.  Due to the small 
magnitudes of ΔΔG for stabilising mutants, they were also plotted separately.   
 
Figure 5.9 and Figure 5.10 show the correlation of ΔΔG with Tm and freeze-drying 
monomer loss, respectively.  Figure 5.11 showed a summary for the correlations 
between freeze-drying monomer loss, Tm, and ΔΔG.  The results indicated that 
increases in ΔΔG resulted in decreases in Tm (R2 = 0.26, Figure 5.9) and increases in 
monomer loss (R2 = 0.33, Figure 5.10), which corresponded to the theory although the 
correlations were poor, and perhaps only significant for destabilising mutants.  In 
general, Rosetta was an acceptable prediction tool that could differentiate mutational 
effects with 30% confidence, but with much greater confidence for the destabilising 
mutants.  When an in vitro study is limited in time and labour cost, this computational 
method could offer the efficiency to screen more than 8000 point mutational candidates 
for a 400-residue protein.  It would certainly be useful for avoiding mutations that cause 
significant destabilisation, or when designing improved mutants in a protein that starts 
with a lower stability than the A33 C226S Fab. 
Similarly to Figure 5.7, the correlation established in Figure 5.9 and Figure 5.10 
relied heavily upon the four destabilising mutants as all the stabilising ones clustered very 
closely at ΔΔG around 0.  If the four unstable mutants were excluded, the correlation 
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would actually be in the opposite direction (Figure 10.3) or no correlation (Figure 10.4).  
This implied that when the mutants had reached sufficient stability, the ΔΔG, which 
denoted the global stability, became less accurate or sensitive in estimating the thermal 
stability and level of aggregate formed due to freeze-drying stress.  The mechanisms 
leading to aggregation (when measuring Tm or when freeze drying) could be different with 
a protein that is already at high conformational stability, and hence other properties could 
provide a better prediction under those conditions.  For example, local instability in 
particular sequence regions may contribute more to aggregation, and other descriptors 
like surface charge, solvent accessible area, and cavity volume may play a more 
important role in predicting the stability. 
 
 
Figure 5.9 The correlation between ΔTm and ΔΔG 
ΔTm was calculated against C226S (Figure 5.6) and ΔΔG is calculated by Rosetta (Figure 5.8).  
Error bar is SEM (standard error of the mean).  Pseudo wild type C226S, stabilising mutants and 
destabilising mutants were coloured in yellow, green and red, respectively. 
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Figure 5.10 The correlation between normalised monomer loss in freeze-drying and ΔΔG 
Normalised monomer loss in freeze-drying was from Figure 5.3 and ΔΔG calculated by Rosetta was 
from Figure 5.8. Error bar is SEM (standard error of the mean).  Pseudo wild-type C226S, stabilising 
mutants and destabilising mutants were coloured in yellow, green and red, respectively. 
 
 
Figure 5.11 A summary of correlations between freeze-drying aggregation rate, Tm and ΔΔG.   
The widths of the arrows were proportional to their coefficient of determination (R2).  “Freeze-
drying aggregation” denoted the normalised monomer loss (Figure 5.3); “Tm” denoted the ΔTm against 
C226S (Figure 5.6); “ΔΔG” was derived from Figure 5.8. 
 
5.4 Conclusion 
This chapter analysed the freeze-drying performance for the designed stabilising and 
destabilising mutants.  The mutational design strategy was shown to be successful for 
nearly half of the stabilising mutants, as 6 out of 13 of them had 20% less monomer loss 
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than C226S after freeze-drying, while 3 out of 4 of the destabilising ones had significantly 
14-46% more monomer loss.  The same design strategy was also successful in 
obtaining mutants with altered Tm values, although the relative Tm of C226S appeared to 
be higher than for all mutants, possibly due to the different scales of purification process.  
The different extent of monomer loss of the mutants could be described by their 
differences in ΔΔG, as stabilising mutants had ΔΔG less than 10 Rosetta Energy Unit 
(REU) while destabilising ones had ΔΔG of 40-235 (REU).  The mutational stability was 
also revealed from measurement of Tm values, whereby destabilising mutants had lower 
Tm-values than stabilising mutants.  It was shown that Tm and ΔΔG estimated the 
monomer loss in freeze-drying with some degree of accuracy (R2 = 0.40 and 0.33).  The 
correlation between Tm and ΔΔG, however, was poor with an R2 of 0.26.  Overall, the 
poor estimation for freeze-drying aggregation by Tm and ΔΔG may come from the 
complex degradation during freeze-drying.  As Tm and ΔΔG mainly characterise the 
unfolding and enthalpy (by Rosetta), the freezing and drying stresses could not be 
effectively captured.  Therefore, it was worthwhile to examine the aggregation in 
aqueous phase so as to validate the performance of Tm and ΔΔG estimates in assessing 
the stability of Fab in the liquid form. 
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6 Liquid aggregation kinetics for 
designed mutant formulations 
6.1 Introduction 
6.1.1 Antibody aggregation in liquid 
formulations 
Liquid formulation strategies to minimise the denaturation and aggregation of 
therapeutic Fab and full antibodies have been well reviewed previously (Uchiyama 2014; 
Lowe et al. 2011).  It is known that colloidal stability and conformational stability are two 
key factors that influence the rate and extent of aggregation (Uchiyama 2014).  Second 
virial coefficients (B22) and the concentration dependence of the apparent diffusion 
constant (kDiff) are two measurable parameters that can be used to describe the colloidal 
stability.  The free energy difference between native and denatured state (ΔGND), and 
the temperatures where unfolding starts (Tonset), where aggregates are first detected 
(Tagg), or for the midpoint of the unfolding/aggregation transition (Tm) are useful 
parameters that describe or indicate the conformational stability.  Various measurement 
techniques have been developed to characterise the protein conformation and progress 
of aggregation, which include DSC, DLS, SEC, optical density and analytical 
ultracentrifugation (Lowe et al. 2011).  To enable efficient screening of optimal 
formulation conditions, accelerated stability studies are also commonly conducted 
(Samra & He 2012; Taylor et al. 2010a), while in silico screening is also emerging as a 
potential method for predicting the behaviour of mutational candidates (Lauer & Agrawal 
2012; Wijma et al. 2013). 
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6.1.2 Formulation with excipients to mitigate 
antibody aggregation in the liquid state 
The use of excipients is a common way to preserve the stability and activity of 
proteins either in the aqueous phase or under freeze-drying conditions (Daugherty & 
Mrsny 2006; Cheng et al. 2012).  Excipients exhibit their stabilising effect on proteins 
through multiple mechanisms, that are still poorly understood.  Understanding the 
mechanism by which excipients stabilise proteins, and the interaction between the 
impacts of excipients and mutations, would provide valuable insights that could guide us 
in the rational engineering of the protein.   
Sugars (sucrose, trehalose) and polyols (mannitol and sorbitol) interact with proteins 
through their hydroxyl groups, which replace the hydrogen bond formed with water 
molecules, and minimise protein denaturation during drying.  They therefore improve the 
conformational stability of proteins, but have little effect on colloidal stability, as observed 
with a native antibody (Uchiyama 2014).  Sugars and polyols are also thought to 
increase the Tm of protein formulations through preferential exclusion from protein 
cavities, which stabilises the protein native state with more hydration layers on the protein 
(Abbas et al. 2012; Timasheff 2002).   
Tween 20 and Tween 80 are widely used excipients for antibody drug formulations.  
They are surfactants that can reduce the surface tension in the air-solvent and surface-
solvent interfaces, and can coat the hydrophobic surfaces of containers and air-solvent 
boundaries.  This then decreases the tendency of proteins to populate and unfold at the 
solvent interface (Kerwin 2008).  However, Tween may also favourably bind to the 
hydrophobic surface of an unfolded antibody which can promote denaturation, but also 
suppress aggregation (Uchiyama 2014).  Tween has also been found to degrade into 
unwanted products by heat and near-UV light (Uchiyama 2014).   
Basic amino acids have been shown to stabilise antibodies by increasing their 
melting temperature (Arakawa et al. 2007; Falconer et al. 2011).  It was found that the 
positive charge of histidine, arginine and lysine performed better in stabilising an IgG 
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compared to neutral amino acids serine and alanine, or acidic amino acids (Falconer et 
al. 2011).  Arginine was found to behave differently to the other stabilising amino acids.  
It decreased the Tm when its concentration exceeded 0.5 M, but was found to suppress 
proteins interactions, and aggregation against heat-induced unfolding (Arakawa et al. 
2007).  An equal molarity (up to 200 mM) of arginine and glutamic acid together 
appeared to suppress mAb aggregation at elevated temperature and pH 7, compared to 
the optimal pH 5 formulation condition (Kheddo et al. 2014).   
6.1.3 Aims of the chapter 
The freeze-drying process described in Chapter 5 involves a more complex range of 
factors that could influence degradation and aggregation, than does liquid storage, which 
may have convoluted any attempts to correlate Tm and ΔΔG to the monomer loss after 
freeze-drying.  In order to validate the usefulness of Tm and ΔΔG more generally for 
protein formulation, it is worthwhile to examine the aggregation in aqueous phase, which 
provides a simpler denaturing pathway whereby the aggregation rate might be expected 
to correlate better (Kamerzell et al. 2011; Chi, Krishnan, Randolph, et al. 2003).  
Therefore, this chapter aimed to perform a liquid aggregation study for the designed 
stabilising and destabilising mutants.  The Tm and ΔΔG were each correlated to the 
aggregation in the aqueous phase, and compared with those correlations found 
previously for freeze-drying.  The stabilising effect provided by excipients was also 
assessed.  This provided insights into the extent that the instability of destabilising 
mutations could be minimised by osmolyte or surfactant.  The excipient effects on 
aggregation were also correlated with their Tm so as a potential route to more efficient 
screening of new formulations. 
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6.2 Materials and methods 
6.2.1 Liquid aggregation kinetics 
Thawed from -80°C stock, Fab was filtered, buffer exchanged to water, concentrated 
at 2 mg/ml and stored at 4°C (Section 2.2.3).  Excipients and buffer were prepared in 
stock solutions before formulating with Fab.  The final formulation conditions used were 
shown in Table 6.1.  Each formulation contained Fab, one type of excipient (or without 
excipient) and one type of buffer. 
 
Table 6.1 The formulation conditions for liquid aggregation study 
Fab 1 mg/ml 
Excipient 
Mannitol 40 mg/ml (219.6 mM) 
Sorbitol 40 mg/ml (219.6 mM) 
Tween 80 4 mg/ml (3.1 mM) 
Glycine 20 mg/ml (266.4 mM) 
Buffer 
condition 
 20 mM acetate pH 5 NaCl to bring the total 
ionic strength to 200 mM  20 mM citrate pH 4 
 
Each sample was aliquoted into 20 μL in a safe-lock micro-centrifuge tube (Fisher 
Scientific, UK).  During the aggregation study, the samples were firstly incubated at 45 
or 65°C.  Samples in triplicates were taken out every 15 or 30 min and centrifuged at 
15,000 rpm, 4°C for 15 min, from which 15 μL supernatant was transferred into a HPLC 
vial insert.  5 μL sample was used to determine the monomer analysed by the SEC-
HPLC (Section 2.2.8). 
The monomer retention at each condition was plotted against incubation time.  To fit 
a linear regression curve, the initial plateau stage (0.5-1 hour) and the monomer retention 
closing to 0 were excluded.  Only data points that covering the same period in a batch 
for all the mutants were used to fit the linear regression.  The slope of each regression 
curve was extracted and normalised against C226S to determine the aggregation rate.   
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6.2.2 Melting temperature (Tm) of C226S 
formulated with excipients 
The Tm measurement followed the same protocol as described in Section 5.2.2 
except the different formulation conditions as shown in Table 6.2.  Each formulation was 
run in triplicate and contained 1 mg/ml Fab, one type of excipient and 10 mM sodium 
phosphate buffer at pH 7,  
Table 6.2 The formulation conditions to perform the Tm measurement 
Fab 1 mg/ml 
Excipient 
Trehalose 50 mg/ml 
Sucrose 50 mg/ml 
Mannitol 40 mg/ml 
Sorbitol 40 mg/ml 
Tween 20 4 mg/ml 
Tween 80 4 mg/ml 
Glycine 20 mg/ml 
Arginine 20 mg/ml 
Buffer Sodium phosphate 10 mM, pH 7 
 
6.3 Results and discussion 
6.3.1 Liquid solution condition scouting to study 
liquid aggregation kinetics 
In order to perform an efficient screening of the mutants and to minimise sample 
evaporation during long-term incubations, a scouting study was conducted to identify the 
conditions that could complete one full kinetics study in a single working day.  It aimed to 
aggregate the majority of the Fab monomers in 5-10 hours.  Based on previous work 
(Chakroun et al. 2016), low pH, high salt concentration and high temperature would 
cause rapid aggregation.  In this work, C226S was firstly tried to provide a benchmark 
for the designed mutants.   
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Figure 6.1 Monomer retention kinetics at 65°C for 1 mg/ml C226S, 20 mM acetate, pH 5, with 
NaCl to bring the total ionic strength to 200 mM 
Error bar: standard error of the mean. 
 
 
Figure 6.2 Monomer retention kinetics at 45°C for 1 mg/ml C226S, 20 mM citrate, pH 4, with NaCl 
to bring the total ionic strength to 200 mM 
Error bar: standard error of the mean. 
 
 
Figure 6.3 Monomer retention of kinetics at 65°C for 1 mg/ml C226S, 20 mM citrate, pH 4, with 
NaCl to bring the total ionic strength to 200 mM 
Error bar: standard error of the mean. 
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Figure 6.1 showed the C226S monomer retention at 20 mM acetate, pH 5 with NaCl 
to bring the total ionic strength to 200 mM at 65°C, which indicated that the monomer 
population decreased by less than 20% in two days.  Based on this trend, it might take a 
week to fully aggregate the monomer at this condition.  A more extreme condition of pH 
4 (20 mM citrate) but with more moderate incubation temperature at 45°C was then 
tested as shown in Figure 6.2.  However, this condition was even milder as no 
detectable monomer was observed for the first 2 days.  After that, a low pH at 4 with 
65°C incubation temperature was further tested as shown in Figure 6.3.  The required 
curve for monomer decay was obtained such that more than 90% monomer was lost in 5 
hours.  Based on the results, this condition was selected to evaluate the stability of 
mutants in the aqueous phase.  In order to obtain a more accurate record for the 
monomer loss, a sampling interval of at least every 30 min would also be used. 
6.3.2 Effect of mutations upon liquid aggregation 
kinetics 
The liquid aggregation kinetics data for C226S and the mutants are shown in Figure 
6.4, in which the aggregation rate was determined based on the slope from a linear 
regression curve as shown on the right.  All of the stabilising mutants (LC-S176W, LC-
L154A, HC-T135Y) performed better than the destabilising ones (LC-A153P, LC-G200W, 
HC-V215W, LC-G66P).  The aggregation rate differences between stabilising mutants 
were much smaller than the differences between destabilising ones, which corresponded 
to the extent shown in the predicted ΔΔG and the experimentally determined Tm.  There 
was evidence of evaporation at later time points in some samples and so these data 
points were excluded from the analysis. 
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Figure A.  C226S and stabilising mutants without excipient 
 
 
Figure B.  C226S and destabilising mutants without excipient (The LC-G66P already achieved 0 
monomer retention at 1.5 hour.  So its aggregation rate was only fitted from 0.5 and 1-hour data 
points.  In order to have an equivalent comparison, the aggregation rates of all the other mutants 
were also fitted from those two time points.) 
 
 
Figure C.  C226S and stabilising mutants with 4 mg/ml Tween 80 
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Figure D.  C226S and destabilising mutants with 4 mg/ml Tween 80 
 
 
Figure E.  C226S, stabilising and destabilising mutants with 40 mg/ml mannitol 
 
 
Figure F.  C226S, stabilising and destabilising mutants with 40 mg/ml sorbitol 
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Figure G.  C226S, stabilising and destabilising mutants with 20 mg/ml glycine 
 
Figure 6.4 The monomer retention of liquid kinetics for 1 mg/ml Fab mutants at 20 mM citrate, pH 
4 with NaCl to bring the total ionic strength to 200 mM at 65°C  
Full triplicates were used for each data point with error bars indicating the standard error of the 
mean.  One type of excipients was added as specified individually.  Left: overall monomer retention 
kinetics; Right: the truncated data points to obtain aggregation rate.  R2 values were not shown if only 
two data points were used to obtain the linear regression. 
 
Considering the batch-to-batch variation, it would be better to normalise the 
aggregation rate before cross-comparing the mutants’ behaviours for quantitative 
analysis.  Figure 6.5 shows the aggregation rate relative to that of C226S for each 
excipient group.  It can be seen that the impact of mutations on aggregation varied 
differently for each excipient type.  The mutants behaved with the most sensitivity for 
mannitol, followed by Tween 80, sorbitol and glycine, and exhibited least sensitivity to 
without the excipient.   
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Figure 6.5 The normalised aggregation rates derived from Figure 6.4.   
For each of the excipient group, the aggregation rate was normalised against the C226S in the 
same group.  The error bars were not shown as the rates were obtained from the slopes of linear 
regression. 
 
 
(A) 
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(B) 
 
 
(C) 
Figure 6.6 Correlations between ΔTm, ΔΔG, normalised freeze-drying monomer loss and 
normalised monomer loss rate.   
Figure A: correlations between ΔTm and normalised monomer loss rate; Figure B: correlations 
between ΔΔG and normalised monomer loss rate; Figure C: correlations between normalised freeze-
drying monomer loss and normalised monomer loss rate. 
Only the 8 mutants used for liquid aggregation study are shown.  The normalised monomer loss 
rates, ΔTm from C226S, ΔΔG, normalised freeze-drying monomer loss were derived from Figure 6.5, 
Figure 5.6, Figure 5.8 and Figure 5.3, respectively.  The Tm data for LC-S176W was excluded as a 
sigmoid function could not be fitted.  The Tm values were measured at 10 mM sodium phosphate at 
pH 7; the liquid aggregation was conducted at 20 mM citrate at pH 4 with NaCl to bring the total ionic 
strength to 200 mM; the freeze-drying was conducted at 20 mM sodium phosphate at pH 7 with NaCl 
to bring the total ionic strength to 200 mM. 
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It is interesting to see whether the impact of mutations upon aggregation could be 
predicted by their Tm and Rosetta-based ΔΔG, and also if there was a connection 
between the aggregation in the aqueous phase and in freeze-drying.  Figure 6.6 showed 
that there existed a strong correlation (R2 = 0.83-0.92) between Tm and the liquid 
aggregation rate, which indicated that the Tm could confidently reflect the global unfolding 
and subsequent aggregation that occurred during liquid aggregation.  It has been shown 
previously (Chakroun et al. 2016) that the liquid-state aggregation rate of A33 Fab C226S 
only correlated well to Tm under conditions in which the protein is globally unstable, i.e. at 
temperatures close to the Tm of the molecules.  This was observed for incubations at 
65°C, but not at 45°C or below.  The results for the mutants are consistent with this 
observation as the incubation was also at 65°C, and because most of the range in Tm 
explored here was due to mutations that were destabilising, and hence more likely to 
promote aggregation via a global unfolding pathway. 
Compared to the correlation between freeze-drying aggregation and Tm (R2=0.40, 
Figure 5.7), the large fitting decline in freeze-drying implied that aggregation due to 
freezing and drying involved at least one further mechanism for monomer loss, in addition 
to simple aggregation driven by global unfolding.   
The correlations between liquid aggregation rate and the ΔΔG predicted by Rosetta 
were much lower (R2 = 0.39-0.51), though a slight improvement compared to correlation 
with freeze-drying aggregation (R2=0.33, Figure 5.10).  This implied that the enthalpy 
free energy calculated in silico could capture one third to half of the denaturing stress 
occurred in aqueous phase.  The poor correlation is most likely to be due to the 
limitation of the Rosetta calculations, and good correlation to an experimentally 
determined ΔΔG cannot, and should not, yet be ruled out. 
Figure 6.6 also shows that the monomer loss observed in the aqueous phase could 
partially be correlated to that in freeze-drying (R2 = 0.53-0.62).  This suggests that the 
mutants undergo aggregation driven by global unfolding in the liquid conditions used 
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(pH 4, 65°C), and that this mechanism is partly attributable to monomer loss during 
freeze-drying. 
 
Figure 6.7 A summary of correlations between liquid aggregation rate, freeze-drying aggregation 
rate, Tm and ΔΔG.   
The widths of the arrows were proportional to their coefficient of determination (R2).  The data 
were derived from the 8 mutants used for liquid aggregation kinetics.  “Liquid aggregation” denoted 
the normalised aggregation rate for the data without excipient (Figure 6.6); “Freeze-drying 
aggregation” denoted the normalised monomer loss (Figure 5.3); “Tm” denoted the ΔTm against C226S 
(Figure 5.6); “ΔΔG” was derived from Figure 5.8. 
 
Figure 6.7 showed the correlations between liquid aggregation rate, freeze-drying 
aggregation rate, Tm and ΔΔG, in which only the 8 mutants used for liquid aggregation 
were included.  It could be seen that liquid aggregation was much more likely to be 
accurately predicted compared to aggregation in freeze-drying.  The ΔΔG, however, 
performed poorly for any of the other three factors, and the correlations were weaker 
compared to Figure 5.11 where 16-18 mutants were included.  Rosetta proposed 
mutations that could improve the global enthalpy for the whole protein with 69% 
confidence (Kellogg 2011), which influenced ΔG through ΔH.  However, the poor 
performance mainly came from not considering entropic contributions to stability, and did 
not separate out the overall global stability (ΔG) from local stability and fluctuations of 
surface features.  It is well known that decreasing surface flexibility at aggregation-prone 
regions leads to improved global stability through entropic factors, but that this is not 
always necessarily the case (Kamerzell & Middaugh 2008; McClelland & Bowler 2016).  
For this work, a default scoring function was used in Rosetta for the ΔΔG calculation.  It 
may be worthwhile to manipulate the weights of the scoring function to customise it to this 
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A33 Fab.  It might also be the reason that the mutants analysed here were very limited.  
So the performance might be improved if more mutants, which cover a wider range of 
ΔΔG, were included in the fitting.  Therefore, ΔΔG could only be used qualitatively for 
the scope of this work.  Other in silico tools could be considered if surface fluctuations 
and instabilities were properly addressed. 
6.3.3 Effect of excipients upon liquid 
aggregation kinetics 
In this work, only one excipient was tested in each batch.  During our experiment, it 
was observed that the temperature of the incubator dropped 5-10°C when samples were 
first put into the chamber.  This was because the sample holders were kept on ice and 
the 65°C incubator needed to heat them together with the sample tubes.  This partially 
accounted for the initial 30-60 min plateau where no significant monomer loss was 
detected.  As a result, this plateau period was excluded when fitting the aggregation 
rate.  In order to minimise the batch-to-batch variation, it would be ideal to include 
C226S without excipients as a common control in every batch, and to normalise 
incubation conditions.  Unfortunately, this was not done and so the batch-to-batch 
variations were not considered when comparing the stabilising effects of different 
excipients.  However, all mutants could be compared against C226S within the same 
formulation, as these were measured within a single batch. 
All of the linear regression curves between liquid aggregation rate and Tm for the 
excipients are shown in Figure 6.6 (A).  The C226S results were set as 1 and results for 
the other mutants were normalised relative to C226S.  It can be seen from the figure that 
all the excipients widened the gaps between the mutants compared to the condition 
without excipient.  This implied that if all the mutants were added with a same excipient, 
their relative aggregation rates with regard to C226S would be magnified.  The 
sensitivity order from high to low followed the trend of mannitol > glycine > sorbitol > 
Tween 80.  However, it may also due to the concentration difference used that caused 
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the sensitivity difference as shown in Table 6.1, though mannitol, sorbitol and glycine 
shared close molarity. 
To examine the absolute stabilising effect from excipients, a generalised criterion 
should be applied to quantify the aggregation among all the batches so as to draw an 
unbiased comparison.  The aggregation rate between 1-1.5 hour was acceptable as this 
period could capture the monomer loss of most of the destabilising mutants.  However, 
the LC-G66P mutant (no excipient) had no monomer at 1.5 hour, which implied that it 
might already lose all of the monomers before the 1.5-hour sampling point as it only 
retained 30% at 1-hour sampling point.  So the aggregation rate was not generalisable 
for all the mutants to quantify the absolute stabilising effect from excipients.  Instead, the 
absolute monomer retention was used in this work.  Figure 6.8 lists the monomer 
retention at 2.5 hour for C226S and stabilising mutants, and at 1.5 hour for destabilising 
mutants.  These two time points were chosen because they can maximally differentiate 
the monomer loss for all the mutants.  The data in the figure were also normalised 
against the results with no excipients so as to present the contrast more clearly as 
influenced by the excipients.   
 
 
Figure 6.8 The impact of excipients on the liquid monomer retention of mutants.   
The monomer retention at 2.5 hour was used for C226S and stabilising mutants, and 1.5 hour for 
destabilising mutants.  The data was normalised against results of no excipients for each mutant.   
219 
 
 
Figure 6.8 showed the impact of excipients on the liquid monomer retention for 
C226S and stabilising mutants at 2.5-hour sampling point, and destabilising mutants at 
1.5-hour sampling point.  The excipients predominantly increased the monomer 
retention of destabilising mutants and by 3-10 fold for LC-A153P, LC-G200W, HC-
V215W, and 22-241 fold for LC-G66P.  However, excipients exerted a considerably 
more limited impact upon the stabilising mutants and C226S.  For these mutants, Tween 
80 and sorbitol had little no difference upon monomer retention compared to the condition 
without excipient.  By contrast, glycine gave an improvement of 50%, whereas mannitol 
surprisingly reduced the monomer retention to 15-40%. 
In general, destabilising mutants were more susceptible to be improved through 
interacting with excipients.  This was reasonable as the mutated residues in the unstable 
mutants were more flexible, disrupted the structure, and promote unfolding.  Through 
associating with excipients, these flexibilities were decreased and the unfolding was 
slowed down, which reduced their chance to aggregate with other proteins.  For the 
stabilising mutants, contrarily, the mutants are already globally very stable, and have 
potentially fewer flexible sites, and so the excipients have less opportunity to improve 
them under the conditions studied.   
The distinctive monomer retention kinetics from mannitol are very interesting.  
C226S and the stabilising mutants lost more than 70-90% monomer in the first 2.5 hours.  
Then they increased slightly and remained at 30-40% for C226S, LC-L154A, HC-T135Y, 
and 12-15% for LC-S176W for at least 1.5 hour before completely aggregating.  This 
relatively stable monomer preservation during the aggregation implied that mannitol 
might suppress Fab self-association as it unfolded.  They may bind to the exposed 
hydrophobic core of Fab and prevent them from complete unfolding and aggregation.  
Sorbitol, which is the isomer of mannitol, did not show a similar preserving effect as the 
monomer concentration for stabilising mutants gradually decreased without a plateau 
state in their progress.  In general, sorbitol preserved the stabilising mutant monomers 
best, while mannitol preserved the destabilising ones better.  The only difference 
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between mannitol and sorbitol is the orientation of the hydroxyl group on carbon 2.  
Therefore, the structure of mannitol may be more likely to bind the hydrophobic regions 
when the protein is unfolded, and so protect the residues mutated to non-polar proline or 
aromatic tryptophan in the destabilising mutants.  Sorbitol retained the monomer 
concentration of the stabilising mutants, potentially through binding to the polar surface of 
the folded protein.   
Glycine performed better than any other excipients to retain the monomers for both 
stabilising and destabilising mutants.  This was promising as it could serve as a 
universal stabiliser for Fab in the aqueous phase.  It was found previously that glycine 
suppressed the pH change in sodium phosphate buffer during freezing and stabilised 
proteins through the preferential exclusion mechanism (Pikal-Cleland et al. 2002).  In the 
preferential exclusion mechanism (Arakawa & Timasheff 1982; Kendrick et al. 1997) the 
stabilisers are preferentially excluded from the protein surface, which increases the free 
energy for proteins to denature and thus retains their native states.  As shown in Figure 
6.4, glycine extended considerably the time for which the monomers were retained, 
compared to other excipients.  For stabilising mutants in glycine, monomer populations 
did not drop to less than 60% until after 4.5 hours.  For two destabilising mutants in 
glycine, LC-A153P and LC-G200W, the monomer population was also not fully depleted 
for the same period.  The molarity of glycine (266 mM) was higher than mannitol and 
sorbitol (220 mM) though its mass-concentration was only half (20 mg/ml versus 40 
mg/ml, Table 6.1).  Therefore, the stabilising effect may also be partly convoluted by the 
molarity difference. 
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Figure 6.9 The absolute aggregation rate correlations between C226S and designed mutants, and 
their correlation accuracy as a function of ΔTm.   
The aggregation rates were derived from the slopes of the right-hand graphs in Figure 6.4.  The 
ΔTm values were derived from Figure 5.6 (LC-S176W was excluded as a sigmoidal Tm curve was not 
obtained).  The slope and R2 values from the left-hand plots were used in the upper-right and lower-
right graphs, respectively, in which green and red dots were used to indicate the stabilising and 
destabilising mutants, respectively. 
 
As the excipients exhibited different effects upon the aggregation of the mutants, it 
was interesting to examine whether the ranking of excipients in their ability to stabilise 
C226S could be generalised to other mutants.  If that were the case, then once a series 
of excipients had been tested on one variant, then new variants with similar structures 
might only need to be screened with the most beneficial excipients.  Figure 6.9 
correlates the aggregation rates for each mutant with those of C226S for the range of 
excipient formulations tested.  It could be seen that the stabilising mutants had slopes 
close to 1 (i.e. 0.85-1.2), and R2 values of more than 0.85, whereas the destabilising 
mutants had slopes of 3-10, and much lower R2 values (0.43-0.65).  This indicated that 
the ranking of excipients for C226S was similar to those of the stabilising mutants, but 
much less predictive of the rank order for the destabilising mutants.  As shown on the 
lower-right of Figure 6.9, the R2 values of absolute aggregation rate correlations 
decreased further from 1 as the ΔTm increased in magnitude.  This implies that the rank 
order of the excipients becomes less reliable as the difference in stability (ΔTm) 
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increases.  Interestingly this was the case even though ΔTm was found to correlate well 
with the absolute aggregation rates of the mutants (R2 of 0.87), in the aqueous phase. 
Admittedly, the present study was not completely rigorous.  As mentioned before, 
there was not a benchmark condition, like C226S without excipient, used for every batch.  
Therefore, the batch variations were not effectively normalised.  The aggregation for 
destabilising mutants occurred very rapidly so a 30 min difference would result in 
significantly different results, while different batches may take a different time to heat the 
tube rack to thermal equilibrium.  The excipient effects for LC-G66P may be far 
exaggerated, as the monomer was nearly completely gone in the absence of excipients, 
at the 1.5-hour sampling time.  Therefore, if the excipient influence needed to be 
precisely studied, Fab samples added with various excipients should be run in the same 
batch. 
In conclusion, it was shown that 1) the excipients in general would stabilise the 
destabilising mutants, but had a more limited influence on the stable mutants (Figure 
6.8); 2) the mutants’ difference with regard to the stabilising effect of excipients was 
amplified as reflected by their different Tm (Figure 6.6A); 3) the rank-order of excipient 
effects for individual mutants, relative to that of wild type, became less similar as the 
mutant ΔTm magnitude increased (Figure 6.9).   
6.3.4 The Tm with excipients and its correlation 
with liquid aggregation kinetics 
In order to investigate if the stabilising roles imposed by excipients could be 
characterised and predicted by a more efficient measurement with less sample, the Tm 
was measured for C226S added with the tested excipients as well as other commonly 
used excipients as shown in Figure 6.10.  It can be seen that most of the excipients 
increased the Tm 0.5-1°C compared to the condition with no excipient added.  Glycine 
increased 2°C, which outweighed any other excipients.  Arginine, however, decreased 
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the Tm by nearly 8°C, which may due to its negative effect on protein thermostability, as it 
contains a guanidine moiety that also acts as a mild detergent (Barata et al. 2016).   
 
 
Figure 6.10 The Tm of 1 mg/ml C226S added with various excipients at 10 mM sodium phosphate, 
pH 7.   
The excipient concentration was shown in Table 6.2. 
 
Figure 6.11 correlated the monomer retention for stabilising mutants (2.5 hour) and 
destabilising ones (1.5 hour) with the Tm values measured with the different excipients 
added.  The correlations for stabilising mutants were fairly poor (R2 = 0.17-0.30), with 
the mannitol data being notable outliers.  Due to mannitol’s unnatural behaviour for the 
monomer retention during liquid aggregation study, those data need to be conducted 
again to confirm its preserving mechanism.  If the mannitol data was excluded, the 
correlations were largely increased (R2 = 0.48-0.95).  Therefore, the excipients’ 
stabilising effect could be mostly reflected by the Tm values even for globally stable 
mutants.  The correlations for the destabilising mutants were very strong (R2 = 0.73-
0.92).  Because the monomers of destabilising mutants were more likely to be preserved 
by the excipients, the extended improvement on monomer retention could be well 
captured.  The results implied that using a relatively unstable mutant could provide more 
insight on the stabilising role from excipients.  It was noted that all the correlations 
decreased for mutants compared to C226S.  This might because the Tm values were 
measured only for C226S.  The correlations would be expected to improve if Tm was 
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measured for each mutant.  Barata (Barata et al. 2016) also conducted a molecular 
docking study to examine the excipients’ role in interacting with aggregation-prone 
regions on this A33 Fab.  It was found that increased Tm values resulted in decreased 
protein binding affinity with a strong correlation (R2 = 0.743).   
 
Figure 6.11 The correlations between monomer retention and Tm as impacted by the excipients. 
The normalised monomer retention was derived from Figure 6.8; the Tm was derived from Figure 
6.10. 
6.4 Conclusion 
This chapter analysed the liquid aggregation for C226S, three stabilising and four 
destabilising mutants at pH 4 and elevated temperature at 65°C.  Compared to freeze-
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drying, a more distinguish difference was observed for aggregation in the aqueous phase 
as all the destabilising mutants aggregated more than 5 times faster than C226S and the 
stabilising mutants did.  The different mutants’ aggregation rates were fully captured by 
their differences in Tm (R2 = 0.92).  There was also a good correlation between 
aggregation in aqueous phase and in freeze-drying with R2 of 0.55.  ΔΔG still behaved 
poorly in predicting the Tm (R2 = 0.20), and with a little better accuracy for liquid 
aggregation (R2 = 0.39) than freeze-drying aggregation (R2 = 0.21), indicating enthalpy 
stability was more important in aqueous phase than that in freeze-drying. 
Excipients’ effect was also assessed for Tween 80, mannitol, sorbitol and glycine.  It 
was found that excipients barely exerted influence on the stable mutants but provided 
sufficient protection for the unstable ones, especially the most unstable LC-G66P mutant.  
Glycine outperformed than any other excipients probably through preferential exclusion 
mechanism.  However, the excipients could not stabilise unstable mutants to the same 
level as stable ones at the tested concentration.  The excipients stabilising effect was 
also reflected by their Tm values, and stronger correlations were found for unstable 
mutants (R2 = 0.73–0.91) than stable ones (R2 = 0.17–0.30) due to the outlier of 
mannitol.  The rank-order of excipient effects for individual mutants, relative to that of 
wild type, became less similar as the mutant ΔTm magnitude increased. 
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7 Conclusion 
This project determined the key factors that would influence the Fab stability in 
freeze-drying and aqueous phase.  A rapid freeze-drying screening platform was 
developed with comparable drying rate, in which samples were filled in the middle 60 
wells of a 96-well plate, while the outer wells, and surrounding trimmed plates were filled 
with water.  Afterwards, the pseudo wild type C226S and four mutants with altered 
surface charge were freeze-dried over a range of solution conditions covering pH 4-9, 
ionic strength (IS) 50-200 mM, and using NaCl or Na2SO4.  In general, losing one 
positive charge increased the degree of monomer loss during freeze-drying, while adding 
one slightly improved the stability.  Freeze-drying at acidic pH resulted on average in 4-
6% more monomer loss than at alkaline pH.  Higher ionic strengths mostly caused more 
aggregation, and yet formulation with Na2SO4 retained 2% more monomer than NaCl on 
average.  An acceptable cake morphology was obtained at the higher ionic strengths, 
although Na2SO4 again performed better than NaCl.  The work suggested that colloidal 
stability due to electrostatic repulsions had a key role in stabilising proteins against 
monomer loss during the freeze-drying process. 
Several in-silico methods were explored to identify potential mutational sites in order 
to improve the Fab stability.  Rosetta software was used to build a homology model and 
screen for all the possible mutant candidates.  RMSF and B-factor were used to restrict 
the mutants mainly located at the flexible sites.  In the meantime, unstable mutants were 
also prepared as controls to validate the prediction accuracy.   
The designed stabilising and destabilising mutants were assessed in freeze-drying 
and aqueous state, and the stabilising mutants showed significant less monomer loss 
than the destabilising ones in both of the processes.  The Tm correlated much stronger 
for aggregation in liquid state than freeze-drying.  This implied that the unfolding, which 
indicated conformation stability, dominated the aggregation in aqueous state at pH 4, 200 
mM NaCl and 65°C; but was not prominent in freeze-drying where freezing and drying 
stress also caused the Fab degradation.  The ΔΔG did not show great impact on Fab 
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stability in the two processes.  This implied that the global stability as depicted by 
enthalpy might not be sufficiently comprehensive to characterise the aggregation due to 
local flexibility on the Fab residues.  Nevertheless, Rosetta was still a good in-silico 
protein modelling software to qualitatively propose the mutational effect on protein 
stability. 
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8 Future work 
8.1 Short-term future work 
Due to the limited time available in the PhD study, there were several perspectives 
that need to be further improved and explored so as to improve the Fab stability in 
freeze-drying and liquid formulations. 
8.1.1 Improve the liquid kinetics operations 
For liquid aggregation kinetic studies, Figure 6.4 showed there was approximately 
one hour lag phase in the beginning of incubation.  This was because the 65°C 
incubator needed to heat the cold sample holders together with the sample tubes.  As a 
result, only the data points after one hour were used to derive the aggregation rate.  This 
was subjective as the lag phase might complete earlier or later at different batches due to 
the varying temperature of the cold sample holders.  It would be better if all the samples 
could be loaded into the incubator to enable direct thermal contact to the air within the 
chamber.  For example, they could be loaded onto several racks and put them into the 
chamber at a time.  In this case, the aggregation could be studied from the very 
beginning of the incubation without arbitrary lag phase subtraction. 
In Figure 6.4, it also showed that the destabilising mutants mostly aggregated in two 
hours.  It turned out that the 30 min interval for sampling is not frequent enough as only 
2-3 time points could be used to fit the aggregation kinetics.  It would be better if a 
shorter sampling interval (e.g. 15 min) could be applied so as to capture the monomer 
loss in greater detail. 
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8.1.2 Compare aggregation driven by global 
unfolding and native states 
Aggregation could be driven by the unfolding of protein and subsequent association 
of exposed hydrophobic residues.  It could also occur when the protein native states 
were retained while association through local flexible residues.  In Chapter 6, the low 
pH, high salt concentration and high incubation temperature for liquid aggregation study 
suggested that its aggregation was subject to be driven by global unfolding.  However, in 
Figure 6.6 (A), the samples for Tm measurement were prepared at pH 7 phosphate buffer 
without additional salt; while the samples for liquid kinetics were prepared at pH 4 citrate 
buffer with NaCl to bring the total ionic strength to 200 mM.  Therefore, Tm with 
conditions the same as liquid kinetics should be conducted so that the Tm could 
reasonably reflect the thermal stability of protein at an unfolding treatment. 
A parallel study is aggregation driven by local flexibility in native states.  This 
requires the incubation temperature is far from the Tm and with neutral and low salt 
concentration.  As the Fab wild type is already very stable, it is difficult to increase its Tm 
to a large extent.  Therefore, liquid incubation at pH 7, 45°C could be used to investigate 
the aggregation with local instability. 
8.1.3 Examine the excipients’ stabilising effect 
Chapter 6 showed that the rank-order of excipient effects for individual mutants, 
relative to that of wild type, became less similar as the mutant ΔTm magnitude increased.  
This might be that different destabilising mutants may preferentially interact with typical 
excipients; while the stable ones were already very stable so their stability could not be 
further improved by interaction with excipients. 
Excipients stabilise the proteins in different ways (Ohtake et al. 2011; Kamerzell et 
al. 2011).  One hypothesis is they interact the flexible residues of proteins, preventing it 
from partially unfolding or association with other protein molecules.  To verify this 
assumption, the protein-excipient docking energy could be screened by docking software 
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(e.g. iGEMDOCK, AUTODOCK), and protein-excipient complex could be simulated to 
examine their flexibility.  
8.1.4 Analyse the degradation stresses in freeze-
drying 
Compared to the monomer loss in aqueous phase (Chapter 6), the monomer loss in 
freeze-drying could not be well correlated with Tm (Chapter 5).  The monomer loss of 
was reduced for some stable mutants though their Tm did not increase compared to the 
wild type.  This implies that freeze-drying involves more complex stresses (e.g. freezing 
and drying) that could not be well captured by the thermal stability of proteins.  To better 
understand the degradation mechanism in freeze-drying, the following could be explored. 
8.1.4.1 More destabilising mutants for freeze-drying 
The freeze-drying analysis in Figure 5.7, Figure 5.9 and Figure 5.10 showed that the 
linear correlation was largely influenced by the destabilising mutants, which accounted for 
less than one third of the total mutants.  Therefore, more mutants covering a wider 
range of Tm, ΔΔG and aggregation propensity could be designed to have a more 
comprehensive understanding for the Fab stability.  This could result in a more unbiased 
conclusion if the mutants could be evenly distributed to study the predictions of Tm, ΔΔG 
upon Fab aggregation. 
8.1.4.2 Step-by-step study for the monomer loss in freeze-drying 
In this research, the monomer loss was determined based on the reconstituted 
sample.  The whole freeze-drying process could generally be divided into freezing, 
drying, storage and reconstitution.  As the denaturation of proteins could occur at 
different steps during freeze-drying, it is worthwhile to identify which step causes the 
most of monomer loss.  For example, a comparison of monomer loss between freeze-
thawing and freeze-drying could be carried out to determine if freezing or drying accounts 
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for more monomer loss.  Once this is determined, the optimisation of operation 
parameters could be reduced and more relevant to the typical stress. 
The molecular dynamic simulation could be tried at sub-zero temperature to reveal 
the flexibility of protein in supercooled or frozen state.  It would also be beneficial if the 
shift of hydrogen bond in protein-water to protein-excipient could be simulated to provide 
in-silico evidence for the excipients’ stabilising effect. 
8.2 Long-term future work 
8.2.1 Improve the mutagenesis strategy 
The mutagenesis strategy needs to be improved.  Rosetta could differentiate the 
stabilising effect from destabilising ones.  However, its correlations with Tm, aggregation 
in liquid state and freeze-drying were fairly poor.  As Tm strongly correlated with 
aggregation in the liquid state (R2 = 0.92), a protein modelling software that could 
precisely calculate the Tm would be very useful.  One solution is to examine the software 
that achieved good performance in the contest Critical Assessment of Structure 
Prediction (CASP).  In general, the prediction tools were developed based on a set of 
various proteins, which made the structural stability averaged from the extensive training 
dataset.  As a result, they may not be adequately accurate for a particular protein.  
Therefore, with the Tm and aggregation data available for the Fab, a combination of 
several prediction tools, ideally orthogonally covering different structural aspects, could 
be developed so as to customise it to the protein of interest.  In addition, double or triple 
mutants that encompass advantageous substitutions could be considered to improve the 
stability and reduce the aggregation propensity. 
8.2.2 Standardised formulation studies 
The formulation studies need to be carried out in more standardised conditions so as 
to enable cross-comparison with other people’s work.  The protein structures have 
already been standardised in PDB format, where identical terms are used to represent 
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the chain ID, residual numbering and atomic coordinates of different proteins.  The 
formulation studies, however, are still performed without strict criteria.  For example, 
concentration, molarity, ionic strength are used relatively interchangeably among different 
research groups.  In addition, most of the formulation literature did not provide their PDB 
files, which made readers not straightforward to examine the relations between different 
formulation performance and their structural difference.   
8.2.3 Study other antibody structures 
Once the formulation conditions are standardised to certain extent, it is promising to 
extend the Fab work to other antibody species like F(ab’)2, scFv, sdAb and full 
antibodies, and investigate their unfolding and aggregation in the same formulations.  
This can provide insights about the antibody stability at different levels of molecular 
weight while maintaining the heterogeneity of protein species in a relatively low level. 
8.2.4 Activity 
Due to the limited information for the binding affinity of Fab, the Fab activity was not 
analysed in this work.  But it is one of the most important factors that determines the 
efficacy of the medical drug.  For the future work, it would be valuable to develop an 
assay (e.g. Western blot, ELISA) to ensure the potency of the Fab.  In that case, both 
thermal stability (e.g. Tm, aggregation) and activity could be used to evaluate the 
formulation performance. 
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10 Appendix 
10.1 Pymol visualisation for the PDB of C226S 
 
Figure 10.1 The C226S structure predicted by Rosetta.   
The crystal structure of human germline antibody 5-51/O12 (PDB ID 4KMT) was used for the 
homology modelling.  Light chain and heave chain were coloured in green and cyans, respectively. 
10.2 Rosetta script 
Examples of a mutfile (i.e. mutation file) and an options file were listed here to 
mutate the 1st residue aspartic acid into alanine. 
10.2.1 Mutfile 
total 1 
1 
D 1 A 
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10.2.2  Option file 
-ddg::mut_file  
/home/ucbechz/Scratch/20150203_ddg_monomer_8398mutants/input/mutfile/D1A.mutfil
e 
-in:file:s 
/home/ucbechz/Scratch/20150203_ddg_monomer_8398mutants/input/C226S.pdb 
-constraints::cst_file 
/home/ucbechz/Scratch/20150203_ddg_monomer_8398mutants/input/input.cst 
-ddg:weight_file soft_rep_design 
-ddg:minimization_scorefunction talaris2013 
-ddg::iterations 50 
-ddg::dump_pdbs true 
-ignore_unrecognized_res 
-ddg::local_opt_only false 
-ddg::min_cst true 
-ddg::suppress_checkpointing true 
-in::file::fullatom 
-ddg::mean false 
-ddg::min true 
-ddg::sc_min_only false 
-ddg::ramp_repulsive true 
-unmute core.optimization.LineMinimizer 
-ddg::output_silent true 
-override_rsd_type_limit 
10.3  The ΔΔG of 8398 mutants 
Light chain: residue 1-214 
Heavy chain: residue 215-442 
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A C D E F G H I K L M N P Q R S T V W Y
1 D -0.266 -4.554 1.972 1.269 0.311 -0.136 -1.118 -0.678 -1.883 -0.006 1.938 -1.892 -6.347 2.638 3.41 1.282 1.65 3.125 -2.594
2 I -0.128 -1.901 3.929 9.957 -1.674 2.211 -0.815 5.895 4.929 5.196 4.558 11.043 1.943 9.736 2.438 1.385 3.773 9.953 -0.817
3 Q 3.197 -3.261 -1.744 0.381 -2.442 -1.581 5.996 -2.909 2.805 4.042 -1.316 0.462 5.491 5.504 4.669 0.597 -0.949 4.853 0.93
4 M 3.76 2.499 1.524 4.424 -0.641 3.987 -1.662 -4.926 8.841 -3.609 2.259 2.74 6.894 8.301 -0.822 3.157 3.749 2.691 5.611
5 T 0.562 -5.183 6.715 1.361 -0.661 -0.585 -0.105 -4.239 3.151 -2.572 -1.796 -0.755 4.557 -1.292 0.738 1.952 -6.372 -1.448 -1.872
6 Q 1.227 6.909 9.483 -0.224 8.212 7.115 8.913 0.342 12.007 6.516 -0.516 3.944 0.075 12.171 4.013 2.556 7.845 20.21 16.298
7 S 2.348 1.44 3.33 -0.903 3.754 -1.275 -0.413 -3.305 0.066 0.709 -1.131 -2.707 8.245 0.223 4.824 -1.436 0.62 -3.419 -1.327
8 P 4.321 3.238 -1.378 -0.645 3.893 2.683 0.1 0.009 5.783 -1.425 0.817 3.072 3.068 0.877 2.422 -1.583 9.678 6.173 2.638
9 S 3.606 5.416 3.146 -1.269 1.274 -3.365 2.117 -1.737 1.952 1.294 -4.314 -5.102 -5.058 -0.654 5.296 -0.87 1.104 5.156 2.646
10 S -1.802 -4.587 1.761 -5.964 -0.814 1.001 -3.115 0.6 1.628 0.947 2.644 -0.412 10.272 -4.537 6.222 1.447 0.714 4.45 2.465
11 L 3.596 5.346 3.273 2.679 -4.597 8.102 0.621 -1.873 2.235 2.088 5.816 0.121 -3.552 0.921 3.384 1.741 -3.619 -1.203 3.251
12 S -2.509 -2.707 -1.813 3.253 -7.845 0.891 -4.823 -3.207 5.228 -4.598 -1.76 -2.61 1.602 -7.841 2.028 0.347 -2.297 -4.706 -4.571
13 A 4.629 7.161 5.799 15.624 2.497 14.752 3.92 1.165 -0.502 2.509 4.933 6.335 5.795 4.926 3.775 4.886 2.512 10.156 11.886
14 S 2.662 -1.517 3.938 1.04 4.847 0.581 -1.546 6.206 -3.382 0.738 1.697 -2.534 4.228 0.47 1.725 -0.438 4.726 3.628 2.163
15 V -1.594 1.156 5.381 1.62 -1.71 1.439 6.972 -0.844 2.548 -2.048 0.334 1.101 3.906 -1.567 -2.728 -4.861 1.644 -3.695 0.84
16 G 2.374 4.233 3.792 2.549 0.131 2.306 10.953 9.778 5.852 9.239 5.833 85.343 2.523 7.302 0.062 5.445 4.681 2.69 2.741
17 D -1.237 0.555 5.121 2.622 1.29 -4.281 -0.05 0.754 -2.524 -0.788 0.171 6.398 5.111 4.936 -0.239 -0.267 2.746 0.871 2.551
18 R 3.014 -0.877 7.802 0.238 3.813 3.559 -2.257 3.131 3.145 -2.689 -1.535 -0.334 -4.204 -3.303 -5.717 -2.678 -5.599 -2.911 -0.398
19 V 2.763 2.483 7.271 9.827 8.791 1.942 8.886 2.46 8.851 1.583 8.23 4.678 5.222 2.443 11.603 3.064 5.75 11.74 13.983
20 T -1.182 -0.291 0.762 -1.151 -2.141 5.406 -2.531 -3.681 -0.433 -1.255 -1.647 1 3.568 0.392 -3.755 0.395 0.147 -2.603 2.011
21 I 4.141 3.931 12.792 6.05 3.387 8.208 7.726 14.739 2.792 5.671 3.944 10.231 10.215 20.277 2.639 4.375 0.668 14.821 6.472
22 T -1.06 -0.371 1.532 -4.987 -6.819 1.872 3.478 -0.412 -2.47 -5.608 -3.364 -4.023 6.685 0.479 1.614 1.736 -4.394 3.286 0.521
23 C 2.327 -1.553 -3.133 -2.368 3.909 4.628 -0.853 -0.45 3.433 -0.214 -0.904 -0.89 1.081 2.132 -3.821 -0.392 -2.544 1.831 0.669
24 K 3.334 1.978 7.279 -3.909 -6.542 5.815 -0.14 -3.285 -0.085 4.47 -1.48 7.705 -2.948 -0.877 4.932 0.196 1.82 -0.618 -5.713
25 A -0.004 8.582 6.645 2.387 4.181 -2.673 2.702 8.292 2.233 -1.374 0.481 3.467 0.897 13.808 -3.843 2.696 3.583 4.322 1.9
26 S 4.901 1.008 0.864 6.125 7.337 4.549 -1.037 0.266 -3.323 2.13 4.205 0.885 1.13 -1.988 2.473 -4.16 5.52 1.725 4.139
27 Q 1.547 1.516 4.776 -3.721 1.582 1.166 -5.748 3.653 2.739 1.585 -2.609 0.054 12.964 1.822 1.642 -2.784 1.957 4.06 -0.702
28 N -3.506 0.66 -0.11 0.589 0.195 2.889 -0.164 -1.253 -0.173 5.344 0.13 -0.084 -4.356 -1.068 0.598 1.53 -4.464 4.022 5.158
29 V 2.861 -1.627 6.631 3.182 9.474 3.143 11.51 2.117 14.312 -2.158 6.516 4.493 3.199 8.016 14.471 4.115 1.745 10.759 20.56
30 R 2.168 -0.368 4.148 -4.223 3.557 -3.207 0.516 1.332 -0.061 -3.618 -1.532 0.201 11.047 2.479 -3.495 2.396 0.268 -1.683 -0.669
31 T 4.395 2.935 1.272 5.805 -2.107 3.174 -2.909 -1.278 -3.077 4.514 3.095 -1.499 10.738 -0.42 -1.395 0.477 0.186 -4.255 0.211
32 V -2.245 3.526 4.121 3.326 0.178 5.497 -3.13 -2.612 4.754 3.595 0.185 4.741 7.702 -0.152 3.676 5.259 2.47 -6.436 -0.758
33 V 4.799 2.599 11.587 2.559 -1.556 7.21 2.491 -1.159 9.613 -0.89 -2.561 4.163 8.745 1.578 10.191 2.867 7.185 17.732 16.336
34 A 4.023 7.927 1.774 -3.083 0.592 -2.433 -1.814 5.324 -0.475 -1.443 0.259 7.601 -0.834 0.807 3.606 -1.638 -4.754 0.557 0.218
35 W 8.603 5.454 18.78 13.949 2.137 11.723 9.541 6.767 15.933 4.176 7.102 10.27 15.68 13.381 14.259 8.144 14.575 8.237 3.389
36 Y 7.84 10.719 10.036 13.08 -0.676 8.874 7.955 8.776 15.227 7.686 8.569 6.774 11.273 2.088 3.762 8.923 0.726 0.161 12.811
37 Q -0.139 1.244 1.83 0.303 2.328 3.554 -2.415 -2.566 5.819 4.588 -3.438 0.728 13.719 6.73 7.052 5.02 -0.394 5.699 -1.309
38 Q 9.852 3.873 8.97 7.426 -1.864 4.731 4.012 8.682 4.843 0.293 -1.431 6.15 8.249 -0.694 6.419 0.919 9.775 5.491 2.842
39 K 3.537 5.224 -0.897 6.144 -2.276 1.274 8.15 -0.044 -3.519 -0.01 -0.638 -0.111 -0.251 2.106 2.378 1.4 -1.267 -3.775 -3.563
40 P -1.554 4.531 5.445 4.741 0.68 7.287 4.519 0.657 9.288 0.673 7.568 2.143 0.927 -1.201 5.74 6.125 0.216 2.052 4.922
41 G -2.665 6.348 5.186 -1.168 4.163 -1.677 4.071 -2.716 -2.689 2.263 0.845 58.336 -2.34 3.077 1.941 4.866 8.184 2.268 2.52
42 K -4.19 0.058 0.052 4.238 -1.391 0.636 -0.774 2.178 -0.238 -0.951 0.775 4.767 -3.518 0.232 -3.732 0.55 -3.139 2.461 4.121
43 A 3.476 6.942 2.185 -3.91 2.768 -5.153 1.423 1.829 6.898 5.554 -1.044 -1.355 -3.483 1.518 -3.057 4.969 1.769 2.029 -3.069
44 P -0.006 8.29 17.404 11.676 5.433 9.992 15.29 13.424 17.272 13.456 13.551 7.071 11.412 20.26 10.701 6.17 4.841 7.853 7.25
45 K 1.345 0.145 5.039 2.012 -4.462 3.414 1.886 -1.791 1.548 -1.699 0.607 7.803 -0.404 6.445 1.889 0.747 -4.429 1.088 -6.191
46 T -0.397 3.145 8.332 8.983 5.618 5.663 2.834 -0.937 8.003 11.877 7.374 3.023 -1.815 5.757 7.33 1.936 5.574 5.633 10.892
47 L 1.005 4.429 9.735 8.309 6.184 3.351 10.141 0.937 4.116 3.477 0.086 17.078 6.364 12.151 9.963 3.865 -2.75 6.005 3.797
48 I 2.241 -2.519 4.891 6.957 24.972 7.374 0.623 5.585 -2.519 7.655 6.163 23.212 -2.671 13.77 3.228 6.185 0.961 10.386 14.392
49 Y 5.873 9.771 8.713 8.047 0.171 11.38 0.848 -0.645 5.411 3.263 4.859 3.203 10.553 11.162 10.826 6.207 5.819 -1.888 2.258
50 L 2.326 3.199 4.398 3.508 -4.695 7.132 -1.743 5.877 5.881 1.246 4.181 41.124 0.643 6.739 0.796 3.005 -0.059 4.481 -1.158
51 A 3.141 5.525 3.052 15.917 -5.174 7.048 5.407 6.362 7.917 8.959 1.476 83.233 15.396 -1.756 4.674 2.127 0.429 12.683 19.457
52 S -1.957 1.996 -2.117 4.07 -4.688 1.188 1.695 8.448 0.551 -1.821 0.688 -0.823 14.943 4.988 6.399 4.722 1.855 -4.523 -1.117
53 N -0.616 2.02 8.227 1.681 0.265 2.195 0.404 -3.097 -0.652 3.928 -0.866 10.784 -4.422 -4.366 4.346 2.19 -3.295 1.904 -1.651
54 R 2.087 -0.157 4.617 1.571 1.554 9.155 5.827 -3.712 0.084 -2.317 0.798 -1.399 -3.72 2.036 0.401 1.5 1.071 4.118 4.514
55 H 4.134 2.448 13.249 9.207 0.858 8.896 11.782 12.879 1.784 7.249 7.1 13.364 8.751 15.932 7.116 7.46 3.714 3.535 3.819
56 T -1.777 2.329 4.42 0.005 0.935 0.841 3.676 1.44 -1.077 4.641 2.42 1.464 -2.134 4.406 3.362 -5.492 -2.93 3.39 3.113
57 G 5.263 7.205 0.4 6.95 9.172 8.603 14.063 6.004 13.853 1.889 2.558 90.729 4.084 6.944 6.679 8.866 15.294 9.16 9.254
58 V 1.919 2.475 4.919 4.975 6.604 3.426 12.476 -2.816 14.359 2.676 4.44 3.182 7.003 3.725 8.151 2.447 3.848 11.133 1.084
59 P 5.73 6.979 5.779 8.468 1.215 -0.486 -0.204 9.329 9.396 4.925 3.538 0.367 6.617 9.986 0.274 2.679 3.021 1.643 2.612
60 S 0.517 1.489 1.55 2.279 -0.692 -1.272 -1.558 -0.014 4.272 -2.721 4.061 5.334 0.768 2.738 -2.698 3.578 -0.798 0.723 5.237
61 R -0.323 -0.777 1.645 4.785 0.63 3.225 0.507 -2.024 2.29 -3.44 -0.836 1.715 4.58 -0.683 1.367 2.743 -1.714 2.261 1.996
62 F 3.332 2.49 11.617 15.028 9.848 7.249 4.884 13.755 11.293 4.818 5.374 19.026 8.561 17.108 9.926 7.937 3.982 4.16 2.751
63 S 1.11 2.902 2.444 5.196 -4.641 1.2 -1.013 -4.954 3.08 -1.794 5.004 1.377 4.76 0.923 3.939 3.743 -0.38 -1.1 0.978
64 G 6.724 2.826 16.1 20.881 38.682 14.303 19.802 17.777 20.171 16.316 5.031 27.826 18.506 26.458 6.29 9.041 9.959 38.128 38.598
65 S -1.352 -2.774 6.749 1.822 6.799 -3.382 6.726 4.736 8.361 0.635 -2.158 4.282 9.373 5.35 -3.672 -2.288 2.45 4.182 -2.689
66 G 10.806 9.081 8.94 8.823 12.916 12.041 19.037 7.706 9.011 7.689 6.791 163.28 5.83 12.541 11.677 13.384 37.979 10.782 8.217
67 S 2.812 0.41 -0.811 -1.861 1.275 4.824 -3.051 0.79 -1.335 1.201 1.758 -1.503 7.318 4.526 3.852 -0.493 -1.667 0.341 2.497
68 G 4.052 0.424 4.117 -1.315 -3.914 3.451 0.214 6.119 3.83 2.143 0.09 68.295 -2.915 2.822 1.199 5.984 2.117 7.779 4.732
69 T 1.862 0.851 3.843 -3.132 5.71 0.207 -1.56 -2.018 3.954 6.894 -2.423 -0.312 5.113 1.883 0.866 0.632 2.766 1.388 1.633
70 D 2.044 0.426 -3.808 -6.984 -1.779 -0.89 -7.063 -5.378 -5.537 0.066 -0.88 3.334 -5.014 -1.508 -2.993 -2.585 -3.83 -0.721 -2.591
71 F 8.608 5.927 11.103 8.351 10.35 6.225 3.242 15.551 7.09 6.217 2.449 12.605 8.997 19.983 7.449 6.614 8.97 11.073 -2.33
72 T -2.033 -3.765 2.041 1.865 -4.796 -0.31 -2.97 -2.221 -0.389 -3.556 -0.524 -6.505 2.381 -0.258 -5.536 1.229 -0.045 -0.569 -8.734
73 L 9.627 3.867 11.425 11.494 -0.403 9.68 -1.47 12.462 17.83 3.977 12.083 18.08 4.944 18.717 6.971 11.248 7.591 11.797 4.493
74 T -4.272 4.605 4.945 2.623 -1.341 -0.683 0.986 -1.666 -3.188 0.018 -1.298 5.127 10.883 0.424 1.523 4.745 -2.362 2.248 -2.663
75 I 4.9 2.046 5.39 7.76 7.077 8.459 8.404 11.6 2.311 3.82 2.523 10.923 9.472 17.728 11.721 5.309 2.886 9.662 7.374
76 S -0.258 -0.613 -1.504 1.29 -2.764 5.269 -0.835 0.385 -0.426 -0.581 -5.288 -0.077 4.27 1.543 -2.414 2.605 -1.133 -2.638 -3.733
77 S -0.147 0.323 3.19 5.044 2.661 2.569 1.857 0.813 1.3 0.689 0.778 -3.364 12.629 3.5 0.388 4.968 6.269 0.791 0.888
78 L 5.028 5.314 9.226 6.563 8.044 6.897 12.903 1.945 11.643 6.012 4.126 7.917 7.31 16.326 3.862 6.003 4.098 12.112 9.23
79 Q -1.862 4.791 0.366 0.954 -2.709 1.499 -2.456 10.622 1.695 -3.891 0.535 -0.071 10.42 1.989 2.471 0.164 3.97 6.155 -4.844
80 P 1.666 7.2 0.273 5.021 0.325 7.66 0.059 2.243 4.624 4.604 -1.21 4.208 1.681 2.811 1.22 -3.788 1.634 3.436 1.263
81 E 4.549 -1.824 1.224 4.047 -4.207 2.2 -2.237 -2.872 -0.95 0.525 0.192 3.885 3.717 -2.13 1.052 3.449 -5.207 1.179 5.488
82 D 6.776 7.725 7.228 -0.457 8.472 2.631 7.983 12.022 3.015 3.262 -2.081 15.969 0.383 3.929 4.287 -0.287 2.918 1.313 2.135
83 F 3.834 9.328 8.874 8.639 6.904 5.874 4.976 8.326 8.629 2.484 3.301 8.821 11.62 14.026 3.525 3.837 0.388 2.667 -0.521
84 A -0.862 2.484 6.341 5.781 3.446 3.299 5.052 4.811 11.204 3.637 7.363 13.032 4.257 8.687 4.241 2.061 6.115 10.472 7.649
85 T -3.771 -3.84 3.96 6.518 -2.283 2.753 3.052 0.27 3.625 -0.494 -6.048 1.719 3.174 -4.46 -1.256 4.429 -1.702 3.822 -1.556
86 Y 9.179 6.62 10.744 11.565 0.123 6.414 1.429 5.873 12.594 3.923 8.951 8.485 17.448 6.006 10.112 14.436 14.8 4.35 11.236
87 F 7.74 8.235 13.027 13.309 9.361 4.277 4.446 10.607 6.599 9.453 7.907 8.086 4.218 11.604 10.766 2.206 7.582 5.368 -0.16
88 C -2.639 -1.17 -4.172 3.147 -1.871 -2.224 -4.201 0.118 0.086 5.626 -5.522 -0.541 3.793 1.735 -1.51 -4.226 0.437 -2.086 -4.149
89 L -0.132 2.405 10.861 6.433 1.15 1.605 3.235 7.272 4.676 3.928 -3.525 8.19 0.597 1.592 4.114 4.678 0.046 1.509 6.68
90 Q 2.247 2.522 5.417 3.837 3.722 8.892 12.076 -0.693 13.472 6.724 6.338 3.973 -4.23 9.328 6.528 6.466 4.131 13.595 8.795
91 H 5.648 4.303 5.006 3.765 3.951 4.435 12.25 9.856 0.839 0.246 3.644 1.719 7.04 4.632 9.915 5.219 8.197 4.897 -0.063
92 W 4.864 -1.624 6.39 6.9 -2.262 2.048 2.797 6.975 0.439 3.805 0.526 4.498 27.151 5.731 1.596 2.862 1.8 6.329 -2.118
93 S 1.541 1.768 2.287 0.669 1.8 0.614 -1.68 1.404 -3.073 -1.093 -0.485 4.791 13.744 -3.124 1.334 -2.732 -2.107 -1.356 -3.574
94 Y 7.929 8.466 12.905 8.676 3.103 6.362 9.081 12.387 8.636 11.358 8.482 4.094 7.014 5.376 11.53 13.019 7.59 7.704 4.595
95 P -2.334 4.213 7.842 6.201 -0.04 3.174 4.129 3.691 4.821 18.39 4.135 5.556 5.381 7.172 5.298 0.705 2.428 9.548 -0.299
96 L -0.884 3.329 7.607 -0.779 3.138 7.382 4.36 11.649 12.157 4.885 7.672 2.318 2.783 9.819 10.727 7.774 7.737 -0.509 -3.153
97 T 1.234 1.008 -2.002 2.926 -1.608 8.039 -0.199 -0.258 -3.128 -0.722 4.005 -0.404 6.783 -1.527 1.604 -3.841 -1.203 -0.763 -5.302
98 F 5.163 6.119 9.832 13.299 10.309 5.453 15.8 12.39 13.977 8.34 8.466 4.488 7.131 13.171 6.752 1.683 6.827 -0.413 0.874
99 G 2.164 6.28 8.891 21.005 27.929 14.53 23.809 30.208 24.497 15.307 10.509 7.09 20.207 34.2 1.762 4.729 6.706 33.018 24.903
100 Q 0.435 -1.187 7.949 1.648 0.909 7.591 5.528 1.908 5.507 2.904 -1.184 0.281 -0.901 3.801 0.574 -0.729 -0.228 -0.984 3.367
Residue
number &
260 
 
A C D E F G H I K L M N P Q R S T V W Y
101 G 13.054 12.37 9.759 8.181 25.107 13.507 14.353 15.194 7.7 10.382 11.284 96.961 6.607 13.789 8.846 6.659 14.412 27.294 23.366
102 T 4.28 3.509 4.854 11.552 8.577 4.805 -0.086 11.115 7.247 3.7 2.396 4.731 11.28 2.266 22.218 -0.307 0.675 17.905 10.157
103 K -1.458 -1.891 -4.823 0.251 -7.504 3.764 -3.64 0.338 -0.146 -2.279 -1.546 -2.368 -4.335 -5.07 -3.333 -7.243 -3.397 -0.803 -8.296
104 V 0.84 -0.613 6.839 4.968 12.477 4.014 2.677 0.662 10.859 -0.067 9.854 4.651 9.748 3.069 18.406 9.578 -1.99 11.17 12.65
105 E -5.507 -0.457 -0.13 -2.346 1.884 -1.226 -2.474 0.07 -6.243 -2.957 -2.574 2.848 -1.828 -2.89 2.201 0.03 -0.954 -3.515 -6.106
106 I 1.414 -1.205 0.865 2.727 -2.06 1.591 0.573 3.01 3.706 0.217 5.44 1.028 2.583 0.081 4.276 4.605 4.307 5.664 -4.526
107 K 4.276 -1.144 2.745 0.481 1.037 1.051 -1.277 5.724 -3.614 4.745 -4.891 3.336 -4.216 -1.583 -3.655 -2.434 4.766 0.794 3.555
108 R 0.212 1.04 0.302 4.633 1.508 3.429 2.368 -4.834 4.327 3.948 0.6 -0.542 7.042 5.542 -0.098 -1.937 1.222 0.304 6.857
109 T -5.691 -0.116 0.252 0.291 2.031 1.643 -2.536 -1.796 1.464 -0.564 4.916 0.14 -3.155 0.83 1.731 1.837 2.863 5.795 -0.852
110 V 0.657 1.809 -0.25 3.188 0.344 4.029 0.59 -0.734 0.457 2.789 -0.223 -2 -2.079 4.807 3.875 0.254 -0.733 2.434 -0.526
111 A -2.295 1.771 1.258 3.251 4.031 0.705 6.03 3.241 -0.187 0.263 7.044 7.256 3.729 -0.604 1.626 -6.39 2.467 2.148 4.455
112 A 0.19 5.323 2.865 8.686 -0.909 6.439 3.659 7.249 7.352 6.917 3.348 -5.952 -0.861 4.926 3.999 2.996 5.542 6.349 10.259
113 P 3.493 6.409 15.724 8.202 25.765 6.19 15.965 10.403 20.1 19.051 18.039 12.209 2.843 24.409 3.177 10.916 11.67 26.718 18.775
114 S 0.801 -0.028 1.572 -5.707 -1.495 0.916 0.958 1.251 -0.699 -3.448 1.446 -1.611 11.519 -6.633 0.227 -2.016 -4.248 -0.234 -3.967
115 V 3.588 8.075 4.541 6.94 15.019 7.315 7.805 5.813 2.772 -0.728 7.956 4.622 2.217 7.076 18.839 8.479 2.779 10.585 17.299
116 F 6.595 -0.566 5.564 10.408 6.576 6.391 5.592 5.555 6.616 3.532 1.092 17.86 6.575 5.558 4.578 4.331 8.655 -0.194 5.3
117 I 0.18 7.326 10.099 5.332 9.002 8.011 4.941 12.012 0.757 6.361 0.097 7.332 8.713 19.069 3.381 5.291 2.815 6.801 5.05
118 F 6.804 7.239 14.087 10.876 9.557 3.577 4.383 5.533 3.194 10.033 6.375 16.205 4.426 8.077 9.313 9.918 -1.427 7.703 2.595
119 P 4.173 4.01 8.81 9.958 0.961 4.835 3.057 5.628 5.141 1.11 4.217 1.998 3.758 10.771 2.643 6.783 6.127 1.167 3.645
120 P 4.486 6.178 7.279 6.238 11.164 5.352 4.465 14.67 18.355 25.918 12.706 11.03 15.032 13.038 0.049 8.408 6.054 14.506 15.505
121 S -0.259 4.618 0.881 0.261 -0.551 0.222 -4.479 0.177 5.529 6.485 -1.856 1.605 -6.927 0.087 4.018 -1.059 -2.551 -4.592 1.657
122 D 2.725 3.646 0.964 -0.89 3.666 4.272 3.205 1.079 3.69 4.944 0.479 -0.217 0.707 2.779 2.048 -0.735 -1.232 -0.928 -2.466
123 E -0.928 4.022 6.483 -0.195 4.363 2.832 2.261 2.73 1.299 -3.529 4.677 1.928 -0.035 0.327 6.125 2.912 3.347 2.798 -1.371
124 Q 2.22 7.869 4.268 -0.785 -0.027 3.574 3.829 6.341 9.075 2.554 6.468 4.91 6.406 11.608 3.154 1.401 7.881 7.924 1.484
125 L 1.693 0.066 2.574 8.536 5.202 2.858 5.008 -2.478 5.102 2.313 -2.471 12.432 1.32 2.771 3.123 -2.044 -0.068 -0.453 -1.81
126 K -2.894 4.773 -0.135 3.407 -4.438 2.727 3.422 1.768 -0.402 5.853 0.69 4.97 -2.179 3.95 -2.816 4.623 2.849 -1.486 0.637
127 S 3.956 4.372 1.959 -2.683 -4.645 5.938 -5.417 2.571 2.379 1.624 -3.666 -5.147 10.284 0.301 0.978 -0.731 2.786 1.504 -2.03
128 G 3.302 -0.037 7.802 4.012 2.004 -0.38 2.9 5.334 0.309 1.673 5.118 86.686 2.141 1.93 4.07 2.055 7 2.805 6.264
129 T -2.211 -0.637 0.389 0.311 -4.092 -3.124 -5.933 3.447 2.512 0.064 1.786 2.147 6.685 -1.544 -1.411 -2.202 -0.633 -4.772 2.396
130 A 5.981 22.259 11.98 21.896 1.304 16.065 15.172 11.734 7.327 2.801 9.823 26.043 3.649 15.871 9.058 10.657 12.254 24.553 27.23
131 S -2.684 3.276 5.597 3.955 -2.238 4.851 -2.062 3.601 7.284 -0.875 -0.52 -0.936 -2.371 0.344 3.13 -4.363 1.884 -3.601 0.378
132 V 4.136 3.642 9.484 2.599 1.527 2.786 2.217 -0.779 12.611 -1.451 1.946 7.608 9.003 5.975 18.651 0.793 1.535 6.103 3.256
133 V -0.477 5.078 8.601 5.14 -0.199 6.513 3.121 2.508 5.734 1.85 0.742 2.88 9.136 -1.788 14.114 6.663 -1.77 -2.142 3.053
134 C -5.23 -2.191 0.55 0.284 -2.568 -1.663 -3.985 4.229 0.001 2.056 -5.106 -0.143 -4.635 3.913 -3.172 2.056 3.974 5.117 -4.774
135 L -1.672 2.371 4.476 9.21 6.442 5.508 7.216 -0.909 9.426 0.063 9.292 5.319 2.983 10.618 -3.022 4.756 -0.247 16.132 5.349
136 L 1.648 2.975 3.511 1.593 6.296 6.406 4.981 3.438 7.285 2.501 6.841 14.221 0.348 13.621 3.227 8.098 -5.129 11.713 7.308
137 N 5.363 -0.288 2.937 0.215 6.698 5.096 -0.221 -3.892 3.247 -9.36 4.662 4.544 -2.923 7.767 3.256 3.856 -3.688 15.673 9.013
138 N 5.064 5.617 1.151 3.159 1.249 3.59 1.1 3.562 4.165 -1.676 0.326 15.047 -3.016 6.36 2.308 7.854 6.793 -4.253 -4.262
139 F 11.228 12.31 15.596 13.397 7.715 0.859 10.979 17.049 8.901 4.725 8.07 13.563 9.363 15.097 9.94 8.732 10.948 4.944 3.973
140 Y 5.745 1.256 5.727 5.134 -1.958 12.668 2.679 4.587 8.357 7.915 4.675 6.321 26.956 2.898 7.786 5.774 8.042 9.917 2.267
141 P 6.345 2.002 6.54 9.49 2.778 7.051 4.43 7.405 6.929 1.212 3.341 6.196 5.501 0.404 0.575 -1.128 -1.285 0.725 -1.763
142 R -1.091 -1.7 0.361 3.021 -2.039 -0.232 -6.123 -4.316 -3.526 3.6 -3.227 -2.364 -6.007 -1.316 -4.924 -0.377 -2.566 -1.387 -3.173
143 E -3.053 3.458 -0.511 -1.33 1.899 -2.416 -0.24 0.206 0.924 -1.243 0.017 2.429 0.565 3.807 -0.067 -1.03 1.256 -3.483 -0.517
144 A 2.773 5.649 9.497 5.713 4.281 16.401 1.663 10.568 9.77 10.308 5.376 4.333 7.298 6.684 5.429 3.366 -1.967 8.537 15.456
145 K 0.682 -3.666 -1.759 2.244 3.068 -1.826 1.129 -6.798 3.854 2.83 1.323 4.983 -0.205 1.082 0.27 2.688 -3.921 -0.116 2.185
146 V 1.372 1.131 14.142 3.027 7.973 2.971 7.601 0.846 4.465 2.519 3.649 6.371 2.921 10.565 8.883 2.6 2.17 15.012 16.691
147 Q -0.16 -3.97 2.636 1.85 1.071 3.719 5.206 0.636 4.042 -2.789 1.207 -2.546 0.36 -4.763 -2.17 1.917 -3.817 -1.787 -0.713
148 W 12.885 10.357 15.639 14.13 0.671 12.461 11.294 7.93 9.642 3.311 10.186 9.004 12.742 10.69 13.767 15.833 9.318 11.633 4.994
149 K -1.092 -2.289 8.244 -0.681 -6.44 -0.348 -4.041 -6.15 -0.623 0.141 4.728 2.659 -3.372 -0.075 -2.746 -0.529 -0.069 -2.22 -1.416
150 V 2.2 4.721 4.028 2.798 12.182 5.489 5.372 1.867 5.444 5.356 5.429 -1.225 8.797 3.087 4.584 4.54 0.833 7.146 9.072
151 D 1.858 2.517 4.301 -0.11 0.995 -0.063 1.726 5.776 2.719 1.923 -2.214 33.815 5.171 3.694 -1.111 1.335 0.864 1.147 1.033
152 N -0.105 1.781 -0.341 -0.772 0.681 2.649 4.546 7.701 1.987 1.603 -0.986 79.539 -1.497 5.835 3.889 7.98 0.919 3.842 0.138
153 A -2.811 -1.943 -1.155 2.815 3.395 -3.104 -2.454 -4.029 -0.441 -4.122 0.413 235.72 -2.44 3.775 -3.077 -1.669 2.748 -1.758 -3.701
154 L -3.753 -6.041 1.324 -0.494 1.351 3.206 2.902 4.998 0.161 -3.59 -0.494 -2.706 5.139 -2.572 0.904 -0.325 0.575 0.626 -1.1
155 Q 5.388 3.622 2.498 2.789 2.22 1.47 0.082 2.618 7.34 0.993 2.239 0.035 1.11 3.031 2.028 -2.19 5.726 1.471 -2.139
156 S 0.65 4.875 -0.002 -0.858 0.818 4.727 -4.082 4.368 -2.411 4.98 -4.097 2.844 1.989 -1.024 0.223 0.103 5.57 3.176 -0.433
157 G 2.565 1.859 5.79 7.6 7.322 -3.783 9.835 3.999 5.048 3.966 -1.004 56.228 1.62 0.986 5.542 6.845 4.046 5.327 2.817
158 N 1.244 -0.569 0.251 -2.583 6.309 -0.597 -2.122 -0.646 0.127 2.315 4.158 -3.188 1.288 -0.306 4.566 3.826 0.201 1.722 0.352
159 S 0.708 3.036 5.593 7.029 -7.209 0.305 0.411 -5.331 4.632 0.64 -2.972 0.826 8.694 0.236 1.83 4.834 1.047 -6.813 -4.591
160 Q -0.524 -1.885 4.584 3.855 -1.413 0.383 4.881 -2.313 0.208 1.689 5.628 3.728 3.53 5.325 -0.964 6.528 5.409 3.69 1.351
161 E 0.01 -1.534 2.324 -5.709 0.425 -5.394 1.592 1.684 2.248 -6.275 0.624 5.619 -0.968 -0.379 -1.4 0.726 1.466 -1.972 3.763
162 S -0.72 -0.35 12.201 2.651 7.355 -1.587 8.241 3.511 6.305 7.708 -1.661 5.498 4.754 3.724 8.555 6.744 -2.655 10.312 5.406
163 V -2.061 -3.644 4.621 2.872 -1.909 0.248 5.874 0.658 4.988 1.191 -3.436 7.431 -1.7 2.008 2.673 -0.551 1.178 -0.308 -2.258
164 T 3.828 -0.481 6.125 8.674 6.954 3.888 1.321 1.354 1.31 0.567 0.592 3.573 4.695 -0.059 0.147 0.875 1.502 -3.047 3.71
165 E 1.449 -4.175 0.494 -3.138 -0.174 -5.207 -1.703 -1.475 -2.261 3.577 4.227 -0.278 2.496 0.395 -0.677 -0.591 1.908 1.066 -0.832
166 Q -0.664 4.038 9.139 6.884 2.271 -0.699 5.034 1.217 10.207 1.485 2.343 5.974 3.463 9.323 3.308 5.381 7.717 15.942 9.771
167 D 5.179 -3.324 5.532 -5.904 -0.813 4.71 3.291 -0.896 1.271 -2.437 2.733 7.943 3.766 2.855 -2.398 -0.554 -0.114 -2.821 3.295
168 S 1.241 4.965 2.194 5.02 -3.143 -1.06 4.009 -1.602 0.74 -4.085 4.152 0.015 -4.009 -0.268 -3.563 1.251 -3.726 -2.404 -3.741
169 K 5.083 -5.309 1.83 -1.452 4.862 5.381 0.694 -0.212 0.103 0.198 -4.008 10.231 3.544 1.853 4.545 -1.182 -1.489 2.037 0.83
170 D -0.649 -5.257 0.639 -5.017 -4.309 -0.951 1.68 3.658 2.837 -6.567 -2.791 5.111 3.902 -3.02 -0.977 -0.59 4.018 2.101 0.377
171 S 1.322 -0.974 3.959 2.236 -4.951 -1.437 -5.18 3.079 -3.293 3.17 -4.096 -1.426 1.288 3.501 -1.387 2.45 -0.172 -5.19 -5.462
172 T 3.207 3.584 5.898 8.246 -0.426 2.793 3.266 -0.704 4.451 -2.184 -1.187 -0.869 18.337 0.817 -0.605 -3.569 0.057 1.069 0.843
173 Y 3.815 5.144 9.593 10.978 0.475 4.543 4.635 3.055 11.747 4.649 3.218 9.296 12.801 3.676 8.517 7.431 5.897 1.396 1.367
174 S 0.517 0.719 3.743 3.591 5.136 0.953 1.194 4.592 1.255 6.629 1.571 4.96 13.798 -0.646 10.222 1.671 4.339 7.062 -0.965
175 L 1.094 3.354 6.854 7.51 3.596 4.051 6.781 -0.038 0.531 4.072 0.174 18.98 3.902 -2.492 3.912 -3.953 -3.048 1.285 5.049
176 S 2.168 -0.456 5.541 4.23 -2.561 -0.639 -5.171 -2.524 3.246 1.626 -4.573 6.09 10.198 0.406 0.534 4.38 2.928 -8.842 -2.328
177 S -2.15 5.976 0.765 4.501 6.994 3.13 5.321 -2.962 4.069 0.789 7.768 4.72 11.613 1.507 6.735 5.294 6.685 6.759 -0.576
178 T 3.874 3.282 -1.262 1.511 1.732 2.02 4.197 -4.644 0.457 -1.101 -4.516 2.458 -0.684 4.123 4.95 2.373 1.909 -6.332 -0.342
179 L 3.998 7.261 3.579 4.284 4.541 13.618 1.721 3.204 12.419 1.335 1.924 18.306 8.268 7.683 6.286 4.664 11.011 4.315 4.489
180 T -1.335 -2.283 -0.356 3.901 0.251 5.283 -3.247 -0.948 0.069 -3.545 -0.361 -0.515 0.164 -5.194 4.069 3.263 -0.369 -7.395 -7.238
181 L -0.141 4.229 4.328 2.099 -2.343 5.259 -1.683 -2.831 3.853 -2.511 3.938 9.012 0.748 1.262 -0.095 2.489 2.702 3.914 2.73
182 S -2.195 2.209 2.002 2.461 1.91 -0.035 4.109 6.568 2.455 0.793 -1.924 -0.546 -0.641 1.475 -3.675 -0.155 6.225 1.813 -0.67
183 K -2.226 2.029 0.915 1.49 -0.456 5.692 0.888 4.498 2.114 2.245 4.289 2.328 -0.131 3.671 -2.013 4.92 -0.331 -5.609 1.92
184 A -0.81 0.817 -3.503 1.386 3.721 5.957 -2.684 0.549 -2.643 -0.484 -2.093 -0.345 1.647 1.103 1.183 -0.56 4.048 3.066 5.865
185 D -0.526 4.968 -0.644 4.469 5.145 0.627 -4.575 -2.756 -0.546 5.776 -0.809 5.732 -2.154 2.317 -3.576 -3.847 1.903 -2.444 -0.344
186 Y 5.205 3.376 11.003 7.741 0.438 10.01 3.176 11.887 9.311 4.642 4.354 4.144 31.728 9.743 6.673 5.905 9.18 6.668 1.876
187 E -1.448 -0.771 -3.545 2.451 3.407 -2.79 -4.021 1.164 -4.379 -1.791 -3.452 6.783 -4.093 -4.329 -4.993 -2.927 -0.047 -1.016 -0.301
188 K -0.644 -2.57 3.663 0.413 0.936 3.714 -1.596 0.252 1.417 0.462 4.003 6.151 -1.851 2.629 1.669 -0.11 1.806 -0.362 -3.375
189 H 6.197 6.296 3.671 4.723 0.667 5.289 5.023 5.055 1.729 1.815 3.266 6.202 4.278 1.009 3.089 -1.944 -0.716 6.959 2.408
190 K 0.296 1.02 -1.491 -1.064 -3.229 1.664 -0.741 -0.291 -1.113 -3.534 1.214 5.734 0.096 0.488 -1.276 -0.161 1.454 2.765 -5.671
191 V 0.799 -3.598 7.111 4.015 -2.91 1.312 1.158 0.095 -3.07 -1.671 2.437 2.434 4.356 -0.825 3.984 -3.212 -0.523 3.176 -1.245
192 Y 5.417 7.674 16.395 7.173 -0.044 10.437 7.567 0.325 8.971 7.567 8.797 8.528 11.949 1.529 8.676 9.71 12.712 7.146 -0.895
193 A 1.907 9.551 -1.91 2.074 -1.957 4.093 -0.492 4.72 -0.159 1.336 1.961 7.805 -3.369 2.547 0.643 4.378 -0.165 9.924 -1.998
194 C -1.407 -1.11 2.032 2.95 -2.401 0.727 0.353 3.038 -0.777 -2.118 3.936 -2.053 -3.724 2.759 0.119 3.846 5.785 -2.876 -2.822
195 E 1.067 -2.849 3.225 1.624 0.7 4.393 0.783 5.55 2.621 2.381 -1.542 3.131 -3.949 -1.409 3.939 -4.561 -0.574 -0.069 2.5
196 V 1.427 7.641 11.846 14.053 11.819 5.314 9.986 1.847 11.581 7.343 8.545 8.583 5.04 10.023 14.135 4.257 4.506 7.054 15.145
197 T -1.609 -3.982 2.978 0.82 -4.775 0.352 1.09 -6.326 -3.957 -3.987 -4.192 -3.259 6.116 -3.338 -5.569 2.916 -6.049 -2.032 1.772
198 H 8.237 11.111 9.889 14.606 6.27 5.051 3.564 9.58 12.42 8.478 3.891 11.633 9.39 22.262 7.827 7.574 6.568 12.067 8.866
199 Q -0.712 -0.102 -2.218 0.305 2.816 1.287 -2.741 -0.345 -3.063 2.159 0.649 1.414 -1.676 2.014 -3.641 -0.218 -3.933 -0.394 3.478
200 G 5.821 11.769 21.519 16.758 35.249 25.559 19.809 15.622 32.011 17.251 2.23 17.151 16.755 2.853 0.083 23.821 28.771 40.77 37.112
Residue
number &
261 
 
A C D E F G H I K L M N P Q R S T V W Y
201 L 5.055 3.608 9.303 2.094 -3.427 6.815 4.589 4.015 8.044 5.227 5.125 6.635 -0.129 10.021 7.111 0.52 0.025 0.883 2.338
202 S -3.315 -3.139 0.209 1.792 0.738 1.463 -4.489 -2.313 -4.111 -1.641 -2.812 -4.766 3.79 -2.094 -5.077 1.943 1.622 5.539 -4.524
203 S 3.439 -0.308 1.024 -3.831 -2.565 -4.826 -7.504 4.999 3.47 -2.613 -1.011 -0.928 11.828 -0.254 4.459 -2.373 5.878 1.356 -1.693
204 P -0.751 3.102 2.332 6.237 -0.963 0.283 7.375 4.446 7.05 3.01 1.909 4.155 2.384 -0.826 0.464 3.289 6.054 0.51 4.866
205 V 5.825 -1.818 0.531 5.942 -1.417 3.062 7.657 -5.174 0.427 -1.215 1.175 1.101 9.804 4.417 7.884 3.524 3.752 -0.303 6.477
206 T -3.344 1.353 3.275 1.38 2.494 4.521 -2.089 0.495 2.652 -3.827 0.221 -3.377 0.423 -2.832 4.872 0.711 2.713 3.378 6.737
207 K 0.877 -2.314 3.077 -2.296 0.137 5.552 -3.084 0.356 1.92 2.664 -0.447 7.087 0.001 5.174 -2.619 -3.697 5.136 3.639 -1.117
208 S -1.385 -4.34 2.588 1.964 -5.97 1.288 0.546 -2.597 0.302 -2.209 -5.973 5.081 -0.82 -0.645 1.251 -3.52 3.812 -2.196 -4.921
209 F 3.478 5.349 12.656 5.226 12.456 7.134 7.645 9.304 5.223 6.424 13.573 20.905 13.244 9.052 9.701 12.259 8.141 4.814 1.059
210 N 0.985 -0.713 1.676 -3.154 -1.777 -0.145 0.477 -1.567 1.029 4.182 -3.659 7.691 -3.946 0.806 2.864 3.184 -2.439 1.293 -0.986
211 R -1.344 3.43 1.095 3.514 3.993 2.337 -0.071 0.832 0.616 -1.04 -3.966 2.927 8.996 1.262 0.378 -1.561 3.057 2.509 1.052
212 G 7.349 1.516 4.531 8.209 1.447 2.91 4.758 5.282 2.401 6.557 -0.44 55.195 2.551 5.195 3.685 6.583 9.161 1.063 3.97
213 E -2.741 -5.161 4.657 -0.442 -3.117 2.949 -1.183 1.397 -1.538 6.211 -0.236 14.852 0.063 -0.291 -1.158 0.666 4.19 -4.899 -5.733
214 C 3.875 0.32 4.468 4.461 1.211 -1.711 0.024 4.017 2.336 2.734 -4.276 4.505 -0.33 1.319 -3.815 -0.924 0.033 2.389 -0.431
215 E -2.563 -0.647 1.808 -3.05 2.354 -0.45 -2.617 -0.634 5.58 -0.421 4.996 -0.909 -2.726 1.085 -3.328 -1.724 2.211 3.74 2.225
216 V 6.177 -3.277 5.496 -1.614 3.236 3.447 0.354 1.057 3.795 6.319 5.542 5.435 13.248 -0.386 2.36 2.962 -0.524 -0.521 -0.112
217 Q 4.059 1.347 6.709 -2.011 4.652 1.736 0.83 2.577 3.623 2.43 -5.199 2.653 -2.86 0.818 2.991 -1.721 2.21 -3.383 -0.304
218 L 4.679 4.732 11.706 5.516 -0.879 3.456 5.785 6.282 13.54 0.708 4.437 8.97 -3.52 11.176 2.466 5.431 7.827 9.355 10.02
219 V 1.495 4.318 1.718 0.317 0.727 3.705 -4.546 -0.611 -1.74 0.828 -2.835 -1.667 7.437 -0.672 4.845 -3.475 4.305 0.022 -0.163
220 E 0.67 -2.126 3.141 9.204 1.297 3.491 -3.495 6.77 -0.864 1.379 -1.64 -0.691 -2.228 11.205 0.842 -2.2 -0.951 11.169 5.034
221 S 1.006 3.462 -0.178 0.674 3.271 -0.107 7.266 3.28 3.783 3.576 3.049 5.579 6.087 -1.317 6.195 4.066 3.334 3.064 0.174
222 G -0.427 -0.347 4.699 -0.644 3.874 2.408 -1.807 3.724 -4.985 2.87 -3.896 2.107 -2.019 -2.144 -0.978 -0.124 -5.188 0.177 3.728
223 G 3.6 8.517 9.336 15.417 31.868 4.711 23.509 4.217 19.819 20.335 12.011 6.588 21.971 4.769 5.642 10.255 9.251 8.804 25.239
224 G 6.82 -2.96 5.909 3.488 11.018 3.313 2.697 7.57 3.721 2.282 13.15 87.695 -1.782 7.192 8.112 -3.737 7.862 5.702 4.439
225 L 6.62 -1.856 9.993 8.142 -2.476 4.799 7.558 2.434 4.744 7.286 0.792 3.914 2.478 4.988 5.512 3.106 1.867 0.142 0.674
226 V 1.031 1.096 6.042 1.297 -3.542 1.713 -5.04 4.521 2.811 4.033 -4.786 2.234 4.721 4.39 -0.971 6.938 -5.003 -6.374 -7.84
227 Q 2.795 1.553 1.684 3.918 0.08 8.916 -0.015 -2.658 -0.176 -0.211 4.695 -4.515 2.031 -1.333 1.21 0.174 -1.805 -0.542 -0.372
228 P 2.291 4.206 11.092 8.529 4.605 2.018 3.386 2.333 2.637 3.697 -1.249 4.495 0.637 7.21 2.858 10.121 7.228 9.428 1.635
229 G 5.606 3.822 2.631 0.091 5.693 1.536 5.658 4.634 6.621 4.846 6.074 66.995 6.832 6.237 10.894 2.425 7.988 -0.745 1.286
230 G 0.292 -0.551 5.64 -2.301 -3.291 -4.339 3.547 -1.17 -0.827 -0.107 4.945 3.828 -3.482 -3.136 -4.539 -2.408 2.227 -4.198 0.613
231 S -3.957 -0.04 1.794 4.179 1.15 4.637 1.454 -1.37 -2.569 3.221 2.28 2.395 -0.368 -1.709 3.748 -1.588 -1.432 -5.785 3.505
232 L 6.329 0.064 8.297 0.514 -1.096 5.811 6.1 -0.484 1.121 -3.288 -1.239 5.366 6.635 11.26 -0.643 7.528 -2.814 0.533 9.368
233 R 1.777 -2.238 2.314 -2.18 0.227 -0.991 1.703 -1.215 0.681 -5.695 3.061 1.274 2.524 -0.051 -0.253 -3.486 -3.506 6.016 2.238
234 L 8.501 3.239 10.036 5.701 -1.68 5.882 0.761 1.613 8.099 5.039 0.451 8.867 3.552 10.57 1.961 4.794 -1.123 -0.711 4.667
235 S 1.648 -6.342 1.215 -2.667 -0.621 1.858 -0.269 0.442 -0.407 -1.619 1.777 2.618 3.711 3.311 0.348 -4.015 1.605 -0.618 -2.819
236 C 0.133 -5.942 -1.295 -2.047 -6.056 -6.038 -0.878 -5.568 -6.069 -6.418 -1.207 -5.452 0.532 -5.927 -5.457 -0.938 -1.607 -2.875 -4.896
237 A -5.882 0.981 -0.442 -1.866 0.719 0.216 0.578 1.767 -1.277 0.903 -4.547 1.363 -5.098 -0.382 -0.682 -5.082 -4.33 -0.463 -3.568
238 A -1.089 8.514 6.696 -2.371 4.334 1.232 1.005 11.313 6.497 7.207 2.88 10.068 5.405 10.127 2.148 0.337 -0.981 6.815 2.619
239 S 1.393 0.492 3.967 -3.328 0.504 5.96 1.03 -0.526 0.082 4.879 4.907 2.346 7.35 -0.72 -1.71 0.73 0.29 -1.41 0.788
240 G 9.903 4.744 5.643 6.283 7.84 2.371 7.974 12.31 14.663 5.539 3.628 97.66 4.617 4.403 4.314 6.634 11.05 9.483 4.353
241 F 3.308 6.522 9.213 11.828 8.736 6.552 4.397 10.073 8.89 -0.577 10.865 8.677 9.772 12.854 8.752 8.906 6.488 3.151 2.071
242 A 0.476 -5.888 6.026 -1.453 -2.268 0.492 0.492 -0.943 1.384 -1.88 1.404 1.733 0.396 1.895 -0.211 1.496 -1.242 -1.532 4.145
243 F 8.325 8.229 7.62 13.97 6.601 1.933 4.043 9.756 12.931 12.909 11.647 9.922 8.522 17.578 4.699 7.008 7.582 5.263 2.042
244 S 3.462 4.181 5.73 1.597 1.888 -3.651 0.402 5.182 -4.535 -0.148 -0.018 1.492 3.796 0.884 3.899 3.186 3.174 -5 1.303
245 T 0.029 2.146 -1.609 0.693 -5.797 -1.352 1.871 0.231 5.7 2.078 -0.986 2.325 13.532 0.328 5.514 3.387 -2.951 4.427 -0.547
246 Y 0.163 4.048 7.12 8.642 1.9 5.024 2.441 4.125 1.68 6.78 3.893 -0.296 29.182 3.327 8.476 0.36 3.307 -0.317 2.717
247 D -5.932 -5.458 1.523 -2.015 -0.447 -2.544 0.468 -0.154 -1.684 -4.739 -0.638 -2.933 -5.88 -3.942 -2.138 2.821 -0.977 -4.073 -2.929
248 M 2.904 0.022 3.724 6.268 3.383 5.151 7.63 5.46 4.774 0.88 -0.62 7.224 0.229 11.831 9.109 2.221 3.596 3.593 3.008
249 S -0.046 -2.832 5.399 10.407 7.353 3.326 3.291 13.361 14.627 7.907 4.169 5.124 23.997 10.519 12.889 3.032 14.437 14.812 5.043
250 W 8.605 7.945 14.279 12.758 5.855 11.218 5.731 4.856 9.438 9.889 5.098 6.189 14.484 10.66 15.431 8.818 8.665 2.735 2.962
251 V 0.1 0.915 8.628 6.273 2.293 11.471 2.605 3.138 1.761 3.683 -2.747 2.443 17.99 5.621 10.145 4.739 0.506 7.724 -0.619
252 R 0.308 2.667 9.712 4.303 -1.433 -1.386 3.557 1.506 -3.718 -1.316 1.903 5.636 20.691 -2.06 -0.486 4.919 -1.712 3.728 4.267
253 Q 5.419 4.677 5.277 5.972 3.329 6.021 6.037 2.302 11.63 1.894 2.145 5.992 18.436 5.601 10.11 6.711 3.791 4.66 2.648
254 A 3.261 8.3 -1.853 3.146 1.112 -1.349 2.939 0.57 -3.101 0.522 2.73 0.112 6.194 1.777 2.122 5.043 1.357 1.408 -5.277
255 P 7.424 0.324 0.854 1.087 0.808 5.77 5.072 4.842 1.574 1.642 2.723 3.077 1.824 2.438 5.965 -1.239 -3.339 3.468 2.801
256 G 3.815 1.414 -0.374 0.105 1.194 3.015 3.736 -0.75 2.696 2.276 -2.474 60.577 0.117 6.339 -2.547 1.249 0.944 4.057 1.496
257 K 2.854 -3.936 -2.525 1.919 -0.468 0.85 -2.636 0.835 -1.428 2.386 -0.774 6.806 0.059 -2.577 -2.852 0.851 4.676 2.959 -5.277
258 G 3.547 6.142 1.171 2.278 -4.448 -3.412 4.353 1.129 8.24 4.613 -2.452 1.156 1.528 -0.914 -3.146 3.798 2.807 0.819 -4.916
259 L 8.861 4.648 8.063 3.229 13.023 10.172 9.846 8.799 7.237 1.324 5.912 5.98 5.226 17.092 3.426 11.374 4.942 7.737 14.51
260 E 0.292 1.809 3.004 -2.206 2.046 -5.023 2.179 7.602 0.524 -0.18 -2.878 12.692 -0.178 2.236 2.55 -1.052 1.719 3.658 0.524
261 W 5.816 9.555 14.917 15.167 5.167 15.994 4.457 13.137 9.308 6.308 5.455 6.242 5.584 11.804 17.467 10.419 11.816 15.077 4.03
262 V 9.252 3.367 3.104 8.32 9.759 2.424 6.524 2.933 11.63 -0.771 2.883 4.681 12.606 -0.97 7.965 3.513 6.654 15.536 19.301
263 A 12.019 2.787 8.735 5.321 -2.756 3.688 7.701 14.94 8.892 10.685 6.956 34.398 6.657 20.636 0.736 15.747 18.012 17.476 6.418
264 T -0.339 1.113 9.711 3.491 7.001 -1.209 2.313 10.354 5.458 6.842 -3.51 1.349 14.26 1.396 7.181 1.31 -0.519 -0.463 5.377
265 I -0.205 -0.464 4.348 3.31 10.458 4.523 11.389 6.032 9.006 7.048 3.695 12.209 2.327 1.684 0.762 8.232 4.818 5.471 13.602
266 S 2.792 5.255 -1.523 -2.146 -1.738 4.168 2.581 2.511 -1.924 0.974 0.067 -1.399 8.415 -1.808 -6.037 4.78 0.079 -0.185 -2.781
267 S -6.374 -0.395 8.805 8.037 4.896 -0.756 5.645 7.02 11.917 8.435 -3.169 1.942 -1.569 4.864 8.786 4.116 -1.18 6.273 9.829
268 G -4.905 3.05 2.579 1.205 5.701 0.887 0.453 -0.262 -3.419 2.286 -0.662 3.807 2.732 -2.123 1.815 -1.121 -0.563 -4.596 -2.166
269 G -0.621 0.833 -3.04 -1.871 3.147 -0.672 4.38 1.194 1.274 -4.856 3.889 0.035 1.064 -0.941 -0.269 2.998 -2.433 3.776 -1.361
270 S 1.648 -1.919 0.802 -6.499 6.972 -2.408 0.297 2.561 0.271 5.108 1.039 -2.054 7.017 2.176 2.896 4.608 1.084 14.025 10.318
271 Y 1.828 1.707 0.207 -0.457 -5.992 -0.192 -2.379 -1.03 2.88 -2.335 5.517 3.429 6.325 -2.952 3.621 1.486 -0.986 3.486 -3.432
272 T 1.248 0.372 6.912 1.688 0.456 1.623 2.266 5.577 0.753 0.029 4.052 -4.062 3.399 4.819 -3.074 -1.086 0.944 1.559 -4.698
273 Y 6.728 8.625 4.253 11.081 3.16 7.471 1.118 2.357 3.721 8.619 2.507 4.701 13.339 6.103 7.828 5.68 1.933 4.797 -2.986
274 Y 8.379 4.393 9.033 6.606 -3.209 6.056 -0.016 5.267 5.422 4.614 1.052 5.87 9.133 2.544 6.873 7.801 4.796 9.567 6.45
275 L 1.424 3.2 3.183 5.241 -0.022 2.834 -8.982 2.513 -0.063 2.193 1.198 9.551 5.108 6.815 2.503 5.854 6.174 2.614 -2.774
276 D -1.939 -0.875 -1.503 -2.925 0.787 1.345 0.155 -0.107 -1.906 -2.664 -4.266 -0.814 -1.221 2.387 -3.246 -4.844 -0.456 -2.018 1.103
277 S -2.368 -2.87 -1.524 5.441 2.824 -1.117 0.871 -0.387 -0.891 -0.39 -0.236 3.562 4.838 -3.245 1.789 3.846 0.797 3.124 5.307
278 V 1.575 -0.637 5.889 3.176 -4.606 7.321 -3.081 1.37 4.223 3.585 -0.884 1.203 10.246 5.469 6.045 3.314 4.408 2.083 -1.109
279 K 4.101 -0.32 0.009 0.193 3.873 1.708 0.963 -1.146 -3.5 3.527 2.56 7.701 0.182 -0.847 -2.987 2.343 -2.248 4.559 -2.743
280 G -1.721 -1.896 2.175 5.296 2.694 3.665 2.614 3.648 4.433 5.94 2.114 53.383 3.7 -0.117 7.008 4.472 4.049 1.178 2.417
281 R 2.821 -3.178 2.86 -0.767 -1.494 -1.315 -1.853 2.958 1.358 -1.704 -4.318 -0.891 2.662 0.73 -1.456 -2.316 0.443 1.926 -1.972
282 F 9.278 6.541 10.948 11.79 7.395 8.845 3.222 7.013 4.739 1.064 5.232 14.977 4.605 8.101 5.774 10.308 3.003 -0.842 4.119
283 T 1.182 2.182 1.737 -1.778 -6.872 0.867 -2.157 -1.312 3.116 2.636 -3.918 1.796 6.316 2.006 6.054 -4.699 -3.751 1.446 0.448
284 I 0.219 7.249 12.406 2.425 -0.134 1.984 6.332 16.058 -0.599 1.262 5.706 1.431 1.975 10.511 4.117 2.66 4.413 14.653 9.808
285 S -0.075 3.257 3.238 -2.392 4.615 2.359 -0.069 0.126 -4.816 1.209 -1.385 -1.569 9.071 -0.023 1.034 0.671 2.807 5.476 -2.71
286 R -5.313 -0.625 2.522 -0.256 -2.598 4.923 0.234 7.095 -0.129 2.46 0.496 0.33 9.83 -4.258 5.443 0.969 5.815 1.474 -2.611
287 D 1.394 2.555 6.992 5.252 4.847 0.134 -1.004 2.821 0.487 1.477 -1.12 21.244 4.184 7.468 1.312 2.044 5.803 5.854 2.914
288 S -2.96 2.071 -1.873 1.653 2.702 3.621 -3.504 1.559 3.798 6.997 -3.432 4.866 -4.355 2.166 2.484 -0.148 4.259 -4.427 -4.62
289 S -3.207 5.959 1.379 2.25 5.223 3.008 1.646 4.108 1.413 6.941 -3.97 -0.643 7.056 4.127 2.826 -2.378 7.353 0.783 -0.557
290 K -2.848 -0.01 -0.884 1.428 0.707 4.537 -2.449 3.429 -0.984 -1.515 1.039 5.514 1.921 -5.973 0.561 -2.455 0.456 6.028 -3.86
291 N 5.894 2.177 8.29 5.062 1.511 7.243 -0.352 2.465 -1.732 0.85 1.157 5.355 0.719 1.321 5.408 4.639 1.337 -4.579 0.655
292 T 3.834 1.238 -1.325 -0.148 -1.093 5.465 -6.567 -4.77 -2.034 -2.934 1.712 1.369 16.355 -3.737 -0.232 6.064 -0.854 -4.087 2.081
293 L -2.094 0.798 4.944 4.052 4.577 4.601 -1.391 5.386 14.382 1.588 2.393 9.624 8.565 17.687 5.401 3.669 2.422 6.415 8.697
294 Y 3.934 4.376 9.553 8.935 -0.062 4.626 1.011 -2.265 2.467 -2.658 4.757 5.354 13.032 2.664 4.073 4.557 3.979 4.804 0.745
295 L 5.336 4.897 12.879 2.49 -2.201 10.45 5.919 12.446 4.519 3.142 1.588 20.988 0.034 12.607 6.39 10.078 13.898 5.428 0.049
296 Q 7.147 -2.953 4.585 0.587 -0.382 2.887 3.127 -1.363 -1.661 3.583 4.186 -0.738 10.324 3.693 2.472 1.172 5.064 5.469 2.004
297 M 2.517 2.774 6.021 1.946 0.031 8.856 4.22 -3.188 0.835 -1.252 1.66 8.059 3.979 5.877 -2.831 -2.154 -3.785 4.024 3.656
298 N 1.57 -2.244 -1.242 2.827 3.182 2.335 -1.376 3.425 2.594 1.543 -4.349 -0.857 1.982 -2.166 -1.381 -0.354 0.374 1.403 -0.309
299 S 5.133 -4.434 4.682 0.396 -5.11 0.599 3.698 -0.28 -0.909 -1.456 0.743 -0.201 8.981 1.301 -0.61 3.886 -3.016 0.092 -5.062
300 L 5.328 1.175 5.848 8.014 7.061 2.527 4.938 5.193 8.118 -1.898 3.039 7.089 8.693 8.646 8.508 9.385 10.388 8.66 4.838
Residue
number &
262 
 
A C D E F G H I K L M N P Q R S T V W Y
301 R -1.96 1.24 1.892 -4.489 1.206 1.018 -4.466 -0.136 -0.224 -6.781 -5.188 -4.395 3.162 -3.425 0.559 -2.693 -2.251 -0.181 -2.595
302 A -2.843 7.113 -0.029 4.153 5.484 1.232 3.393 -0.272 -5.292 -4.157 5.402 1.006 -3.385 1.231 2.566 0.106 -5.339 -0.283 -1.238
303 E 2.271 4.294 3.975 -2.476 -1.8 1.488 1.744 -0.4 4.641 -1.871 -4.563 -1.388 2.234 -3.612 0.186 -2.843 0.441 2.172 4.783
304 D -4.179 3.164 2.451 -2.048 2.78 -3.77 -1.955 1.432 -3.709 -4.022 -0.965 9.094 -2.411 0.639 4.34 0.602 -2.776 0.568 -2.285
305 T 2.631 -4.138 4.724 1.685 -2.717 0.199 1.743 2.853 3.762 0.969 3.681 2.205 9.67 1.18 7.268 3.949 3.984 1.228 -3.41
306 A -0.43 7.966 9.525 13.252 1.84 13.722 11.714 14.561 8.351 5.337 9.168 22.394 8.976 9.961 2.812 7.071 9.071 14.197 14.613
307 V 4.882 1.898 8.867 2.997 -4.036 9.879 5.979 -3.949 4.809 0.447 3.875 7.1 8.572 0.043 5.792 4.157 4.604 0.957 -1.812
308 Y 10.352 10.18 11.532 15.304 -3.136 13.814 6.254 10.359 12.365 12.953 10.247 7.879 9.776 7.834 11.851 9.86 12.003 10.164 -0.707
309 Y 5.82 11.536 10.957 10.398 -3.822 14.271 1.402 6.171 8.462 0.183 2.549 8.445 17.207 6.354 12.349 12.209 9.621 11.545 5.241
310 C -6.426 -0.643 -1.371 -1.839 -5.633 -4.531 -5.58 -6.255 -2.386 -5.426 -6.037 -1.445 -1.133 -5.44 -2.42 -3.202 -6.412 -2.384 -1.147
311 A 4.532 5.316 5.6 -3.228 -1.022 1.496 5.722 4.558 0.76 -1.953 1.271 2.083 0.352 3.249 0.857 3.47 3.219 6.806 -0.584
312 P 0.096 4.195 4.235 8.446 17.043 0.436 9.146 0.652 15.335 3.056 11.285 10.364 4.763 12.039 4.831 -1.164 -0.451 17.843 18.004
313 T -2.614 1.209 4.573 3.573 11.005 -0.019 5.073 -1.905 6.24 -1.275 2.967 -1.894 7.086 4.231 6.952 -4.779 -0.251 4.073 17.993
314 T 0.61 3.413 4.247 2.147 2.563 3.53 -2.005 0.918 4.116 4.725 4.826 3.241 3.635 2.803 0.423 4.669 2.078 2.767 6.828
315 V 2.42 3.044 2.322 3.316 -1.914 0.442 2.413 5.628 5.707 1.433 -0.406 5.733 -0.886 -2.369 -0.664 1.513 0.185 -0.864 -2.004
316 V 2.663 2.163 -4.701 -2.241 0.496 2.335 1.672 6.388 -5.132 -2.758 -1.106 -3.139 11.529 -4.267 -1.243 -0.222 -1.523 -0.204 -6.931
317 P 1.935 5.397 3.624 2.966 7.131 4.686 10.18 8.637 1.289 5.531 4.62 -0.058 3.19 8.947 2.848 7.238 6.254 7.407 12.002
318 F 7.091 7.031 -3.884 5.999 0.124 -0.134 4.777 4.585 -2.25 8.365 5.886 24.275 4.666 2.247 -1.478 7.21 -0.853 7.093 -1.059
319 A -4.637 -2.693 3.995 -6.237 5.481 -5.622 -1.955 0.58 -1.882 -4.484 4.425 16.521 -2.71 5.898 -2.841 2.119 -5.309 3.286 1.986
320 Y 6.572 6.485 7.473 2.902 -0.502 10.224 -0.975 15.812 5.12 6.607 0.159 10.16 3.138 4.597 13.068 6.25 3.446 12.668 7.766
321 W 13.347 13.176 8.905 12.298 8.15 15.297 4.51 4.796 14.68 11.116 7.992 7.901 14.278 8.949 12.988 12.376 9.284 9.319 5.148
322 G 1.863 5.03 12.093 19.756 17.904 21.208 19.518 34.101 22.026 15.728 7.85 8.435 15.371 27.315 5.937 7.039 8.397 25.592 18.766
323 Q 0.121 4.444 4.479 1.414 -2.11 7.283 0.955 1.797 1.353 2.718 2.432 7.032 -4.104 2.351 1.495 4.49 3.773 -4.635 -2.429
324 G 9.756 7.105 14.956 13.506 14.91 18.57 15 11.57 2.349 10.44 13.954 86.35 9.484 12.608 3.016 7.938 16.3 30.193 21.462
325 T 3.709 -1.429 3.801 6.093 13.172 5.19 14.561 -0.724 10.928 3.851 10.716 3.885 5.775 3.493 11.624 3.153 0.445 14.124 12.385
326 L 4.161 1.45 0.897 1.325 -0.955 3.803 2.576 -0.813 3.106 -2.502 0.967 -2.445 -1.609 6.658 4.711 2.824 0.207 0.184 -3.427
327 V 3.674 3.137 5.577 9.037 4.508 1.735 4.174 0.03 5.774 1.501 6.038 0.103 7.255 7.067 4.382 1.258 2.928 10.427 5.243
328 T -0.058 3.126 7.777 -1.925 2.908 3.767 3.111 -1.394 3.12 -3.42 -0.597 -3.43 -2.544 1.059 -1.537 -2.214 -2.855 -0.73 -1.699
329 V -1.83 5.822 1.654 11.546 3.476 5.707 8.868 6.655 14.39 8.777 4.026 4.447 9.646 9.614 15.089 6.47 5.59 4.822 4.929
330 S 0.662 4.964 -0.03 2.677 4.151 4.334 4.341 -0.097 3.985 0.564 0.286 -1.349 16.058 3.392 8.262 8.793 -0.286 7.37 -1.157
331 S 4.15 -4.532 5.684 0.385 0.421 1.34 5.098 0.178 0.12 3.36 -4.713 -0.845 -0.307 -5.073 -3.366 2.105 3.825 1.217 -4.102
332 A 2.439 2.184 2.235 -4.416 1.615 3.727 -0.414 3.647 6.849 -4.162 1.663 4.59 -4.748 2.674 -0.701 -3.149 -3.748 5.085 1.749
333 S -1.905 0.623 0.225 2.275 -3.516 2.78 1.144 1.528 -1.971 -4.023 -0.074 2.004 -6.242 0.683 3.169 0.875 4.599 0.663 -1.092
334 T -2.521 -3.567 2.319 1.701 -1.035 1.102 0.932 -5.486 -0.582 1.997 -1.08 3.891 0.186 3.97 3.121 -0.479 -1.427 1.703 -1.644
335 K -2.663 2.159 1.725 0.427 -4.239 8.479 0.16 -3.216 -0.402 -1.789 -0.712 7.117 2.374 -0.167 2.217 5.451 -5.969 1.874 -4.355
336 G 0.183 -3.716 3.05 -1.363 4.044 -5.007 1.193 0.05 0.753 -0.678 2.619 -2.983 0.996 -2.992 -0.435 0.297 5.104 1.301 2.388
337 P 2.58 4.909 7.961 5.925 26.279 3.329 11.478 3.191 15.922 11.034 12.476 5.917 0.876 25.267 6.734 11.008 3.46 20.316 14.067
338 S 2.092 -0.739 2.503 -3.27 -1.546 5.084 -5.578 3.835 5.197 -1.683 -3.412 -0.407 3.766 -5.995 -1.035 -2.591 1.122 2.214 -6.68
339 V 2.816 7.492 7.52 13.752 21.513 4.249 11.217 1.33 20.842 4.979 9.098 8.579 5.353 13.572 15.043 4.605 -2.307 38.267 18.352
340 F 5.084 8.157 10.945 1.669 2.367 -1.665 6.222 5.307 3.311 5.197 5.12 7.118 9.523 12.49 6.065 3.979 3.767 0.581 0.549
341 P 6.366 7.842 7.968 10.992 9.694 1.638 4.517 5.252 7.738 0.587 3.583 2.022 1.727 4.812 5.754 5.631 5.875 3.909 6.534
342 L 4.397 8.339 4.684 6.831 3.836 7.868 8.163 1.573 8.16 1.843 2.915 22.971 4.74 11.477 11.608 7.33 2.835 9.066 7.469
343 A 5.183 1.059 -0.489 -0.06 -0.183 -3.511 3.299 0.098 -2.142 -2.747 1.57 2.037 -0.876 -1.73 -1.301 2.858 4.897 1.757 1.065
344 P 9.748 6.451 12.866 7.361 13.013 8.121 1.881 1.931 10.198 9.13 0.923 3.211 7.509 10.82 7.474 4.67 5.94 0.909 -2.924
345 S 3.483 7.298 2.499 -2.371 -2.552 0.418 -2.643 2.077 -3.533 1.815 -6.213 0.687 -6.888 3.358 1.221 1.948 -4.713 -2.337 -1.288
346 S 0.408 7.892 4.569 1.632 5.84 5.846 0.528 0.547 0.907 4.962 -1.716 1.393 7.702 4.124 -2.177 6.964 -2.276 1.173 0.345
347 K -2.443 -0.693 1.864 0.277 -3.455 3.909 -2.429 -1.971 0.1 1.105 4.555 3.708 -2.983 3.532 5.335 -0.06 4.544 -3.053 -0.493
348 S -2.429 -3.984 1.496 -1.544 0.178 4.888 -1.044 -3.43 2.482 2.679 -5.256 -0.655 -3.98 -3.864 -0.774 1.195 -1.841 1.578 -5.998
349 T -0.135 1.106 0.122 0.075 -2.524 6.212 2.809 -6.086 -0.935 2.076 5.017 2.555 2.366 0.354 4.76 -2.07 -0.706 -8.032 -2.581
350 S -0.461 -1.79 3.483 1.607 2.923 -4.32 4.248 0.878 -0.286 0.914 1.478 -0.09 -0.747 -1.06 0.486 0.603 -0.529 -2.42 -3.073
351 G 3.403 4.66 -0.075 2.362 5.962 2.439 5.52 2.02 4.478 -1.256 -1.879 65.807 3.305 4.568 3.865 4.43 6.28 4.863 4.164
352 G -2.159 -0.114 4.228 3.271 0.886 2.255 13.723 0.174 2.919 -0.009 3.465 6.802 0.991 0.79 8.136 -1.651 6.626 6.755 3.181
353 T -2.55 -1.537 7.594 -0.872 -1.169 -2.573 -2.759 2.631 0.001 -3.165 0.943 0.613 -1.482 -3.789 3.538 2.702 0.375 -2.628 -0.654
354 A -0.346 -0.972 -1.749 -1.367 -2.472 -2.838 3.976 0.935 -0.251 -0.728 1.58 10.867 -1.932 0.944 -0.357 -1.76 1.954 -0.514 -2.217
355 A 3.146 2.576 8.244 5.792 4.634 5.637 9.376 9.358 6.002 5.424 -0.643 3.427 5.854 18.196 3.56 -0.015 0.434 13.222 10.229
356 L 2.702 3.944 7.844 2.322 1.824 11.134 6.645 2.627 3.928 2.943 2.176 8.442 4.852 11.346 2.199 0.505 6.077 11.723 6.564
357 G 3.587 10.458 22.68 21.316 11.794 19.176 21.146 28.696 18.318 13.724 16.762 22.313 17.372 23.798 12.433 15.537 21.871 23.938 18.775
358 C -5.42 1.917 -5.832 -0.544 0.705 0.151 -1.802 1.471 3.576 -3.029 -0.519 1.433 0.158 -0.136 -1.126 -3.247 0.887 3.235 -0.523
359 L 9.35 5.985 4.067 8.24 -4.055 5.433 1.376 2.708 10.748 -2.208 0.569 21.972 1.122 3.116 6.774 7.488 3.793 5.529 -5.456
360 V 1.304 3.004 5.657 10.898 10.655 6.958 8.747 6.149 12.941 2.299 8.707 8.827 5.557 0.837 23.706 3.944 4.715 18.298 15.203
361 K -2.665 -0.982 7.673 -0.485 -0.768 5.274 1.047 2.017 0.298 3.959 7.506 7.168 -0.487 7.782 2.462 6.32 4.45 1.777 -2.467
362 D 5.501 4.575 5.978 2.034 -1.593 -1.702 6.819 -0.311 4.78 2.171 -2.608 53.251 4.147 4.596 4.167 2.713 6.78 -2.366 1.321
363 Y 11.473 11.802 10.156 11.947 2.592 10.195 3.113 14.06 9.806 7.892 12.63 10.042 19.497 6.618 8.835 12.394 10.114 8.844 2.768
364 F 3.604 9.497 7.356 10.642 12.813 4.791 7.773 7.944 3.548 1.972 2.205 19.538 7.133 13.737 4.256 10.38 12.362 2.096 1.909
365 P 1.886 3.106 4.568 6.835 -1.258 4.921 6.917 4.584 7.348 9.986 -1.443 6.354 8.37 6.325 2.042 3.616 0.737 3.581 5.268
366 E -1.391 0.261 -0.962 0.859 3.573 -1.503 8.044 3.744 6.005 -0.368 3.124 -4.443 0.184 3.849 3.217 1.842 3.171 1.59 -4.45
367 P 1.663 4.745 0.3 -3.412 1.397 -1.419 -0.44 -2.652 2.054 -1.027 -1.231 2.918 -3.981 3.817 -3.334 -5.954 2.887 0.034 -4.914
368 V -1.863 6.874 7.076 13.048 16.302 1.019 10.075 3.664 23.024 6.459 10.415 3.161 7.13 6.644 33.335 2.847 -2.592 31.794 22.655
369 T 3.754 1.538 -0.173 2.401 -1.215 1.101 -2.186 -1.173 -5.339 -1.81 2.056 2.355 2.787 1.916 3.904 0.872 -5.955 -1.787 0.773
370 V 2.461 6.513 12.215 7.172 3.708 7.699 4.027 8.361 14.453 9.508 4.979 5.664 3.811 4.563 22.613 6.971 -0.118 20.389 0.468
371 S 1.399 -0.518 5.319 1.966 -3.803 0.708 4.86 -0.191 0.177 -0.193 -2.18 0.855 2.482 -0.249 -0.646 -3.129 2.129 -3.644 2.441
372 W 5.451 11.083 9.911 13.045 5.763 8.7 4.057 8.148 12.441 13.527 7.814 12.037 12.712 13.839 14.745 11.61 12.265 11.692 9.247
373 N -0.675 4.916 8.233 3.915 2.412 3.042 4.074 2.143 6.862 -3.085 -2.548 25.136 1.724 6.73 5.692 0.538 0.796 9.066 14.167
374 S 0.878 -1.342 1.987 -3.216 -5.083 -2.38 -6.931 4.156 -1.606 5.776 -0.257 2.466 26.197 0.274 3.652 -2.792 0.805 -4.061 3.043
375 G 4.057 3.637 4.326 1.177 -0.853 5.393 5.401 3.275 1.505 4.541 -2.86 63.958 4.158 3.739 4.48 9.292 5.675 3.93 2.187
376 A -2.407 -2.87 1.924 1.373 4.239 5.146 1.977 0.517 -2.057 1.576 3.688 2.904 1.472 1.089 -2.306 -2.672 2.766 -5.091 1.97
377 L 6.995 11.985 7.32 1.915 1.473 5.814 3.907 -1.937 4.214 1.285 3.465 17.366 1.595 4.238 5.118 0.468 -0.043 4.066 7.568
378 T 3.594 -2.301 2.905 0.734 0.268 -1.552 -0.083 -3.41 -1.838 -4.416 4.098 1.166 5.067 -1.897 4.605 2.032 -0.89 1.971 -0.749
379 S 3.205 -3.836 4.091 -0.56 -2.808 2.774 3.784 -0.088 3.554 3.274 1.894 -1.897 9.127 3.951 -0.624 5.317 -0.516 -0.687 2.19
380 G 1.614 5.254 1.42 -1.461 -1.349 4.069 6.219 6.355 -1.436 -4.28 0.108 54.732 1.681 5.902 0.256 1.471 6.409 1.492 1.074
381 V 0.095 4.311 5.552 3.825 6.153 4.403 -3.253 -1.539 4.614 7.692 3.945 9.154 11.473 0.943 3.538 -0.05 2.559 -1.342 10.854
382 H 6.165 2.621 4.073 4.181 -2.192 5.612 -1.278 1.867 3.004 1.325 2.344 10.999 -3.355 -0.026 3.679 1.676 3.907 -1.737 -4.035
383 T -0.166 -2.189 3.138 0.309 1.527 2.676 1.636 -4.719 0.593 -1.398 -0.755 -1.071 1.343 1.601 2.985 1.622 -1.172 -1.977 -2.529
384 F 6.679 10.951 12.758 9.18 6.56 -0.943 8.394 9.04 11.793 6.881 6.732 13.864 5.014 11.248 3.95 6.308 8.881 5.809 0.875
385 P 0.9 4.194 6.627 5.079 5.068 5.412 -4.212 2.896 3.583 -0.38 7.014 0.058 -0.424 3.896 1.145 -0.771 -2.461 1.88 0.612
386 A 1.911 4.958 5.026 0.98 0.385 -0.689 11.001 9.884 9.748 0.063 -2.407 -4.958 -3.511 0.905 0.743 3.767 0.957 2.283 2.522
387 V -0.077 1.242 0.022 9.032 -5.333 2.019 4.379 -3.673 -1.632 0.39 3.86 1.914 5.839 1.959 0.159 1.286 1.725 -1.315 -3.58
388 L 2.131 -0.555 0.204 0.421 -0.601 4.003 3.398 1.082 3.049 -2.24 6.312 1.482 1.192 6.573 6.308 2.818 0.133 -3.53 4.281
389 Q 4.736 0.982 0.762 -1.07 2.373 -3.713 0.168 3.133 6.405 -5.542 0.791 8.171 14.203 6.361 -1.342 -1.613 4.318 2.095 2.168
390 S -2.061 -3.973 0.45 5.154 3.856 -1.455 1.303 4.053 -0.274 0.485 0.051 3.246 0.042 3.743 5.908 -1.632 5.425 -0.063 3.061
391 S 0.376 -0.114 1.352 0.371 5.187 -0.08 -0.951 0.32 -2.151 1.106 -0.674 -1.103 2.555 1.958 -0.306 -0.383 -0.723 5.775 -2.684
392 G 2.986 6.008 4.881 1.981 2.47 5.684 7.197 1.493 3.536 0.647 -1.752 86.001 0.119 0.811 5.935 8.132 1.483 -0.378 2.403
393 L 0.599 -0.829 3.988 0.139 5.048 8.361 1.209 7.099 2.515 2.487 2.788 4.893 2.413 4.378 8.283 2.188 -0.461 0.109 5.457
394 Y 4.44 9.947 11.664 10.644 3.209 14.085 8.489 10.477 6.936 2.848 5.415 8.003 20.25 4.376 10.228 8.716 9.323 9.802 0.791
395 S -5.316 -3.273 -2.134 1.62 -3.145 5.678 1.957 2.935 4.42 -2.735 0.354 0.04 16.812 -4.267 -1.603 0.81 -3.773 -0.175 1.773
396 L 1.297 2.537 11.575 0.811 -3.068 3.713 5.97 -0.676 1.474 -1.426 -0.113 13.997 3.808 1.917 0.99 7.197 1.457 4.616 1.573
397 S 0.184 -0.791 0.874 1.528 0.207 2.955 2.927 -6.497 3.483 -1.371 -2.243 1.787 2.464 -1.04 -1.286 -1.269 0.359 -7.216 4.134
398 S 4.139 0.365 1.048 9.851 5.994 0.033 14.62 -3.157 7.556 8.221 9.384 -4.784 13.753 0.403 11.686 -0.44 4.868 14.261 14.302
399 V 1.736 3.263 13.016 2.359 5.469 -1.639 3.974 -4.982 14.465 -2.899 -1.411 0.89 6.46 7.412 18.663 1.851 0.679 11.657 4.361
400 V 0.419 4.578 10.764 4.423 8.052 5.995 4.138 0.219 3.081 4.352 1.767 5.837 8.548 2.028 6.794 0.632 -1.006 10.244 9.468
Residue
number &
263 
 
 
 
A C D E F G H I K L M N P Q R S T V W Y
401 T 1.542 -0.762 5.505 0.865 -1.251 -2.055 1.806 -0.874 -6.369 2.898 -0.325 0.797 5.82 0.417 -2.159 -2.841 0.082 -6.34 0.96
402 V -0.104 6.59 6.449 0.136 5.557 4.974 0.637 -1.725 5.036 0.452 3.517 8.733 2.196 5.887 -1.578 6.718 -0.578 7.884 4.983
403 P 0.387 0.623 2.845 6.157 2.199 2.909 -5.861 2.352 2.465 -2.01 3.283 -0.819 1.055 3.648 -1.357 -1.116 3.336 6.215 -1.779
404 S -0.506 2.623 11.042 10.522 1.354 0.805 7.991 -2.656 3.235 0.577 2.114 6.901 10.015 2.137 8.627 5.682 7.659 7.589 5.107
405 S -0.267 1.154 -0.862 1.225 0.377 1.761 -1.858 -0.05 -0.301 -0.284 -2.772 0.367 4.173 -4.852 0.698 -1.401 2.974 1.851 2.699
406 S 6.106 -2.109 5.23 1.411 -3.292 1.997 2.286 3.908 -1.374 3.339 4.063 -3.577 7.435 -3.429 1.559 4.301 -0.431 1.227 2.282
407 L 8.847 6.939 10.46 9.583 2.07 4.385 3.537 4.319 4.497 0.635 -0.095 8.797 2.417 4.909 1.592 4.026 2.106 5.305 10.114
408 G -0.809 5.609 0.945 0.398 -3.397 -5.381 4.104 -4.179 -2.614 -3.04 -3.835 4.637 -0.289 -1.567 3.061 0.677 -3.663 1.646 -3.44
409 T -3.235 -2.478 1.061 0.96 -1.6 2.912 1.268 0.248 -0.913 -5.064 3.749 4.434 4.627 -1.387 -0.279 -0.687 -1.663 -3.055 -1.041
410 Q -3.643 1.001 2.518 7.743 0.414 3.178 3.655 -0.57 -0.032 -2.807 1.098 -2.365 13.214 5.639 1.07 -0.749 4.473 0.623 0.045
411 T 0.505 -1.895 0.861 2.849 -2.456 4.051 3.364 2.347 3.578 -4.003 4.563 2.059 -0.137 1.368 5.257 2.865 3.584 5.136 -1.087
412 Y 7.405 11.336 15.775 8.269 -0.946 5.521 3.363 1.373 8.233 0.491 8.924 10.445 11.947 10.782 11.602 5.824 10.189 6.715 2.755
413 I 1.978 6.719 3.614 2.456 -0.263 2.329 1.163 5.078 3.557 4.772 4.386 7.798 1.464 0.841 6.234 2.241 0.279 3.182 6.118
414 C 0.372 0.845 -1.382 -4.565 1.662 -0.497 6.331 -3.386 -2.66 2.971 1.214 2.953 0.946 -4.587 -3.672 -3.143 0.414 -1.506 -1.017
415 N -0.226 1.919 -3.1 -6.435 -2.755 -0.761 -1.971 -3.446 -3.671 0.642 -4.847 2.815 -5.925 7.304 -1.37 1.559 -2.546 -1.803 -7.173
416 V 2.709 3.345 5.661 13.272 16.157 9.367 8.84 1.392 14.141 8.793 8.43 8.227 9.614 3.375 24.482 4.896 3.869 11.213 14.279
417 N 6.536 0.823 -0.873 -3.627 1.01 0.746 -5.281 2.709 3.537 0.608 2.084 5.354 -2.197 2.179 1.876 -2.108 -4.793 -2.941 -4.772
418 H 12.037 9.4 13.09 8.018 3.043 10.385 9.753 8.601 1.024 6.397 11.635 15.75 9.745 13.291 11.248 13.564 9.33 11.258 10.45
419 K -0.749 4.379 1.961 2.762 -4.333 1.584 -3.536 3.675 1.445 -1.352 -0.109 5.16 -2.864 5.502 -1.386 2.8 -0.589 -2.252 -0.051
420 P -1.672 0.825 5.829 4.097 -0.146 3.207 5.014 1.176 2.365 8.681 2.297 1.983 -0.562 2.598 9.692 2.109 3.791 2.653 1.868
421 S 2.052 2.139 4.419 7.932 12.421 5.834 8.611 4.107 4.12 2.688 0.666 6.24 13.446 4.749 5.769 0.182 0.367 4.654 14.047
422 N 3.968 0.274 -1.538 1.862 -0.438 -1.745 -0.696 6.312 4.812 -2.326 4.73 52.194 3.564 0.713 3.932 -2.168 7.447 1.634 -3.047
423 T 2.116 2.014 7.725 5.033 4.278 4.136 0.725 0.886 -3.819 1.455 0.907 3.201 17.44 1.776 2.169 2.217 3.144 -1.28 0.694
424 K -0.914 -2.712 -5.057 1.813 -2.83 -2.069 -2.2 -1.255 -2.443 -5.24 -0.172 0.059 -1.661 -1.397 2.015 -0.201 -2.895 -3.527 -0.361
425 V 0.331 2.2 -0.511 -0.602 -2.687 6.654 6.268 1.401 3.696 -2.142 1.996 5.114 4.654 0.921 -1.758 -1.844 0.133 4.253 3.18
426 D -1.042 0.879 0.247 -3.885 -3.169 -0.184 1.043 -5.573 -3.332 -6.253 -7.402 0.876 -5.439 -2.326 -4.452 -6.664 -0.971 -3.695 -3.301
427 K 7.47 4.543 9.181 4.039 7.146 7.094 2.349 2.109 0.341 -0.51 -0.708 9.97 3.389 -3.586 -1.423 1.157 -3.589 0.238 2.084
428 K 0.827 0.94 7.348 1.894 -2.073 2.791 -1.054 4.606 4.333 2.132 1.742 -5.795 -0.719 1.447 -1.295 1.818 -1.31 -4.337 -2.76
429 V 4.894 9.44 12.986 14.507 20.067 3.89 12.27 4.473 19.453 10.238 9.542 4.472 3.423 4.9 19.017 7.419 0.793 39.057 24.498
430 E 0.515 2.423 -0.494 -5.275 -2.385 -0.32 -3.533 1.203 -3.471 2.774 3.933 2.521 -0.324 0.16 0.494 0.969 -4.263 -3.623 -6.213
431 P 3.711 2.116 1.753 7.11 6.144 7.747 4.894 6.337 -1.114 2.478 -2.701 5.56 6.442 6.377 5.582 0.81 5.649 -1.282 1.864
432 K -6.012 -0.517 0.834 2.638 -2.114 -2.292 -1.247 -2.167 -0.975 -5.598 0.5 5.533 -1.204 -0.807 2.289 -0.688 -3.125 -1.995 -1.096
433 S -3.607 -1.351 4.562 -2.604 2.349 4.451 0.871 -2.655 5.355 -4.214 0.161 0.097 4.278 0.224 -4.636 1.684 2.058 -1.191 -4.956
434 C 1.025 -0.421 0.506 -0.049 2.352 -1.051 -1.278 1.548 2.438 2.128 -2.286 -3.409 -0.417 0.615 3.837 1.582 5.584 1.91 1.025
435 D 0.975 2.269 1.889 -4.332 -2.314 -3.273 4.303 1.15 2.847 -1.953 -0.729 -6.658 -3.014 -2.669 0.322 -2.818 -3.39 1.419 -0.642
436 K 1.317 0.68 5.31 2.438 2.228 -3.576 -0.5 -0.257 -4.638 0.162 3.375 6.277 1.757 -0.928 -1.54 -3.831 0.667 -1.046 -1.214
437 T -0.897 3.659 0.702 2.182 0.848 2.77 6.494 4.589 -1.073 6.186 2.598 3.879 3.242 4.901 -1.561 -3.336 0.985 6.294 6.223
438 H -1.848 4.172 3.511 -1.676 -2.13 7.626 -0.287 -0.976 5.46 -1.056 1.99 0.769 -1.087 2.75 -2.998 -0.798 3.979 0.505 -1.119
439 T 1.531 -3.449 -1.738 -0.732 1.915 1.347 -2.76 4.773 -1.336 -0.365 0.346 3.078 2.657 -2.654 -4.31 -0.121 -3.815 -0.98 4.696
440 S 4.636 -4.364 -2.279 3.519 0.495 -2.046 2.986 3.555 -1.784 -0.833 -3.376 5.218 8.741 0.358 2.697 -0.663 6.009 -0.521 -1.045
441 A 3.746 -1.631 -4.42 0.703 3.923 -1.46 1.497 -0.786 -1.378 -0.709 2.074 14.309 2.58 5.542 1.589 -4.446 10.207 -1.902 4.989
442 A 3.296 4.79 1.074 -0.629 2.381 -3.535 1.792 0.287 1.81 -1.9 -3.324 1.512 0.186 2.373 5.212 0.193 3.159 4.68 1.336
Residue
number &
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10.4 The ΔΔG of all the stabilising mutants and their relation 
with CDR regions, RMSF and Depth 
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Figure 10.2 The ΔΔG of all the stabilising mutants and their relation with CDR regions, RMSF and 
Depth.   
Red to yellow gradient was used to indicate the stabilising extent from most stable to least stable.  
Cells without any values indicated destabilising effect.  The magnitudes of RMSF (Figure 4.3) and 
depth (Figure 4.11) were displayed by corresponding length of the colour bars.   
10.5 The sequence alignment for C226S from human Fab 
PDB 
Table 10.1 The sequence alignment for heavy chain 
PDB 
ID 
Sequence of heavy chain 
C226
S 
EVQLVESGGGLVQPGGSLRLSCAASGFAFSTYD-MSWVRQAPGKGLEWVATISS
--GGSYTYYLDSVKGRFTISRDSSKNTLYLQMNSLRAEDTAVYYCAPTTVVPF------
-----AYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTV
SWNSGALT--SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTK
VDKKVEPKSCDKTHTSAA 
1A6T EVQLQQSGPDLVKPGASVKISCKASGYSFSTYY-MHWVKQSHGKSLEWIGRVD--
-DNGGTSFNQKFKGKAILTVDKSSSTAYMEL---TSEDSAVYYCARRDD-----------
YYFDFWGQGTSLTVSSAKTTPPSVYPLAPVCGGTTGSSVTLGCLVKGYFPEPVT
LTWNSGSLS--SGVHTFPAVLQS-GLYTLSSSVTVTSSTWPSQTITCNVAHPASST
KVDKKIEPR---------- 
1B2W -VQLVQSGGGVVQPGRSLKLSCLASGYIFTSSW-INWVKQRPGRGLEWIGRIDP--
SDGEVHYNQDFKDRFTISRDKSKNTLYLQMNSLRPEDTAVYYCARG-----------FL
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PWFADWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVT
VSWNSGALT--SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNT
KVDKKVEPKSC-------- 
1C5D EVKLLESGPGLVQPSQTLSLTCTVSGFPLTTNG-VSWVRQPPGKGLEWIAAISS---
GGSPYYNSALKSRLSINRDTSKSQVFLKMNSLQTEDTAIYFCTREDGWNY---------
-FDYWGPGTMVTVSSAQTTAPSVYPLAPGCGDTTSSTVTLGCLVKGYFPEPVTV
TWNSGALS--SDVHTFPAVLQS-GLYTLTSSVT--SSTWPSQTVTCNVAHPASSTKV
DKKLER----------- 
1DFB EVQLVESGGGLVQPGRSLRLSCAASGFTFNDYA-MHWVRQAPGKGLEWVSGIS
W--DSSSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDMALYYCVKGRDYYDS
G--GYFTVAFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDY
FPEPVTVSWNSGALT--SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVN
HKPSNTKVDKKVEPKSC-------- 
1DN0 EVQLQQWGAGLLKPSETLSLTCAVYGGSFSDYY-WSWIRQPPGKGLEWIGEINH-
--SGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARPPHDTSG------
-HYWNYWGQGTLVTVSSGSASAPTLFPLVSCT-----SSVAVGCLAQDFLPDSITFS
WKYKNNSDISSTRGFPSVLRG-GKYAATSQVLLPSKDVTDEHVVCKVQHPNGNK
EKNVPLPV----------- 
1DQD EVQLQESGPSLVKPSQTLSLTCSVTGDSITSGY-WNWIRKFPGNKLEYMGYISY---
SGSTYYNPSLKSRLSITRDTSRNQYYLQLKSVTPEDTATYYCASPPGYYGSGP----
-YAMDYWGQGTSVTVSSAKTTPPSVYPLAPGS-AQTNSMVTLGCLVKGYFPEPV
TVTWNSGSLS--SGVHTFPAVLQS-DLYTLSSSVTVPSSTWPSETVTCNVAHPASS
TKVDKKISPG---------- 
1FGN EIQLQQSGAELVRPGALVKLSCKASGFNIKDYY-MHWVKQRPEQGLEWIGLIDP—
ENGNTIYDPKFQGKASITADTSSNTAYLQLSSLTSEDTAVYYCARDNS-----------YY
FDYWGQGTTLTVSSAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVT
WNSGSLS--SGVHTFPAVLQS-DLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKV
DKKI------------- 
1IT9 QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYW-MQWVKQAPGQGLEWMGEI
DP--SDSYTNYNQKFKGKATLTVDTSTSTAYMELSSLRSEDTAVYYCARNRD-------
YSNNWYFDVWGEGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFP
EPVTVSWNSGALT--SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHK
PSNTKVDKKV------------- 
1L7I EVQLVESGGGLVQPGGSLRLSCAASGFTFTDYT-MDWVRQAPGKGLEWVADVN
---NSGGSIYNQRFKGRFTLSVDRSKNTLYLQM---RAEDTAVYYCARNLGPSF-------
----DYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTV
SWNSGALT--SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTK
VDKKVEPKSC-------- 
1OPG EVQLVQSGGGLVNPGRSLKLSCAASGFTFSSYG-MSWVRQTPEKRLEWVAAISG
--GGTYIHYPDSVKGRFTISRDNAKNNLYLQMSSLRSEDTALYYCTRHPFYRYDG
G---NYYAMDHWGQGTSVTVSAAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGY
FPEPVTVTWNSGSLS--SGVHTFPAVLQS-DLYTLSSSVTVPSSPRPSETVTCNVA
HPASSTKVDKKIVPRDC-------- 
1T3F -VQLVQSGAELKKPGSSVKVSCKASGYIFTSSW-INWVKQAPGQGLEWIGRIDP—
SDGEVHYNQDFKDKATLTVDKSTNTAYMELSSLRSEDTAVYYCARG---------FLP--
WFADWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTV
SWNSGALT--SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTK
VDKKVEPKSC-------- 
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2Z4Q QVQLQQSGSEMARPGASVKLPCKASGDTFTSYW-MHWVKQRHGHGPEWIGNIY
P--GSGGTNYAEKFKNKVTLTVDRSSRTVYMHLSRLTSEDSAVYYCTRSGGP------
----YFFDYWGQGTSLTVSSAKTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEP
VTLTWNSGSLS--SGVHTFPAVLQS-DLYTLSSSVTVTSSTWPSQSITCNVAHPAS
STKVDKKIEPR---------- 
2ZKH EVKLEESGGGLVQPGGSMKLSCAASGFTFSDAW-MDWVRQSPEKGLEWVAEIR
SKVNNHAIHYAESVKGRFTVSRDDSKSSVYLQMNSLRAEDTGIYYCSGWSFL-----
---------YWGQGTLVTVSAAKTTPPSVYPLAP-------SMVTLGCLVKGYFPEPVTVTW
NSGSLS--SGVHTFPAVLQS-DLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVD
KKIVPR---------- 
3D69 GVQLVESGGGVVQPGRSLRLSCAASGFTFSTYA-MHWVRQAPGKGLEWVAIIS--
-DGSKKYYADSVKGRFTISRDNSKNTLYLQM---RAEDTAVYYCARASIAAA----------
-DYWGRGTMVTVSSASTKGPSVFPLAPS------GTAALGCLVKDYFPEPVTVSWNS
GALT--SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKK
VEPKSCD------- 
3G6A QVQLVESGGGLVQPGGSLRLSCAASGFTFNSYW-INWVRQAPGKGLEWVSGIA
Y--DSSNTLYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGLGAFHW
D--MQP----DYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYF
PEPVTVSWNSGALT--SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNH
KPSNTKVDKKVEP----------- 
3HC0 QVQLVQSGAEVKKPGSSVKVSCKASGYTFTTYY-LHWVRQAPGQGLEWMGWIY
P--GNVHAQYNEKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARS------------
WEGFPYWGQGTTVTVSSASTKGPSVFPLAPSS----GGTAALGCLVKDYFPEPVT
VSWNSGALT--SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNT
KVDKKVEPK---------- 
3HI5 -VQLLESGGGLVQPGGSLRLSCAASGFTFSRYV-MWWVRQAPGKGLEWVSYIW
P--SGGNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASSYDFWSN
A--F------DIWGQGTMVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPE
PVTVSWNSGALT--SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHK
PSNTKVDKRVES----------- 
3VG0 EVKLLESGPGLVAPSESLSITCTISGFSLTDDG-VSWIRQPPGKGLEWLGVIWG---
GGSTYFNSLFKSRLSITRDNSKSQVFLEMDSLQTDDTAMYYCAKHDGHET---------
-MDYWGQGTSVTVSSSKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTV
TWNSGSLS--SGVHTFPAVLQS-DLYTLSSSVTVPSSTWPSETVTCNVAHPASSTK
VDKKIVPRDC-------- 
4GSD -VQLQESGPGLVKPSGTVSLTCAVSGGSISSSYWWSWVRQPPGKGLEWIGEIYH
---SGNTNYNPSLKSRVTISVDKSKNLFSLKLSSVTAADTAVYYCARVALFDILTGG
W-----FDPWGQGTLVTVSSAGTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEP
VTVSWNSGALT--SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPS
NTKVDKRVEP----------- 
4HBC -QSVEESGGRLVTPGTPLTLACTVSGFSLNTYS-MFWVRQAPGKGLQWIGIISN---
FGVIYYATWAKGRFTIS--KTSTTVDLKITSPTTEDTATYFCVRKYGSEWG---------G
DLWGPGTLVTVSSGQPKAPSVFPLAPCCGDT--PTVTLGCLVKGYLPEPVTVTWN
SGTLT--NGVRTFPSVRQSSGLYSLSSVVSVTSP------VTCNVAHPATNTKVDKTV
APSTC-------- 
4HH9 QVQLVESGGGVVQPGRSLRLSCAASGFTFSNHG-MHWVRQAPGKRLEWVAVIS
---DGRHEHYADLVKGRFTISRDNSKNTLYLQM---RAEDRALYFCAREGLSRD------
-----DYWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVT
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VSWNSGALT--SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNT
KVDKKVEPKSCD------- 
4HIE LINLVESGGGVVQPGRSLRLSCAASGFTFSRYG-MHWVRQAPGKGLEWVAVVS-
--DGRTTYYADSVKGRFTISRDNSKNTLYLQM---RAEDTAVFYCAKE---GGDN--K--
----DYWGQGTLVTVSSASTKGPSVFPLA------SESTAALGCLVKDYFPEPVTVSWN
SGALT--SGVHTFPAVLQSSGLYSLSSVVTVP------QTYTCNVDHKPSNTKVDKTV-
------------ 
4LKX QVQLQESGPGLVKPSETLSLTCTVSGYSITSDYAW-WIRQPPGKGLEWIGSISY---
SGITGYNPSLKSRVTISRDTSKNQFSLKL---TAADTAVYYCARMG-YDGLAY---------
-WGQGTLVTVSSASTKGPSVFPLAPS-----GGTAALGCLVKDYFPEPVTVSWNSG
ALT--SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKA
EPKS--------- 
4OCY DVQLQESGPGLVKPSQSLSLTCTVTGFSITSPYAWNWIRQFPGNTLEWMGYISY-
--RGSTTYHPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYFCSS-YGNYG----------
-AYSGQGTLVTVSAAKTTPPSVYPLAPG------SMVTLGCLVKGYFPEPVTVTWNS
GSLS--SGVHTFPAVLQS-DLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKI
VPR---------- 
4OSU QVQLVQSGAEVRKPGASVKVSCKASGYSLKDHY-MVWVRQAPGQGLEWMGWI
NP--QSGGTGYGQKFQGRVTMTRDTSTNTAYMILSSLRSDDTAVYFCARDGAKT
VSNSLLYYHNRLDAWGQGTMVTVSSASTKGPSVFPLAPS------GTAALGCLVKDY
FPEPVTVSWNSGALT--SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVN
HKPSNTKVDKKVEPK---------- 
7FAB AVQLEQSGPGLVRPSQTLSLTCTVSGTSFDDYY-WTWVRQPPGRGLEWIGYVFY
---TGTTLLDPSLRGRVTMLVNTSKNQFSLRLSSVTAADTAVYYCARNLIAGG--------
--IDVWGQGSLVTVSSASTKGPSVFPLAP--------TAALGCLVKDYFPEPVTVSWNS
GALT--SGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKK
VEP----------- 
 
Table 10.2 The sequence alignment for light chain 
PDB 
ID 
Sequence of light chain 
C226
S 
DIQMTQSPSSLSASVGDRVTITCKAS-QNVR-----TVVAWYQQKPGKAPKTLIYLAS
NRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYFCLQHWSYP--LTFGQGTKVEI
KRTV-AAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQ
ESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC- 
1A6T QSVLSQSPAILSASPGEKVIMTCSPS-SSVS------YMQWYQQKPGSSPKPWIYSTS
NLASGVPGRFSGGGSGTSFSLTISGVEAEDAATYYCQQYSSHP--LTFGGGTKLEL
KRAD-AAPTVSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLN
SWTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR---- 
1B2
W 
DIQMTQSPSTLSASVGDRVTITCKAS-ENVD-----TYVSWYQQKPGKAPKLLIYGAS
NRYTGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCGQSYNYP--FTFGQGTKVEV
KRTV-AAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQ
ESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC- 
1C5D DIQMTQSPPSLSASLGDKVTITCQAS-QDINK-----YIAWYQQKPGKAPRQLIRYTSIL
VLGTPSRFSGSGSGRDFSFSISNVASEDIASYYCLQYGN-L--YTFGAGTKLEIKRA
D-AAPTVSIFPPSTEQLATGGASVVCLMNNFYPRDISVKWKIDGTERRDGVLDSVT
DQDSKDSTYSMSSTLSLTKADYESHNLYTCEVVHKTSSSPVVKSFNRNEC- 
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1DF
B 
DIQMTQSPSTLSASVGDRVTITCRAS-QSIS-----RWLAWYQQKPGKVPKLLIYKASS
LESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQ-YNSY--S-FGPGTKVDIKR
TV-AAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQES
VTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC- 
1DN0 EIVLTQSPATLSLSPGERATLSCGAS-QSVSS----NYLAWYQQKPGQAPRLLIYDAS
SRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSP--LTFGGGTKVEIK
RTV-AAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQE
SVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC- 
1DQ
D 
DIVLSQSPAIMSASPGEKVTITCSAS-SSVS------YMHWFQQKPGTSPKLCIYTTSNL
ASGVPARFSGSGSGTSYSLTISRMEAEDAATYYCQQRSTYP--PTFGSGTKLEIKR
AD-AAPTVSIFPPSSEQLTSGGASVVCFLNNFYPRDINVKWKIDGSERQNGVLNS
WTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNECA 
1FG
N 
DIKMTQSPSSMYASLGERVTITCKAS-QDIRK-----YLNWYQQKPWKSPKTLIYYATS
LADGVPSRFSGSGSGQDYSLTISSLESDDTATYYCLQHGESP--YTFGGGTKLEIN
RAD-AAPTVSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNS
WTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC- 
1IT9 EIVLTQSPGTLSLSPGERATLSCKAS-QSVDYDGD-SYMNWYQQKPGQAPRLLIYA
ASNLESGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQSNEDP--RTFGQGTKL
EIKRTV-AAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNS
QESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFN----- 
1L7I DIQMTQSPSSLSASVGDRVTITCKAS-QDVS-----IGVAWYQQKPGKAPKLLIYSASY
RYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYIYP--YTFGQGTKVEIKR
TV-AAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQES
VTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC- 
1OP
G 
DELLTQSPATLSVTPGDSVSLSCRAS-QSISNN-----LHWYQQKSHESPRLLIKYAS
QSISGIPSRFSGSGSGTDFTLSINSVETEDFGMYFCQQSNSWP--LTFGGGSKLEIK
RAD-AAPTVSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNS
WTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC- 
1T3F DIQMTQSPSTLSASVGDRVTITCKAS-ENVD-----TYVSWYQQKPGKAPKLLIYGAS
NRYTGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCGQSYNYP--FTFGQGTKVEV
KRTV-AAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQ
ESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC- 
2Z4Q DILMTQTPLSLPVSLGDQASISCRSS-QNIVHNNGITYLEWYLQRPGQSPKLLIYKV
SDRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGIYYCFQGSHIP--PTFGGGTKLEI
KRAD-AAPTVSIFPPSSEQLTSGGASVVCFLNNFYPRDINVKWKIDGSERQNGVLN
SWTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC- 
2ZK
H 
QVVLTQSPGIMSASPGEKVTITCSAS-SSVS------YMYWFQQKPGTSPKLWIYSTS
NLASGVPARFRGSGSGTSYSLTISRMEAEDAATYYCQQRSGYP--RTFGGGTKLEI
KRAD-AAPTVSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLN
SWTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR---- 
3D69 --VLTQ-PPSVSAAPGQKVTISCSG--STIGNNY----VSWYQQHPGKAPKLMIYDVSK
RPSGVPDRFSGSKSGNSASLDISGLQSEDEADYYCAAWDDSLF--LFGTGTKLTVL
GQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVET
TTPSKQS-NNKYAASSYLSLTPEQWKSHKSYSCQVTHEG--STVEKTVAPT--- 
3G6
A 
SYELTQ-PPSVSVAPGQTARISCSG--DNIGGTF----VSWYQQKPGQAPVLVIYDDN
DRPSGIPERFSGSNSGNTATLTISGTQAEDEADYYCGTWDMVTN-NVFGGGTKLT
VLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGV
ETTTPSKQS-NNKYAASSYLSLTPEQWKSHRSYSCQVTHEG--STVEKTVAPT--- 
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3HC0 DIQMTQSPSSLSASVGDRVTITCKAS-QNVG-----INVAWYQQKPGKAPKSLISSAS
YRYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYFCQQYDTYP--FTFGQGTKVEI
KRTV-AAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQ
ESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG--- 
3HI5 DIQMTQSPSSLSASVGDRVTITCRAS-QSIG-----SYLNWYQQKTGKAPKALIYAASS
LQSGVPSRFSGSGSGTDFTLTISSLQLEDFATYYCQQSYSTP--S-FGQGTKVEIKR
TV-AAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQES
VTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG--- 
3VG0 EIVMTQSPKFMSTSIGDRVNITCKAT-QNVRT-----AVTWYQQKPGQSPQALIFLAS
NRHTGVPARFTGSGSGTDFTLTINNVKSEDLADYFCLQHWNYP--LTFGSGTKLEI
KRAD-AAPTVSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLN
SWTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNE-- 
4GS
D 
---LTQ-PPSVSVSPGQTVNITCSG--DTLGDKY----VCWYQQKPGQSPVLVIYQDTK
RPSGIPERFSGSNSGDTATLTVSGTQAMDEADYYCQAWDSSS--FVFGTGTKVTV
LRQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVE
TTKPSKQS-NNKYAASSYLSLTPEQWKSHRSYSCQVTHEG--STVEKTVAPTE-- 
4HB
C 
DVVMTQTPASVSEPVGGTVTIKCQAS-QSISS-----YLAWYQQKPGQRPRLLIYETS
TLASGVPSRFKGSGSGTDFTLTISDLECADAATYYCQSTYENPTYVSFGGGTEVG
VKGDP-VAPTVLIFPPSADLVATGTVTIVCVANKYFP-DVTVTWEVDGTTQTTGIEN
SKTPQNSADCTYNLSSTLTLTSTEYNSHKEYTCKVTQG--TTSVVQSFNRGDC- 
4HH9 EVVLTQSPATLSLSPGERATISCRAS-QSVG-----GYLTWYQQKPGQAPRLLIYDAS
NRATGIPARFSGSGSGTDFTLTISGLEPEDFAIYYCQQRGNWP--ITFGQGTRLEIK
RTV-AAPSVFIFPPSDEQLK-GTASVVCLLNNFYPREAKVQWKVDNALQSGNSQE
SVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC- 
4HIE -GQLTQSPATLSLSPGERATLSCRAS-QSVT-----NYLAWYQQKPGQAPRLLIYGAS
NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRDNWP--ATFGQGTKVEI
KRTV-AAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQ
ESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLRSPVTKSFNR---- 
4LKX DIVMTQTPLSLSVTPGQPASISCRSS-QNGN-----TYLEWYLQKPGQSPQLLIYKVS
NRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVP--PTFGGGTKVEI
KRTV-AAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQ
ESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC- 
4OC
Y 
DVLLTQIPLSLPVSLGDQASISCRSS-QSIVHSNGNTYLEWYLQKPGQSPKLLIYKV
STRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVP--LTFGAGTQLE
LKRAD-AAPTVSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVL
NSWTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR---- 
4OS
U 
QSVLTQ-PPSVSAAPGQMVTISCSGSSSNIGKNY----VSWYQQLPGAAPKLLIFDN
NKRPSGTPDRFSGSKSGTSATLVITGLQTGDEADYYCGTPDRSLS-VIFGGGTKVT
VLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGV
ETTTPSKQS-NNKYAASSYLSLTPEQWKSHRSYSCQVTHEG--STVEKTVAPT--- 
7FA
B 
ASVLTQ-PPSVSGAPGQRVTISCTGSSSNIGAGHN---VKWYQQLPGTAPKLLIFHN
N-------ARFSVSKSGTSATLAITGLQAEDEADYYCQSYDRSLR--VFGGGTKLTVLR
QPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETT
TPSKQS-NNKYAASSYLSLTPEQWKSHKSYSCQVTHEG--STVEKTVAP---- 
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10.6 The correlation between ΔTm, ΔΔG 
 
 
Figure 10.3 The correlation between ΔTm and ΔΔG without destabilising mutants  
This is a supplementary information for Figure 5.9.  ΔTm was calculated against C226S (Figure 5.6) 
and ΔΔG is calculated by Rosetta (Figure 5.8).  Error bar is SEM (standard error of the mean).  
Pseudo wild type C226S and stabilising mutants were coloured in yellow and green, respectively. 
 
 
Figure 10.4 The correlation between normalised monomer loss in freeze-drying and ΔΔG without 
destabilising mutants  
This is a supplementary information for Figure 5.10.  Normalised monomer loss in freeze-drying 
was from Figure 5.3 and ΔΔG calculated by Rosetta was from Figure 5.8.  Error bar is SEM (standard 
error of the mean).  Pseudo wild-type C226S and stabilising mutants were coloured in yellow and 
green, respectively. 
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10.7  GROMACS code 
10.7.1 Code for “job.sh” file 
#!/bin/bash -l 
#$ -S /bin/bash 
#$ -l h_rt=0:30:0 
#$ -l mem=4G 
#$ -l tmpfs=15G 
#$ -N MD 
#$ -pe openmpi 32 
#$ -cwd  
 
module unload compilers 
module unload mpi 
module unload mkl 
module load compilers/intel/13.0/028_cxx11 
module load mpi/openmpi/1.6.5/intel.13.0-028_cxx11 
module load atlas/3.10.1/intel.13.0-028_cxx11 
module load fftw/3.3.4/double/intel.13.0-028_cxx11 
module load gromacs/5.0/openmpi/intel.13.0-028_cxx11 
 
gerun convert-tpr -s md_0_1.tpr -o md_0_1.tpr 
gerun mdrun_mpi -deffnm md_0_1 -cpi md_0_1.cpt -maxh 0.5 -append 
